data_5jdp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jdp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.62 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.515 ' C ' HD21 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 3' ' ' VAL . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.535 ' HG1' ' H ' ' A' ' 9' ' ' ASP . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.625 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.535 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CD1' ' OG ' ' A' ' 260' ' ' SER . 16.1 m-85 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.535 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 55' ' ' THR . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.462 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.535 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 71' ' ' PHE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' OG ' ' A' ' 101' ' ' SER . 41.5 m-85 . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.515 HD21 ' C ' ' A' ' 4' ' ' PRO . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.504 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.588 ' C ' HE22 ' A' ' 154' ' ' GLN . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.625 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.588 HE22 ' C ' ' A' ' 139' ' ' ARG . 61.0 tp60 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.568 ' ND2' ' HH ' ' A' ' 7' ' ' TYR . 3.1 t-20 -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 168' ' ' ASN . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.427 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 24' ' ' PHE . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.619 ' H ' ' CE1' ' A' ' 273' ' ' HIS . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . . . . . . 0 N--CA 1.425 -2.1 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 271' ' ' GLY . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.526 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HZ2' ' HG1' ' A' ' 42' ' ' THR . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.506 ' HG1' ' HZ2' ' A' ' 32' ' ' LYS . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 57' ' ' SER . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.1 t-20 -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 44' ' ' SER . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.58 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.492 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 102' ' ' SER . 68.4 mttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.561 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.448 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 159' ' ' THR . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.561 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.488 ' CG1' ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.448 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.56 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 16.8 t-20 -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.628 ' H ' ' C ' ' A' ' 176' ' ' ASP . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.428 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.593 HD21 ' HH ' ' A' ' 7' ' ' TYR . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.413 ' O ' ' OD1' ' A' ' 168' ' ' ASN . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.54 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.504 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.625 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.625 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.439 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 217' ' ' THR . 0.0 OUTLIER -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m . . . . . 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 120.164 -0.242 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.449 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 115' ' ' LYS . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 89.3 t80 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 57' ' ' SER . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 44' ' ' SER . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.445 ' C ' ' CD1' ' A' ' 75' ' ' TRP . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 79' ' ' ASN . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 6' ' ' THR . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.558 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.503 ' O ' ' OG1' ' A' ' 159' ' ' THR . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.521 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 124' ' ' ASN . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.658 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.521 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.488 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.488 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.427 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.427 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.578 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.466 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.466 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 1.02 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.521 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 240' ' ' SER . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 1.02 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 72.6 p . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.51 ' HG ' ' H ' ' A' ' 276' ' ' GLY . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 CA-C-O 120.279 -0.178 . . . . 0.0 113.236 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.51 ' H ' ' HG ' ' A' ' 260' ' ' SER . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.276 0.56 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.409 ' CA ' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' CD1' ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.531 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 79' ' ' ASN . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.572 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 121' ' ' GLU . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.429 HD21 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 159' ' ' THR . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.511 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.429 ' HB ' HD21 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.689 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.644 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 154' ' ' GLN . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.479 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.426 ' CE1' ' CD1' ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.2 mp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.416 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m . . . . . 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.992 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.504 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.992 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.314 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.475 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' THR . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.665 HD21 ' HG1' ' A' ' 51' ' ' THR . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.665 ' HG1' HD21 ' A' ' 48' ' ' ASN . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 78' ' ' ASP . 39.4 m-20 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 85' ' ' ILE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' A' ' 5' ' ' PRO . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 114' ' ' ILE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.481 ' O ' ' OG1' ' A' ' 159' ' ' THR . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.579 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.504 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 67.5 tp60 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.627 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.404 ' CB ' ' CE2' ' A' ' 210' ' ' TRP . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.619 ' CD1' ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.619 ' H ' ' CD1' ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.415 ' C ' HD21 ' A' ' 207' ' ' ASN . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.41 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.652 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 10' ' ' LEU . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.659 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.538 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.532 ' HG ' ' H ' ' A' ' 55' ' ' THR . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.532 ' H ' ' HG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.538 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 95' ' ' LEU . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.744 ' NZ ' ' HG1' ' A' ' 98' ' ' THR . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.744 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.135 0.017 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.464 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 159' ' ' THR . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.659 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.497 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.431 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.768 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.768 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.431 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.611 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.611 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.232 0.539 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 86.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.529 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 1.6 m-80 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.473 ' O ' ' OG ' ' A' ' 46' ' ' SER . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 79' ' ' ASN . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.504 HD21 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 159' ' ' THR . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.587 ' NH1' HD22 ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.504 ' CG1' HD21 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.461 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.587 HD22 ' NH1' ' A' ' 139' ' ' ARG . 38.8 t-20 -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.529 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 56.1 m-20 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.589 ' H ' ' C ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.488 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.402 ' N ' ' CD2' ' A' ' 190' ' ' PHE . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 10.4 tp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.266 0.555 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.558 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.553 HD22 ' CD1' ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.695 0 CA-C-O 120.846 0.355 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' HZ2' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.571 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.405 ' CD1' ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.501 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 87.0 t80 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' OG ' ' A' ' 46' ' ' SER . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.515 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 69' ' ' LEU . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 77' ' ' THR . 3.3 m120 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 122.151 0.977 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.571 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HZ2' ' N ' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.548 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.486 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.498 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.656 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 157' ' ' PHE . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.407 ' O ' ' OG ' ' A' ' 193' ' ' SER . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' HIS . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 178' ' ' PHE . 7.1 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.491 ' OG1' ' NE2' ' A' ' 196' ' ' GLN . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.6 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 112.388 -0.285 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.566 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.72 0 CA-C-O 121.145 0.497 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.613 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' C ' HD22 ' A' ' 124' ' ' ASN . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.506 ' HG ' ' HH ' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.481 ' CG1' ' HZ3' ' A' ' 236' ' ' LYS . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.536 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 30' ' ' ASP . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.536 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.595 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.595 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 77' ' ' THR . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 . . . . . 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.535 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.633 HD21 ' CG2' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 159' ' ' THR . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.475 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.633 ' CG2' HD21 ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.453 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 1.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.479 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.479 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 177' ' ' GLU . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.558 ' CZ ' ' OG1' ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.506 ' HH ' ' HG ' ' A' ' 13' ' ' SER . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.452 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 56.9 tp . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.452 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.481 ' HZ3' ' CG1' ' A' ' 17' ' ' VAL . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.628 HD22 ' CD1' ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.628 ' CD1' HD22 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.631 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.434 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' ' OG1' ' A' ' 49' ' ' THR . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.506 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 57' ' ' SER . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 44' ' ' SER . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.506 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' GLY . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.643 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.643 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 67' ' ' TYR . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 53.5 m-20 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.587 ' HZ3' ' HZ1' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.391 0.139 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HZ1' ' HZ3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.569 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.491 ' O ' ' OG1' ' A' ' 159' ' ' THR . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.7 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.43 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 45.1 tp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.561 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.624 HD22 ' CD1' ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.624 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.537 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.411 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.476 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.529 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.446 ' OG ' ' OG1' ' A' ' 55' ' ' THR . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 50' ' ' GLU . 61.1 t-20 -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.62 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.505 ' OG1' ' ND2' ' A' ' 48' ' ' ASN . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 46' ' ' SER . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 93' ' ' ARG . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.441 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.482 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.554 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.577 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.495 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 21.0 tp60 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.577 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.425 ' C ' ' ND2' ' A' ' 168' ' ' ASN . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.425 ' ND2' ' C ' ' A' ' 167' ' ' SER . 4.9 m120 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.484 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.484 ' CD2' ' OG1' ' A' ' 175' ' ' THR . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.421 ' C ' ' OD1' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m . . . . . 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 221' ' ' ILE . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 255' ' ' ILE . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.47 ' H ' HG13 ' A' ' 27' ' ' ILE . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 282' ' ' GLN . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' THR . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.688 ' HH ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.499 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.448 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 86.5 t80 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 37' ' ' ASN . 8.3 m120 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' THR . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.474 ' HG1' ' H ' ' A' ' 53' ' ' LYS . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' H ' ' HG1' ' A' ' 51' ' ' THR . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.579 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 79' ' ' ASN . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.454 ' NH1' HD22 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.5 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.511 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.454 HD22 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.546 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CD1' ' NE2' ' A' ' 196' ' ' GLN . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.688 HD21 ' HH ' ' A' ' 7' ' ' TYR . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.602 ' CD1' ' NE1' ' A' ' 210' ' ' TRP . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.499 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.107 0.48 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 196' ' ' GLN . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.448 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.9 m-20 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m . . . . . 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.4 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.631 HD22 ' CD1' ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.631 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.584 ' HG ' ' CA ' ' A' ' 276' ' ' GLY . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.213 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . 0.532 ' CD2' ' O ' ' A' ' 272' ' ' GLY . 33.6 m170 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.584 ' CA ' ' HG ' ' A' ' 260' ' ' SER . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.495 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 60.5 t80 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 57' ' ' SER . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 55' ' ' THR . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' O ' ' OG1' ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' ASN . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 66' ' ' GLU . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 123' ' ' ILE . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 159' ' ' THR . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.579 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.719 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.537 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.537 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 166' ' ' GLN . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.684 ' H ' ' HG1' ' A' ' 165' ' ' THR . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 68.4 m-20 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.773 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.773 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.503 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 183' ' ' ASN . 0.3 OUTLIER -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.406 ' O ' ' OD1' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.419 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.597 HD22 ' CD1' ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.487 ' C ' ' HG ' ' A' ' 241' ' ' SER . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.487 ' HG ' ' C ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.597 ' CD1' HD22 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.589 ' CA ' HD22 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 5' ' ' PRO . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 4.0 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.531 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' C ' HD21 ' A' ' 111' ' ' ASN . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 110' ' ' LYS . 1.5 m120 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.606 ' CG ' HD21 ' A' ' 124' ' ' ASN . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.568 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.606 HD21 ' CG ' ' A' ' 119' ' ' LYS . 4.1 m120 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.688 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.512 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 67.8 tp60 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.688 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.437 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.457 ' CD2' ' N ' ' A' ' 179' ' ' GLN . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.616 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m . . . . . 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 228' ' ' ASP 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.429 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.592 HD22 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.592 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.699 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.403 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 120.282 -0.177 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.412 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' C ' HD22 ' A' ' 124' ' ' ASN . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 5' ' ' PRO . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.458 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.3 t80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' ' OG ' ' A' ' 57' ' ' SER . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' O ' ' OG1' ' A' ' 49' ' ' THR . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.401 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HZ3' HD22 ' A' ' 76' ' ' ASN . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.419 HD22 ' HZ3' ' A' ' 74' ' ' LYS . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.467 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 159' ' ' THR . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.495 ' CG2' HD21 ' A' ' 124' ' ' ASN . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.432 ' C ' HD21 ' A' ' 156' ' ' ASN . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.637 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.539 HD22 ' ND2' ' A' ' 183' ' ' ASN . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.495 ' CD2' ' OG1' ' A' ' 175' ' ' THR . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.465 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.539 ' ND2' HD22 ' A' ' 168' ' ' ASN . 12.2 p-10 -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.596 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.474 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.474 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.458 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 98.0 m-20 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.444 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.499 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.498 HD22 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.46 ' ND2' ' C ' ' A' ' 239' ' ' ASN . 0.0 OUTLIER -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.498 ' CG ' HD22 ' A' ' 238' ' ' ASN . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 120.05 -0.306 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.446 ' OD2' ' OG ' ' A' ' 241' ' ' SER . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.598 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.511 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.451 ' CA ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 207' ' ' ASN . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' THR . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.53 HD21 ' HG1' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HG1' HD21 ' A' ' 48' ' ' ASN . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.519 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.448 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.483 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.631 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.658 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.479 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.527 HD21 ' HH ' ' A' ' 7' ' ' TYR . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 185' ' ' ASN . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.609 ' CE1' ' CZ2' ' A' ' 210' ' ' TRP . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.706 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.706 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.831 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.831 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.451 ' CA ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 207' ' ' ASN . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.519 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' THR . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.53 HD21 ' HG1' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HG1' HD21 ' A' ' 48' ' ' ASN . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.519 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.448 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.483 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.631 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.658 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.479 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.527 HD21 ' HH ' ' A' ' 7' ' ' TYR . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 185' ' ' ASN . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.609 ' CE1' ' CZ2' ' A' ' 210' ' ' TRP . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.706 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.706 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.831 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.831 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.654 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.415 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 . . . . . 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CG ' ' OG ' ' A' ' 260' ' ' SER . 10.8 m-85 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' ' H ' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.541 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 55' ' ' THR . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.541 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.587 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 77' ' ' THR . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.495 ' CD ' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 102' ' ' SER . 98.1 mttt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.654 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.467 ' O ' ' OG1' ' A' ' 159' ' ' THR . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.554 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 50.7 m-20 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.664 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.664 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 33.8 m170 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.564 ' ND2' ' HH ' ' A' ' 7' ' ' TYR . 43.3 t30 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.554 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.642 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 54.7 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.642 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.466 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.704 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.704 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 250' ' ' THR . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.594 ' HG ' ' N ' ' A' ' 276' ' ' GLY . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.594 ' N ' ' HG ' ' A' ' 260' ' ' SER . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.434 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.574 ' C ' ' HZ3' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.724 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 10' ' ' LEU . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.626 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 79' ' ' ASN . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.702 ' NZ ' ' HG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.702 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.724 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.558 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.476 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.701 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.65 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.499 ' CG2' ' ND2' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.449 ' CD1' ' HE2' ' A' ' 181' ' ' HIS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.701 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 7.9 mm-40 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 150' ' ' LEU . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.597 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 78.2 p . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.435 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 CA-C-O 120.152 -0.249 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-O 120.947 0.404 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.556 ' N ' ' HG ' ' A' ' 260' ' ' SER . 45.9 m-85 . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' NZ ' ' OG ' ' A' ' 44' ' ' SER . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.662 ' NZ ' ' HZ3' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' NZ ' ' A' ' 28' ' ' LYS . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' H ' ' HG1' ' A' ' 51' ' ' THR . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.5 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' CE ' ' HG1' ' A' ' 72' ' ' THR . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.442 ' HG1' ' CE ' ' A' ' 61' ' ' LYS . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.635 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.441 ' C ' ' CD1' ' A' ' 75' ' ' TRP . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.635 ' ND2' ' NZ ' ' A' ' 74' ' ' LYS . 88.5 m-20 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 122.416 1.103 . . . . 0.0 113.787 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' ARG . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.471 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.694 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.697 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.413 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.479 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.0 tp . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.475 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' TYR . . . . . 0.478 ' C ' ' SG ' ' A' ' 232' ' ' CYS . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.458 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.577 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.565 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 85.5 m . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.662 ' HZ3' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . -61.26 -35.71 78.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.62 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.515 ' C ' HD21 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 3' ' ' VAL . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.535 ' HG1' ' H ' ' A' ' 9' ' ' ASP . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.625 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.535 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 -63.66 -44.29 94.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.506 ' HG1' ' H ' ' A' ' 20' ' ' LYS . 60.5 p -61.47 -50.74 71.55 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' H ' ' HG1' ' A' ' 19' ' ' THR . 75.5 mmtt -53.1 139.07 29.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.12 -122.39 25.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CE2' ' CZ ' ' A' ' 18' ' ' PHE . 84.7 t80 56.09 102.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.98 0.39 . . . . 0.0 110.441 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 97.86 1.07 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' CD1' ' OG ' ' A' ' 260' ' ' SER . 16.1 m-85 -113.41 -138.84 0.38 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.535 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 55' ' ' THR . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.462 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.535 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.416 ' CD2' ' N ' ' A' ' 71' ' ' PHE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.567 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 62.01 40.2 12.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.518 HE22 ' CB ' ' A' ' 97' ' ' LEU . 45.9 mt-30 -69.72 -39.14 77.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.286 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.4 tp -89.26 -67.11 0.86 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.086 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 176.64 -41.31 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.893 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -76.76 -80.17 0.1 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.518 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.43 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CE1' ' OG ' ' A' ' 101' ' ' SER . 41.5 m-85 -109.36 106.58 16.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.66 32.23 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 107' ' ' THR . 83.5 Cg_exo -39.36 -49.65 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 124.094 3.196 . . . . 0.0 114.709 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 95.3 m-20 -36.44 93.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' PRO . 43.6 p 34.13 45.84 0.13 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.79 48.14 86.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' ASN . 88.7 tttt -65.22 114.06 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.515 HD21 ' C ' ' A' ' 4' ' ' PRO . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.504 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.588 ' C ' HE22 ' A' ' 154' ' ' GLN . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.625 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.588 HE22 ' C ' ' A' ' 139' ' ' ARG . 61.0 tp60 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.568 ' ND2' ' HH ' ' A' ' 7' ' ' TYR . 3.1 t-20 -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.401 ' O ' ' OD1' ' A' ' 168' ' ' ASN . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.524 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt -85.86 98.53 10.82 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.73 -41.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.321 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.8 t30 -168.72 -169.61 1.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.523 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 98.8 mttt -62.3 -42.08 99.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.829 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -97.62 -5.67 34.97 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.57 110.47 17.97 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -129.63 115.43 17.37 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 211' ' ' THR . . . -41.93 100.41 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.681 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 211' ' ' THR . . . 173.88 -158.68 27.78 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -99.39 10.02 42.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.0 p -78.24 166.23 22.97 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.427 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m -98.72 118.64 35.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 119.254 -0.403 . . . . 0.0 111.537 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.97 -54.43 11.17 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 88.5 Cg_exo -38.69 -15.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.508 2.139 . . . . 0.0 112.681 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 94.95 33.69 6.53 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.541 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.466 ' OG ' ' CD1' ' A' ' 24' ' ' PHE . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.735 ' O ' ' N ' ' A' ' 268' ' ' VAL . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.41 -20.3 10.51 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.497 ' C ' HD21 ' A' ' 267' ' ' ASN . 84.3 mttt -95.06 -12.26 26.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 271' ' ' GLY . 0.7 OUTLIER -137.97 27.62 2.66 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.283 177.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.735 ' N ' ' O ' ' A' ' 264' ' ' ASP . 4.8 t -65.05 -26.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 CA-C-N 120.159 1.345 . . . . 0.0 107.616 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -93.61 -4.06 51.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.449 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 267' ' ' ASN . . . -106.29 -35.24 7.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . 110.92 -122.33 6.14 Favored Glycine 0 C--N 1.366 2.213 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.622 ' CE1' ' O ' ' A' ' 271' ' ' GLY . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.526 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 47.52 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.443 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.723 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.33 139.84 52.1 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.2 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 -68.55 -46.94 68.15 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 54.5 p -68.73 -45.82 70.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.79 -44.02 63.28 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.816 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' TYR . . . -77.28 -133.14 0.59 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 23' ' ' GLY . 8.6 t80 147.41 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.221 0.608 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' N ' ' CD2' ' A' ' 22' ' ' TYR . . . -166.92 173.34 42.22 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -118.75 -175.74 2.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.461 ' O ' ' OG1' ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' HZ2' ' HG1' ' A' ' 42' ' ' THR . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.506 ' HG1' ' HZ2' ' A' ' 32' ' ' LYS . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.523 ' HG ' ' N ' ' A' ' 57' ' ' SER . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.1 t-20 -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.523 ' N ' ' HG ' ' A' ' 44' ' ' SER . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.58 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.58 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 75' ' ' TRP . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.41 53.71 9.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -60.28 -10.12 4.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 27.6 tp -148.96 40.32 0.88 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.369 1.08 . . . . 0.0 109.232 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 73.16 -0.24 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.734 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 -139.71 167.11 22.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.492 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -106.46 85.42 2.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -107.12 160.56 25.97 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.788 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 104' ' ' SER . 80.7 Cg_exo -37.9 -129.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.53 3.487 . . . . 0.0 114.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.67 -41.83 92.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.555 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.405 ' O ' ' OG ' ' A' ' 104' ' ' SER . 7.7 p -89.22 166.58 13.71 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 38.61 54.54 2.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -51.77 -112.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.561 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.448 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.545 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.485 ' O ' ' OG1' ' A' ' 159' ' ' THR . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.561 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.65 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.499 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.488 ' CG1' ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.448 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.676 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.56 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 16.8 t-20 -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.441 ' CB ' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.628 ' H ' ' C ' ' A' ' 176' ' ' ASP . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.464 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.428 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.593 HD21 ' HH ' ' A' ' 7' ' ' TYR . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.413 ' O ' ' OD1' ' A' ' 168' ' ' ASN . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.54 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt -101.05 100.34 10.92 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.47 -43.55 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.24 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.5 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.9 t30 -165.82 -170.29 1.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.5 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 88.8 tttt -61.21 -41.12 96.29 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.708 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -97.05 -8.53 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt -117.97 106.32 12.82 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.578 ' CH2' ' O ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m -144.16 105.84 4.3 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.578 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 43.98 -156.65 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.85 52.95 0.16 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.495 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.508 ' O ' ' CE3' ' A' ' 210' ' ' TRP . 83.9 m-20 -128.4 132.37 48.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.4 m -81.7 -3.64 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.49 110.8 20.01 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.727 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.625 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.625 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.439 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 217' ' ' THR . 0.0 OUTLIER -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m 91.69 -104.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 252' ' ' LYS . 20.4 mt 71.01 -151.77 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.971 0.415 . . . . 0.0 110.24 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.635 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 59.88 145.77 0.06 OUTLIER Pre-proline 0 N--CA 1.445 -0.709 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 252' ' ' LYS . 74.2 Cg_exo -39.04 85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.306 1.338 . . . . 0.0 111.227 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -178.63 -113.48 0.37 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.852 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.5 93.64 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.7 mttt -84.38 -7.69 59.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.572 1.686 . . . . 0.0 109.566 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 -24.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 266' ' ' LYS . 69.1 t -74.76 -37.17 42.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 118.471 0.578 . . . . 0.0 109.877 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -63.51 -44.4 94.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.56 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -84.93 -35.65 21.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.226 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.02 -9.65 2.84 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.57 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.449 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 73.13 113.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -82.2 147.06 29.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.826 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.66 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.16 139.9 57.48 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.529 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.534 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 115' ' ' LYS . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 89.3 t80 -61.68 -48.67 79.76 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p 68.4 166.49 0.25 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 120.992 0.425 . . . . 0.0 112.095 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -65.86 -43.21 89.09 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 22' ' ' TYR . . . -172.43 -56.88 0.04 OUTLIER Glycine 0 CA--C 1.542 1.761 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' GLY . 58.6 t80 56.22 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.492 1.146 . . . . 0.0 110.512 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 72.18 -115.34 5.39 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.003 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 48.3 m-85 17.8 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.508 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 57' ' ' SER . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' N ' ' HG ' ' A' ' 44' ' ' SER . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.445 ' C ' ' CD1' ' A' ' 75' ' ' TRP . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 79' ' ' ASN . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 73.38 46.22 0.23 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -90.21 -38.85 13.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.421 ' H ' ' HB3' ' A' ' 95' ' ' LEU . 48.7 tp -83.57 -70.56 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 175.95 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.927 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -82.49 -63.92 1.28 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.421 ' HB3' ' H ' ' A' ' 91' ' ' LEU . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.63 90.36 3.33 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.0 160.86 54.37 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.518 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' SER . 94.3 Cg_exo -37.5 175.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.76 2.973 . . . . 0.0 113.505 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -48.3 -31.03 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.234 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.7 m -62.16 -45.01 95.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.788 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.33 -172.11 43.01 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.04 -165.42 1.79 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 6' ' ' THR . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.558 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.503 ' O ' ' OG1' ' A' ' 159' ' ' THR . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.521 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.532 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.413 HG23 HD21 ' A' ' 124' ' ' ASN . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.658 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.592 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.521 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.488 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.488 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.427 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.427 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.578 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.466 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.58 93.1 4.94 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.477 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 67.6 t -74.33 -46.74 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.158 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 84.2 m-20 -160.13 -174.45 4.55 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.85 -39.56 89.59 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.962 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.96 -8.92 38.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp -126.88 107.25 9.93 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.466 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m -137.75 112.54 8.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 188' ' ' THR . . . -43.59 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.082 0.467 . . . . 0.0 109.91 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.74 -153.41 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -101.15 11.62 39.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.668 0.734 . . . . 0.0 109.939 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.518 ' O ' ' CZ3' ' A' ' 210' ' ' TRP . 18.6 p -81.97 165.32 20.81 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.384 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -89.75 -177.61 5.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 1.02 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.521 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 240' ' ' SER . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 1.02 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 72.6 p -96.52 130.59 43.66 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 255' ' ' ILE . 2.0 mm? -110.47 127.02 54.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.692 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.93 -54.25 11.42 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 89.5 Cg_exo -40.33 -19.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.169 1.912 . . . . 0.0 112.982 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 101.35 32.88 5.05 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.52 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.51 ' HG ' ' H ' ' A' ' 276' ' ' GLY . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -17.9 -83.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.17 2.08 54.72 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.787 1.794 . . . . 0.0 111.073 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.449 ' ND2' ' CE1' ' A' ' 273' ' ' HIS . 31.2 m120 63.7 -3.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.308 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.75 -40.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.901 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.22 -45.04 89.98 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.748 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.24 -35.75 19.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.581 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 81.73 1.42 90.19 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.236 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.449 ' CE1' ' ND2' ' A' ' 267' ' ' ASN . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.51 ' H ' ' HG ' ' A' ' 260' ' ' SER . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.85 146.48 35.87 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.429 ' O ' ' OXT' ' A' ' 285' ' ' SER . 95.8 mtt-85 -101.99 136.71 41.36 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.429 ' OXT' ' O ' ' A' ' 284' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.47 142.5 50.2 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.592 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' CA ' ' OD1' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' CD1' ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' LYS . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 -62.66 -43.14 99.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.5 p -105.55 4.12 30.06 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 16' ' ' ASP . 61.4 tttp -52.37 -44.33 65.22 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.759 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 107.13 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 96.9 m-85 -62.54 -45.85 91.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 24' ' ' PHE . . . 67.04 -128.2 28.3 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 10.6 m-85 36.77 107.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.531 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 79' ' ' ASN . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 91' ' ' LEU . 86.6 m-20 60.7 60.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.502 ' O ' ' CB ' ' A' ' 91' ' ' LEU . 83.0 mt-30 -61.64 26.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.615 -0.834 . . . . 0.0 113.224 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.62 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 88.68 -13.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.64 -139.37 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.833 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -84.25 -65.52 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.42 104.08 11.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -125.83 161.02 53.61 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 104' ' ' SER . 77.0 Cg_exo -39.16 174.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.833 3.022 . . . . 0.0 112.995 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -46.35 -20.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.458 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.9 p -67.05 -33.82 76.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.063 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -145.27 97.5 0.19 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.5 mttt -54.96 -153.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.572 ' C ' ' ND1' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 121' ' ' GLU . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.429 HD21 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 159' ' ' THR . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.644 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.676 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB2' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.511 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.429 ' HB ' HD21 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.689 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.506 ' N ' ' CD1' ' A' ' 150' ' ' LEU . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.644 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 154' ' ' GLN . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.479 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.426 ' CE1' ' CD1' ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.04 98.48 11.79 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 83.7 t -74.36 -42.58 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 201' ' ' LYS . 9.8 p30 -168.52 -167.32 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.38 -41.35 98.57 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.146 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 98.7 mttt -96.92 -10.97 25.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.403 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 9.2 mp -115.62 113.8 24.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.416 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m -145.7 106.57 4.13 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 188' ' ' THR . . . -43.36 115.23 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.999 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 121.65 -25.96 6.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -106.35 141.32 37.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.1 p -88.74 -7.27 56.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -104.64 138.69 40.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.176 0.898 . . . . 0.0 112.962 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.992 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.504 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.992 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m -85.84 86.74 7.35 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 252' ' ' LYS . 55.7 tp -79.4 101.72 8.3 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.261 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 62.11 126.88 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.49 -11.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.113 1.209 . . . . 0.0 112.606 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -90.66 -43.57 4.8 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.763 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 251' ' ' LEU . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.36 98.31 Favored Glycine 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.4 mttp -83.45 -8.62 59.34 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 118.803 1.302 . . . . 0.0 109.803 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 55.67 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.9 t -77.14 -37.21 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.862 0.755 . . . . 0.0 110.634 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.57 -45.04 92.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.014 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.25 -35.71 19.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.788 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.8 -6.97 0.76 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.462 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.449 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.09 33.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.7 138.43 48.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.626 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.732 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.42 140.54 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.95 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 19' ' ' THR . 87.6 t80 -62.83 -46.92 85.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 ' C ' ' O ' ' A' ' 18' ' ' PHE . 73.8 m 2.02 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -146.16 -1.53 0.74 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.018 0.437 . . . . 0.0 110.051 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.15 -166.18 52.71 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -135.26 137.72 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 97.58 -102.73 2.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.307 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 84.3 m-85 19.9 79.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' THR . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.665 HD21 ' HG1' ' A' ' 51' ' ' THR . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.665 ' HG1' HD21 ' A' ' 48' ' ' ASN . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 78' ' ' ASP . 39.4 m-20 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.407 HG22 HD13 ' A' ' 85' ' ' ILE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.64 46.98 16.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -56.65 -19.92 18.8 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.7 mt -140.27 41.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.736 0.779 . . . . 0.0 110.399 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 75.18 -6.95 1.86 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.212 178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 -140.49 175.3 9.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' A' ' 5' ' ' PRO . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 -113.37 86.84 2.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -93.07 160.99 32.48 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.341 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 104' ' ' SER . 92.6 Cg_exo -37.91 172.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.866 3.044 . . . . 0.0 113.327 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 107' ' ' THR . 51.7 p30 -46.88 -30.49 2.55 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.69 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 73.3 m -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.47 -179.88 49.32 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.39 153.86 51.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 114' ' ' ILE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.481 ' O ' ' OG1' ' A' ' 159' ' ' THR . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.579 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.504 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 67.5 tp60 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.627 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.627 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.473 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.531 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.404 ' CB ' ' CE2' ' A' ' 210' ' ' TRP . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -108.4 104.69 14.11 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' ' 199' ' ' ASN . 38.9 t -70.99 -41.8 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 29.9 t30 90.23 -71.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.292 0.37 . . . . 0.0 110.612 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.56 -40.47 89.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.565 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.7 mttt -92.98 -66.17 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.619 ' CD1' ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER 173.88 -139.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.559 0.618 . . . . 0.0 110.93 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.619 ' H ' ' CD1' ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.415 ' C ' HD21 ' A' ' 207' ' ' ASN . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m -127.09 117.53 22.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.47 56.19 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.67 22.88 19.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.905 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -60.09 138.15 57.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.1 m -57.74 -35.64 70.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.73 112.19 19.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.57 ' O ' ' O ' ' A' ' 201' ' ' LYS . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.497 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m -102.19 109.1 20.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 252' ' ' LYS . 1.0 OUTLIER -75.04 142.18 43.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.421 -177.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -43.84 -54.79 10.16 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.6 Cg_exo -42.05 -114.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.205 2.603 . . . . 0.0 113.168 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -154.05 34.18 0.73 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.46 -41.46 97.11 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.9 mttt -84.53 -9.04 58.69 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 56.67 -22.67 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.1 t -75.33 -37.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -63.13 -44.87 94.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.793 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.57 -35.27 19.57 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.832 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.01 -7.06 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.44 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.41 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.24 155.56 44.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.1 mtp180 -86.04 137.46 32.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.814 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.201 0.524 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . -128.99 144.09 51.08 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.469 ' CG1' ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 10' ' ' LEU . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HA ' ' HG1' ' A' ' 19' ' ' THR . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 -65.25 -44.91 86.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' HG1' ' HA ' ' A' ' 16' ' ' ASP . 57.9 p -64.95 -45.02 87.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.81 127.19 27.35 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.867 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.57 136.89 3.22 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.254 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.53 160.95 43.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 99.87 -103.44 2.67 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.032 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.3 m-85 27.46 72.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.538 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.532 ' HG ' ' H ' ' A' ' 55' ' ' THR . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.532 ' H ' ' HG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.538 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 65.28 55.27 1.1 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -94.78 -33.49 12.86 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.449 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 8.4 mp -105.02 15.01 28.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.336 0.589 . . . . 0.0 109.908 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 91' ' ' LEU . . . 84.45 -36.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.801 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.55 -90.16 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 95' ' ' LEU . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.744 ' NZ ' ' HG1' ' A' ' 98' ' ' THR . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.744 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.93 79.21 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.61 156.37 70.88 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' ASN . 94.3 Cg_exo -40.67 -36.13 1.78 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.979 3.119 . . . . 0.0 114.684 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 105' ' ' PRO . 99.8 m-20 -43.96 171.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.613 0.244 . . . . 0.0 111.588 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.5 p -62.63 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.782 0.325 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.64 -32.13 72.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 50.27 -114.25 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.962 -0.14 . . . . 0.0 110.97 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.464 ' N ' ' CG1' ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.473 ' O ' ' OG1' ' A' ' 159' ' ' THR . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.659 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.497 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.412 ' O ' ' CG2' ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.431 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.768 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.768 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.431 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -90.7 95.19 10.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.62 -43.58 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.06 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 23.2 p30 -159.84 -174.18 4.47 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.06 -40.56 94.12 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.798 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 99.1 mttt -96.85 -8.03 32.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 55.7 tp -120.06 109.3 15.32 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.13 109.86 6.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 38.58 90.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.471 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.16 162.52 11.45 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -103.76 14.16 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 62.0 p -62.28 -98.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.688 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -96.97 106.95 19.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.611 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.611 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p -108.47 106.6 16.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 252' ' ' LYS . 7.9 mt -71.47 157.07 38.68 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -42.79 -56.83 5.55 Favored Pre-proline 0 C--N 1.357 0.909 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -41.06 -126.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 123.553 2.835 . . . . 0.0 113.935 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -142.2 32.62 1.97 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.677 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.63 93.94 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.9 mmtt -84.69 -7.35 59.26 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 119.559 1.68 . . . . 0.0 110.971 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 55.83 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.0 t -77.92 -34.75 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -64.68 -44.86 89.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.63 -35.85 20.71 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.832 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.95 -5.25 3.74 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.533 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.575 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.89 146.63 41.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -89.62 138.93 31.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.657 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.748 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.182 0.515 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.37 146.5 26.75 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.338 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 86.4 t80 -60.06 -40.64 90.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.4 p -74.23 -10.05 59.21 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.16 -32.6 23.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.988 -1.485 . . . . 0.0 110.478 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 69.56 -128.6 21.41 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 19.3 m-85 171.62 -179.84 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.26 74.88 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 33.19 64.75 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.529 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 1.6 m-80 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.473 ' O ' ' OG ' ' A' ' 46' ' ' SER . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 79' ' ' ASN . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 63.11 45.41 5.2 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.536 HE22 ' CB ' ' A' ' 97' ' ' LEU . 46.3 mt-30 -79.43 -35.89 39.78 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.9 tp -90.86 -64.67 1.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 175.29 -43.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.643 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -75.69 -79.08 0.1 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.536 ' CB ' HE22 ' A' ' 90' ' ' GLN . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.2 102.37 10.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.5 161.0 52.99 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 104' ' ' SER . 76.6 Cg_exo -38.84 176.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 124.235 3.29 . . . . 0.0 113.288 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.5 p30 -45.69 -14.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.858 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' PRO . 30.0 p -68.86 -32.83 72.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.751 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -157.38 94.85 0.14 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 108' ' ' GLY . 71.1 tttt -57.64 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.504 HD21 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.496 ' O ' ' OG1' ' A' ' 159' ' ' THR . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.587 ' NH1' HD22 ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.535 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.504 ' CG1' HD21 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.461 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.69 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.587 HD22 ' NH1' ' A' ' 139' ' ' ARG . 38.8 t-20 -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.529 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 56.1 m-20 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.589 ' C ' ' H ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.589 ' H ' ' C ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.488 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.402 ' N ' ' CD2' ' A' ' 190' ' ' PHE . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 64.3 tttm -88.2 109.46 19.94 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.5 ' CB ' ' O ' ' A' ' 197' ' ' LYS . 8.9 t 93.19 54.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 123.651 0.594 . . . . 0.0 110.729 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.548 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 2.3 t-20 -84.73 -162.68 0.71 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.44 -38.81 92.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.795 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 15.4 mttp -105.18 -5.03 21.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 10.4 tp 143.2 -103.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 119.114 0.87 . . . . 0.0 109.764 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.558 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.548 ' OG1' ' ND2' ' A' ' 199' ' ' ASN . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m -131.81 115.06 15.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.74 41.74 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 0.0 109.729 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.46 24.56 69.4 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.738 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.62 148.31 38.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.9 p -60.49 -33.43 72.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 -84.22 113.48 21.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.007 0.821 . . . . 0.0 112.988 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.4 ' CB ' ' OH ' ' A' ' 22' ' ' TYR . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.569 ' NZ ' ' H ' ' A' ' 21' ' ' GLY . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.438 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.553 HD22 ' CD1' ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m -107.08 123.57 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.42 139.77 38.89 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.598 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.6 -53.78 14.16 Favored Pre-proline 0 C--N 1.358 0.94 0 O-C-N 124.63 1.206 . . . . 0.0 108.0 176.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 97.0 Cg_exo -38.84 -19.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.802 2.334 . . . . 0.0 112.955 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 97.76 38.09 4.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.895 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.74 -39.4 95.24 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 268' ' ' VAL . 85.5 mttt -83.16 -7.96 59.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.125 1.463 . . . . 0.0 110.206 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 56.05 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.9 t -78.28 -36.93 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.354 0.525 . . . . 0.0 110.963 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -64.2 -44.22 92.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -85.51 -35.53 21.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.325 -1.35 . . . . 0.0 108.79 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.64 -15.47 0.46 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.321 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 64.6 114.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -79.46 145.23 33.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.708 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.26 149.74 31.43 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.24 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.575 ' N ' ' HZ2' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.571 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.405 ' CD1' ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.501 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 87.0 t80 -62.99 -43.34 99.05 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.568 ' O ' ' N ' ' A' ' 21' ' ' GLY . 70.4 p -61.46 -50.18 73.81 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.538 ' HZ3' ' NZ ' ' A' ' 224' ' ' LYS . 99.2 mttt -46.96 91.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.19 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 19' ' ' THR . . . -76.18 -80.31 0.6 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.272 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 21' ' ' GLY . 96.8 m-85 44.49 103.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.973 0.386 . . . . 0.0 111.45 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 24' ' ' PHE . . . 111.9 98.46 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.225 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 83.3 m-85 -161.95 30.59 0.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' OG ' ' A' ' 46' ' ' SER . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.515 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 69' ' ' LEU . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 3.3 m120 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.09 -0.87 24.41 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 92' ' ' ALA . 9.4 mt-30 -49.45 -11.11 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.42 -4.48 11.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.275 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 93' ' ' ARG . . . -140.16 46.81 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.955 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 55.9 mtt85 133.55 -89.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 124.541 1.151 . . . . 0.0 111.364 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.85 115.99 30.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.3 t -115.23 87.57 16.38 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.124 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -41.39 -41.3 5.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.838 2.359 . . . . 0.0 114.459 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' ND2' ' OD1' ' A' ' 79' ' ' ASN . 91.7 m-20 -63.23 -40.84 98.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.943 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.5 p -98.19 -11.55 22.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.146 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.14 30.5 73.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.11 111.14 23.79 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.571 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HZ2' ' N ' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.548 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.486 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.498 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.656 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.612 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.416 ' CG2' ' CD2' ' A' ' 157' ' ' PHE . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.611 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.611 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.549 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.407 ' O ' ' OG ' ' A' ' 193' ' ' SER . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 181' ' ' HIS . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 178' ' ' PHE . 7.1 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -108.39 92.61 4.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.28 -49.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.522 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.451 ' O ' ' CG ' ' A' ' 199' ' ' ASN . 9.3 t30 173.59 60.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 109.806 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 69.58 -52.81 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.454 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.517 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.4 mttt -64.42 -43.61 93.81 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 57.0 tp -123.8 118.56 27.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.491 ' OG1' ' NE2' ' A' ' 196' ' ' GLN . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m -145.3 119.34 9.4 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -46.16 123.1 4.38 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.062 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.96 -24.62 24.69 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.59 141.34 34.61 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.9 p -92.17 -21.45 20.38 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -85.38 126.79 34.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.068 0.849 . . . . 0.0 113.161 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.538 ' NZ ' ' HZ3' ' A' ' 20' ' ' LYS . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.517 ' O ' ' O ' ' A' ' 201' ' ' LYS . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.501 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.6 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m -91.35 131.84 36.57 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 87.1 mt -110.41 130.29 55.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 117.069 -1.443 . . . . 0.0 111.518 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 254' ' ' GLY . 3.8 mmtt -39.93 -55.03 3.99 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 124.685 1.241 . . . . 0.0 107.655 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -37.99 -13.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.915 2.41 . . . . 0.0 113.427 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 91.19 28.99 13.25 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.32 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.57 -40.26 54.8 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.561 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.0 mmtt -84.69 0.17 51.36 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.646 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 271' ' ' GLY . 90.7 m-20 55.23 -18.9 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.488 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.561 ' H ' ' C ' ' A' ' 266' ' ' LYS . 60.9 t -72.44 -42.69 64.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.289 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.297 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.528 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -83.63 -35.62 24.48 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.35 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 65.48 -12.36 0.32 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.388 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.566 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.24 151.95 51.08 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.84 137.32 34.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.749 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.766 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.899 0.38 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.2 134.4 40.05 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.613 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.613 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' C ' HD22 ' A' ' 124' ' ' ASN . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.504 ' N ' ' CD1' ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HG ' ' HH ' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' OG1' ' A' ' 19' ' ' THR . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.481 ' CG1' ' HZ3' ' A' ' 236' ' ' LYS . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -67.34 -46.33 73.74 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 15' ' ' ARG . 31.5 p -95.43 136.77 35.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -157.97 4.12 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 -138.06 49.82 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' O ' ' NZ ' ' A' ' 274' ' ' LYS . 94.8 m-85 -40.73 -35.16 0.45 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.943 0.872 . . . . 0.0 110.716 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.58 -128.0 37.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.113 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -68.04 -174.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.433 ' OD1' ' OG ' ' A' ' 44' ' ' SER . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.536 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' OG ' ' OD1' ' A' ' 30' ' ' ASP . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.536 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.595 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.595 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 77' ' ' THR . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 81.39 46.62 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -86.8 -40.72 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 13.1 mt -103.1 23.17 12.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.491 0.587 . . . . 0.0 110.196 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 75.58 -37.84 0.34 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.816 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 -74.82 -89.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.535 ' N ' ' CD2' ' A' ' 103' ' ' PHE . 1.2 m-85 80.69 160.84 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -125.4 159.37 60.49 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -39.6 -51.59 2.8 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.939 3.093 . . . . 0.0 114.612 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.29 -39.95 94.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 104' ' ' SER . 96.6 m -128.31 129.61 46.56 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.737 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 -162.03 50.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.74 121.68 39.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.633 HD21 ' CG2' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 159' ' ' THR . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.475 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.633 ' CG2' HD21 ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.453 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 1.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.479 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.479 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 151' ' ' ALA . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 177' ' ' GLU . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.558 ' CZ ' ' OG1' ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.506 ' HH ' ' HG ' ' A' ' 13' ' ' SER . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.491 ' NE2' ' OD1' ' A' ' 199' ' ' ASN . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 67.9 mttm -108.29 101.14 10.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.419 ' CB ' ' O ' ' A' ' 197' ' ' LYS . 3.4 t 83.61 69.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 O-C-N 123.716 0.635 . . . . 0.0 111.382 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 201' ' ' LYS . 39.0 t30 -105.58 94.33 5.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 44.98 -76.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.245 0.966 . . . . 0.0 111.599 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 199' ' ' ASN . 68.1 mttm -64.15 -44.15 93.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 201' ' ' LYS . 56.9 tp 166.82 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.452 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m -129.18 115.96 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.36 47.24 3.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.43 24.22 61.32 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.848 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.44 143.26 57.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 63.3 m -57.91 -36.17 72.07 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.8 112.61 18.34 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.481 ' HZ3' ' CG1' ' A' ' 17' ' ' VAL . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.628 HD22 ' CD1' ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.628 ' CD1' HD22 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.6 m -88.61 87.57 7.31 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.634 ' O ' ' O ' ' A' ' 252' ' ' LYS . 84.4 mt -82.51 102.75 11.57 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.957 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.634 ' O ' ' O ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER 59.86 125.61 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.921 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -42.68 -12.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 120.863 1.042 . . . . 0.0 112.094 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.45 -38.85 6.96 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 121.328 -0.463 . . . . 0.0 113.631 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 251' ' ' LEU . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -14.69 -84.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -91.49 3.52 54.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.271 1.535 . . . . 0.0 111.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 271' ' ' GLY . 82.0 m-20 68.0 -0.38 2.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.263 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.54 -41.65 34.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.278 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.25 -45.66 92.3 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.693 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.67 -35.72 20.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 119.113 -1.035 . . . . 0.0 108.887 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 80.53 -16.03 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.266 -1.445 . . . . 0.0 113.077 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 22' ' ' TYR . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.434 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.29 149.32 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.06 135.88 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.365 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 285' ' ' SER . 17.3 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.66 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.12 36.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.819 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 -64.31 -44.74 90.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.8 p -85.6 -26.44 26.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 22' ' ' TYR . 66.0 mttm -78.37 10.64 2.93 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 118.761 -1.176 . . . . 0.0 110.427 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.19 157.67 12.39 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 20' ' ' LYS . 94.2 m-85 -154.28 156.83 37.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 103.72 -114.62 4.85 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.47 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLY . 86.2 m-85 21.14 75.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.457 ' O ' ' OG1' ' A' ' 49' ' ' THR . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.506 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 57' ' ' SER . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.6 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 ' O ' ' OG1' ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.448 ' N ' ' HG ' ' A' ' 44' ' ' SER . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.506 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 38' ' ' GLY . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.643 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.643 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 ' CD1' ' O ' ' A' ' 67' ' ' TYR . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.507 HD21 ' ND2' ' A' ' 106' ' ' ASN . 53.5 m-20 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 67.75 38.48 2.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.537 HE22 ' CB ' ' A' ' 97' ' ' LEU . 50.2 mt-30 -75.57 -43.55 47.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 52.2 tp -82.77 -66.62 0.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 171.85 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -75.47 -71.89 0.34 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.587 ' HZ3' ' HZ1' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.537 ' CB ' HE22 ' A' ' 90' ' ' GLN . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 -111.78 111.87 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 107' ' ' THR . 1.3 t -125.46 90.62 50.36 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 119.148 0.886 . . . . 0.0 113.013 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.68 -49.38 3.38 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.058 2.505 . . . . 0.0 114.575 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' HD21 ' A' ' 79' ' ' ASN . 89.6 m-20 -62.99 -41.15 99.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.909 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.4 t -147.0 148.07 31.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.847 0.356 . . . . 0.0 110.253 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 54.06 101.52 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -57.29 -120.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.822 -0.222 . . . . 0.0 111.187 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HZ1' ' HZ3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.569 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.491 ' O ' ' OG1' ' A' ' 159' ' ' THR . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.7 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.43 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.517 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -99.91 97.63 8.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 199' ' ' ASN . 40.4 t -75.51 -21.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.968 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 32.4 t30 90.67 -40.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.559 0.537 . . . . 0.0 110.935 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 202' ' ' LEU . 99.0 mttt -81.79 80.81 8.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.702 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 38.34 21.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 200' ' ' LYS . 45.1 tp -131.72 113.96 14.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m -130.5 114.13 15.12 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.71 46.17 11.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.874 0.845 . . . . 0.0 109.469 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 54.7 25.82 37.46 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.97 -1.468 . . . . 0.0 114.52 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.09 149.43 32.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.4 m -59.16 -36.83 75.97 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.75 109.17 17.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.561 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.561 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.624 HD22 ' CD1' ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.624 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p 67.09 -101.15 0.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.46 ' O ' ' C ' ' A' ' 252' ' ' LYS . 55.5 tp 64.74 -34.7 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.502 0.501 . . . . 0.0 111.469 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 250' ' ' THR . 1.5 mttp -42.28 158.21 0.21 Allowed Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -40.6 88.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.867 1.711 . . . . 0.0 111.76 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 170.43 -101.73 0.17 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.774 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.537 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.08 -38.08 94.97 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 268' ' ' VAL . 54.4 mmtt -86.1 -7.75 58.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.968 1.384 . . . . 0.0 109.535 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.98 -21.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 266' ' ' LYS . 53.4 t -77.01 -35.24 22.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.438 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -64.34 -44.48 91.37 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.788 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.94 -34.89 19.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 118.564 -1.254 . . . . 0.0 107.814 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.93 -12.97 0.36 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.356 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -151.32 156.86 41.66 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -100.41 138.19 37.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.5 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.839 -179.887 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.544 ' H2 ' ' HG ' ' A' ' 1' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . -132.6 139.51 47.83 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.741 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.527 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.75 -47.32 78.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.416 ' HG1' ' H ' ' A' ' 20' ' ' LYS . 38.3 p -71.17 -45.04 64.3 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' H ' ' HG1' ' A' ' 19' ' ' THR . 99.2 mttt -65.17 132.47 49.22 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 118.929 -1.108 . . . . 0.0 109.147 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 163.08 170.25 27.7 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.915 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 98.4 m-85 -163.6 -120.27 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 40.73 -115.14 0.63 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.706 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 66.4 m-85 14.64 73.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.47 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.476 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.529 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.409 ' O ' ' OD1' ' A' ' 30' ' ' ASP . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.446 ' OG ' ' OG1' ' A' ' 55' ' ' THR . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 50' ' ' GLU . 61.1 t-20 -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.62 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.505 ' OG1' ' ND2' ' A' ' 48' ' ' ASN . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.446 ' OG1' ' OG ' ' A' ' 46' ' ' SER . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.476 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.611 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.422 ' CD2' ' N ' ' A' ' 71' ' ' PHE . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 56.6 49.66 14.22 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -59.26 -7.85 1.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 22.4 tp -153.7 40.9 0.51 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.461 1.124 . . . . 0.0 109.202 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 77.48 -15.8 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.871 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 -131.58 173.43 11.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 93' ' ' ARG . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.441 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.482 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 -93.88 153.63 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 105' ' ' PRO . 12.5 m -115.19 147.59 38.83 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.413 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' O ' ' O ' ' A' ' 104' ' ' SER . 65.5 Cg_exo -37.49 -125.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 124.571 3.514 . . . . 0.0 114.707 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -58.94 -31.83 69.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.442 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 m -59.61 -42.47 92.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.092 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 18.86 79.57 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -66.94 123.42 20.15 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.554 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.554 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.577 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.495 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 21.0 tp60 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.577 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.425 ' C ' ' ND2' ' A' ' 168' ' ' ASN . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.425 ' ND2' ' C ' ' A' ' 167' ' ' SER . 4.9 m120 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.484 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.484 ' CD2' ' OG1' ' A' ' 175' ' ' THR . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.421 ' C ' ' OD1' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.96 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.41 -50.53 79.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.719 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 52.4 p30 178.91 63.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.231 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.8 tttm 68.42 -55.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.86 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.99 -43.59 98.38 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 9.7 mp -115.49 117.27 29.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m -148.62 116.0 6.19 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 188' ' ' THR . . . -48.92 110.16 0.33 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.502 0.668 . . . . 0.0 111.049 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.42 -46.02 1.17 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -96.65 116.0 28.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.9 m -67.03 -37.8 84.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -51.21 123.15 8.9 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 221' ' ' ILE . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m -99.6 117.02 33.07 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.88 86.72 2.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.273 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 254' ' ' GLY . 11.0 mttt 72.54 116.96 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 252' ' ' LYS . 73.1 Cg_exo -38.62 93.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.391 1.394 . . . . 0.0 111.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 162.63 -35.85 0.34 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.761 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 255' ' ' ILE . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.27 96.0 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.4 mttt -85.23 -5.99 59.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.19 1.995 . . . . 0.0 110.33 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.13 -18.77 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.0 t -79.04 -35.98 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.316 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -64.15 -44.34 92.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.445 -0.785 . . . . 0.0 110.702 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -85.53 -35.75 20.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.706 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.61 -3.98 3.28 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.986 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.583 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.417 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.47 ' H ' HG13 ' A' ' 27' ' ' ILE . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.417 ' O ' ' CB ' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 282' ' ' GLN . . . 76.87 108.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.75 147.97 35.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.603 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.29 144.26 50.04 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.692 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' O ' ' C ' ' A' ' 6' ' ' THR . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.688 ' HH ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.499 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.448 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 86.5 t80 -65.78 -44.73 84.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.6 p -81.47 -34.47 31.35 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -76.78 11.02 1.87 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.314 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.57 148.57 9.27 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -152.19 164.73 36.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 90.25 -113.35 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.002 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' GLY . 69.2 m-85 19.84 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.403 HD21 ' HA ' ' A' ' 37' ' ' ASN . 8.3 m120 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.53 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 55' ' ' THR . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.474 ' HG1' ' H ' ' A' ' 53' ' ' LYS . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' H ' ' HG1' ' A' ' 51' ' ' THR . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.53 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.579 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.401 ' C ' ' H ' ' A' ' 79' ' ' ASN . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 63.92 39.65 7.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -69.04 -40.29 78.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.454 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 57.7 tp -91.41 -56.74 3.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 91' ' ' LEU . . . 162.3 -39.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.51 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.26 -77.94 0.11 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 78.84 165.11 0.21 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.38 160.94 35.78 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 121.09 0.471 . . . . 0.0 112.203 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 107' ' ' THR . 91.7 Cg_exo -39.53 135.89 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.598 2.866 . . . . 0.0 113.372 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 49.8 5.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.708 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.566 ' H ' ' C ' ' A' ' 105' ' ' PRO . 76.4 m -127.21 86.3 2.48 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.08 14.51 74.63 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.59 112.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.472 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.454 ' NH1' HD22 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.5 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.511 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.5 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.454 HD22 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.546 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CD1' ' NE2' ' A' ' 196' ' ' GLN . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.688 HD21 ' HH ' ' A' ' 7' ' ' TYR . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.602 ' CD1' ' NE1' ' A' ' 210' ' ' TRP . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.499 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 198' ' ' VAL . 65.2 tttm -88.01 114.73 24.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 197' ' ' LYS . 3.9 t 24.84 106.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 196' ' ' GLN . 63.0 t30 -132.57 79.42 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.136 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.1 tttt 67.12 7.03 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.29 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 99.5 mttt -139.16 -60.09 0.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.548 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 1.0 OUTLIER 150.51 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.068 0.855 . . . . 0.0 110.448 -177.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 196' ' ' GLN . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.448 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.9 m-20 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m -147.78 104.51 3.6 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.429 ' HA ' ' CZ2' ' A' ' 210' ' ' TRP . . . -44.36 114.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.72 0.771 . . . . 0.0 111.433 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.11 -26.83 5.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.36 140.16 42.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 87.4 p -89.61 -2.82 58.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -104.23 140.08 38.34 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.229 0.922 . . . . 0.0 113.103 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.4 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.631 HD22 ' CD1' ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.631 ' CD1' HD22 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m -107.99 110.86 22.68 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 252' ' ' LYS . 44.1 tp -112.07 121.64 45.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 251' ' ' LEU . 50.2 tttm 56.61 104.56 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.46 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' LYS . 68.8 Cg_exo -36.22 101.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.916 1.744 . . . . 0.0 111.875 -177.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 154.67 -31.58 0.68 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.887 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.584 ' HG ' ' CA ' ' A' ' 276' ' ' GLY . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -11.22 -89.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -89.12 5.26 45.38 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 117.137 0.469 . . . . 0.0 111.395 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 264' ' ' ASP . 61.1 t30 62.98 -5.94 0.19 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.62 -39.64 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.02 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.51 -45.72 89.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.998 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.86 -5.92 84.13 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 119.44 -1.362 . . . . 0.0 112.479 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . 0.532 ' CD2' ' O ' ' A' ' 272' ' ' GLY . 33.6 m170 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.584 ' CA ' ' HG ' ' A' ' 260' ' ' SER . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.67 48.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -68.17 139.33 56.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.834 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.29 149.21 31.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.433 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.427 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.495 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 60.5 t80 -62.72 -45.32 93.3 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 20' ' ' LYS . 6.9 p -96.04 167.25 11.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.597 ' HZ3' ' HZ1' ' A' ' 74' ' ' LYS . 98.6 mttt 45.83 -174.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.94 68.52 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -139.84 160.39 40.01 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . -119.52 -43.93 0.48 Allowed Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 57.1 m-85 18.74 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 57' ' ' SER . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 55' ' ' THR . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' O ' ' OG1' ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' ASN . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.463 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.484 ' C ' ' H ' ' A' ' 66' ' ' GLU . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.597 ' HZ1' ' HZ3' ' A' ' 20' ' ' LYS . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.484 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 61.58 40.73 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 72.9 mt-30 -51.35 -37.52 48.34 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 6.7 tp 166.12 56.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.985 0.897 . . . . 0.0 110.067 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -161.47 -150.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.526 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -81.02 -42.64 20.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' CB ' HE22 ' A' ' 90' ' ' GLN . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.93 99.17 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.68 161.09 52.84 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -38.79 -179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 124.036 3.158 . . . . 0.0 113.129 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -51.9 -32.26 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.686 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.4 p -64.05 -35.95 82.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.166 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -131.75 80.68 0.33 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.1 mttt -54.19 -159.0 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 123' ' ' ILE . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 159' ' ' THR . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.579 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.719 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.537 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.537 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.684 ' HG1' ' H ' ' A' ' 166' ' ' GLN . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.684 ' H ' ' HG1' ' A' ' 165' ' ' THR . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 68.4 m-20 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.773 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.773 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.503 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.514 ' O ' ' ND2' ' A' ' 183' ' ' ASN . 0.3 OUTLIER -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.406 ' O ' ' OD1' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.444 ' OE1' ' CG2' ' A' ' 198' ' ' VAL . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -94.58 96.24 9.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.444 ' CG2' ' OE1' ' A' ' 196' ' ' GLN . 86.9 t -75.78 -43.93 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.617 -175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 81.9 m-20 -161.87 -171.17 2.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.038 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.71 -11.4 27.12 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 48.6 tp -117.74 111.41 19.07 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p -131.82 114.66 14.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -46.74 131.87 11.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.003 0.906 . . . . 0.0 111.732 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.94 -28.29 15.92 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.632 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -102.98 141.88 35.03 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.1 p -90.24 -4.44 57.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -98.37 129.47 45.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.346 0.975 . . . . 0.0 113.386 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.419 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.597 HD22 ' CD1' ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.487 ' C ' ' HG ' ' A' ' 241' ' ' SER . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.487 ' HG ' ' C ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.597 ' CD1' HD22 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m -111.84 124.54 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 2.2 mt -102.65 144.07 31.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.195 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.83 -53.45 15.63 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.733 1.27 . . . . 0.0 107.941 176.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 86.3 Cg_exo -39.9 -15.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.78 2.32 . . . . 0.0 112.782 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 93.77 38.25 5.27 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.067 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.412 ' OD2' ' CA ' ' A' ' 267' ' ' ASN . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.51 95.54 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.521 ' C ' ' H ' ' A' ' 268' ' ' VAL . 84.0 mttt -84.33 -10.85 57.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.412 ' CA ' ' OD2' ' A' ' 264' ' ' ASP . 66.0 t30 58.43 -24.91 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.3 t -75.71 -34.81 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.235 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -63.82 -45.68 88.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.421 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.82 -35.59 19.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.18 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.2 -15.08 0.79 Allowed Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.382 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.488 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.582 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.47 154.0 46.46 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.65 137.49 33.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.855 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 138.94 53.07 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.589 ' CA ' HD22 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD1' ' O ' ' A' ' 5' ' ' PRO . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.21 -44.74 82.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.0 p -62.82 109.25 1.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 21' ' ' GLY . 83.0 tttt -146.36 136.64 23.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -56.31 -171.52 0.13 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 21' ' ' GLY . 98.9 m-85 -26.83 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.38 0.59 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . 60.66 -64.78 0.01 OUTLIER Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.573 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 22' ' ' TYR . 4.0 m-85 -98.77 120.01 38.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.586 -0.361 . . . . 0.0 111.965 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.531 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.438 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.531 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 65.52 43.79 3.26 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 90.4 mt-30 -51.49 -37.4 48.9 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER 165.16 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.714 0.769 . . . . 0.0 110.123 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.26 -148.49 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.24 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -79.11 -45.79 19.34 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -117.95 80.83 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.26 160.71 25.51 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 118.874 0.761 . . . . 0.0 112.205 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 104' ' ' SER . 75.1 Cg_exo -37.69 -127.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.59 3.527 . . . . 0.0 114.306 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -67.16 -41.55 85.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.328 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' GLY . 7.8 p -86.21 163.32 17.86 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.823 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.46 ' O ' ' OG ' ' A' ' 104' ' ' SER . . . 37.0 64.1 0.69 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.5 mttt -55.28 -119.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' C ' HD21 ' A' ' 111' ' ' ASN . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.471 HD21 ' C ' ' A' ' 110' ' ' LYS . 1.5 m120 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.606 ' CG ' HD21 ' A' ' 124' ' ' ASN . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 123' ' ' ILE . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.568 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.606 HD21 ' CG ' ' A' ' 119' ' ' LYS . 4.1 m120 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' OG1' ' A' ' 159' ' ' THR . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.688 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.501 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.512 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 67.8 tp60 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.688 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.437 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.457 ' CD2' ' N ' ' A' ' 179' ' ' GLN . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.408 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.616 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt -105.68 99.29 8.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 78.7 t -76.61 -45.49 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.51 -175.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 83.8 m-20 -159.66 -170.94 3.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.2 -39.79 91.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.767 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -96.08 -11.38 26.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 10.3 mp -114.93 107.61 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m -148.82 105.94 3.61 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 188' ' ' THR . . . -42.49 109.7 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.67 -6.13 12.63 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -126.79 130.45 50.31 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 94.4 p -83.55 -7.81 59.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -98.97 140.05 33.71 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.25 0.932 . . . . 0.0 112.917 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 228' ' ' ASP 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.429 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.592 HD22 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.592 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -98.19 118.81 35.65 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 45.2 mt -97.72 133.25 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.575 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.5 tttt -45.57 -51.94 25.66 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 91.2 Cg_exo -39.48 -14.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.648 2.232 . . . . 0.0 112.634 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 95.05 30.45 8.31 Favored Glycine 0 N--CA 1.466 0.699 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.132 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.403 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 268' ' ' VAL . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.22 83.22 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.551 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 45.5 mmtt -82.99 -2.73 56.0 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.545 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.696 ' C ' ' H ' ' A' ' 269' ' ' ASN . 7.6 m-20 164.58 76.8 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' A' ' 264' ' ' ASP . 20.0 t -60.2 -9.61 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.696 ' H ' ' C ' ' A' ' 267' ' ' ASN . 41.7 m-20 -83.36 -30.17 27.65 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 111.582 -2.553 . . . . 0.0 112.273 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.4 ' H ' ' HB3' ' A' ' 267' ' ' ASN . . . -84.21 -32.46 24.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . -94.15 35.71 4.07 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.662 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.412 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.69 141.84 45.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -95.37 137.41 34.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.653 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . -72.5 144.67 47.93 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' C ' HD22 ' A' ' 124' ' ' ASN . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 5' ' ' PRO . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.458 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.3 t80 -63.46 -44.63 93.89 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.2 p -81.65 -42.29 20.19 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.41 139.34 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.73 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 22' ' ' TYR . . . 164.65 173.94 33.85 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.564 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 64.6 m-85 -160.06 149.76 18.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 116.54 -114.37 3.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.344 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.0 m-85 24.31 70.69 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.52 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.401 ' OG ' ' OG ' ' A' ' 57' ' ' SER . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' O ' ' OG1' ' A' ' 49' ' ' THR . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.401 ' OG ' ' OG ' ' A' ' 44' ' ' SER . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' HZ3' HD22 ' A' ' 76' ' ' ASN . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.419 HD22 ' HZ3' ' A' ' 74' ' ' LYS . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 56.97 45.01 21.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -52.63 -20.85 3.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.412 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 88.7 mt -138.59 39.55 2.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.938 0.875 . . . . 0.0 110.172 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 91' ' ' LEU . . . 81.64 -24.63 0.18 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.087 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 -126.21 179.48 5.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.467 ' CD1' ' C ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.59 93.19 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.46 159.54 59.87 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.507 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 64.4 Cg_exo -38.11 -63.24 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.905 3.07 . . . . 0.0 114.046 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' PRO . 28.7 m120 -147.39 -175.53 4.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.293 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.18 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.443 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 106' ' ' ASN . . . 174.92 55.15 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -55.84 -117.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.462 ' O ' ' OG1' ' A' ' 159' ' ' THR . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.495 ' CG2' HD21 ' A' ' 124' ' ' ASN . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.675 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.432 ' C ' HD21 ' A' ' 156' ' ' ASN . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.637 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.7 OUTLIER -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.539 HD22 ' ND2' ' A' ' 183' ' ' ASN . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.495 ' CD2' ' OG1' ' A' ' 175' ' ' THR . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.465 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.539 ' ND2' HD22 ' A' ' 168' ' ' ASN . 12.2 p-10 -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 212' ' ' ALA . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.596 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.474 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -98.42 91.36 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.94 -45.84 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.0 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 35.1 p30 -170.46 163.68 8.5 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -40.54 -33.9 0.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.74 -26.6 19.43 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 4.1 mp -116.38 116.28 27.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.474 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.458 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 98.0 m-20 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m -145.65 108.58 4.55 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 188' ' ' THR . . . -39.24 123.38 1.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 111.191 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.85 18.97 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -102.67 139.34 38.38 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -87.84 -16.21 34.65 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -102.67 144.21 31.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.222 0.919 . . . . 0.0 113.344 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.444 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.499 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.498 HD22 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.46 ' ND2' ' C ' ' A' ' 239' ' ' ASN . 0.0 OUTLIER -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.498 ' CG ' HD22 ' A' ' 238' ' ' ASN . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m -85.58 84.9 7.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.654 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.1 mt -78.46 104.8 9.3 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 251' ' ' LEU . 47.5 mttt 58.32 128.54 0.01 OUTLIER Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 282' ' ' GLN . 97.0 Cg_exo -43.89 -11.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.204 1.27 . . . . 0.0 112.361 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.26 -36.71 8.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.474 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 251' ' ' LEU . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 268' ' ' VAL . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.83 -39.03 94.9 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 49.8 mttp -82.75 -1.99 53.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.486 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.648 ' C ' ' H ' ' A' ' 269' ' ' ASN . 8.6 m-20 170.27 74.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 264' ' ' ASP . 22.0 t -56.47 -12.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.648 ' H ' ' C ' ' A' ' 267' ' ' ASN . 38.5 m-80 -81.51 -29.87 33.44 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 112.282 -2.236 . . . . 0.0 112.14 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . -83.15 -31.8 26.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -90.75 32.62 4.99 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.263 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.511 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 253' ' ' PRO . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -66.0 142.83 57.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -75.38 143.45 42.78 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.764 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' CA ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 207' ' ' ASN . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' THR . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.53 HD21 ' HG1' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HG1' HD21 ' A' ' 48' ' ' ASN . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.519 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.551 HE22 ' CB ' ' A' ' 97' ' ' LEU . 44.6 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.551 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.448 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.483 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.631 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.658 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.479 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.527 HD21 ' HH ' ' A' ' 7' ' ' TYR . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 185' ' ' ASN . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.609 ' CE1' ' CZ2' ' A' ' 210' ' ' TRP . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.706 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.706 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.831 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.831 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.442 ' CD2' HD22 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 272' ' ' GLY . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.442 HD22 ' CD2' ' A' ' 263' ' ' LEU . 0.9 OUTLIER -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' CA ' HD22 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.449 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' C ' HD22 ' A' ' 207' ' ' ASN . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.519 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.486 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 55' ' ' THR . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.53 HD21 ' HG1' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HG1' HD21 ' A' ' 48' ' ' ASN . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.486 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.519 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.551 HE22 ' CB ' ' A' ' 97' ' ' LEU . 44.6 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.551 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' C ' ' H ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' H ' ' C ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.451 HD22 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.448 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.483 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.631 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.631 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.658 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.479 ' N ' ' NE2' ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.402 ' O ' ' CG2' ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.527 HD21 ' HH ' ' A' ' 7' ' ' TYR . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 185' ' ' ASN . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.609 ' CE1' ' CZ2' ' A' ' 210' ' ' TRP . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.408 HD22 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.706 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.706 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.831 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.596 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.831 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.442 ' CD2' HD22 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 272' ' ' GLY . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . 0.442 HD22 ' CD2' ' A' ' 263' ' ' LEU . 0.9 OUTLIER -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.09 140.79 58.27 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.744 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.654 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.415 ' CD2' ' CE1' ' A' ' 181' ' ' HIS . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 -62.44 -43.36 99.0 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.3 p -88.12 -12.58 43.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.12 -43.51 66.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.648 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.39 103.04 0.21 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.99 -44.52 91.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.72 -178.82 18.25 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.266 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' CG ' ' OG ' ' A' ' 260' ' ' SER . 10.8 m-85 -124.16 -149.89 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' ' H ' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.541 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 55' ' ' THR . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.541 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.587 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.587 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 77' ' ' THR . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 58.83 55.98 4.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.445 HE22 HD23 ' A' ' 97' ' ' LEU . 81.5 mt-30 -82.41 1.9 35.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 92' ' ' ALA . 35.0 tp -171.31 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 91' ' ' LEU . . . 151.37 155.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.95 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.495 ' CD ' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 65.98 62.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.445 HD23 HE22 ' A' ' 90' ' ' GLN . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -110.34 90.36 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -125.39 87.84 55.07 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.69 139.1 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.537 2.158 . . . . 0.0 113.115 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' O ' ' OG1' ' A' ' 107' ' ' THR . 96.2 m-20 57.98 27.03 14.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.043 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 106' ' ' ASN . 3.2 m 175.13 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 63.79 71.69 0.81 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -49.23 -112.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.654 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.467 ' O ' ' OG1' ' A' ' 159' ' ' THR . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.681 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.705 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.415 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 50.7 m-20 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.664 ' HG1' ' H ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.664 ' H ' ' HG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.401 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 10' ' ' LEU . 33.8 m170 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.564 ' ND2' ' HH ' ' A' ' 7' ' ' TYR . 43.3 t30 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.554 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 96.75 10.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.66 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -167.49 -135.24 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.85 -0.04 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.479 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -121.21 -32.16 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.67 127.19 52.66 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.642 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 213' ' ' GLY . 54.7 m -110.33 103.36 12.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 51.7 16.11 0.44 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.493 ' N ' ' C ' ' A' ' 211' ' ' THR . . . 79.51 17.46 75.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -65.34 156.22 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -59.25 -38.82 81.0 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.24 114.67 12.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.642 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.466 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.704 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.704 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.416 ' CG ' ' O ' ' A' ' 250' ' ' THR . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.455 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m -93.31 122.17 35.44 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.16 128.68 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.685 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.9 mttt -42.95 -55.82 7.04 Favored Pre-proline 0 C--N 1.359 0.987 0 O-C-N 124.981 1.425 . . . . 0.0 107.32 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -38.84 -19.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.628 2.219 . . . . 0.0 113.008 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 99.72 32.96 5.48 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.197 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.594 ' HG ' ' N ' ' A' ' 276' ' ' GLY . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.87 -35.99 88.6 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.55 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.8 mmtt -84.93 -7.72 59.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.407 1.104 . . . . 0.0 110.331 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 56.1 -23.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.0 t -74.56 -37.73 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.296 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.311 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.84 -35.21 19.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 118.451 -1.3 . . . . 0.0 108.246 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 62.92 -7.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.048 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.594 ' N ' ' HG ' ' A' ' 260' ' ' SER . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.44 142.51 39.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -87.71 138.44 31.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.306 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.21 140.25 57.42 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' C ' ' HZ3' ' A' ' 119' ' ' LYS . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.724 ' N ' ' HZ3' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 10' ' ' LEU . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 -59.56 -45.6 91.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 43.2 m -23.19 115.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.54 139.0 35.36 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . 160.69 -172.34 37.01 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' GLY . 91.1 m-85 32.46 89.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.614 0.244 . . . . 0.0 110.574 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 120.13 -135.03 10.77 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.9 m-85 16.42 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.513 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.626 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 79' ' ' ASN . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 59.02 47.79 11.62 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -55.83 -18.25 8.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 28.1 tp -142.25 41.18 1.63 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.462 1.125 . . . . 0.0 108.978 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 76.63 -13.55 0.91 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.585 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 -134.36 174.22 10.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.702 ' NZ ' ' HG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.702 ' HG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.437 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 -96.3 150.97 19.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -113.04 153.28 45.35 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.3 Cg_exo -37.37 -124.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 124.399 3.4 . . . . 0.0 114.64 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -60.26 -35.47 75.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.37 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.47 ' HG1' ' N ' ' A' ' 108' ' ' GLY . 1.6 p -54.62 -38.53 66.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.868 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.47 ' N ' ' HG1' ' A' ' 107' ' ' THR . . . 68.06 20.42 72.83 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -70.56 120.36 16.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.724 ' HZ3' ' N ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.558 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.476 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.701 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.65 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.499 ' CG2' ' ND2' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.611 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.449 ' CD1' ' HE2' ' A' ' 181' ' ' HIS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.701 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 198' ' ' VAL . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.497 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 7.9 mm-40 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.472 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' HE2' ' CD1' ' A' ' 150' ' ' LEU . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 190' ' ' PHE . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.471 ' NE2' ' OD1' ' A' ' 199' ' ' ASN . 48.6 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 88.2 tttt -101.36 105.33 16.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.559 ' CB ' ' O ' ' A' ' 197' ' ' LYS . 45.9 t 108.31 64.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 125.144 1.528 . . . . 0.0 112.408 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.471 ' OD1' ' NE2' ' A' ' 196' ' ' GLN . 67.0 t30 -114.87 66.2 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 59.79 71.96 0.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt 65.19 27.85 12.2 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.57 147.78 38.24 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 214' ' ' ASN . 16.9 m -150.24 116.56 5.72 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 211' ' ' THR . . . -31.2 113.91 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.463 0.649 . . . . 0.0 112.201 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.52 -0.99 68.59 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.959 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 211' ' ' THR . 55.2 t30 -98.97 107.41 19.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.1 m -57.75 -34.62 69.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -96.15 139.22 32.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . 0.409 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.597 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.439 ' N ' ' CD1' ' A' ' 242' ' ' LEU . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 78.2 p 54.42 -157.82 0.19 Allowed 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 250' ' ' THR . 20.8 tp 139.23 -79.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 124.244 0.965 . . . . 0.0 110.863 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.532 ' N ' ' CD ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -58.29 -46.18 99.66 Favored Pre-proline 0 CA--C 1.518 -0.276 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -42.88 -18.55 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.837 1.691 . . . . 0.0 112.182 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 122.94 -26.93 6.04 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.12 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.435 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 267' ' ' ASN . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 50.93 -102.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -98.73 6.33 47.02 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.845 -1.677 . . . . 0.0 110.455 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 264' ' ' ASP . 5.7 m120 75.86 -42.28 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.741 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.43 -15.89 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -64.91 -42.93 94.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.242 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -83.11 -34.8 26.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.0 22.18 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.795 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 54.54 104.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.98 135.93 55.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.812 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.67 142.91 33.37 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.232 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.465 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 -63.02 -43.63 98.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.7 m -95.87 120.46 36.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -155.59 111.53 3.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.697 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -74.07 -127.72 0.15 Allowed Glycine 0 C--N 1.331 0.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.512 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 55.5 m-85 28.53 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.804 0.302 . . . . 0.0 111.471 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 139.63 -142.91 13.18 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.03 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.556 ' N ' ' HG ' ' A' ' 260' ' ' SER . 45.9 m-85 20.33 76.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.662 ' NZ ' ' HZ3' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.5 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' OG ' ' NZ ' ' A' ' 28' ' ' LYS . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 25' ' ' GLY . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' H ' ' HG1' ' A' ' 51' ' ' THR . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.5 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' CE ' ' HG1' ' A' ' 72' ' ' THR . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.442 ' HG1' ' CE ' ' A' ' 61' ' ' LYS . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.635 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.441 ' C ' ' CD1' ' A' ' 75' ' ' TRP . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.635 ' ND2' ' NZ ' ' A' ' 74' ' ' LYS . 88.5 m-20 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 59.66 48.43 9.4 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.17 -11.41 3.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 30.0 tp -150.91 40.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.428 1.109 . . . . 0.0 109.223 178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 74.33 1.76 3.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.455 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 -144.54 171.11 14.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.787 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' ARG . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.429 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 -114.26 108.72 17.31 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.55 87.62 55.48 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.81 -28.76 0.38 Allowed 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.05 2.5 . . . . 0.0 114.586 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' GLY . 56.3 t30 -86.97 105.46 17.14 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.427 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 43.09 14.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' ASN . . . -98.82 177.0 30.15 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -139.6 150.16 44.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.471 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.694 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.697 ' N ' ' CD1' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.479 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.413 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.479 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.426 ' CD2' ' N ' ' A' ' 190' ' ' PHE . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -96.33 97.76 9.74 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 80.1 t -74.46 -43.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.336 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 27.7 p30 -157.76 -171.45 3.55 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.0 -41.75 98.4 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.225 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.84 -7.63 33.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 53.0 tp -120.98 113.72 20.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.475 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -142.35 115.84 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.02 46.49 9.29 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.37 25.8 42.29 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 114.452 -1.249 . . . . 0.0 114.338 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 215' ' ' SER . 59.6 t-20 -59.18 149.29 28.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 78.0 p -59.71 -32.94 70.99 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -85.19 107.99 17.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 112.833 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' TYR . . . . . 0.478 ' C ' ' SG ' ' A' ' 232' ' ' CYS . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.458 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.577 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.565 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 85.5 m -128.84 86.68 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.596 ' CG ' ' H ' ' A' ' 252' ' ' LYS . 0.8 OUTLIER -175.62 -145.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.962 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . 0.721 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 56.25 161.02 0.07 OUTLIER Pre-proline 0 C--O 1.222 -0.367 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -41.69 72.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.032 1.822 . . . . 0.0 113.103 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 60.23 43.14 98.77 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.662 ' HZ3' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.556 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.41 -43.16 95.93 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.4 mttt -84.1 -9.72 58.38 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 118.917 1.359 . . . . 0.0 109.227 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.3 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 266' ' ' LYS . 60.0 t -73.45 -36.84 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 118.842 0.747 . . . . 0.0 110.069 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.96 -44.34 96.31 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.14 -35.68 20.02 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.209 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.02 -7.13 10.35 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.378 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.571 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.54 143.46 57.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -66.71 133.26 49.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.51 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.442 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' C ' HD22 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.729 ' O ' HG23 ' A' ' 6' ' ' THR . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 5' ' ' PRO . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.749 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HG ' ' HE1' ' A' ' 195' ' ' TYR . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 40' ' ' GLU . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 35' ' ' SER . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.465 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.693 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 75' ' ' TRP . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 71' ' ' PHE . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' THR . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.64 ' ND2' HG23 ' A' ' 6' ' ' THR . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.749 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 5' ' ' PRO . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.462 HD12 ' NE2' ' A' ' 181' ' ' HIS . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 143' ' ' VAL . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 8.4 tp-100 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.44 ' H ' ' HB2' ' A' ' 180' ' ' LEU . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.594 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.462 ' NE2' HD12 ' A' ' 150' ' ' LEU . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.581 HG22 ' CE1' ' A' ' 190' ' ' PHE . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 188' ' ' THR . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 184' ' ' VAL . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 208' ' ' LEU . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.44 ' HE1' ' HG ' ' A' ' 13' ' ' SER . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 223' ' ' ALA . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 194' ' ' ILE . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.59 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 241' ' ' SER . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 279' ' ' LEU . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 259' ' ' LEU . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 258' ' ' THR . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 263' ' ' LEU . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.661 ' H ' ' CE1' ' A' ' 273' ' ' HIS . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . . . . . . 0 N--CA 1.425 -2.1 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' HIS . . . . . 0.661 ' CE1' ' H ' ' A' ' 264' ' ' ASP . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.486 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 27' ' ' ILE . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 257' ' ' LEU . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 141' ' ' ALA . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HD13 ' A' ' 150' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 3.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 ' HB2' ' A' ' 277' ' ' LEU . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 39' ' ' LEU . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' THR . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.582 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.47 HD12 ' CE3' ' A' ' 75' ' ' TRP . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 87' ' ' VAL . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.47 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 71' ' ' PHE . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 119' ' ' LYS . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 102' ' ' SER . 68.4 mttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.576 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' H ' ' HA3' ' A' ' 94' ' ' GLY . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.557 ' ND2' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' GLY . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.576 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.79 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.862 HD13 HD23 ' A' ' 10' ' ' LEU . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 157' ' ' PHE . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 184' ' ' VAL . 0.3 OUTLIER -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.439 ' N ' HD21 ' A' ' 168' ' ' ASN . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' HD12 ' A' ' 150' ' ' LEU . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.612 HG22 ' HA2' ' A' ' 192' ' ' GLY . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.777 HG13 ' CE2' ' A' ' 190' ' ' PHE . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.777 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.612 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.727 HG23 ' CE2' ' A' ' 178' ' ' PHE . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.709 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.504 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.616 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.58 HD12 ' CG1' ' A' ' 237' ' ' VAL . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.624 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.624 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.696 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.58 ' CG1' HD12 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 217' ' ' THR . 6.7 p-10 -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.568 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 241' ' ' SER . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m . . . . . 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.407 ' HB3' ' CG ' ' A' ' 24' ' ' PHE . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 120.164 -0.242 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.705 ' HB2' HG23 ' A' ' 27' ' ' ILE . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.716 ' CB ' HD11 ' A' ' 10' ' ' LEU . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.815 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.716 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.721 ' N ' ' HG ' ' A' ' 260' ' ' SER . 48.3 m-85 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.687 HG23 ' HB3' ' A' ' 277' ' ' LEU . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 42' ' ' THR . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.49 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.542 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD2' HG23 ' A' ' 116' ' ' THR . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 HD12 ' HE1' ' A' ' 131' ' ' PHE . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 97' ' ' LEU . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.588 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE1' HD12 ' A' ' 114' ' ' ILE . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 160' ' ' ALA . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.552 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.602 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.658 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 142' ' ' LEU . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.552 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.504 ' CD1' HG22 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 134' ' ' ALA . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.51 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.51 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 192' ' ' GLY . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.649 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.649 ' CE2' HG13 ' A' ' 184' ' ' VAL . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.465 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.465 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.822 ' ND2' HD12 ' A' ' 242' ' ' LEU . 13.6 p30 -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.504 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.822 HD12 ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 262' ' ' LEU . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.483 HG22 ' NZ ' ' A' ' 256' ' ' LYS . 72.6 p . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.483 ' NZ ' HG22 ' A' ' 250' ' ' THR . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 279' ' ' LEU . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.721 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.501 HD12 ' HA3' ' A' ' 244' ' ' GLY . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 CA-C-O 120.279 -0.178 . . . . 0.0 113.236 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 25' ' ' GLY . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.687 ' HB3' HG23 ' A' ' 27' ' ' ILE . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 257' ' ' LEU . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.276 0.56 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG21 ' A' ' 143' ' ' VAL . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.712 HG22 ' HA3' ' A' ' 126' ' ' GLY . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD2' HG23 ' A' ' 42' ' ' THR . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 41' ' ' PHE . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 72' ' ' THR . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 87' ' ' VAL . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 61' ' ' LYS . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.712 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.712 HD22 ' CE2' ' A' ' 75' ' ' TRP . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.606 HG23 ' CD2' ' A' ' 71' ' ' PHE . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 96' ' ' LYS . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' N ' HD23 ' A' ' 95' ' ' LEU . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 98' ' ' THR . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.572 ' ND1' ' C ' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.676 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.517 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.719 ' C ' HD12 ' A' ' 150' ' ' LEU . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 149' ' ' TRP . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.676 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.765 ' CE1' HD11 ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.677 HG13 ' CE1' ' A' ' 190' ' ' PHE . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 206' ' ' VAL . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 225' ' ' TYR . 9.2 mp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.579 ' HB ' HD12 ' A' ' 194' ' ' ILE . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.419 HD11 HD11 ' A' ' 194' ' ' ILE . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m . . . . . 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.733 ' CE2' HD21 ' A' ' 202' ' ' LEU . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.779 HD22 ' CG ' ' A' ' 242' ' ' LEU . 14.7 p30 -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.522 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.779 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 262' ' ' LEU . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.48 HG23 ' HZ3' ' A' ' 256' ' ' LYS . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.314 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.48 ' HZ3' HG23 ' A' ' 248' ' ' THR . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 243' ' ' ILE . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 27' ' ' ILE . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.247 0.941 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 2' ' ' ALA . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 4' ' ' PRO . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.656 ' N ' ' HG ' ' A' ' 260' ' ' SER . 84.3 m-85 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 277' ' ' LEU . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' CZ ' ' A' ' 41' ' ' PHE . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' HD22 ' A' ' 39' ' ' LEU . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' THR . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.581 HG23 ' C ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 10.6 m120 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 114' ' ' ILE . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.425 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' CE1' ' A' ' 99' ' ' PHE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' GLY . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB2' HE22 ' A' ' 154' ' ' GLN . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.7 tp-100 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HB3' HH21 ' A' ' 163' ' ' ARG . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.586 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.481 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 190' ' ' PHE . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 188' ' ' THR . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 186' ' ' ASP . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.667 HD12 ' HB ' ' A' ' 206' ' ' VAL . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.687 ' H ' HD12 ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 220' ' ' GLY . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 206' ' ' VAL . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.676 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.63 ' HB3' HD23 ' A' ' 202' ' ' LEU . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 250' ' ' THR . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 238' ' ' ASN . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.656 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 242' ' ' LEU . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.41 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.551 ' HB2' HG23 ' A' ' 27' ' ' ILE . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.848 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.652 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 5' ' ' PRO . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.682 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' N ' ' HG ' ' A' ' 260' ' ' SER . 71.3 m-85 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 277' ' ' LEU . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 42' ' ' THR . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.473 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 48' ' ' ASN . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' SER . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' O ' ' OG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.525 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.663 ' CE2' HG23 ' A' ' 85' ' ' ILE . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' OE2' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.663 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.41 HG21 ' HE2' ' A' ' 96' ' ' LYS . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 96' ' ' LYS . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.709 ' N ' HD23 ' A' ' 95' ' ' LEU . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.51 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.135 0.017 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' H ' HG13 ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 135' ' ' GLY . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.682 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 4' ' ' PRO . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 170' ' ' ALA . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 134' ' ' ALA . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.541 ' HB3' ' HA3' ' A' ' 152' ' ' GLY . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.511 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.593 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.511 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 190' ' ' PHE . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 208' ' ' LEU . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 225' ' ' TYR . 55.7 tp . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.529 ' HB ' HD12 ' A' ' 194' ' ' ILE . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 194' ' ' ILE . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.464 ' CD1' HD13 ' A' ' 202' ' ' LEU . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HB1' ' OH ' ' A' ' 247' ' ' TYR . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 243' ' ' ILE . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.611 HD21 ' CD1' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 HG13 ' A' ' 237' ' ' VAL . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.429 ' OH ' ' HB1' ' A' ' 231' ' ' ALA . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.493 ' C ' HD22 ' A' ' 259' ' ' LEU . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 27' ' ' ILE . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.232 0.539 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 222' ' ' ALA . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 262' ' ' LEU . 64.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 41' ' ' PHE . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.507 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' THR . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 3.2 m120 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 50' ' ' GLU . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.507 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.621 ' CD2' HD22 ' A' ' 81' ' ' LEU . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 75' ' ' TRP . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' CE1' ' A' ' 71' ' ' PHE . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 117' ' ' GLY . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 98' ' ' THR . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 133' ' ' ILE . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.412 ' N ' ' OD2' ' A' ' 132' ' ' ASP . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.637 ' HB3' HD22 ' A' ' 156' ' ' ASN . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' NE ' ' OD1' ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.546 ' CG1' HD22 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.483 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.637 HD22 ' HB3' ' A' ' 137' ' ' SER . 0.3 OUTLIER -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.512 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 11.1 m120 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.525 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 190' ' ' PHE . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.598 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 184' ' ' VAL . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 206' ' ' VAL . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 3.3 tp60 -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 10.4 tp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.266 0.555 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.58 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 194' ' ' ILE . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 202' ' ' LEU . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.566 ' HB2' HD22 ' A' ' 202' ' ' LEU . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.652 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.472 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.89 HD21 HD13 ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 262' ' ' LEU . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 24' ' ' PHE . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.695 0 CA-C-O 120.846 0.355 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' HD22 ' A' ' 150' ' ' LEU . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.0 t80 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 277' ' ' LEU . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 41' ' ' PHE . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 39' ' ' LEU . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 42' ' ' THR . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' H ' HG21 ' A' ' 77' ' ' THR . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.474 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.649 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 9.8 m-20 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 75' ' ' TRP . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 122.151 0.977 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' THR . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HZ1' ' HB3' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.656 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 4' ' ' PRO . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 165' ' ' THR . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB2' HD12 ' A' ' 180' ' ' LEU . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 173' ' ' TYR . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.685 ' CE1' HD11 ' A' ' 10' ' ' LEU . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.663 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 190' ' ' PHE . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 206' ' ' VAL . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.562 ' NE2' ' CE1' ' A' ' 178' ' ' PHE . 55.4 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 204' ' ' THR . 57.0 tp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.444 ' CG2' HD11 ' A' ' 202' ' ' LEU . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.668 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.694 HG23 ' HD2' ' A' ' 229' ' ' PRO 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.694 ' HD2' HG23 ' A' ' 227' ' ' ILE . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.708 HD21 HD13 ' A' ' 242' ' ' LEU . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.561 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.491 ' H ' ' HB2' ' A' ' 274' ' ' LYS . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 112.388 -0.285 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.533 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . . . . . . . . 0 C--O 1.243 0.72 0 CA-C-O 121.145 0.497 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.477 HG23 ' NZ ' ' A' ' 115' ' ' LYS . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' HB3' ' HG ' ' A' ' 260' ' ' SER . 28.4 m-85 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 HD12 ' A' ' 277' ' ' LEU . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 41' ' ' PHE . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE1' HD22 ' A' ' 39' ' ' LEU . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 50' ' ' GLU . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.493 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.442 ' CE2' HD22 ' A' ' 81' ' ' LEU . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 75' ' ' TRP . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 71' ' ' PHE . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 . . . . . 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 103' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' NZ ' HG23 ' A' ' 6' ' ' THR . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.428 HG21 ' OD1' ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.493 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 7' ' ' TYR . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.456 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.65 ' NZ ' ' HB2' ' A' ' 2' ' ' ALA . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.821 HG21 ' CE1' ' A' ' 178' ' ' PHE . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.821 ' CE1' HG21 ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.534 HG22 ' HA3' ' A' ' 192' ' ' GLY . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 188' ' ' THR . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.534 ' HA3' HG22 ' A' ' 182' ' ' THR . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 56.9 tp . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 204' ' ' THR . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.469 ' HB1' ' HZ2' ' A' ' 236' ' ' LYS . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' A' ' 202' ' ' LEU . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.469 ' HZ2' ' HB1' ' A' ' 222' ' ' ALA . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.912 HD21 HD13 ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.912 HD13 HD21 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' THR . . . . . 0.41 HG23 ' OG1' ' A' ' 258' ' ' THR . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 250' ' ' THR . 5.6 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.631 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 248' ' ' THR . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 277' ' ' LEU . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.506 ' HG ' ' HB3' ' A' ' 24' ' ' PHE . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.415 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 27' ' ' ILE . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 4' ' ' PRO . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.596 ' C ' HG23 ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' HD3' ' A' ' 61' ' ' LYS . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.636 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.636 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 69' ' ' LEU . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 58' ' ' LEU . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 53.5 m-20 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG23 ' CD2' ' A' ' 71' ' ' PHE . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HE3' ' HZ2' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.391 0.139 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HZ2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.536 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.63 ' C ' HD22 ' A' ' 144' ' ' LEU . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 143' ' ' VAL . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.7 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.438 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' ILE . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.577 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.431 HG22 ' CD2' ' A' ' 190' ' ' PHE . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 184' ' ' VAL . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.403 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' HB1' ' A' ' 223' ' ' ALA . 45.1 tp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 202' ' ' LEU . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.56 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.964 HD21 HD13 ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 242' ' ' LEU . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 27' ' ' ILE . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' C ' HD21 ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 4' ' ' PRO . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 17' ' ' VAL . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 13' ' ' SER . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.753 ' N ' ' HG ' ' A' ' 260' ' ' SER . 66.4 m-85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 ' CE1' ' A' ' 41' ' ' PHE . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' CE1' HD22 ' A' ' 39' ' ' LEU . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.434 ' OG ' HD23 ' A' ' 58' ' ' LEU . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.41 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.52 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.494 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.494 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.6 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.52 ' CE3' HD12 ' A' ' 58' ' ' LEU . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.598 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 101' ' ' SER . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 69' ' ' LEU . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 93' ' ' ARG . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 98' ' ' THR . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 83' ' ' THR . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' O ' ' HA3' ' A' ' 94' ' ' GLY . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.536 HD21 ' C ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.8 tp-100 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.43 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.46 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 192' ' ' GLY . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' A' ' 184' ' ' VAL . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 206' ' ' VAL . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 225' ' ' TYR . 9.7 mp . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.647 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m . . . . . 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.658 ' CD1' HD11 ' A' ' 202' ' ' LEU . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.782 HD21 HD13 ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.594 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.782 HD13 HD21 ' A' ' 238' ' ' ASN . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.499 ' O ' HD23 ' A' ' 262' ' ' LEU . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.431 ' C ' HD22 ' A' ' 259' ' ' LEU . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.753 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 24' ' ' PHE . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.646 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 276' ' ' GLY . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 143' ' ' VAL . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.685 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.492 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.658 ' N ' ' HG ' ' A' ' 260' ' ' SER . 69.2 m-85 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 277' ' ' LEU . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' THR . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' LEU . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.522 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 87' ' ' VAL . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 85' ' ' ILE . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.556 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 75' ' ' TRP . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 71' ' ' PHE . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HD23 ' A' ' 69' ' ' LEU . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.44 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' A' ' 99' ' ' PHE . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.479 ' NH1' HD21 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 5' ' ' PRO . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.535 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.698 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.479 HD21 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 164' ' ' VAL . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 180' ' ' LEU . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.515 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 173' ' ' TYR . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' A' ' 190' ' ' PHE . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HB3' ' OG1' ' A' ' 204' ' ' THR . 0.6 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.107 0.48 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 203' ' ' GLU . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m . . . . . 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.213 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.696 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 276' ' ' GLY . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 ' NE2' ' A' ' 181' ' ' HIS . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 60.5 t80 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.656 HD22 ' CE2' ' A' ' 41' ' ' PHE . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE2' HD22 ' A' ' 39' ' ' LEU . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' C ' ' A' ' 50' ' ' GLU . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' SER . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.566 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.482 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 87' ' ' VAL . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.629 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' THR . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.446 ' HG ' ' HE2' ' A' ' 103' ' ' PHE . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HE2' ' HG ' ' A' ' 101' ' ' SER . 3.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.614 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 185' ' ' ASN . 17.0 m120 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.733 ' HB2' HD12 ' A' ' 180' ' ' LEU . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.623 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.623 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 173' ' ' TYR . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.517 ' NE2' HD21 ' A' ' 10' ' ' LEU . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 9.4 p30 -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.493 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.502 ' HA ' HD21 ' A' ' 168' ' ' ASN . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 208' ' ' LEU . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 220' ' ' GLY . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 194' ' ' ILE . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.523 ' CD2' HG22 ' A' ' 227' ' ' ILE . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 225' ' ' TYR 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' CD ' ' A' ' 274' ' ' LYS . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.57 ' CD ' HD23 ' A' ' 262' ' ' LEU . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 27' ' ' ILE . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.534 ' HA ' HD22 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 181' ' ' HIS . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HB1' ' A' ' 222' ' ' ALA . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 4.0 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 42' ' ' THR . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.48 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.526 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.508 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.476 ' CD2' HD22 ' A' ' 81' ' ' LEU . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 75' ' ' TRP . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG23 ' CD2' ' A' ' 71' ' ' PHE . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 117' ' ' GLY . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 98' ' ' THR . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.599 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.541 ' O ' ' CZ ' ' A' ' 118' ' ' TYR . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.552 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' A' ' 3' ' ' VAL . 3.5 m-80 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.538 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 170' ' ' ALA . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.3 tp-100 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.731 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.445 ' H ' ' HB3' ' A' ' 154' ' ' GLN . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.666 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.474 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 10' ' ' LEU . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.601 HG22 ' HA2' ' A' ' 192' ' ' GLY . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.667 HG13 ' CE1' ' A' ' 190' ' ' PHE . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.667 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 206' ' ' VAL . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.66 HD21 ' CE2' ' A' ' 225' ' ' TYR . 10.3 mp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 223' ' ' ALA . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.702 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m . . . . . 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.66 ' CE2' HD21 ' A' ' 202' ' ' LEU . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 225' ' ' TYR 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.584 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.622 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.622 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.699 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.428 HD23 ' CD ' ' A' ' 274' ' ' LYS . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 120.282 -0.177 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.428 ' CD ' HD23 ' A' ' 262' ' ' LEU . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.405 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 27' ' ' ILE . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.535 ' C ' HD12 ' A' ' 279' ' ' LEU . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 278' ' ' GLY . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 6' ' ' THR . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 17' ' ' VAL . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 13' ' ' SER . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 t80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 277' ' ' LEU . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' A' ' 41' ' ' PHE . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 72' ' ' THR . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 61' ' ' LYS . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 71' ' ' PHE . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' C ' HD13 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.618 ' HG2' HD21 ' A' ' 124' ' ' ASN . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.618 HD21 ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 135' ' ' GLY . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.586 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' ILE . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.602 HD21 ' HB2' ' A' ' 166' ' ' GLN . 2.0 m-20 -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.602 ' HB2' HD21 ' A' ' 156' ' ' ASN . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.492 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 192' ' ' GLY . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.699 HG13 ' CE1' ' A' ' 190' ' ' PHE . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.699 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.568 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' A' ' 207' ' ' ASN . 8.0 m120 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.608 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.48 ' CZ ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 227' ' ' ILE . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.458 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.53 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 217' ' ' THR . 3.2 p-10 -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 262' ' ' LEU . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 262' ' ' LEU . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 120.05 -0.306 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 279' ' ' LEU . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.446 ' OD2' ' OG ' ' A' ' 241' ' ' SER . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.598 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 27' ' ' ILE . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.431 ' CD2' HD12 ' A' ' 257' ' ' LEU . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.711 HD21 ' HB ' ' A' ' 143' ' ' VAL . 4.1 m-80 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 124' ' ' ASN . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 5.1 tp-100 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.628 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.628 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 242' ' ' LEU . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.443 ' CG ' HD11 ' A' ' 242' ' ' LEU . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.711 HD21 ' HB ' ' A' ' 143' ' ' VAL . 4.1 m-80 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 124' ' ' ASN . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 5.1 tp-100 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.628 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.628 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 242' ' ' LEU . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.443 ' CG ' HD11 ' A' ' 242' ' ' LEU . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.719 ' N ' ' HZ1' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.643 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 . . . . . 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CB ' ' HG ' ' A' ' 260' ' ' SER . 10.8 m-85 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.658 HD22 ' CE1' ' A' ' 41' ' ' PHE . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE1' HD22 ' A' ' 39' ' ' LEU . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.781 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.556 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 HG22 ' A' ' 87' ' ' VAL . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.627 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' CD2' ' A' ' 71' ' ' PHE . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 HD23 ' A' ' 69' ' ' LEU . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD2' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 95' ' ' LEU . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 98' ' ' THR . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 102' ' ' SER . 98.1 mttt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.719 ' HZ1' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 10' ' ' LEU . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 183' ' ' ASN . 10.2 m120 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.617 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 194' ' ' ILE . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 179' ' ' GLN . 22.1 m-70 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.686 HD22 ' HB3' ' A' ' 168' ' ' ASN . 13.7 t-20 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 202' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 194' ' ' ILE . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.629 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 54.7 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.629 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.789 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.789 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.488 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' THR . . . . . 0.593 ' O ' HD23 ' A' ' 277' ' ' LEU . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.651 ' HG ' ' CB ' ' A' ' 24' ' ' PHE . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.646 ' HB2' HG23 ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.754 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.52 ' CA ' ' HZ1' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.732 ' N ' ' HG ' ' A' ' 260' ' ' SER . 71.9 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 41' ' ' PHE . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 60' ' ' THR . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.588 ' CB ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.524 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.595 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE2' HG23 ' A' ' 85' ' ' ILE . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' CE2' HD22 ' A' ' 81' ' ' LEU . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.774 HD12 ' CE2' ' A' ' 131' ' ' PHE . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HZ1' ' CA ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.774 ' CE2' HD12 ' A' ' 114' ' ' ILE . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.739 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.699 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.436 HD11 ' HE3' ' A' ' 174' ' ' LYS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.739 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 150' ' ' LEU . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.875 ' CE1' HG23 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.7 mm100 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 173' ' ' TYR . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.526 HG22 ' HA2' ' A' ' 192' ' ' GLY . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 190' ' ' PHE . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' HD2' HG22 ' A' ' 184' ' ' VAL . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.875 HG23 ' CE1' ' A' ' 178' ' ' PHE . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 225' ' ' TYR . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.53 ' CE1' HD11 ' A' ' 202' ' ' LEU . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 227' ' ' ILE 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.598 ' OG ' HD13 ' A' ' 242' ' ' LEU . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.626 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 241' ' ' SER . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 262' ' ' LEU . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 78.2 p . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.732 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 CA-C-O 120.152 -0.249 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 27' ' ' ILE . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-O 120.947 0.404 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 3' ' ' VAL . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.607 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 17' ' ' VAL . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' SER . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' N ' ' HG ' ' A' ' 260' ' ' SER . 45.9 m-85 . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.638 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.642 HD22 ' CE2' ' A' ' 41' ' ' PHE . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.642 ' CE2' HD22 ' A' ' 39' ' ' LEU . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.48 HD22 ' CE3' ' A' ' 75' ' ' TRP . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' THR . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.621 ' CD2' HG12 ' A' ' 87' ' ' VAL . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 85' ' ' ILE . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.48 ' CE3' HD22 ' A' ' 58' ' ' LEU . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 71' ' ' PHE . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 122.416 1.103 . . . . 0.0 113.787 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' ARG . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HD21 ' A' ' 124' ' ' ASN . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.662 HD21 ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.746 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 183' ' ' ASN . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' A' ' 175' ' ' THR . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 194' ' ' ILE . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.549 ' CE1' HD22 ' A' ' 10' ' ' LEU . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 180' ' ' LEU . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.0 tp . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 223' ' ' ALA . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 227' ' ' ILE . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 225' ' ' TYR 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 231' ' ' ALA . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 230' ' ' ASP . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.599 HD21 ' CG ' ' A' ' 242' ' ' LEU . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.599 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 256' ' ' LYS . 85.5 m . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 27' ' ' ILE . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . -61.26 -35.71 78.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' C ' HD22 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.729 ' O ' HG23 ' A' ' 6' ' ' THR . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 5' ' ' PRO . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.749 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HG ' ' HE1' ' A' ' 195' ' ' TYR . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 19' ' ' THR . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 -63.66 -44.29 94.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 15' ' ' ARG . 60.5 p -61.47 -50.74 71.55 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -53.1 139.07 29.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.12 -122.39 25.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CE2' ' CZ ' ' A' ' 18' ' ' PHE . 84.7 t80 56.09 102.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.98 0.39 . . . . 0.0 110.441 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 97.86 1.07 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -113.41 -138.84 0.38 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 40' ' ' GLU . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 35' ' ' SER . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.465 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.693 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 75' ' ' TRP . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 71' ' ' PHE . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 62.01 40.2 12.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.514 ' HB2' HD23 ' A' ' 95' ' ' LEU . 49.9 mt-30 -69.72 -39.14 77.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.286 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 53.4 tp -89.26 -67.11 0.86 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.086 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 176.64 -41.31 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.893 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -76.76 -80.17 0.1 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 90' ' ' GLN . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' THR . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -109.36 106.58 16.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.66 32.23 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 107' ' ' THR . 83.5 Cg_exo -39.36 -49.65 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 124.094 3.196 . . . . 0.0 114.709 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 95.3 m-20 -36.44 93.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' PRO . 43.6 p 34.13 45.84 0.13 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.79 48.14 86.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' ASN . 88.7 tttt -65.22 114.06 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.64 ' ND2' HG23 ' A' ' 6' ' ' THR . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.749 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 5' ' ' PRO . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.462 HD12 ' NE2' ' A' ' 181' ' ' HIS . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 143' ' ' VAL . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 8.4 tp-100 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 184' ' ' VAL . 0.1 OUTLIER -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.44 ' H ' ' HB2' ' A' ' 180' ' ' LEU . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.594 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.462 ' NE2' HD12 ' A' ' 150' ' ' LEU . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.581 HG22 ' CE1' ' A' ' 190' ' ' PHE . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 188' ' ' THR . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 184' ' ' VAL . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 208' ' ' LEU . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.44 ' HE1' ' HG ' ' A' ' 13' ' ' SER . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt -85.86 98.53 10.82 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.73 -41.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.321 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.8 t30 -168.72 -169.61 1.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 98.8 mttt -62.3 -42.08 99.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.829 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -97.62 -5.67 34.97 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.57 110.47 17.97 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 223' ' ' ALA . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 194' ' ' ILE . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -129.63 115.43 17.37 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 190' ' ' PHE . . . -41.93 100.41 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.681 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 211' ' ' THR . . . 173.88 -158.68 27.78 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -99.39 10.02 42.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.0 p -78.24 166.23 22.97 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.59 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 241' ' ' SER . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m -98.72 118.64 35.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.661 HD12 ' HB ' ' A' ' 255' ' ' ILE . 44.4 mt -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 119.254 -0.403 . . . . 0.0 111.537 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.97 -54.43 11.17 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 88.5 Cg_exo -38.69 -15.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.508 2.139 . . . . 0.0 112.681 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 94.95 33.69 6.53 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.541 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 251' ' ' LEU . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 279' ' ' LEU . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 259' ' ' LEU . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 258' ' ' THR . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 263' ' ' LEU . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.735 ' O ' ' N ' ' A' ' 268' ' ' VAL . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.41 -20.3 10.51 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -95.06 -12.26 26.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.555 ' CB ' ' HB3' ' A' ' 270' ' ' ALA . 4.1 m-20 -137.97 27.62 2.66 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.283 177.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.735 ' N ' ' O ' ' A' ' 264' ' ' ASP . 4.8 t -65.05 -26.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 CA-C-N 120.159 1.345 . . . . 0.0 107.616 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -93.61 -4.06 51.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.449 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 267' ' ' ASN . . . -106.29 -35.24 7.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . 110.92 -122.33 6.14 Favored Glycine 0 C--N 1.366 2.213 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' HIS . . . . . 0.661 ' CE1' ' H ' ' A' ' 264' ' ' ASP . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.486 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 27' ' ' ILE . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 257' ' ' LEU . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 47.52 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.443 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.723 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.33 139.84 52.1 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.2 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 141' ' ' ALA . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HD13 ' A' ' 150' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 19' ' ' THR . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 -68.55 -46.94 68.15 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 15' ' ' ARG . 54.5 p -68.73 -45.82 70.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.79 -44.02 63.28 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.816 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' TYR . . . -77.28 -133.14 0.59 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 23' ' ' GLY . 8.6 t80 147.41 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.221 0.608 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' N ' ' CD2' ' A' ' 22' ' ' TYR . . . -166.92 173.34 42.22 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' H ' HD12 ' A' ' 262' ' ' LEU . 3.1 m-85 -118.75 -175.74 2.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 ' HB2' ' A' ' 277' ' ' LEU . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 39' ' ' LEU . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' THR . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.582 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.47 HD12 ' CE3' ' A' ' 75' ' ' TRP . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 87' ' ' VAL . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.47 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 71' ' ' PHE . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.41 53.71 9.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HB2' HD13 ' A' ' 95' ' ' LEU . 71.3 mt-30 -60.28 -10.12 4.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 27.6 tp -148.96 40.32 0.88 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.369 1.08 . . . . 0.0 109.232 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 73.16 -0.24 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.734 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 -139.71 167.11 22.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 119' ' ' LYS . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 90' ' ' GLN . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -106.46 85.42 2.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -107.12 160.56 25.97 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.788 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 104' ' ' SER . 80.7 Cg_exo -37.9 -129.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.53 3.487 . . . . 0.0 114.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.67 -41.83 92.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.555 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.7 p -89.22 166.58 13.71 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 38.61 54.54 2.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -51.77 -112.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.576 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' H ' ' HA3' ' A' ' 94' ' ' GLY . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.557 ' ND2' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' GLY . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.576 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.79 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.862 HD13 HD23 ' A' ' 10' ' ' LEU . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 157' ' ' PHE . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 184' ' ' VAL . 0.3 OUTLIER -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.439 ' N ' HD21 ' A' ' 168' ' ' ASN . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' HD12 ' A' ' 150' ' ' LEU . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.612 HG22 ' HA2' ' A' ' 192' ' ' GLY . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.459 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.777 HG13 ' CE2' ' A' ' 190' ' ' PHE . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.777 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.612 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.727 HG23 ' CE2' ' A' ' 178' ' ' PHE . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt -101.05 100.34 10.92 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.47 -43.55 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.24 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.483 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.9 t30 -165.82 -170.29 1.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.483 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 88.8 tttt -61.21 -41.12 96.29 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.708 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -97.05 -8.53 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt -117.97 106.32 12.82 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.709 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.578 ' CH2' ' O ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m -144.16 105.84 4.3 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.578 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 43.98 -156.65 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.85 52.95 0.16 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.495 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.508 ' O ' ' CE3' ' A' ' 210' ' ' TRP . 83.9 m-20 -128.4 132.37 48.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.4 m -81.7 -3.64 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.49 110.8 20.01 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.727 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.616 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.58 HD12 ' CG1' ' A' ' 237' ' ' VAL . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.624 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.624 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.696 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.58 ' CG1' HD12 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 217' ' ' THR . 6.7 p-10 -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.568 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 241' ' ' SER . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.689 ' CG2' HD21 ' A' ' 251' ' ' LEU . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m 91.69 -104.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 248' ' ' THR . 20.4 mt 71.01 -151.77 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.971 0.415 . . . . 0.0 110.24 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.635 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 59.88 145.77 0.06 OUTLIER Pre-proline 0 N--CA 1.445 -0.709 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 252' ' ' LYS . 74.2 Cg_exo -39.04 85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.306 1.338 . . . . 0.0 111.227 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -178.63 -113.48 0.37 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.852 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.471 ' HG2' HD23 ' A' ' 251' ' ' LEU . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.407 ' HB3' ' CG ' ' A' ' 24' ' ' PHE . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 24' ' ' PHE . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.5 93.64 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.7 mttt -84.38 -7.69 59.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.572 1.686 . . . . 0.0 109.566 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 -24.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 266' ' ' LYS . 69.1 t -74.76 -37.17 42.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 118.471 0.578 . . . . 0.0 109.877 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -63.51 -44.4 94.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.56 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -84.93 -35.65 21.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.226 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.02 -9.65 2.84 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.57 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.705 ' HB2' HG23 ' A' ' 27' ' ' ILE . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . 73.13 113.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -82.2 147.06 29.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.826 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.66 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.16 139.9 57.48 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.529 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.716 ' CB ' HD11 ' A' ' 10' ' ' LEU . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.815 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.716 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.551 ' C ' HG23 ' A' ' 19' ' ' THR . 89.3 t80 -61.68 -48.67 79.76 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 18' ' ' PHE . 1.1 p 68.4 166.49 0.25 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 120.992 0.425 . . . . 0.0 112.095 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -65.86 -43.21 89.09 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 22' ' ' TYR . . . -172.43 -56.88 0.04 OUTLIER Glycine 0 CA--C 1.542 1.761 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' GLY . 58.6 t80 56.22 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.492 1.146 . . . . 0.0 110.512 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 72.18 -115.34 5.39 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.003 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 48.3 m-85 17.8 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.687 HG23 ' HB3' ' A' ' 277' ' ' LEU . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 285' ' ' SER . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 42' ' ' THR . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.49 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.542 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 73.38 46.22 0.23 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' CB ' HD23 ' A' ' 95' ' ' LEU . 77.9 mm-40 -90.21 -38.85 13.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CE1' ' A' ' 118' ' ' TYR . 48.7 tp -83.57 -70.56 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 175.95 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.927 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -82.49 -63.92 1.28 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.589 HD23 ' CB ' ' A' ' 90' ' ' GLN . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD2' HG23 ' A' ' 116' ' ' THR . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.63 90.36 3.33 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.0 160.86 54.37 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.518 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' SER . 94.3 Cg_exo -37.5 175.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.76 2.973 . . . . 0.0 113.505 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -48.3 -31.03 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.234 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.7 m -62.16 -45.01 95.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.788 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.33 -172.11 43.01 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.04 -165.42 1.79 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 HD12 ' HE1' ' A' ' 131' ' ' PHE . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 97' ' ' LEU . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.588 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.684 ' CE1' HD23 ' A' ' 91' ' ' LEU . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE1' HD12 ' A' ' 114' ' ' ILE . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 160' ' ' ALA . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.552 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.602 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.658 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 142' ' ' LEU . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.552 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.504 ' CD1' HG22 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 134' ' ' ALA . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.51 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.51 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 192' ' ' GLY . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.649 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.649 ' CE2' HG13 ' A' ' 184' ' ' VAL . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.465 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.58 93.1 4.94 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.477 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 67.6 t -74.33 -46.74 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.158 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 84.2 m-20 -160.13 -174.45 4.55 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.85 -39.56 89.59 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.962 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.96 -8.92 38.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp -126.88 107.25 9.93 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.465 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m -137.75 112.54 8.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -43.59 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.082 0.467 . . . . 0.0 109.91 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.74 -153.41 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -101.15 11.62 39.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.668 0.734 . . . . 0.0 109.939 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.518 ' O ' ' CZ3' ' A' ' 210' ' ' TRP . 18.6 p -81.97 165.32 20.81 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.384 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -89.75 -177.61 5.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.822 ' ND2' HD12 ' A' ' 242' ' ' LEU . 13.6 p30 -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.504 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.822 HD12 ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 262' ' ' LEU . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.483 HG22 ' NZ ' ' A' ' 256' ' ' LYS . 72.6 p -96.52 130.59 43.66 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 255' ' ' ILE . 2.0 mm? -110.47 127.02 54.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.692 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.93 -54.25 11.42 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 89.5 Cg_exo -40.33 -19.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.169 1.912 . . . . 0.0 112.982 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 101.35 32.88 5.05 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.52 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.483 ' NZ ' HG22 ' A' ' 250' ' ' THR . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 279' ' ' LEU . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' PHE . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.501 HD12 ' HA3' ' A' ' 244' ' ' GLY . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -17.9 -83.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.17 2.08 54.72 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.787 1.794 . . . . 0.0 111.073 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 271' ' ' GLY . 74.2 m-20 63.7 -3.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.308 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.75 -40.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.901 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.22 -45.04 89.98 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.748 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.24 -35.75 19.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.581 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 81.73 1.42 90.19 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.236 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 25' ' ' GLY . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.687 ' HB3' HG23 ' A' ' 27' ' ' ILE . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 257' ' ' LEU . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -141.85 146.48 35.87 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.429 ' O ' ' OXT' ' A' ' 285' ' ' SER . 95.8 mtt-85 -101.99 136.71 41.36 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.454 ' OXT' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -71.47 142.5 50.2 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.592 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG21 ' A' ' 143' ' ' VAL . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.712 HG22 ' HA3' ' A' ' 126' ' ' GLY . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' LYS . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 -62.66 -43.14 99.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.5 p -105.55 4.12 30.06 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 16' ' ' ASP . 61.4 tttp -52.37 -44.33 65.22 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.759 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 107.13 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 96.9 m-85 -62.54 -45.85 91.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 24' ' ' PHE . . . 67.04 -128.2 28.3 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 10.6 m-85 36.77 107.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD2' HG23 ' A' ' 42' ' ' THR . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 41' ' ' PHE . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 72' ' ' THR . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 87' ' ' VAL . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 61' ' ' LYS . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.712 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.712 HD22 ' CE2' ' A' ' 75' ' ' TRP . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.606 HG23 ' CD2' ' A' ' 71' ' ' PHE . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 91' ' ' LEU . 86.6 m-20 60.7 60.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.768 ' OE1' HD13 ' A' ' 95' ' ' LEU . 83.0 mt-30 -61.64 26.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.615 -0.834 . . . . 0.0 113.224 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 88.68 -13.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.64 -139.37 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.833 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -84.25 -65.52 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.768 HD13 ' OE1' ' A' ' 90' ' ' GLN . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' N ' HD23 ' A' ' 95' ' ' LEU . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 98' ' ' THR . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.42 104.08 11.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -125.83 161.02 53.61 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 104' ' ' SER . 77.0 Cg_exo -39.16 174.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.833 3.022 . . . . 0.0 112.995 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -46.35 -20.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.458 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.9 p -67.05 -33.82 76.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.063 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -145.27 97.5 0.19 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.5 mttt -54.96 -153.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.572 ' ND1' ' C ' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.676 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.517 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.719 ' C ' HD12 ' A' ' 150' ' ' LEU . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 149' ' ' TRP . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.676 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.765 ' CE1' HD11 ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.677 HG13 ' CE1' ' A' ' 190' ' ' PHE . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 206' ' ' VAL . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.04 98.48 11.79 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 83.7 t -74.36 -42.58 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.781 HD21 HD13 ' A' ' 202' ' ' LEU . 9.8 p30 -168.52 -167.32 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.38 -41.35 98.57 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.146 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.684 ' C ' HD12 ' A' ' 202' ' ' LEU . 98.7 mttt -96.92 -10.97 25.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.781 HD13 HD21 ' A' ' 199' ' ' ASN . 9.2 mp -115.62 113.8 24.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.579 ' HB ' HD12 ' A' ' 194' ' ' ILE . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.419 HD11 HD11 ' A' ' 194' ' ' ILE . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m -145.7 106.57 4.13 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -43.36 115.23 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.999 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 121.65 -25.96 6.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -106.35 141.32 37.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.1 p -88.74 -7.27 56.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -104.64 138.69 40.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.176 0.898 . . . . 0.0 112.962 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.733 ' CE2' HD21 ' A' ' 202' ' ' LEU . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.779 HD22 ' CG ' ' A' ' 242' ' ' LEU . 14.7 p30 -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.522 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.779 ' CG ' HD22 ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 262' ' ' LEU . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.48 HG23 ' HZ3' ' A' ' 256' ' ' LYS . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m -85.84 86.74 7.35 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 252' ' ' LYS . 55.7 tp -79.4 101.72 8.3 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.261 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 62.11 126.88 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.49 -11.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.113 1.209 . . . . 0.0 112.606 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -90.66 -43.57 4.8 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.763 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 251' ' ' LEU . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.48 ' HZ3' HG23 ' A' ' 248' ' ' THR . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 243' ' ' ILE . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.36 98.31 Favored Glycine 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.4 mttp -83.45 -8.62 59.34 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 118.803 1.302 . . . . 0.0 109.803 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 55.67 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.9 t -77.14 -37.21 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.862 0.755 . . . . 0.0 110.634 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.57 -45.04 92.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.014 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.25 -35.71 19.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.788 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.8 -6.97 0.76 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.462 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 27' ' ' ILE . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.09 33.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.7 138.43 48.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.626 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.732 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -69.42 140.54 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.95 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 2' ' ' ALA . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 4' ' ' PRO . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 19' ' ' THR . 87.6 t80 -62.83 -46.92 85.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.573 HG22 ' N ' ' A' ' 20' ' ' LYS . 73.8 m 2.02 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' N ' HG22 ' A' ' 19' ' ' THR . 98.7 mttt -146.16 -1.53 0.74 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.018 0.437 . . . . 0.0 110.051 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.15 -166.18 52.71 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -135.26 137.72 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 97.58 -102.73 2.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.307 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 84.3 m-85 19.9 79.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 277' ' ' LEU . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' CZ ' ' A' ' 41' ' ' PHE . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' HD22 ' A' ' 39' ' ' LEU . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' THR . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.581 HG23 ' C ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 10.6 m120 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.64 46.98 16.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.53 ' HB2' HD23 ' A' ' 95' ' ' LEU . 81.8 mt-30 -56.65 -19.92 18.8 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 82.7 mt -140.27 41.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.736 0.779 . . . . 0.0 110.399 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 75.18 -6.95 1.86 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.212 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 -140.49 175.3 9.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HG ' HE22 ' A' ' 90' ' ' GLN . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 114' ' ' ILE . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 -113.37 86.84 2.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -93.07 160.99 32.48 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.341 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 104' ' ' SER . 92.6 Cg_exo -37.91 172.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.866 3.044 . . . . 0.0 113.327 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 107' ' ' THR . 51.7 p30 -46.88 -30.49 2.55 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.69 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 73.3 m -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.47 -179.88 49.32 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.39 153.86 51.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.425 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' CE1' ' A' ' 99' ' ' PHE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' GLY . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB2' HE22 ' A' ' 154' ' ' GLN . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.7 tp-100 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HB3' HH21 ' A' ' 163' ' ' ARG . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.586 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.481 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 190' ' ' PHE . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 188' ' ' THR . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 186' ' ' ASP . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.667 HD12 ' HB ' ' A' ' 206' ' ' VAL . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -108.4 104.69 14.11 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 201' ' ' LYS . 38.9 t -70.99 -41.8 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 29.9 t30 90.23 -71.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.292 0.37 . . . . 0.0 110.612 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.56 -40.47 89.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.565 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.7 mttt -92.98 -66.17 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER 173.88 -139.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.559 0.618 . . . . 0.0 110.93 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.687 ' H ' HD12 ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 220' ' ' GLY . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 206' ' ' VAL . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m -127.09 117.53 22.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.47 56.19 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.67 22.88 19.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.905 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -60.09 138.15 57.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.1 m -57.74 -35.64 70.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.73 112.19 19.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.676 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.63 ' HB3' HD23 ' A' ' 202' ' ' LEU . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 250' ' ' THR . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 238' ' ' ASN . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m -102.19 109.1 20.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 252' ' ' LYS . 1.0 OUTLIER -75.04 142.18 43.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.421 -177.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -43.84 -54.79 10.16 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.6 Cg_exo -42.05 -114.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.205 2.603 . . . . 0.0 113.168 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -154.05 34.18 0.73 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 242' ' ' LEU . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.46 -41.46 97.11 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.9 mttt -84.53 -9.04 58.69 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 73.9 m-20 56.67 -22.67 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.1 t -75.33 -37.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -63.13 -44.87 94.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.793 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.57 -35.27 19.57 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.832 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.01 -7.06 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.44 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.551 ' HB2' HG23 ' A' ' 27' ' ' ILE . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.24 155.56 44.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.1 mtp180 -86.04 137.46 32.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.814 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.201 0.524 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.848 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -128.99 144.09 51.08 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 5' ' ' PRO . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.682 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 19' ' ' THR . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 -65.25 -44.91 86.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 15' ' ' ARG . 57.9 p -64.95 -45.02 87.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.81 127.19 27.35 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.867 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.57 136.89 3.22 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.254 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.53 160.95 43.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 99.87 -103.44 2.67 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.032 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.3 m-85 27.46 72.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 277' ' ' LEU . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 42' ' ' THR . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.473 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 48' ' ' ASN . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' SER . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' O ' ' OG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.525 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.663 ' CE2' HG23 ' A' ' 85' ' ' ILE . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.516 HG23 ' OG ' ' A' ' 104' ' ' SER . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' OE2' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.663 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.41 HG21 ' HE2' ' A' ' 96' ' ' LYS . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 65.28 55.27 1.1 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' OE1' HD22 ' A' ' 95' ' ' LEU . 77.9 mt-30 -94.78 -33.49 12.86 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 95' ' ' LEU . 8.4 mp -105.02 15.01 28.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.336 0.589 . . . . 0.0 109.908 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 84.45 -36.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.801 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.55 -90.16 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 91' ' ' LEU . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.709 ' N ' HD23 ' A' ' 95' ' ' LEU . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.51 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.93 79.21 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' HG23 ' A' ' 80' ' ' THR . 0.4 OUTLIER -125.61 156.37 70.88 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' ASN . 94.3 Cg_exo -40.67 -36.13 1.78 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.979 3.119 . . . . 0.0 114.684 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 105' ' ' PRO . 99.8 m-20 -43.96 171.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.613 0.244 . . . . 0.0 111.588 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.5 p -62.63 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.782 0.325 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.64 -32.13 72.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 50.27 -114.25 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.962 -0.14 . . . . 0.0 110.97 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' H ' HG13 ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 135' ' ' GLY . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.682 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 4' ' ' PRO . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 170' ' ' ALA . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 134' ' ' ALA . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.541 ' HB3' ' HA3' ' A' ' 152' ' ' GLY . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.511 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.593 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.511 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 190' ' ' PHE . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 208' ' ' LEU . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -90.7 95.19 10.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.62 -43.58 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.06 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 23.2 p30 -159.84 -174.18 4.47 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.06 -40.56 94.12 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.798 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 99.1 mttt -96.85 -8.03 32.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 55.7 tp -120.06 109.3 15.32 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.529 ' HB ' HD12 ' A' ' 194' ' ' ILE . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 194' ' ' ILE . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.13 109.86 6.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 38.58 90.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.471 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.16 162.52 11.45 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -103.76 14.16 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 62.0 p -62.28 -98.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.688 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -96.97 106.95 19.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.464 ' CD1' HD13 ' A' ' 202' ' ' LEU . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HB1' ' OH ' ' A' ' 247' ' ' TYR . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 243' ' ' ILE . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.611 HD21 ' CD1' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 HG13 ' A' ' 237' ' ' VAL . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.429 ' OH ' ' HB1' ' A' ' 231' ' ' ALA . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p -108.47 106.6 16.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 252' ' ' LYS . 7.9 mt -71.47 157.07 38.68 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -42.79 -56.83 5.55 Favored Pre-proline 0 C--N 1.357 0.909 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -41.06 -126.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 123.553 2.835 . . . . 0.0 113.935 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -142.2 32.62 1.97 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.677 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.493 ' C ' HD22 ' A' ' 259' ' ' LEU . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.63 93.94 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 268' ' ' VAL . 51.9 mmtt -84.69 -7.35 59.26 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 119.559 1.68 . . . . 0.0 110.971 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 55.83 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 266' ' ' LYS . 50.0 t -77.92 -34.75 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -64.68 -44.86 89.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.63 -35.85 20.71 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.832 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.95 -5.25 3.74 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.533 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 27' ' ' ILE . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -138.89 146.63 41.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -89.62 138.93 31.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.657 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.748 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.182 0.515 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -150.37 146.5 26.75 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.338 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 19' ' ' THR . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 222' ' ' ALA . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -60.06 -40.64 90.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 15' ' ' ARG . 57.4 p -74.23 -10.05 59.21 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.16 -32.6 23.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.988 -1.485 . . . . 0.0 110.478 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 69.56 -128.6 21.41 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 19.3 m-85 171.62 -179.84 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.26 74.88 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 262' ' ' LEU . 64.4 m-85 33.19 64.75 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 41' ' ' PHE . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.507 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' THR . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 3.2 m120 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 50' ' ' GLU . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.507 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.621 ' CD2' HD22 ' A' ' 81' ' ' LEU . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 75' ' ' TRP . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' CE1' ' A' ' 71' ' ' PHE . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 63.11 45.41 5.2 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.573 ' HB2' HD23 ' A' ' 95' ' ' LEU . 53.2 mt-30 -79.43 -35.89 39.78 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 64.9 tp -90.86 -64.67 1.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 175.29 -43.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.643 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -75.69 -79.08 0.1 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 117' ' ' GLY . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 98' ' ' THR . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.2 102.37 10.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.5 161.0 52.99 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 104' ' ' SER . 76.6 Cg_exo -38.84 176.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 124.235 3.29 . . . . 0.0 113.288 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.5 p30 -45.69 -14.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.858 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' PRO . 30.0 p -68.86 -32.83 72.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.751 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -157.38 94.85 0.14 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 108' ' ' GLY . 71.1 tttt -57.64 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CE2' HD23 ' A' ' 91' ' ' LEU . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 133' ' ' ILE . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.412 ' N ' ' OD2' ' A' ' 132' ' ' ASP . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.637 ' HB3' HD22 ' A' ' 156' ' ' ASN . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' NE ' ' OD1' ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.546 ' CG1' HD22 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.483 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.637 HD22 ' HB3' ' A' ' 137' ' ' SER . 0.3 OUTLIER -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.512 ' N ' HD21 ' A' ' 156' ' ' ASN . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.598 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 11.1 m120 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.525 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 190' ' ' PHE . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.598 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 184' ' ' VAL . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 206' ' ' VAL . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 3.3 tp60 -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.587 ' C ' HG23 ' A' ' 198' ' ' VAL . 64.3 tttm -88.2 109.46 19.94 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 197' ' ' LYS . 8.9 t 93.19 54.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 123.651 0.594 . . . . 0.0 110.729 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.548 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 2.3 t-20 -84.73 -162.68 0.71 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.44 -38.81 92.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.795 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 15.4 mttp -105.18 -5.03 21.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 10.4 tp 143.2 -103.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 119.114 0.87 . . . . 0.0 109.764 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.58 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.548 ' OG1' ' ND2' ' A' ' 199' ' ' ASN . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 194' ' ' ILE . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m -131.81 115.06 15.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.74 41.74 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 0.0 109.729 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.46 24.56 69.4 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.738 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.62 148.31 38.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.9 p -60.49 -33.43 72.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 -84.22 113.48 21.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.007 0.821 . . . . 0.0 112.988 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 202' ' ' LEU . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.566 ' HB2' HD22 ' A' ' 202' ' ' LEU . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . 0.4 ' CB ' ' OH ' ' A' ' 22' ' ' TYR . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.652 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.598 ' NZ ' ' H ' ' A' ' 21' ' ' GLY . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.472 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.89 HD21 HD13 ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 262' ' ' LEU . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m -107.08 123.57 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 255' ' ' ILE . 7.7 mt -104.42 139.77 38.89 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.598 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.6 -53.78 14.16 Favored Pre-proline 0 C--N 1.358 0.94 0 O-C-N 124.63 1.206 . . . . 0.0 108.0 176.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 97.0 Cg_exo -38.84 -19.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.802 2.334 . . . . 0.0 112.955 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 97.76 38.09 4.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.895 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' HB ' HD12 ' A' ' 251' ' ' LEU . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 24' ' ' PHE . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.74 -39.4 95.24 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 268' ' ' VAL . 85.5 mttt -83.16 -7.96 59.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.125 1.463 . . . . 0.0 110.206 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 56.05 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.9 t -78.28 -36.93 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.354 0.525 . . . . 0.0 110.963 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -64.2 -44.22 92.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -85.51 -35.53 21.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.325 -1.35 . . . . 0.0 108.79 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.64 -15.47 0.46 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.321 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 64.6 114.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -79.46 145.23 33.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.708 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.26 149.74 31.43 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.24 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' HD22 ' A' ' 150' ' ' LEU . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 19' ' ' THR . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.0 t80 -62.99 -43.34 99.05 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 15' ' ' ARG . 70.4 p -61.46 -50.18 73.81 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' NZ ' ' NZ ' ' A' ' 224' ' ' LYS . 99.2 mttt -46.96 91.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.19 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 19' ' ' THR . . . -76.18 -80.31 0.6 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.272 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 21' ' ' GLY . 96.8 m-85 44.49 103.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.973 0.386 . . . . 0.0 111.45 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 24' ' ' PHE . . . 111.9 98.46 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.225 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 83.3 m-85 -161.95 30.59 0.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 277' ' ' LEU . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 41' ' ' PHE . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 39' ' ' LEU . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 42' ' ' THR . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' H ' HG21 ' A' ' 77' ' ' THR . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.474 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.649 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 3.3 m120 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 75' ' ' TRP . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.09 -0.87 24.41 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -49.45 -11.11 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 91' ' ' LEU . 96.7 mt -67.42 -4.48 11.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.275 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 93' ' ' ARG . . . -140.16 46.81 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.955 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 55.9 mtt85 133.55 -89.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 124.541 1.151 . . . . 0.0 111.364 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' THR . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.85 115.99 30.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.3 t -115.23 87.57 16.38 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.124 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -41.39 -41.3 5.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.838 2.359 . . . . 0.0 114.459 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' ND2' ' OD1' ' A' ' 79' ' ' ASN . 91.7 m-20 -63.23 -40.84 98.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.943 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.5 p -98.19 -11.55 22.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.146 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.14 30.5 73.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.11 111.14 23.79 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.656 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 4' ' ' PRO . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 165' ' ' THR . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB2' HD12 ' A' ' 180' ' ' LEU . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 173' ' ' TYR . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.685 ' CE1' HD11 ' A' ' 10' ' ' LEU . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.663 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 190' ' ' PHE . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 206' ' ' VAL . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 178' ' ' PHE . 7.1 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -108.39 92.61 4.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.28 -49.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.522 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 199' ' ' ASN . 9.3 t30 173.59 60.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 109.806 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 69.58 -52.81 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.454 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.517 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.4 mttt -64.42 -43.61 93.81 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 204' ' ' THR . 57.0 tp -123.8 118.56 27.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.491 ' OG1' ' NE2' ' A' ' 196' ' ' GLN . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.668 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m -145.3 119.34 9.4 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.514 ' HB2' ' CE2' ' A' ' 190' ' ' PHE . . . -46.16 123.1 4.38 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.062 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.96 -24.62 24.69 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.59 141.34 34.61 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.9 p -92.17 -21.45 20.38 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -85.38 126.79 34.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.068 0.849 . . . . 0.0 113.161 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.462 ' NZ ' ' NZ ' ' A' ' 20' ' ' LYS . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.517 ' O ' ' O ' ' A' ' 201' ' ' LYS . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.694 HG23 ' HD2' ' A' ' 229' ' ' PRO 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.694 ' HD2' HG23 ' A' ' 227' ' ' ILE . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.708 HD21 HD13 ' A' ' 242' ' ' LEU . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.561 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m -91.35 131.84 36.57 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.617 HD12 ' HB ' ' A' ' 255' ' ' ILE . 87.1 mt -110.41 130.29 55.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 117.069 -1.443 . . . . 0.0 111.518 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 254' ' ' GLY . 3.8 mmtt -39.93 -55.03 3.99 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 124.685 1.241 . . . . 0.0 107.655 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -37.99 -13.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.915 2.41 . . . . 0.0 113.427 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 91.19 28.99 13.25 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.32 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 251' ' ' LEU . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.491 ' H ' ' HB2' ' A' ' 274' ' ' LYS . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.57 -40.26 54.8 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.0 mmtt -84.69 0.17 51.36 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.646 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 271' ' ' GLY . 90.7 m-20 55.23 -18.9 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.488 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 266' ' ' LYS . 60.9 t -72.44 -42.69 64.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.289 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.533 ' CB ' HD21 ' A' ' 242' ' ' LEU . 73.7 m-20 -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.297 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -83.63 -35.62 24.48 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.35 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 65.48 -12.36 0.32 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.388 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.533 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -135.24 151.95 51.08 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.84 137.32 34.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.749 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.766 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.899 0.38 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . . . -135.2 134.4 40.05 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.613 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.487 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.477 HG23 ' NZ ' ' A' ' 115' ' ' LYS . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -67.34 -46.33 73.74 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.5 p -95.43 136.77 35.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -157.97 4.12 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 -138.06 49.82 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' O ' ' NZ ' ' A' ' 274' ' ' LYS . 94.8 m-85 -40.73 -35.16 0.45 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.943 0.872 . . . . 0.0 110.716 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.58 -128.0 37.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.113 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' HB3' ' HG ' ' A' ' 260' ' ' SER . 28.4 m-85 -68.04 -174.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 HD12 ' A' ' 277' ' ' LEU . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 41' ' ' PHE . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE1' HD22 ' A' ' 39' ' ' LEU . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 50' ' ' GLU . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.493 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.442 ' CE2' HD22 ' A' ' 81' ' ' LEU . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 75' ' ' TRP . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 71' ' ' PHE . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 81.39 46.62 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -86.8 -40.72 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.552 HD12 HD22 ' A' ' 95' ' ' LEU . 13.1 mt -103.1 23.17 12.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.491 0.587 . . . . 0.0 110.196 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 75.58 -37.84 0.34 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.816 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 -74.82 -89.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.552 HD22 HD12 ' A' ' 91' ' ' LEU . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 103' ' ' PHE . 1.2 m-85 80.69 160.84 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -125.4 159.37 60.49 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -39.6 -51.59 2.8 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.939 3.093 . . . . 0.0 114.612 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.29 -39.95 94.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 104' ' ' SER . 96.6 m -128.31 129.61 46.56 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.737 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 -162.03 50.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.74 121.68 39.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' NZ ' HG23 ' A' ' 6' ' ' THR . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.428 HG21 ' OD1' ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.493 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 7' ' ' TYR . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.456 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.65 ' NZ ' ' HB2' ' A' ' 2' ' ' ALA . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.821 HG21 ' CE1' ' A' ' 178' ' ' PHE . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.821 ' CE1' HG21 ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.534 HG22 ' HA3' ' A' ' 192' ' ' GLY . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 188' ' ' THR . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.534 ' HA3' HG22 ' A' ' 182' ' ' THR . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.491 ' NE2' ' OD1' ' A' ' 199' ' ' ASN . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.562 ' C ' HG23 ' A' ' 198' ' ' VAL . 67.9 mttm -108.29 101.14 10.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 197' ' ' LYS . 3.4 t 83.61 69.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 O-C-N 123.716 0.635 . . . . 0.0 111.382 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 201' ' ' LYS . 39.0 t30 -105.58 94.33 5.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 44.98 -76.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.245 0.966 . . . . 0.0 111.599 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 199' ' ' ASN . 68.1 mttm -64.15 -44.15 93.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 201' ' ' LYS . 56.9 tp 166.82 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 204' ' ' THR . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m -129.18 115.96 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.36 47.24 3.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.43 24.22 61.32 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.848 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.44 143.26 57.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 63.3 m -57.91 -36.17 72.07 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.8 112.61 18.34 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.469 ' HB1' ' HZ2' ' A' ' 236' ' ' LYS . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' A' ' 202' ' ' LEU . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.469 ' HZ2' ' HB1' ' A' ' 222' ' ' ALA . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.912 HD21 HD13 ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.912 HD13 HD21 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' THR . . . . . 0.41 HG23 ' OG1' ' A' ' 258' ' ' THR . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 250' ' ' THR . 5.6 m -88.61 87.57 7.31 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.634 ' O ' ' O ' ' A' ' 252' ' ' LYS . 84.4 mt -82.51 102.75 11.57 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.957 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.634 ' O ' ' O ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER 59.86 125.61 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.921 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -42.68 -12.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 120.863 1.042 . . . . 0.0 112.094 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.45 -38.85 6.96 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 121.328 -0.463 . . . . 0.0 113.631 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 251' ' ' LEU . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 248' ' ' THR . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 277' ' ' LEU . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.506 ' HG ' ' HB3' ' A' ' 24' ' ' PHE . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -14.69 -84.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -91.49 3.52 54.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.271 1.535 . . . . 0.0 111.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 271' ' ' GLY . 82.0 m-20 68.0 -0.38 2.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.263 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.54 -41.65 34.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.278 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.25 -45.66 92.3 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.693 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.67 -35.72 20.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 119.113 -1.035 . . . . 0.0 108.887 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 80.53 -16.03 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.266 -1.445 . . . . 0.0 113.077 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 22' ' ' TYR . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.415 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 27' ' ' ILE . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.29 149.32 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.06 135.88 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.365 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.66 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.12 36.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.819 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 4' ' ' PRO . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 -64.31 -44.74 90.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.8 p -85.6 -26.44 26.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 22' ' ' TYR . 66.0 mttm -78.37 10.64 2.93 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 118.761 -1.176 . . . . 0.0 110.427 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.19 157.67 12.39 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 20' ' ' LYS . 94.2 m-85 -154.28 156.83 37.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 103.72 -114.62 4.85 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.47 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLY . 86.2 m-85 21.14 75.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.596 ' C ' HG23 ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' HD3' ' A' ' 61' ' ' LYS . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.636 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.636 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 69' ' ' LEU . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 58' ' ' LEU . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.9 m120 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG23 ' CD2' ' A' ' 71' ' ' PHE . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 67.75 38.48 2.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -75.57 -43.55 47.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 52.2 tp -82.77 -66.62 0.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 171.85 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -75.47 -71.89 0.34 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' LEU . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HE3' ' HZ2' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 -111.78 111.87 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 107' ' ' THR . 1.3 t -125.46 90.62 50.36 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 119.148 0.886 . . . . 0.0 113.013 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.68 -49.38 3.38 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.058 2.505 . . . . 0.0 114.575 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -62.99 -41.15 99.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.909 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.487 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.4 t -147.0 148.07 31.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.847 0.356 . . . . 0.0 110.253 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 54.06 101.52 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -57.29 -120.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.822 -0.222 . . . . 0.0 111.187 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HZ2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.536 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.63 ' C ' HD22 ' A' ' 144' ' ' LEU . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 143' ' ' VAL . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.7 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.438 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' ILE . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.577 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.431 HG22 ' CD2' ' A' ' 190' ' ' PHE . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 184' ' ' VAL . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.403 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -99.91 97.63 8.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 199' ' ' ASN . 40.4 t -75.51 -21.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.968 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 32.4 t30 90.67 -40.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.559 0.537 . . . . 0.0 110.935 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 202' ' ' LEU . 99.0 mttt -81.79 80.81 8.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.702 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 38.34 21.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 200' ' ' LYS . 45.1 tp -131.72 113.96 14.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m -130.5 114.13 15.12 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.71 46.17 11.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.874 0.845 . . . . 0.0 109.469 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 54.7 25.82 37.46 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.97 -1.468 . . . . 0.0 114.52 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.09 149.43 32.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.4 m -59.16 -36.83 75.97 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.75 109.17 17.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 202' ' ' LEU . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.56 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.964 HD21 HD13 ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p 67.09 -101.15 0.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.46 ' O ' ' C ' ' A' ' 252' ' ' LYS . 55.5 tp 64.74 -34.7 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.502 0.501 . . . . 0.0 111.469 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 254' ' ' GLY . 1.5 mttp -42.28 158.21 0.21 Allowed Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -40.6 88.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.867 1.711 . . . . 0.0 111.76 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 170.43 -101.73 0.17 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.774 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 242' ' ' LEU . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.08 -38.08 94.97 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 268' ' ' VAL . 54.4 mmtt -86.1 -7.75 58.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.968 1.384 . . . . 0.0 109.535 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.98 -21.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 266' ' ' LYS . 53.4 t -77.01 -35.24 22.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.438 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -64.34 -44.48 91.37 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.788 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.94 -34.89 19.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 118.564 -1.254 . . . . 0.0 107.814 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.93 -12.97 0.36 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.356 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 27' ' ' ILE . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -151.32 156.86 41.66 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -100.41 138.19 37.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.5 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.839 -179.887 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -132.6 139.51 47.83 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.741 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' C ' HD21 ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 4' ' ' PRO . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 17' ' ' VAL . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 13' ' ' SER . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.75 -47.32 78.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 p -71.17 -45.04 64.3 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.17 132.47 49.22 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 118.929 -1.108 . . . . 0.0 109.147 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 163.08 170.25 27.7 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.915 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 98.4 m-85 -163.6 -120.27 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 40.73 -115.14 0.63 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.706 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CG ' HD12 ' A' ' 262' ' ' LEU . 66.4 m-85 14.64 73.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 ' CE1' ' A' ' 41' ' ' PHE . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' CE1' HD22 ' A' ' 39' ' ' LEU . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.434 ' OG ' HD23 ' A' ' 58' ' ' LEU . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.41 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.52 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.494 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.494 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.6 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.52 ' CE3' HD12 ' A' ' 58' ' ' LEU . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.598 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 101' ' ' SER . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 69' ' ' LEU . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 56.6 49.66 14.22 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.554 ' HB2' HD23 ' A' ' 95' ' ' LEU . 74.6 mt-30 -59.26 -7.85 1.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 22.4 tp -153.7 40.9 0.51 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.461 1.124 . . . . 0.0 109.202 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 77.48 -15.8 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.871 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 -131.58 173.43 11.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 90' ' ' GLN . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 98' ' ' THR . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 83' ' ' THR . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 -93.88 153.63 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 105' ' ' PRO . 12.5 m -115.19 147.59 38.83 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.413 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' O ' ' O ' ' A' ' 104' ' ' SER . 65.5 Cg_exo -37.49 -125.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 124.571 3.514 . . . . 0.0 114.707 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -58.94 -31.83 69.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.442 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 m -59.61 -42.47 92.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.092 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 18.86 79.57 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 104' ' ' SER . 88.4 tttt -66.94 123.42 20.15 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' O ' ' HA3' ' A' ' 94' ' ' GLY . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.536 HD21 ' C ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.8 tp-100 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.43 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.46 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 192' ' ' GLY . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' A' ' 184' ' ' VAL . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 206' ' ' VAL . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.96 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.41 -50.53 79.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.719 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 52.4 p30 178.91 63.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.231 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.8 tttm 68.42 -55.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.86 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 227' ' ' ILE . 98.7 mttt -62.99 -43.59 98.38 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 225' ' ' TYR . 9.7 mp -115.49 117.27 29.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.647 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m -148.62 116.0 6.19 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -48.92 110.16 0.33 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.502 0.668 . . . . 0.0 111.049 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.42 -46.02 1.17 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -96.65 116.0 28.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.9 m -67.03 -37.8 84.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -51.21 123.15 8.9 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.658 ' CD1' HD11 ' A' ' 202' ' ' LEU . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.42 HG22 ' HD3' ' A' ' 201' ' ' LYS . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.782 HD21 HD13 ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.594 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.782 HD13 HD21 ' A' ' 238' ' ' ASN . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.499 ' O ' HD23 ' A' ' 262' ' ' LEU . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m -99.6 117.02 33.07 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.88 86.72 2.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.273 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 254' ' ' GLY . 11.0 mttt 72.54 116.96 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 252' ' ' LYS . 73.1 Cg_exo -38.62 93.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.391 1.394 . . . . 0.0 111.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 162.63 -35.85 0.34 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.761 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.431 ' C ' HD22 ' A' ' 259' ' ' LEU . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 24' ' ' PHE . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.27 96.0 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 268' ' ' VAL . 83.4 mttt -85.23 -5.99 59.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.19 1.995 . . . . 0.0 110.33 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.13 -18.77 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 266' ' ' LYS . 54.0 t -79.04 -35.98 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.316 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -64.15 -44.34 92.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.445 -0.785 . . . . 0.0 110.702 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.53 -35.75 20.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.706 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.61 -3.98 3.28 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.986 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.646 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 276' ' ' GLY . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . 76.87 108.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.75 147.97 35.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.603 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.29 144.26 50.04 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.692 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 143' ' ' VAL . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.685 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.492 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 19' ' ' THR . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -65.78 -44.73 84.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 15' ' ' ARG . 48.6 p -81.47 -34.47 31.35 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -76.78 11.02 1.87 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.314 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.57 148.57 9.27 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -152.19 164.73 36.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 90.25 -113.35 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.002 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' GLY . 69.2 m-85 19.84 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 277' ' ' LEU . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' C ' ' HG ' ' A' ' 285' ' ' SER . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' THR . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' LEU . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.522 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 87' ' ' VAL . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 85' ' ' ILE . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.556 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 104' ' ' SER . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 71' ' ' PHE . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HD23 ' A' ' 69' ' ' LEU . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 63.92 39.65 7.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HB2' HD23 ' A' ' 95' ' ' LEU . 88.0 mt-30 -69.04 -40.29 78.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 57.7 tp -91.41 -56.74 3.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 162.3 -39.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.51 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.26 -77.94 0.11 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 90' ' ' GLN . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.44 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 78.84 165.11 0.21 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -117.38 160.94 35.78 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 121.09 0.471 . . . . 0.0 112.203 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 107' ' ' THR . 91.7 Cg_exo -39.53 135.89 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.598 2.866 . . . . 0.0 113.372 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 49.8 5.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.708 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 105' ' ' PRO . 76.4 m -127.21 86.3 2.48 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.08 14.51 74.63 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.59 112.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' A' ' 99' ' ' PHE . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.479 ' NH1' HD21 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 5' ' ' PRO . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.535 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.698 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.479 HD21 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 164' ' ' VAL . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 180' ' ' LEU . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.515 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CD1' ' NE2' ' A' ' 196' ' ' GLN . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 173' ' ' TYR . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' A' ' 190' ' ' PHE . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 198' ' ' VAL . 65.2 tttm -88.01 114.73 24.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 197' ' ' LYS . 3.9 t 24.84 106.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 196' ' ' GLN . 63.0 t30 -132.57 79.42 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.136 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.1 tttt 67.12 7.03 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.29 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 99.5 mttt -139.16 -60.09 0.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.548 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 1.0 OUTLIER 150.51 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.068 0.855 . . . . 0.0 110.448 -177.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 203' ' ' GLU . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m -147.78 104.51 3.6 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -44.36 114.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.72 0.771 . . . . 0.0 111.433 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.11 -26.83 5.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.36 140.16 42.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 87.4 p -89.61 -2.82 58.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -104.23 140.08 38.34 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.229 0.922 . . . . 0.0 113.103 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m -107.99 110.86 22.68 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 252' ' ' LYS . 44.1 tp -112.07 121.64 45.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 251' ' ' LEU . 50.2 tttm 56.61 104.56 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.46 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' LYS . 68.8 Cg_exo -36.22 101.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.916 1.744 . . . . 0.0 111.875 -177.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 154.67 -31.58 0.68 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.887 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -11.22 -89.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -89.12 5.26 45.38 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 117.137 0.469 . . . . 0.0 111.395 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 264' ' ' ASP . 61.1 t30 62.98 -5.94 0.19 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.62 -39.64 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.02 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.51 -45.72 89.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.998 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.86 -5.92 84.13 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 119.44 -1.362 . . . . 0.0 112.479 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 48.8 m-70 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.696 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 276' ' ' GLY . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.67 48.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -68.17 139.33 56.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' SER . . . . . 0.443 ' HG ' ' C ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.834 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.29 149.21 31.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.433 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 ' NE2' ' A' ' 181' ' ' HIS . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 60.5 t80 -62.72 -45.32 93.3 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 20' ' ' LYS . 6.9 p -96.04 167.25 11.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' NZ ' ' NZ ' ' A' ' 74' ' ' LYS . 98.6 mttt 45.83 -174.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.94 68.52 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -139.84 160.39 40.01 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . -119.52 -43.93 0.48 Allowed Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 57.1 m-85 18.74 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.656 HD22 ' CE2' ' A' ' 41' ' ' PHE . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE2' HD22 ' A' ' 39' ' ' LEU . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' C ' ' A' ' 50' ' ' GLU . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' SER . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.566 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.482 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 87' ' ' VAL . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' NZ ' ' NZ ' ' A' ' 20' ' ' LYS . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.629 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 61.58 40.73 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.609 ' HB2' HD23 ' A' ' 95' ' ' LEU . 33.4 mt-30 -51.35 -37.52 48.34 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 6.7 tp 166.12 56.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.985 0.897 . . . . 0.0 110.067 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -161.47 -150.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.526 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -81.02 -42.64 20.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 90' ' ' GLN . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' THR . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.446 ' HG ' ' HE2' ' A' ' 103' ' ' PHE . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HE2' ' HG ' ' A' ' 101' ' ' SER . 3.7 m-85 -104.93 99.17 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.68 161.09 52.84 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -38.79 -179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 124.036 3.158 . . . . 0.0 113.129 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -51.9 -32.26 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.686 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.4 p -64.05 -35.95 82.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.166 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -131.75 80.68 0.33 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.1 mttt -54.19 -159.0 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.614 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.502 HD21 ' HA ' ' A' ' 185' ' ' ASN . 17.0 m120 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.733 ' HB2' HD12 ' A' ' 180' ' ' LEU . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.623 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.623 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 173' ' ' TYR . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.517 ' NE2' HD21 ' A' ' 10' ' ' LEU . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 9.4 p30 -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.493 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.502 ' HA ' HD21 ' A' ' 168' ' ' ASN . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.548 ' HE2' ' HB2' ' A' ' 212' ' ' ALA . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 208' ' ' LEU . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.444 ' OE1' ' CG2' ' A' ' 198' ' ' VAL . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -94.58 96.24 9.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.444 ' CG2' ' OE1' ' A' ' 196' ' ' GLN . 86.9 t -75.78 -43.93 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.617 -175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 81.9 m-20 -161.87 -171.17 2.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.038 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.71 -11.4 27.12 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 198' ' ' VAL . 48.6 tp -117.74 111.41 19.07 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 220' ' ' GLY . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 194' ' ' ILE . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p -131.82 114.66 14.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.548 ' HB2' ' HE2' ' A' ' 190' ' ' PHE . . . -46.74 131.87 11.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.003 0.906 . . . . 0.0 111.732 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.94 -28.29 15.92 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.632 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -102.98 141.88 35.03 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.1 p -90.24 -4.44 57.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -98.37 129.47 45.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.346 0.975 . . . . 0.0 113.386 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.523 ' CD2' HG22 ' A' ' 227' ' ' ILE . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 225' ' ' TYR 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m -111.84 124.54 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.403 HD12 ' HB ' ' A' ' 255' ' ' ILE . 2.2 mt -102.65 144.07 31.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.195 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.83 -53.45 15.63 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.733 1.27 . . . . 0.0 107.941 176.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 86.3 Cg_exo -39.9 -15.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.78 2.32 . . . . 0.0 112.782 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 93.77 38.25 5.27 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.067 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 251' ' ' LEU . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' CD ' ' A' ' 274' ' ' LYS . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 267' ' ' ASN . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.51 95.54 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 268' ' ' VAL . 84.0 mttt -84.33 -10.85 57.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 66.0 t30 58.43 -24.91 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.3 t -75.71 -34.81 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.235 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -63.82 -45.68 88.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.421 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.82 -35.59 19.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.18 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.2 -15.08 0.79 Allowed Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.382 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.57 ' CD ' HD23 ' A' ' 262' ' ' LEU . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 27' ' ' ILE . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.47 154.0 46.46 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.65 137.49 33.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.855 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 138.94 53.07 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 ' HA ' HD22 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 181' ' ' HIS . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' THR . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HB1' ' A' ' 222' ' ' ALA . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.21 -44.74 82.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' ARG . 8.0 p -62.82 109.25 1.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 21' ' ' GLY . 83.0 tttt -146.36 136.64 23.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -56.31 -171.52 0.13 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 21' ' ' GLY . 98.9 m-85 -26.83 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.38 0.59 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . 60.66 -64.78 0.01 OUTLIER Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.573 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 22' ' ' TYR . 4.0 m-85 -98.77 120.01 38.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.586 -0.361 . . . . 0.0 111.965 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 42' ' ' THR . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.48 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.526 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.508 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.476 ' CD2' HD22 ' A' ' 81' ' ' LEU . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 75' ' ' TRP . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG23 ' CD2' ' A' ' 71' ' ' PHE . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 65.52 43.79 3.26 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HB2' HD23 ' A' ' 95' ' ' LEU . 90.4 mt-30 -51.49 -37.4 48.9 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER 165.16 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.714 0.769 . . . . 0.0 110.123 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.26 -148.49 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.24 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -79.11 -45.79 19.34 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 117' ' ' GLY . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 98' ' ' THR . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -117.95 80.83 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.26 160.71 25.51 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 118.874 0.761 . . . . 0.0 112.205 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 104' ' ' SER . 75.1 Cg_exo -37.69 -127.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.59 3.527 . . . . 0.0 114.306 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -67.16 -41.55 85.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.328 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' GLY . 7.8 p -86.21 163.32 17.86 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.823 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 37.0 64.1 0.69 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.5 mttt -55.28 -119.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.599 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' O ' ' CZ ' ' A' ' 118' ' ' TYR . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.552 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' A' ' 3' ' ' VAL . 3.5 m-80 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.538 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 170' ' ' ALA . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.3 tp-100 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.731 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.445 ' H ' ' HB3' ' A' ' 154' ' ' GLN . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.666 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.474 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 10' ' ' LEU . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.601 HG22 ' HA2' ' A' ' 192' ' ' GLY . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.667 HG13 ' CE1' ' A' ' 190' ' ' PHE . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.667 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 206' ' ' VAL . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt -105.68 99.29 8.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 78.7 t -76.61 -45.49 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.51 -175.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 83.8 m-20 -159.66 -170.94 3.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.2 -39.79 91.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.767 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.67 ' C ' HD12 ' A' ' 202' ' ' LEU . 98.6 mttt -96.08 -11.38 26.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.67 HD12 ' C ' ' A' ' 201' ' ' LYS . 10.3 mp -114.93 107.61 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 223' ' ' ALA . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.702 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m -148.82 105.94 3.61 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -42.49 109.7 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.67 -6.13 12.63 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -126.79 130.45 50.31 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 94.4 p -83.55 -7.81 59.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -98.97 140.05 33.71 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.25 0.932 . . . . 0.0 112.917 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.66 ' CE2' HD21 ' A' ' 202' ' ' LEU . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 225' ' ' TYR 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.584 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.622 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.622 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -98.19 118.81 35.65 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' A' ' 255' ' ' ILE . 45.2 mt -97.72 133.25 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.5 tttt -45.57 -51.94 25.66 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 91.2 Cg_exo -39.48 -14.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.648 2.232 . . . . 0.0 112.634 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 95.05 30.45 8.31 Favored Glycine 0 N--CA 1.466 0.699 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.132 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' A' ' 251' ' ' LEU . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.428 HD23 ' CD ' ' A' ' 274' ' ' LYS . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 268' ' ' VAL . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.22 83.22 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.479 ' O ' ' CG ' ' A' ' 267' ' ' ASN . 45.5 mmtt -82.99 -2.73 56.0 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.545 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.581 ' C ' ' N ' ' A' ' 269' ' ' ASN . 1.6 m120 164.58 76.8 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' A' ' 264' ' ' ASP . 20.0 t -60.2 -9.61 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.581 ' N ' ' C ' ' A' ' 267' ' ' ASN . 41.7 m-20 -83.36 -30.17 27.65 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 111.582 -2.553 . . . . 0.0 112.273 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' A' ' 267' ' ' ASN . . . -84.21 -32.46 24.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . -94.15 35.71 4.07 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.662 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.428 ' CD ' HD23 ' A' ' 262' ' ' LEU . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.405 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 27' ' ' ILE . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.535 ' C ' HD12 ' A' ' 279' ' ' LEU . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 278' ' ' GLY . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -135.69 141.84 45.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -95.37 137.41 34.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.653 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -72.5 144.67 47.93 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 6' ' ' THR . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 17' ' ' VAL . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 19' ' ' THR . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 13' ' ' SER . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -63.46 -44.63 93.89 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 15' ' ' ARG . 25.2 p -81.65 -42.29 20.19 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.41 139.34 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.73 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 22' ' ' TYR . . . 164.65 173.94 33.85 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 64.6 m-85 -160.06 149.76 18.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 116.54 -114.37 3.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.344 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.0 m-85 24.31 70.69 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 277' ' ' LEU . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' A' ' 41' ' ' PHE . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 72' ' ' THR . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 61' ' ' LYS . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 71' ' ' PHE . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 56.97 45.01 21.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.572 ' HB2' HD23 ' A' ' 95' ' ' LEU . 82.9 mt-30 -52.63 -20.85 3.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 88.7 mt -138.59 39.55 2.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.938 0.875 . . . . 0.0 110.172 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 81.64 -24.63 0.18 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.087 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 -126.21 179.48 5.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 ' HB2' ' A' ' 90' ' ' GLN . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' C ' HD13 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.59 93.19 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.46 159.54 59.87 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -38.11 -63.24 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.905 3.07 . . . . 0.0 114.046 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.481 ' O ' ' N ' ' A' ' 108' ' ' GLY . 83.3 m-20 -147.39 -175.53 4.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.293 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.18 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.443 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' ASN . . . 174.92 55.15 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -55.84 -117.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.618 ' HG2' HD21 ' A' ' 124' ' ' ASN . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.618 HD21 ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 135' ' ' GLY . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.586 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 138' ' ' ILE . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.602 HD21 ' HB2' ' A' ' 166' ' ' GLN . 2.0 m-20 -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.602 ' HB2' HD21 ' A' ' 156' ' ' ASN . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.492 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 192' ' ' GLY . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.699 HG13 ' CE1' ' A' ' 190' ' ' PHE . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.699 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.568 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -98.42 91.36 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.94 -45.84 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.0 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 35.1 p30 -170.46 163.68 8.5 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -40.54 -33.9 0.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.74 -26.6 19.43 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.486 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 4.1 mp -116.38 116.28 27.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.405 HD21 ' HA ' ' A' ' 207' ' ' ASN . 8.0 m120 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m -145.65 108.58 4.55 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -39.24 123.38 1.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 111.191 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.85 18.97 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -102.67 139.34 38.38 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -87.84 -16.21 34.65 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -102.67 144.21 31.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.222 0.919 . . . . 0.0 113.344 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.608 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.48 ' CZ ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 227' ' ' ILE . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.458 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.53 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 217' ' ' THR . 3.2 p-10 -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 262' ' ' LEU . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 262' ' ' LEU . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m -85.58 84.9 7.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.654 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.1 mt -78.46 104.8 9.3 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 251' ' ' LEU . 47.5 mttt 58.32 128.54 0.01 OUTLIER Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 282' ' ' GLN . 97.0 Cg_exo -43.89 -11.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.204 1.27 . . . . 0.0 112.361 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.26 -36.71 8.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.474 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 251' ' ' LEU . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 279' ' ' LEU . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 268' ' ' VAL . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.83 -39.03 94.9 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 49.8 mttp -82.75 -1.99 53.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.486 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.575 ' C ' ' N ' ' A' ' 269' ' ' ASN . 8.6 m-20 170.27 74.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 264' ' ' ASP . 22.0 t -56.47 -12.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.575 ' N ' ' C ' ' A' ' 267' ' ' ASN . 38.5 m-80 -81.51 -29.87 33.44 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 112.282 -2.236 . . . . 0.0 112.14 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.484 ' H ' ' HB3' ' A' ' 267' ' ' ASN . . . -83.15 -31.8 26.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -90.75 32.62 4.99 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.263 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 27' ' ' ILE . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.431 ' CD2' HD12 ' A' ' 257' ' ' LEU . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 253' ' ' PRO . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -66.0 142.83 57.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -75.38 143.45 42.78 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.764 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.823 ' O ' HG22 ' A' ' 19' ' ' THR . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 16' ' ' ASP . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' A' ' 95' ' ' LEU . 51.3 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.711 HD21 ' HB ' ' A' ' 143' ' ' VAL . 4.1 m-80 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 124' ' ' ASN . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 5.1 tp-100 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.628 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.628 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 242' ' ' LEU . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.639 HD22 HD22 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.566 ' H ' ' HB3' ' A' ' 264' ' ' ASP . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.639 HD22 HD22 ' A' ' 263' ' ' LEU . 5.6 m-20 -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' HD22 ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.823 ' O ' HG22 ' A' ' 19' ' ' THR . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 16' ' ' ASP . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.541 ' HB2' HD23 ' A' ' 95' ' ' LEU . 51.3 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.711 HD21 ' HB ' ' A' ' 143' ' ' VAL . 4.1 m-80 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.711 ' HB ' HD21 ' A' ' 124' ' ' ASN . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 5.1 tp-100 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 183' ' ' ASN . 0.1 OUTLIER -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.628 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.0 p-10 -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.628 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 242' ' ' LEU . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.639 HD22 HD22 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.566 ' H ' ' HB3' ' A' ' 264' ' ' ASP . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ASN . . . . . 0.639 HD22 HD22 ' A' ' 263' ' ' LEU . 5.6 m-20 -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.09 140.79 58.27 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.744 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.719 ' N ' ' HZ1' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.643 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 -62.44 -43.36 99.0 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.3 p -88.12 -12.58 43.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.12 -43.51 66.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.648 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.39 103.04 0.21 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.99 -44.52 91.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.72 -178.82 18.25 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.266 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CB ' ' HG ' ' A' ' 260' ' ' SER . 10.8 m-85 -124.16 -149.89 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.658 HD22 ' CE1' ' A' ' 41' ' ' PHE . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE1' HD22 ' A' ' 39' ' ' LEU . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.781 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.556 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 HG22 ' A' ' 87' ' ' VAL . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.627 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' CD2' ' A' ' 71' ' ' PHE . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 HD23 ' A' ' 69' ' ' LEU . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 58.83 55.98 4.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.497 ' HB2' HD23 ' A' ' 95' ' ' LEU . 81.5 mt-30 -82.41 1.9 35.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.639 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 35.0 tp -171.31 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 151.37 155.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.95 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD2' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 65.98 62.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 90' ' ' GLN . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 98' ' ' THR . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -110.34 90.36 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -125.39 87.84 55.07 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.69 139.1 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.537 2.158 . . . . 0.0 113.115 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 57.98 27.03 14.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.043 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 107' ' ' THR . 3.2 m 175.13 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 63.79 71.69 0.81 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -49.23 -112.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.719 ' HZ1' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 10' ' ' LEU . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 183' ' ' ASN . 10.2 m120 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.617 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.509 ' HB3' ' CE1' ' A' ' 181' ' ' HIS . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 194' ' ' ILE . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.509 ' CE1' ' HB3' ' A' ' 179' ' ' GLN . 22.1 m-70 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.686 HD22 ' HB3' ' A' ' 168' ' ' ASN . 13.7 t-20 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 96.75 10.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.66 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.636 ' OD1' HD12 ' A' ' 202' ' ' LEU . 56.0 p30 -167.49 -135.24 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.85 -0.04 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.479 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -121.21 -32.16 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.642 ' H ' HD12 ' A' ' 202' ' ' LEU . 0.0 OUTLIER -119.67 127.19 52.66 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 194' ' ' ILE . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.629 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 213' ' ' GLY . 54.7 m -110.33 103.36 12.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 51.7 16.11 0.44 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.493 ' N ' ' C ' ' A' ' 211' ' ' THR . . . 79.51 17.46 75.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -65.34 156.22 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -59.25 -38.82 81.0 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.24 114.67 12.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.629 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.789 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.789 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.488 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m -93.31 122.17 35.44 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.16 128.68 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.685 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.9 mttt -42.95 -55.82 7.04 Favored Pre-proline 0 C--N 1.359 0.987 0 O-C-N 124.981 1.425 . . . . 0.0 107.32 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -38.84 -19.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.628 2.219 . . . . 0.0 113.008 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 99.72 32.96 5.48 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.197 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' THR . . . . . 0.593 ' O ' HD23 ' A' ' 277' ' ' LEU . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.651 ' HG ' ' CB ' ' A' ' 24' ' ' PHE . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.87 -35.99 88.6 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 268' ' ' VAL . 51.8 mmtt -84.93 -7.72 59.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.407 1.104 . . . . 0.0 110.331 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 56.1 -23.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 266' ' ' LYS . 54.0 t -74.56 -37.73 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.296 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.311 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.84 -35.21 19.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 118.451 -1.3 . . . . 0.0 108.246 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 62.92 -7.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.048 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.646 ' HB2' HG23 ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.44 142.51 39.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -87.71 138.44 31.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.306 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.21 140.25 57.42 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.754 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' CA ' ' HZ1' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 -59.56 -45.6 91.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 43.2 m -23.19 115.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.54 139.0 35.36 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . 160.69 -172.34 37.01 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' GLY . 91.1 m-85 32.46 89.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.614 0.244 . . . . 0.0 110.574 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 120.13 -135.03 10.77 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.9 m-85 16.42 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 41' ' ' PHE . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 60' ' ' THR . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.588 ' CB ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.524 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.595 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE2' HG23 ' A' ' 85' ' ' ILE . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' CE2' HD22 ' A' ' 81' ' ' LEU . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 59.02 47.79 11.62 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.561 ' HB2' HD23 ' A' ' 95' ' ' LEU . 71.0 mt-30 -55.83 -18.25 8.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 tp -142.25 41.18 1.63 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.462 1.125 . . . . 0.0 108.978 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 76.63 -13.55 0.91 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.585 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 -134.36 174.22 10.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 -96.3 150.97 19.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -113.04 153.28 45.35 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.3 Cg_exo -37.37 -124.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 124.399 3.4 . . . . 0.0 114.64 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -60.26 -35.47 75.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.37 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 p -54.62 -38.53 66.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.868 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.42 72.83 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -70.56 120.36 16.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.774 HD12 ' CE2' ' A' ' 131' ' ' PHE . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HZ1' ' CA ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.774 ' CE2' HD12 ' A' ' 114' ' ' ILE . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.739 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.699 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.436 HD11 ' HE3' ' A' ' 174' ' ' LYS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.739 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 150' ' ' LEU . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 198' ' ' VAL . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.875 ' CE1' HG23 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 2.7 mm100 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 173' ' ' TYR . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.526 HG22 ' HA2' ' A' ' 192' ' ' GLY . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 190' ' ' PHE . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' HD2' HG22 ' A' ' 184' ' ' VAL . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.875 HG23 ' CE1' ' A' ' 178' ' ' PHE . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 198' ' ' VAL . 88.2 tttt -101.36 105.33 16.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 197' ' ' LYS . 45.9 t 108.31 64.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 125.144 1.528 . . . . 0.0 112.408 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.87 66.2 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 59.79 71.96 0.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt 65.19 27.85 12.2 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 225' ' ' TYR . 0.7 OUTLIER -141.57 147.78 38.24 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 214' ' ' ASN . 16.9 m -150.24 116.56 5.72 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 211' ' ' THR . . . -31.2 113.91 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.463 0.649 . . . . 0.0 112.201 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.52 -0.99 68.59 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.959 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 211' ' ' THR . 55.2 t30 -98.97 107.41 19.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.1 m -57.75 -34.62 69.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -96.15 139.22 32.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.53 ' CE1' HD11 ' A' ' 202' ' ' LEU . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 227' ' ' ILE 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.598 ' OG ' HD13 ' A' ' 242' ' ' LEU . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.626 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 241' ' ' SER . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 262' ' ' LEU . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 78.2 p 54.42 -157.82 0.19 Allowed 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 250' ' ' THR . 20.8 tp 139.23 -79.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 124.244 0.965 . . . . 0.0 110.863 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.532 ' N ' ' CD ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -58.29 -46.18 99.66 Favored Pre-proline 0 CA--C 1.518 -0.276 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -42.88 -18.55 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.837 1.691 . . . . 0.0 112.182 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 122.94 -26.93 6.04 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.12 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.461 ' HG ' ' H ' ' A' ' 276' ' ' GLY . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.511 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 50.93 -102.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -98.73 6.33 47.02 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.845 -1.677 . . . . 0.0 110.455 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 264' ' ' ASP . 20.7 m-20 75.86 -42.28 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.741 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.43 -15.89 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -64.91 -42.93 94.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.242 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ALA . . . . . 0.511 ' HB2' ' CB ' ' A' ' 264' ' ' ASP . . . -83.11 -34.8 26.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.0 22.18 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.795 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.461 ' H ' ' HG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 27' ' ' ILE . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 54.54 104.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.98 135.93 55.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.812 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.67 142.91 33.37 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.232 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 3' ' ' VAL . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.607 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 17' ' ' VAL . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' SER . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 -63.02 -43.63 98.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.7 m -95.87 120.46 36.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -155.59 111.53 3.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.697 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -74.07 -127.72 0.15 Allowed Glycine 0 C--N 1.331 0.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.512 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 55.5 m-85 28.53 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.804 0.302 . . . . 0.0 111.471 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 139.63 -142.91 13.18 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.03 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 45.9 m-85 20.33 76.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.642 HD22 ' CE2' ' A' ' 41' ' ' PHE . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.642 ' CE2' HD22 ' A' ' 39' ' ' LEU . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.48 HD22 ' CE3' ' A' ' 75' ' ' TRP . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' THR . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.621 ' CD2' HG12 ' A' ' 87' ' ' VAL . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 85' ' ' ILE . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.48 ' CE3' HD22 ' A' ' 58' ' ' LEU . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 71' ' ' PHE . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 59.66 48.43 9.4 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.651 ' HB2' HD23 ' A' ' 95' ' ' LEU . 78.5 mt-30 -59.17 -11.41 3.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 tp -150.91 40.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.428 1.109 . . . . 0.0 109.223 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 74.33 1.76 3.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.455 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 -144.54 171.11 14.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.787 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 90' ' ' GLN . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 -114.26 108.72 17.31 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.55 87.62 55.48 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.81 -28.76 0.38 Allowed 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.05 2.5 . . . . 0.0 114.586 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' GLY . 56.3 t30 -86.97 105.46 17.14 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.427 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 43.09 14.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' ASN . . . -98.82 177.0 30.15 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -139.6 150.16 44.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.662 ' HG2' HD21 ' A' ' 124' ' ' ASN . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.662 HD21 ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.746 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 183' ' ' ASN . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' A' ' 175' ' ' THR . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 194' ' ' ILE . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.549 ' CE1' HD22 ' A' ' 10' ' ' LEU . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 180' ' ' LEU . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -96.33 97.76 9.74 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 202' ' ' LEU . 80.1 t -74.46 -43.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.336 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 27.7 p30 -157.76 -171.45 3.55 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.0 -41.75 98.4 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.225 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.84 -7.63 33.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 53.0 tp -120.98 113.72 20.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 223' ' ' ALA . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -142.35 115.84 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.02 46.49 9.29 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.37 25.8 42.29 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 114.452 -1.249 . . . . 0.0 114.338 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 215' ' ' SER . 59.6 t-20 -59.18 149.29 28.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 78.0 p -59.71 -32.94 70.99 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -85.19 107.99 17.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 112.833 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 227' ' ' ILE . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 225' ' ' TYR 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 231' ' ' ALA . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 230' ' ' ASP . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.599 HD21 ' CG ' ' A' ' 242' ' ' LEU . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.599 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 256' ' ' LYS . 85.5 m -128.84 86.68 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.541 ' CG ' ' H ' ' A' ' 252' ' ' LYS . 0.8 OUTLIER -175.62 -145.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.962 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LYS . . . . . 0.721 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 56.25 161.02 0.07 OUTLIER Pre-proline 0 C--O 1.222 -0.367 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -41.69 72.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.032 1.822 . . . . 0.0 113.103 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 60.23 43.14 98.77 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 276' ' ' GLY . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.41 -43.16 95.93 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 268' ' ' VAL . 83.4 mttt -84.1 -9.72 58.38 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 118.917 1.359 . . . . 0.0 109.227 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 66.5 t30 58.3 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 266' ' ' LYS . 60.0 t -73.45 -36.84 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 118.842 0.747 . . . . 0.0 110.069 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.96 -44.34 96.31 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.14 -35.68 20.02 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.209 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.02 -7.13 10.35 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.378 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 27' ' ' ILE . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.54 143.46 57.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -66.71 133.26 49.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.51 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.442 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' C ' HD22 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.729 ' O ' HG23 ' A' ' 6' ' ' THR . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 5' ' ' PRO . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.749 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.44 ' HG ' ' HE1' ' A' ' 195' ' ' TYR . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 40' ' ' GLU . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 37' ' ' ASN . 3.0 m120 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 35' ' ' SER . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.465 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.465 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.693 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 75' ' ' TRP . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 71' ' ' PHE . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 . . . . . 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' THR . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 . . . . . 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.464 0.233 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.64 ' ND2' HG23 ' A' ' 6' ' ' THR . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.621 ' C ' HE22 ' A' ' 154' ' ' GLN . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.749 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 5' ' ' PRO . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.462 HD12 ' NE2' ' A' ' 181' ' ' HIS . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 143' ' ' VAL . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.621 HE22 ' C ' ' A' ' 139' ' ' ARG . 61.0 tp60 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 3.1 t-20 -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.44 ' H ' ' HB2' ' A' ' 180' ' ' LEU . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.594 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.462 ' NE2' HD12 ' A' ' 150' ' ' LEU . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.581 HG22 ' CE1' ' A' ' 190' ' ' PHE . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 188' ' ' THR . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 184' ' ' VAL . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 208' ' ' LEU . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.44 ' HE1' ' HG ' ' A' ' 13' ' ' SER . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt . . . . . 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 223' ' ' ALA . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 194' ' ' ILE . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.59 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 241' ' ' SER . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.791 0 N-CA-C 112.541 -0.223 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 279' ' ' LEU . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 259' ' ' LEU . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 258' ' ' THR . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 263' ' ' LEU . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.661 ' H ' ' CE1' ' A' ' 273' ' ' HIS . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . . . . . . 0 N--CA 1.425 -2.1 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.661 ' CE1' ' H ' ' A' ' 264' ' ' ASP . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.486 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 27' ' ' ILE . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 257' ' ' LEU . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.814 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 141' ' ' ALA . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HD13 ' A' ' 150' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.407 ' CG ' ' HB3' ' A' ' 260' ' ' SER . 3.1 m-85 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 ' HB2' ' A' ' 277' ' ' LEU . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 39' ' ' LEU . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' THR . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.1 t-20 -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.47 HD12 ' CE3' ' A' ' 75' ' ' TRP . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 87' ' ' VAL . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.47 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 71' ' ' PHE . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 . . . . . 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 119' ' ' LYS . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 102' ' ' SER . 68.4 mttm . . . . . 0 CA--C 1.531 0.224 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.576 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' H ' ' HA3' ' A' ' 94' ' ' GLY . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.512 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.557 ' ND2' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' GLY . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.576 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.79 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.862 HD13 HD23 ' A' ' 10' ' ' LEU . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 157' ' ' PHE . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.583 HD21 ' ND2' ' A' ' 183' ' ' ASN . 16.8 t-20 -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' HD12 ' A' ' 150' ' ' LEU . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.612 HG22 ' HA2' ' A' ' 192' ' ' GLY . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.583 ' ND2' HD21 ' A' ' 168' ' ' ASN . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.777 HG13 ' CE2' ' A' ' 190' ' ' PHE . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.777 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.612 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.727 HG23 ' CE2' ' A' ' 178' ' ' PHE . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt . . . . . 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.709 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.504 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m . . . . . 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.58 HD12 ' CG1' ' A' ' 237' ' ' VAL . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.624 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.624 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.696 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.58 ' CG1' HD12 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 217' ' ' THR . 0.0 OUTLIER -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.568 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 241' ' ' SER . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m . . . . . 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.407 ' HB3' ' CG ' ' A' ' 24' ' ' PHE . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.727 0 CA-C-O 120.164 -0.242 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.705 ' HB2' HG23 ' A' ' 27' ' ' ILE . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.801 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.716 ' CB ' HD11 ' A' ' 10' ' ' LEU . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.815 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.716 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.3 t80 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.721 ' N ' ' HG ' ' A' ' 260' ' ' SER . 48.3 m-85 . . . . . 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.687 HG23 ' HB3' ' A' ' 277' ' ' LEU . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 42' ' ' THR . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.542 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.49 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.542 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD2' HG23 ' A' ' 116' ' ' THR . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt . . . . . 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 HD12 ' HE1' ' A' ' 131' ' ' PHE . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 97' ' ' LEU . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.588 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE1' HD12 ' A' ' 114' ' ' ILE . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 160' ' ' ALA . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.552 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.602 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.658 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 142' ' ' LEU . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.552 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.504 ' CD1' HG22 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 134' ' ' ALA . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.51 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.51 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 192' ' ' GLY . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.649 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.649 ' CE2' HG13 ' A' ' 184' ' ' VAL . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.465 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp . . . . . 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.465 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m . . . . . 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 1.082 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.542 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 1.082 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 262' ' ' LEU . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.483 HG22 ' NZ ' ' A' ' 256' ' ' LYS . 72.6 p . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.483 ' NZ ' HG22 ' A' ' 250' ' ' THR . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 279' ' ' LEU . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.721 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.501 HD12 ' HA3' ' A' ' 244' ' ' GLY . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.788 0 CA-C-O 120.279 -0.178 . . . . 0.0 113.236 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 25' ' ' GLY . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.687 ' HB3' HG23 ' A' ' 27' ' ' ILE . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 257' ' ' LEU . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.243 0.73 0 CA-C-O 121.276 0.56 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG21 ' A' ' 143' ' ' VAL . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.712 HG22 ' HA3' ' A' ' 126' ' ' GLY . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 . . . . . 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD2' HG23 ' A' ' 42' ' ' THR . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 41' ' ' PHE . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 72' ' ' THR . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 87' ' ' VAL . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 61' ' ' LYS . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.712 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.712 HD22 ' CE2' ' A' ' 75' ' ' TRP . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.606 HG23 ' CD2' ' A' ' 71' ' ' PHE . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 96' ' ' LYS . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' N ' HD23 ' A' ' 95' ' ' LEU . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 98' ' ' THR . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.572 ' ND1' ' C ' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.676 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.517 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.719 ' C ' HD12 ' A' ' 150' ' ' LEU . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 149' ' ' TRP . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.676 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.765 ' CE1' HD11 ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.677 HG13 ' CE1' ' A' ' 190' ' ' PHE . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 206' ' ' VAL . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.733 HD21 ' CE2' ' A' ' 225' ' ' TYR . 9.2 mp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.579 ' HB ' HD12 ' A' ' 194' ' ' ILE . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.419 HD11 HD11 ' A' ' 194' ' ' ILE . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m . . . . . 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.733 ' CE2' HD21 ' A' ' 202' ' ' LEU . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 1.056 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.503 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 1.056 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 262' ' ' LEU . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.48 HG23 ' HZ3' ' A' ' 256' ' ' LYS . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.314 0 CA-C-O 120.064 -0.298 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.48 ' HZ3' HG23 ' A' ' 248' ' ' THR . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 243' ' ' ILE . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.915 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 27' ' ' ILE . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.247 0.941 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 2' ' ' ALA . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 4' ' ' PRO . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.6 t80 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.656 ' N ' ' HG ' ' A' ' 260' ' ' SER . 84.3 m-85 . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 277' ' ' LEU . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' CZ ' ' A' ' 41' ' ' PHE . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' HD22 ' A' ' 39' ' ' LEU . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' THR . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.581 HG23 ' C ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 78' ' ' ASP . 39.4 m-20 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 114' ' ' ILE . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB3' HD22 ' A' ' 111' ' ' ASN . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 . . . . . 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.425 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 102' ' ' SER . 79.2 m-20 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' CE1' ' A' ' 99' ' ' PHE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' GLY . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.579 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 67.5 tp60 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HB3' HH21 ' A' ' 163' ' ' ARG . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.586 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.481 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.524 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 190' ' ' PHE . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 188' ' ' THR . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 186' ' ' ASP . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.667 HD12 ' HB ' ' A' ' 206' ' ' VAL . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.17 0.509 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.687 ' H ' HD12 ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 220' ' ' GLY . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 206' ' ' VAL . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m . . . . . 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.676 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.63 ' HB3' HD23 ' A' ' 202' ' ' LEU . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 250' ' ' THR . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 238' ' ' ASN . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.656 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 242' ' ' LEU . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.41 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.551 ' HB2' HG23 ' A' ' 27' ' ' ILE . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.848 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.652 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 5' ' ' PRO . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.682 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' N ' ' HG ' ' A' ' 260' ' ' SER . 71.3 m-85 . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 277' ' ' LEU . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 42' ' ' THR . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.473 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 48' ' ' ASN . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' SER . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' O ' ' OG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.525 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.663 ' CE2' HG23 ' A' ' 85' ' ' ILE . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.476 ' OE2' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.663 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.41 HG21 ' HE2' ' A' ' 96' ' ' LYS . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 . . . . . 0 CA--C 1.517 -0.324 0 CA-C-O 121.083 0.468 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.709 HD23 ' N ' ' A' ' 96' ' ' LYS . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.709 ' N ' HD23 ' A' ' 95' ' ' LEU . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.51 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.135 0.017 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' H ' HG13 ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 135' ' ' GLY . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.682 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 4' ' ' PRO . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 170' ' ' ALA . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 134' ' ' ALA . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.541 ' HB3' ' HA3' ' A' ' 152' ' ' GLY . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.511 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.593 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.511 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 190' ' ' PHE . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 208' ' ' LEU . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 225' ' ' TYR . 55.7 tp . . . . . 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.529 ' HB ' HD12 ' A' ' 194' ' ' ILE . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 194' ' ' ILE . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.464 ' CD1' HD13 ' A' ' 202' ' ' LEU . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HB1' ' OH ' ' A' ' 247' ' ' TYR . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 243' ' ' ILE . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.611 HD21 ' CD1' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 HG13 ' A' ' 237' ' ' VAL . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.429 ' OH ' ' HB1' ' A' ' 231' ' ' ALA . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.493 ' C ' HD22 ' A' ' 259' ' ' LEU . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.511 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.736 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 27' ' ' ILE . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.232 0.539 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.41 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 222' ' ' ALA . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.4 t80 . . . . . 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 262' ' ' LEU . 64.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 41' ' ' PHE . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.507 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' THR . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 1.6 m-80 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 50' ' ' GLU . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.507 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.621 ' CD2' HD22 ' A' ' 81' ' ' LEU . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 75' ' ' TRP . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' CE1' ' A' ' 71' ' ' PHE . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 . . . . . 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 117' ' ' GLY . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 98' ' ' THR . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 133' ' ' ILE . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.412 ' N ' ' OD2' ' A' ' 132' ' ' ASP . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.625 ' NH1' HD21 ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.546 ' CG1' HD22 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.483 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.625 HD21 ' NH1' ' A' ' 139' ' ' ARG . 38.8 t-20 -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.529 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 56.1 m-20 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.525 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.493 ' HD1' ' HA3' ' A' ' 172' ' ' GLY . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 190' ' ' PHE . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 184' ' ' VAL . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 206' ' ' VAL . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.3 tttm . . . . . 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.58 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 10.4 tp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.266 0.555 . . . . 0.0 109.764 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.58 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 194' ' ' ILE . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m . . . . . 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 202' ' ' LEU . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.566 ' HB2' HD22 ' A' ' 202' ' ' LEU . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.652 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.472 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.89 HD21 HD13 ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 262' ' ' LEU . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.509 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 24' ' ' PHE . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.731 0 N-CA-C 112.321 -0.312 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.695 0 CA-C-O 120.846 0.355 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' HD22 ' A' ' 150' ' ' LEU . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.0 t80 . . . . . 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 . . . . . 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 277' ' ' LEU . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 41' ' ' PHE . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 39' ' ' LEU . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 42' ' ' THR . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.414 ' H ' HG21 ' A' ' 77' ' ' THR . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.474 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.649 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 77' ' ' THR . 3.3 m120 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 75' ' ' TRP . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.9 mtt85 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 122.151 0.977 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' THR . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HZ1' ' HB3' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.656 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 4' ' ' PRO . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 165' ' ' THR . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB2' HD12 ' A' ' 180' ' ' LEU . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 173' ' ' TYR . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.685 ' CE1' HD11 ' A' ' 10' ' ' LEU . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.663 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 190' ' ' PHE . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 206' ' ' VAL . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 178' ' ' PHE . 7.1 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 204' ' ' THR . 57.0 tp . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.491 ' OG1' ' NE2' ' A' ' 196' ' ' GLN . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.668 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m . . . . . 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.694 HG23 ' HD2' ' A' ' 229' ' ' PRO 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.694 ' HD2' HG23 ' A' ' 227' ' ' ILE . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.708 HD21 HD13 ' A' ' 242' ' ' LEU . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.561 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.563 0 N-CA-C 112.32 -0.312 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.491 ' H ' ' HB2' ' A' ' 274' ' ' LYS . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 112.388 -0.285 . . . . 0.0 112.388 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.533 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . . . . . . . . 0 C--O 1.243 0.72 0 CA-C-O 121.145 0.497 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.613 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.539 ' C ' HD21 ' A' ' 124' ' ' ASN . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.477 HG23 ' NZ ' ' A' ' 115' ' ' LYS . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' HB3' ' HG ' ' A' ' 260' ' ' SER . 28.4 m-85 . . . . . 0 N--CA 1.465 0.296 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 HD12 ' A' ' 277' ' ' LEU . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 41' ' ' PHE . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE1' HD22 ' A' ' 39' ' ' LEU . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 50' ' ' GLU . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.493 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.442 ' CE2' HD22 ' A' ' 81' ' ' LEU . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 75' ' ' TRP . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 71' ' ' PHE . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 . . . . . 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 . . . . . 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 103' ' ' PHE . 1.2 m-85 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' NZ ' HG23 ' A' ' 6' ' ' THR . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.753 HD22 HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.493 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 7' ' ' TYR . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.456 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.65 ' NZ ' ' HB2' ' A' ' 2' ' ' ALA . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.821 HG21 ' CE1' ' A' ' 178' ' ' PHE . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.821 ' CE1' HG21 ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.534 HG22 ' HA3' ' A' ' 192' ' ' GLY . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 188' ' ' THR . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.534 ' HA3' HG22 ' A' ' 182' ' ' THR . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.47 ' HG ' ' N ' ' A' ' 203' ' ' GLU . 56.9 tp . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 204' ' ' THR . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.469 ' HB1' ' HZ2' ' A' ' 236' ' ' LYS . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' A' ' 202' ' ' LEU . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.469 ' HZ2' ' HB1' ' A' ' 222' ' ' ALA . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.912 HD21 HD13 ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.912 HD13 HD21 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . 0.41 HG23 ' OG1' ' A' ' 258' ' ' THR . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 250' ' ' THR . 5.6 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.328 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.631 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 248' ' ' THR . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 277' ' ' LEU . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.506 ' HG ' ' HB3' ' A' ' 24' ' ' PHE . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.798 0 CA-C-O 120.13 -0.261 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.415 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 27' ' ' ILE . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.025 0.441 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 4' ' ' PRO . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.596 ' C ' HG23 ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' HD3' ' A' ' 61' ' ' LYS . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.636 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.636 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 69' ' ' LEU . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 58' ' ' LEU . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 53.5 m-20 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.732 HG23 ' CD2' ' A' ' 71' ' ' PHE . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HE3' ' HZ2' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 . . . . . 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.462 0.135 0 CA-C-O 120.391 0.139 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HZ2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.536 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.63 ' C ' HD22 ' A' ' 144' ' ' LEU . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 143' ' ' VAL . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.7 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.438 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' ILE . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.577 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.431 HG22 ' CD2' ' A' ' 190' ' ' PHE . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 184' ' ' VAL . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.403 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.46 HD11 ' HB1' ' A' ' 223' ' ' ALA . 45.1 tp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m . . . . . 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 202' ' ' LEU . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.56 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.964 HD21 HD13 ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p . . . . . 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' OE1' ' A' ' 282' ' ' GLN . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.479 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 242' ' ' LEU . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 N-CA-C 112.356 -0.298 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 27' ' ' ILE . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.247 0.928 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.536 ' C ' HD21 ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 4' ' ' PRO . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 17' ' ' VAL . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 13' ' ' SER . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.753 ' N ' ' HG ' ' A' ' 260' ' ' SER . 66.4 m-85 . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 ' CE1' ' A' ' 41' ' ' PHE . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.688 ' CE1' HD22 ' A' ' 39' ' ' LEU . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.434 ' OG ' HD23 ' A' ' 58' ' ' LEU . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 50' ' ' GLU . 61.1 t-20 -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.505 ' OG1' ' ND2' ' A' ' 48' ' ' ASN . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.52 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.494 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.494 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.6 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.52 ' CE3' HD12 ' A' ' 58' ' ' LEU . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.598 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 101' ' ' SER . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 69' ' ' LEU . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 93' ' ' ARG . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 98' ' ' THR . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 83' ' ' THR . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' O ' ' HA3' ' A' ' 94' ' ' GLY . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.536 HD21 ' C ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 21.0 tp60 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.425 ' C ' ' ND2' ' A' ' 168' ' ' ASN . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.425 ' ND2' ' C ' ' A' ' 167' ' ' SER . 4.9 m120 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.43 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.46 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 192' ' ' GLY . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' A' ' 184' ' ' VAL . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 206' ' ' VAL . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 225' ' ' TYR . 9.7 mp . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.647 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m . . . . . 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.658 ' CD1' HD11 ' A' ' 202' ' ' LEU . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.782 HD21 HD13 ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.594 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.782 HD13 HD21 ' A' ' 238' ' ' ASN . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.499 ' O ' HD23 ' A' ' 262' ' ' LEU . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.663 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.761 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.431 ' C ' HD22 ' A' ' 259' ' ' LEU . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.753 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 24' ' ' PHE . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.907 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.646 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 276' ' ' GLY . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . . . . . . 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.722 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 143' ' ' VAL . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.685 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.492 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.461 ' CB ' HD22 ' A' ' 207' ' ' ASN . 86.5 t80 . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.658 ' N ' ' HG ' ' A' ' 260' ' ' SER . 69.2 m-85 . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 277' ' ' LEU . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 37' ' ' ASN . 8.3 m120 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' THR . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' LEU . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.522 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 87' ' ' VAL . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 85' ' ' ILE . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.556 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 75' ' ' TRP . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 71' ' ' PHE . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HD23 ' A' ' 69' ' ' LEU . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.44 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 . . . . . 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' A' ' 99' ' ' PHE . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.479 ' NH1' HD21 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 5' ' ' PRO . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.535 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.698 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.479 HD21 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 164' ' ' VAL . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 180' ' ' LEU . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.515 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CD1' ' NE2' ' A' ' 196' ' ' GLN . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 173' ' ' TYR . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' A' ' 190' ' ' PHE . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.107 0.48 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 203' ' ' GLU . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.461 HD22 ' CB ' ' A' ' 18' ' ' PHE . 92.9 m-20 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m . . . . . 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.829 0 CA-C-O 119.68 -0.511 . . . . 0.0 112.887 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.658 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.213 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . 0.532 ' CD2' ' O ' ' A' ' 272' ' ' GLY . 33.6 m170 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.696 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 276' ' ' GLY . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.538 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 ' NE2' ' A' ' 181' ' ' HIS . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 60.5 t80 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.656 HD22 ' CE2' ' A' ' 41' ' ' PHE . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE2' HD22 ' A' ' 39' ' ' LEU . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' C ' ' A' ' 50' ' ' GLU . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' SER . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.566 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.482 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 87' ' ' VAL . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.629 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' THR . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.446 ' HG ' ' HE2' ' A' ' 103' ' ' PHE . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HE2' ' HG ' ' A' ' 101' ' ' SER . 3.7 m-85 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.614 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 68.4 m-20 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.733 ' HB2' HD12 ' A' ' 180' ' ' LEU . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.623 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.623 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 173' ' ' TYR . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.517 ' NE2' HD21 ' A' ' 10' ' ' LEU . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 183' ' ' ASN . 0.3 OUTLIER -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.493 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.406 ' O ' ' OD1' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 208' ' ' LEU . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 220' ' ' GLY . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 194' ' ' ILE . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.523 ' CD2' HG22 ' A' ' 227' ' ' ILE . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 225' ' ' TYR 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m . . . . . 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.547 0 N-CA-C 112.067 -0.413 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' CD ' ' A' ' 274' ' ' LYS . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 112.382 -0.287 . . . . 0.0 112.382 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.57 ' CD ' HD23 ' A' ' 262' ' ' LEU . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 27' ' ' ILE . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.621 ' CA ' HD21 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 181' ' ' HIS . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HB1' ' A' ' 222' ' ' ALA . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.462 ' CD2' ' N ' ' A' ' 24' ' ' PHE . 4.0 m-85 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 42' ' ' THR . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.48 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.526 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.508 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.476 ' CD2' HD22 ' A' ' 81' ' ' LEU . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 75' ' ' TRP . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG23 ' CD2' ' A' ' 71' ' ' PHE . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 . . . . . 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 117' ' ' GLY . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 98' ' ' THR . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 . . . . . 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' C ' HD22 ' A' ' 111' ' ' ASN . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 110' ' ' LYS . 1.5 m120 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.599 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.648 ' CG ' HD22 ' A' ' 124' ' ' ASN . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.552 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.648 HD22 ' CG ' ' A' ' 119' ' ' LYS . 4.1 m120 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.538 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 170' ' ' ALA . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 67.8 tp60 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.731 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.445 ' H ' ' HB3' ' A' ' 154' ' ' GLN . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.666 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.474 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 10' ' ' LEU . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.601 HG22 ' HA2' ' A' ' 192' ' ' GLY . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.667 HG13 ' CE1' ' A' ' 190' ' ' PHE . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.667 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 206' ' ' VAL . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.66 HD21 ' CE2' ' A' ' 225' ' ' TYR . 10.3 mp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 223' ' ' ALA . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.702 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m . . . . . 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.66 ' CE2' HD21 ' A' ' 202' ' ' LEU . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 225' ' ' TYR 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.584 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.622 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.622 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.699 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.428 HD23 ' CD ' ' A' ' 274' ' ' LYS . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . . . . . . 0 CA--C 1.537 1.425 0 CA-C-O 120.282 -0.177 . . . . 0.0 112.662 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.428 ' CD ' HD23 ' A' ' 262' ' ' LEU . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.405 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 27' ' ' ILE . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.535 ' C ' HD12 ' A' ' 279' ' ' LEU . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 278' ' ' GLY . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.5 ' C ' HD21 ' A' ' 124' ' ' ASN . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 17' ' ' VAL . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 13' ' ' SER . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.458 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.3 t80 . . . . . 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 277' ' ' LEU . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' A' ' 41' ' ' PHE . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 72' ' ' THR . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 61' ' ' LYS . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 71' ' ' PHE . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 . . . . . 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' C ' HD13 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 135' ' ' GLY . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.586 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 124' ' ' ASN . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.465 ' C ' HD22 ' A' ' 156' ' ' ASN . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.556 HD21 ' ND2' ' A' ' 183' ' ' ASN . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 192' ' ' GLY . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 168' ' ' ASN . 12.2 p-10 -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.699 HG13 ' CE1' ' A' ' 190' ' ' PHE . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.699 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.568 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.568 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.458 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 98.0 m-20 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m . . . . . 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.48 ' CZ ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 227' ' ' ILE . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.458 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.53 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.46 ' C ' ' ND2' ' A' ' 239' ' ' ASN . 0.0 OUTLIER -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 262' ' ' LEU . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 262' ' ' LEU . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.18 0 CA-C-O 120.05 -0.306 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 279' ' ' LEU . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.446 ' OD2' ' OG ' ' A' ' 241' ' ' SER . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.598 0 N-CA-C 112.263 -0.335 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 27' ' ' ILE . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.431 ' CD2' HD12 ' A' ' 257' ' ' LEU . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CA ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 124' ' ' ASN . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.483 HD21 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.48 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.493 ' C ' HE21 ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.905 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.628 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.905 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.443 ' CG ' HD11 ' A' ' 242' ' ' LEU . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . . . . . . 0 C--O 1.241 0.608 0 CA-C-O 121.211 0.529 . . . . 0.0 109.819 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CA ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.5 t80 . . . . . 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 124' ' ' ASN . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.483 HD21 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.48 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.493 ' C ' HE21 ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.905 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.628 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.905 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 255' ' ' ILE . 1.5 m . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.719 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.443 ' CG ' HD11 ' A' ' 242' ' ' LEU . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 2.177 0 CA-C-O 119.824 -0.431 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.793 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.719 ' N ' ' HZ1' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.643 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 . . . . . 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CB ' ' HG ' ' A' ' 260' ' ' SER . 10.8 m-85 . . . . . 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.658 HD22 ' CE1' ' A' ' 41' ' ' PHE . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE1' HD22 ' A' ' 39' ' ' LEU . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.781 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.556 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 HG22 ' A' ' 87' ' ' VAL . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.627 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' CD2' ' A' ' 71' ' ' PHE . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 HD23 ' A' ' 69' ' ' LEU . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD2' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 95' ' ' LEU . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 98' ' ' THR . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' A' ' 102' ' ' SER . 98.1 mttt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.719 ' HZ1' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 10' ' ' LEU . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 183' ' ' ASN . 50.7 m-20 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.617 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 194' ' ' ILE . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.476 ' CE1' HD22 ' A' ' 10' ' ' LEU . 33.8 m170 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 168' ' ' ASN . 43.3 t30 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 202' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 194' ' ' ILE . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.629 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 54.7 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.629 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.486 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.789 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.789 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.488 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 112.197 -0.361 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . 0.593 ' O ' HD23 ' A' ' 277' ' ' LEU . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.651 ' HG ' ' CB ' ' A' ' 24' ' ' PHE . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.805 0 N-CA-C 112.048 -0.421 . . . . 0.0 112.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.646 ' HB2' HG23 ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.754 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.52 ' CA ' ' HZ1' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.732 ' N ' ' HG ' ' A' ' 260' ' ' SER . 71.9 m-85 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 37' ' ' ASN . 4.4 m120 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 41' ' ' PHE . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 60' ' ' THR . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.454 HD22 ' HG1' ' A' ' 51' ' ' THR . 60.7 t30 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.588 ' CB ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.524 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.595 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE2' HG23 ' A' ' 85' ' ' ILE . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' CE2' HD22 ' A' ' 81' ' ' LEU . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 . . . . . 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.774 HD12 ' CE2' ' A' ' 131' ' ' PHE . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HZ1' ' CA ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 143' ' ' VAL . 0.1 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.774 ' CE2' HD12 ' A' ' 114' ' ' ILE . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.739 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.699 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.593 HG21 ' ND2' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.436 HD11 ' HE3' ' A' ' 174' ' ' LYS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.739 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 150' ' ' LEU . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.875 ' CE1' HG23 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 7.9 mm-40 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 173' ' ' TYR . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.526 HG22 ' HA2' ' A' ' 192' ' ' GLY . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 190' ' ' PHE . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.513 ' HD2' HG22 ' A' ' 184' ' ' VAL . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.875 HG23 ' CE1' ' A' ' 178' ' ' PHE . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 225' ' ' TYR . 0.7 OUTLIER . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 16.9 m . . . . . 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.53 ' CE1' HD11 ' A' ' 202' ' ' LEU . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 227' ' ' ILE 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.598 ' OG ' HD13 ' A' ' 242' ' ' LEU . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.626 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 241' ' ' SER . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 262' ' ' LEU . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 78.2 p . . . . . 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.12 -0.392 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.732 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.998 0 CA-C-O 120.152 -0.249 . . . . 0.0 112.795 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.4 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 27' ' ' ILE . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.737 0 CA-C-O 120.947 0.404 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 3' ' ' VAL . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.442 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.607 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 17' ' ' VAL . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' SER . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.593 ' N ' ' HG ' ' A' ' 260' ' ' SER . 45.9 m-85 . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.638 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.642 HD22 ' CE2' ' A' ' 41' ' ' PHE . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.642 ' CE2' HD22 ' A' ' 39' ' ' LEU . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.48 HD22 ' CE3' ' A' ' 75' ' ' TRP . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' THR . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.621 ' CD2' HG12 ' A' ' 87' ' ' VAL . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 85' ' ' ILE . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.635 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.48 ' CE3' HD22 ' A' ' 58' ' ' LEU . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.635 ' ND2' ' NZ ' ' A' ' 74' ' ' LYS . 88.5 m-20 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 71' ' ' PHE . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 . . . . . 0 N--CA 1.449 -0.501 0 CA-C-O 122.416 1.103 . . . . 0.0 113.787 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.616 ' N ' ' O ' ' A' ' 93' ' ' ARG . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 . . . . . 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.746 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 183' ' ' ASN . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' A' ' 175' ' ' THR . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 194' ' ' ILE . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.549 ' CE1' HD22 ' A' ' 10' ' ' LEU . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 180' ' ' LEU . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.0 tp . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 223' ' ' ALA . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 227' ' ' ILE . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 225' ' ' TYR 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 231' ' ' ALA . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 230' ' ' ASP . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.599 HD21 ' CG ' ' A' ' 242' ' ' LEU . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.599 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 256' ' ' LYS . 85.5 m . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 24' ' ' PHE . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 27' ' ' ILE . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 3' ' ' VAL . . . -61.26 -35.71 78.02 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.673 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 26.4 t 29.23 69.46 0.59 Allowed Pre-proline 0 C--O 1.214 -0.793 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.305 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' C ' HD22 ' A' ' 124' ' ' ASN . 1.6 Cg_endo -87.48 94.79 0.45 Allowed 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 123.32 2.68 . . . . 0.0 111.212 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.729 ' O ' HG23 ' A' ' 6' ' ' THR . 37.0 Cg_endo -67.01 -90.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.323 0 N-CA-C 120.782 3.339 . . . . 0.0 120.782 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 5' ' ' PRO . 13.1 p 96.5 125.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -172.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.749 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 82.6 t80 -37.73 -54.36 1.22 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.993 -172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.58 86.3 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 119.035 -1.066 . . . . 0.0 112.619 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 2.8 m-20 -96.96 16.65 18.86 Favored 'General case' 0 C--O 1.259 1.595 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.343 -177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 6' ' ' THR . 41.4 tp -64.99 118.71 9.51 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.86 47.28 72.78 Favored Glycine 0 CA--C 1.532 1.131 0 N-CA-C 110.411 -1.075 . . . . 0.0 110.411 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -47.07 -41.43 16.96 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.44 ' HG ' ' HE1' ' A' ' 195' ' ' TYR . 31.4 t -59.75 -47.31 86.18 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.691 -0.63 . . . . 0.0 112.075 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.32 -37.86 89.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.65 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.699 ' O ' HG23 ' A' ' 19' ' ' THR . 94.4 mtt-85 -64.1 -39.87 94.99 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.55 -42.59 99.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.43 -43.46 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 119.041 0.837 . . . . 0.0 109.848 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.518 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 86.2 t80 -63.66 -44.29 94.2 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.632 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 15' ' ' ARG . 60.5 p -61.47 -50.74 71.55 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -53.1 139.07 29.57 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.12 -122.39 25.47 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CE2' ' CZ ' ' A' ' 18' ' ' PHE . 84.7 t80 56.09 102.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.98 0.39 . . . . 0.0 110.441 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.48 97.86 1.07 Allowed Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -113.41 -138.84 0.38 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.839 0.352 . . . . 0.0 111.886 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.486 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 107.31 -12.38 40.06 Favored Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.763 -0.653 . . . . 0.0 113.356 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mp -120.33 136.25 54.75 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.69 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.7 mt -85.48 116.87 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -111.64 128.6 56.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.217 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.02 117.29 34.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.425 -1.261 . . . . 0.0 108.112 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -118.04 130.21 56.03 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.124 0.488 . . . . 0.0 111.391 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.8 mt -113.17 124.65 53.04 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.869 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -107.98 129.26 55.13 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -120.52 115.77 24.1 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.069 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -81.93 119.55 24.09 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.16 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' H ' ' A' ' 40' ' ' GLU . 10.5 m -84.16 152.41 24.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -82.81 -31.71 28.03 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.189 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.436 HD22 ' HA ' ' A' ' 37' ' ' ASN . 3.0 m120 -64.34 -41.54 96.72 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 127.49 15.62 2.42 Favored Glycine 0 C--O 1.223 -0.538 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 61' ' ' LYS . 12.0 mt -64.07 -39.98 95.25 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.804 0.355 . . . . 0.0 111.799 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' H ' ' HB2' ' A' ' 35' ' ' SER . 68.3 mm-40 57.15 79.63 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.309 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.465 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 35.6 m-85 -97.08 113.61 25.19 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.495 0.664 . . . . 0.0 112.355 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -124.63 106.93 10.49 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.212 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 82.4 p -96.63 160.06 14.59 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.819 -0.752 . . . . 0.0 109.17 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.5 p -141.86 160.38 40.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.782 0.801 . . . . 0.0 112.717 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.86 123.28 1.83 Allowed Glycine 0 CA--C 1.518 0.262 0 N-CA-C 107.877 -2.089 . . . . 0.0 107.877 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.6 p -137.85 172.0 13.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.0 111.861 -176.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -141.63 163.71 32.18 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.938 177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -97.12 126.8 42.53 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.8 p -71.79 -5.05 31.37 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -107.47 -46.41 3.85 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.206 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 52' ' ' THR . 43.8 p -92.73 -15.41 26.7 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.88 13.65 2.17 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.034 0.445 . . . . 0.0 110.218 -179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 53.3 mmtt -66.06 168.6 8.1 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.725 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.8 t -130.27 107.53 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 124.272 1.029 . . . . 0.0 110.314 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 ' O ' ' OG ' ' A' ' 46' ' ' SER . 39.9 p -126.17 136.68 53.15 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.888 0.767 . . . . 0.0 109.993 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.18 -153.42 9.35 Favored Glycine 0 N--CA 1.466 0.67 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -174.89 162.98 3.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.432 0.634 . . . . 0.0 111.052 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.17 107.18 9.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.435 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.29 119.39 39.11 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.465 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 81.9 m -130.36 110.96 11.9 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.565 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 38' ' ' GLY . 17.5 tttt -111.12 112.75 24.77 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -95.64 127.59 41.8 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.03 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.768 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 5.8 ttt180 79.16 -112.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.988 0.805 . . . . 0.0 112.499 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 24.1 m0 148.29 -166.04 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' GLU . 45.4 p -80.47 16.43 1.34 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.31 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 65' ' ' THR . 98.2 mt-10 -46.03 -97.41 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.602 -0.439 . . . . 0.0 109.923 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -88.28 27.01 1.3 Allowed 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 77.25 16.53 80.46 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.977 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.4 mt -106.05 67.46 0.74 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.183 0.491 . . . . 0.0 111.207 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m -91.69 113.58 25.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.506 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.693 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.5 m-85 -110.16 96.41 6.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -88.1 138.53 31.37 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.195 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.44 120.23 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.559 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -120.6 113.46 20.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.259 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m0 -116.29 142.59 46.64 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -135.69 164.15 28.53 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.245 0.545 . . . . 0.0 110.655 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 79' ' ' ASN . 46.8 p -64.1 -35.05 79.5 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.097 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 30.4 p30 -60.9 0.65 0.2 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.382 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 77' ' ' THR . 30.0 m-20 85.43 -3.15 0.85 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.901 0.88 . . . . 0.0 113.115 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.8 m -64.38 129.31 39.4 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 119.432 -0.907 . . . . 0.0 109.692 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD22 ' CE2' ' A' ' 75' ' ' TRP . 11.1 mt -120.43 131.66 54.88 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.94 124.07 2.73 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 119.862 -1.161 . . . . 0.0 112.087 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.3 m -125.67 121.79 34.49 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -119.67 110.89 17.36 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.693 HG23 ' CD2' ' A' ' 71' ' ' PHE . 72.8 mt -102.13 116.47 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' GLY . 82.7 p -118.52 132.93 56.21 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.8 t -119.71 102.02 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -95.32 154.39 17.22 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.454 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 62.01 40.2 12.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.55 HE22 ' CB ' ' A' ' 97' ' ' LEU . 45.9 mt-30 -69.72 -39.14 77.03 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.498 -0.881 . . . . 0.0 113.286 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 53.4 tp -89.26 -67.11 0.86 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.086 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 176.64 -41.31 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.893 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -76.76 -80.17 0.1 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.499 0.666 . . . . 0.0 109.248 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -155.45 96.6 0.16 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 90' ' ' GLN . 39.0 tp -126.12 120.12 29.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.355 -0.923 . . . . 0.0 108.879 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.27 127.89 48.34 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.599 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.0 tp -125.14 106.43 9.9 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' THR . 53.6 m -110.82 99.91 8.74 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -83.29 127.76 33.92 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 174.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -119.47 150.16 40.67 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.644 -176.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.06 110.35 6.27 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.152 0.908 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.53 112.93 16.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.828 0.823 . . . . 0.0 110.188 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -109.36 106.58 16.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.853 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.46 159.66 32.23 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' O ' ' N ' ' A' ' 107' ' ' THR . 83.5 Cg_exo -39.36 -49.65 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 124.094 3.196 . . . . 0.0 114.709 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 109' ' ' LYS . 95.3 m-20 -36.44 93.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.33 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 105' ' ' PRO . 43.6 p 34.13 45.84 0.13 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.79 48.14 86.79 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 106' ' ' ASN . 88.7 tttt -65.22 114.06 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.599 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -98.23 121.85 40.66 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.143 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -112.83 104.68 12.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.051 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.49 110.58 20.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.04 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -117.78 145.26 44.63 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -125.03 103.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -98.43 124.27 43.03 Favored 'General case' 0 CA--C 1.51 -0.587 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.402 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 97.2 m -124.51 106.96 10.57 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.26 102.71 1.48 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -92.67 133.58 35.86 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.9 mttp -117.73 152.9 34.34 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.999 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.643 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.6 ttt-85 -171.49 86.21 0.09 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.643 ' O ' ' O ' ' A' ' 120' ' ' ARG . 94.4 mt-10 34.59 118.88 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 122.147 0.975 . . . . 0.0 112.404 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 56.82 -14.6 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.834 -1.075 . . . . 0.0 113.772 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -114.04 113.47 43.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.469 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.64 ' ND2' HG23 ' A' ' 6' ' ' THR . 14.1 t-20 -122.11 127.05 49.68 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.183 176.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 65.4 mt -122.18 110.69 16.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.424 -0.798 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.424 ' O ' ' CA ' ' A' ' 140' ' ' GLY . . . -108.97 138.77 14.94 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 119.321 0.964 . . . . 0.0 111.265 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.6 t -124.77 102.79 7.75 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.503 0.766 . . . . 0.0 111.048 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -100.63 108.18 20.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.68 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.9 mtp -101.07 112.42 24.87 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 68.3 t0 -96.91 102.5 14.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.259 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.87 83.52 7.17 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.733 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -125.63 167.91 14.45 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.1 mt -62.42 -41.46 91.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.483 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.12 74.22 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.03 -171.23 34.55 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 106.676 -2.569 . . . . 0.0 106.676 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 76.3 Cg_exo -54.01 123.91 0.6 Allowed 'Cis proline' 0 N--CA 1.509 2.422 0 CA-C-N 120.891 2.346 . . . . 0.0 115.331 -1.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.0 m -113.25 139.47 48.78 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 155' ' ' MET . 85.4 mt -108.75 102.56 14.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.767 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.621 ' C ' HE22 ' A' ' 154' ' ' GLN . 75.8 mtp85 -109.27 104.83 14.03 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.726 0.641 . . . . 0.0 110.534 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -121.46 164.75 14.56 Favored Glycine 0 C--O 1.208 -1.519 0 CA-C-O 117.711 -1.605 . . . . 0.0 110.515 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.749 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -134.88 125.84 27.55 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 119.645 1.722 . . . . 0.0 107.933 177.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.38 110.27 20.99 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG11 ' CG ' ' A' ' 5' ' ' PRO . 87.9 t -114.45 139.41 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.227 1.013 . . . . 0.0 111.133 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.9 mt -120.91 137.84 54.4 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 112.916 -1.947 . . . . 0.0 108.13 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -106.7 149.28 16.57 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.823 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.9 m-85 -146.39 -160.3 1.13 Allowed 'General case' 0 C--O 1.223 -0.295 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.004 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.6 mt-10 -46.48 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.783 1.302 . . . . 0.0 113.378 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.706 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 88.25 34.6 9.47 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.5 m95 -133.08 141.89 48.44 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.371 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.462 HD12 ' NE2' ' A' ' 181' ' ' HIS . 89.0 mt -122.27 111.23 16.67 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.709 176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 143' ' ' VAL . . . -113.08 140.05 48.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 143' ' ' VAL . . . -132.13 151.14 19.77 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 119.684 1.129 . . . . 0.0 112.259 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -128.58 112.3 14.15 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.621 HE22 ' C ' ' A' ' 139' ' ' ARG . 61.0 tp60 -104.13 113.62 27.29 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 118.977 -0.535 . . . . 0.0 110.094 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.406 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.6 ttp -106.64 117.39 33.92 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -103.43 114.25 28.39 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.93 95.68 5.81 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.293 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.9 mt-10 -74.41 98.36 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 65.4 p -67.68 -33.1 74.26 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.52 87.58 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.658 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -98.88 -13.75 19.91 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.563 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.5 m 55.5 51.45 12.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.053 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -128.32 139.28 52.49 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.676 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.0 101.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 58.2 p -120.28 -57.12 1.95 Allowed 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 122.377 1.084 . . . . 0.0 110.798 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.455 ' N ' ' OG1' ' A' ' 165' ' ' THR . 2.9 mm-40 -69.68 108.85 4.06 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 113.509 -1.678 . . . . 0.0 110.815 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 41.8 t -139.8 140.32 36.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.621 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.539 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 3.1 t-20 -128.49 120.63 27.17 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.06 114.47 27.01 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -92.75 131.63 37.65 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.728 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 62.8 t -131.83 125.99 56.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.77 146.3 18.23 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.249 -0.977 . . . . 0.0 112.88 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.44 ' H ' ' HB2' ' A' ' 180' ' ' LEU . 38.9 t80 -128.22 128.51 44.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.885 -1.157 . . . . 0.0 108.437 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -91.64 146.37 23.84 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.35 151.76 46.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.309 -1.769 . . . . 0.0 107.403 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 178' ' ' PHE . 66.1 t0 -38.36 120.89 0.94 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.796 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.422 ' OE2' ' O ' ' A' ' 197' ' ' LYS . 92.1 mt-10 59.45 -19.35 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.613 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.9 OUTLIER -103.98 136.49 43.53 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -175.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -116.61 140.43 49.4 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 119.753 -0.165 . . . . 0.0 110.67 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.594 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 15.0 mt -107.71 110.11 21.87 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.462 ' NE2' HD12 ' A' ' 150' ' ' LEU . 41.8 m170 -119.01 117.97 30.21 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 123.432 0.458 . . . . 0.0 111.936 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 71.9 p -133.96 153.96 51.42 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 118.632 -0.699 . . . . 0.0 109.247 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -139.75 136.63 34.34 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.683 1.129 . . . . 0.0 109.565 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.581 HG22 ' CE1' ' A' ' 190' ' ' PHE . 10.9 t -91.32 117.89 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.035 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -97.41 111.74 23.87 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.138 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.455 ' OD1' ' NE2' ' A' ' 166' ' ' GLN . 92.0 m-20 53.37 24.05 3.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 125.763 1.914 . . . . 0.0 112.979 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 69.08 17.29 71.71 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 188' ' ' THR . 19.3 p -122.33 -67.62 0.94 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -108.98 124.65 51.03 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 119.782 -0.767 . . . . 0.0 112.832 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.581 ' CE1' HG22 ' A' ' 184' ' ' VAL . 15.0 m-85 -90.33 150.63 21.82 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 120.81 0.338 . . . . 0.0 110.379 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -172.84 142.66 6.87 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.969 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.68 -161.49 26.1 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 34.7 p -137.03 173.58 11.54 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.745 0.783 . . . . 0.0 112.565 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.748 HD11 HD11 ' A' ' 208' ' ' LEU . 69.6 mt -131.37 112.42 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.44 ' HE1' ' HG ' ' A' ' 13' ' ' SER . 53.8 t80 -85.23 118.95 25.09 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -123.48 102.54 7.94 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.422 ' O ' ' OE2' ' A' ' 177' ' ' GLU . 88.3 tttt -85.86 98.53 10.82 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 79.5 t -75.73 -41.39 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.321 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.494 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.8 t30 -168.72 -169.61 1.05 Allowed 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.494 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 98.8 mttt -62.3 -42.08 99.06 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.569 -0.453 . . . . 0.0 111.829 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -97.62 -5.67 34.97 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.6 mt -117.57 110.47 17.97 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -119.73 108.14 14.06 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 115.232 -0.895 . . . . 0.0 108.786 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 223' ' ' ALA . 11.1 p -120.24 160.85 22.14 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.848 -0.532 . . . . 0.0 110.621 -177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -142.95 126.92 17.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.337 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.0 t -101.45 126.01 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 99.4 m-20 -98.25 127.72 44.33 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.128 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.748 HD11 HD11 ' A' ' 194' ' ' ILE . 77.6 mt -112.7 110.41 20.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 123.719 0.637 . . . . 0.0 110.963 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.19 123.17 40.18 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.557 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.524 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 1.7 p90 -138.57 171.09 14.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 120.549 -0.46 . . . . 0.0 109.859 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -129.63 115.43 17.37 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.847 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.532 ' HB2' ' HE2' ' A' ' 190' ' ' PHE . . . -41.93 100.41 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.681 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 211' ' ' THR . . . 173.88 -158.68 27.78 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -99.39 10.02 42.19 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.0 p -78.24 166.23 22.97 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.8 m -103.18 114.59 29.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.727 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -79.15 113.24 17.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -132.92 146.42 51.78 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 119.378 -0.929 . . . . 0.0 111.886 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.33 157.13 15.51 Favored Glycine 0 CA--C 1.504 -0.607 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.766 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.0 mt -126.13 104.36 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.91 119.99 40.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.038 -0.665 . . . . 0.0 111.2 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.508 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -115.4 123.54 48.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.41 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.29 98.84 8.49 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -100.24 99.99 10.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -71.92 123.9 23.72 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 104.527 -2.397 . . . . 0.0 104.527 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 231' ' ' ALA . 3.0 mt -83.66 -59.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.224 0 CA-C-O 122.744 1.259 . . . . 0.0 113.176 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 0.1 OUTLIER -144.92 176.74 2.07 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 103.083 -2.932 . . . . 0.0 103.083 178.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -63.98 -16.38 54.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 CA-C-N 121.011 1.397 . . . . 0.0 112.813 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 99.5 m-20 -107.72 3.75 24.96 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.445 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -153.64 146.14 24.07 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.306 0.957 . . . . 0.0 112.485 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.445 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 3.3 m -148.62 144.82 27.47 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.466 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.661 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.4 t80 -114.91 119.2 35.73 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 29.0 t -107.5 129.96 54.9 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.661 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -138.27 147.19 43.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 77.6 mttt -146.39 118.67 8.37 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.584 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.468 ' CG1' HD12 ' A' ' 221' ' ' ILE . 1.0 OUTLIER -112.12 117.01 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 120.626 -0.43 . . . . 0.0 112.053 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.562 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.2 p30 -85.46 169.0 14.05 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -88.14 2.52 51.89 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.158 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.562 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.0 p -90.14 4.49 50.27 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.59 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 88.54 34.9 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 113.901 -1.5 . . . . 0.0 113.446 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 241' ' ' SER . 9.2 mp -112.67 107.59 16.33 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.476 0.58 . . . . 0.0 111.446 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -93.86 129.2 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-O 117.716 -1.135 . . . . 0.0 109.896 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -113.34 137.81 14.47 Favored Glycine 0 C--N 1.352 1.428 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 60.6 mt -121.21 112.02 18.12 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.08 106.28 0.85 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 119.659 -1.258 . . . . 0.0 112.69 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -95.93 124.05 39.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.177 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 84.7 m -115.22 128.82 56.4 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.467 0.48 . . . . 0.0 111.051 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -121.12 110.61 16.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.253 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 22.6 m -98.72 118.64 35.9 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.661 HD12 ' HB ' ' A' ' 255' ' ' ILE . 44.4 mt -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 119.254 -0.403 . . . . 0.0 111.537 -178.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.97 -54.43 11.17 Favored Pre-proline 0 N--CA 1.482 1.133 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 88.5 Cg_exo -38.69 -15.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.142 0 C-N-CA 122.508 2.139 . . . . 0.0 112.681 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 94.95 33.69 6.53 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.541 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.661 ' HB ' HD12 ' A' ' 251' ' ' LEU . 93.5 mt -123.21 130.0 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 120.65 -0.42 . . . . 0.0 112.087 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -109.4 123.25 49.02 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.641 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' CD2' ' A' ' 279' ' ' LEU . 57.5 tp -123.57 103.58 8.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.043 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 259' ' ' LEU . 23.5 m -116.37 138.32 51.44 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 258' ' ' THR . 10.5 mp -114.04 143.26 45.05 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.006 178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 34.0 m -134.29 146.87 50.42 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.422 0.63 . . . . 0.0 112.512 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.73 112.47 2.93 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.671 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.447 ' C ' HD12 ' A' ' 263' ' ' LEU . 0.5 OUTLIER -109.83 103.58 12.4 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.7 mp -102.02 127.17 49.01 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.735 ' O ' ' N ' ' A' ' 268' ' ' VAL . 62.1 t0 -94.83 104.28 16.17 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-O 121.43 0.633 . . . . 0.0 112.033 -177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -53.41 -20.3 10.51 Favored Glycine 0 C--N 1.311 -0.818 0 CA-C-N 114.715 -1.129 . . . . 0.0 114.02 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.535 ' C ' HD22 ' A' ' 267' ' ' ASN . 84.3 mttt -95.06 -12.26 26.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.555 ' CB ' ' HB3' ' A' ' 270' ' ' ALA . 0.7 OUTLIER -137.97 27.62 2.66 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 118.67 -0.681 . . . . 0.0 110.283 177.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.735 ' N ' ' O ' ' A' ' 264' ' ' ASP . 4.8 t -65.05 -26.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 CA-C-N 120.159 1.345 . . . . 0.0 107.616 176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -93.61 -4.06 51.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 112.072 -2.331 . . . . 0.0 110.449 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.555 ' HB3' ' CB ' ' A' ' 267' ' ' ASN . . . -106.29 -35.24 7.22 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.622 ' O ' ' CE1' ' A' ' 273' ' ' HIS . . . 110.92 -122.33 6.14 Favored Glycine 0 C--N 1.366 2.213 0 CA-C-O 122.599 1.111 . . . . 0.0 112.33 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 47.08 53.26 11.05 Favored Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.661 ' CE1' ' H ' ' A' ' 264' ' ' ASP . 23.5 m-70 -107.74 117.78 35.02 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 121.594 0.711 . . . . 0.0 111.493 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.13 123.72 18.05 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.057 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.486 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 96.5 mt -122.93 111.05 16.17 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.0 154.77 22.39 Favored Glycine 0 N--CA 1.462 0.384 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.299 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.69 ' HB2' HG23 ' A' ' 27' ' ' ILE . 79.4 mt -134.88 133.65 39.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -110.78 114.67 3.8 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.402 ' CD2' HD12 ' A' ' 257' ' ' LEU . 52.9 mt -119.78 99.03 6.4 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -114.15 125.29 53.79 Favored 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 123.432 0.457 . . . . 0.0 110.064 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.68 134.95 52.9 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.835 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -87.01 114.39 23.57 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.467 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 47.52 -175.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.102 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -82.7 147.4 28.5 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.443 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.723 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.33 139.84 52.1 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.2 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 3' ' ' VAL . 22.7 m -147.07 65.66 9.8 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.494 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 169.77 13.38 Favored 'Trans proline' 0 N--CA 1.501 1.964 0 C-N-CA 123.435 2.757 . . . . 0.0 114.223 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.14 -166.68 0.21 Allowed 'Trans proline' 0 N--CA 1.534 3.896 0 C-N-CA 125.063 3.842 . . . . 0.0 116.597 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.79 HG22 ' HB3' ' A' ' 141' ' ' ALA . 10.7 p -51.23 138.21 21.13 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.698 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.67 -49.44 1.56 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -176.284 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.698 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -53.24 -39.28 63.7 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 117.221 -1.792 . . . . 0.0 110.631 -175.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -68.73 -24.88 64.51 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 117.879 -1.528 . . . . 0.0 110.914 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HD13 ' A' ' 150' ' ' LEU . 8.0 mp -60.82 129.93 43.92 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.777 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.42 11.47 59.54 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.053 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -49.74 -36.94 27.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 63.5 m -58.26 -44.37 88.33 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.472 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.27 -42.71 99.15 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.855 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.505 ' O ' HG23 ' A' ' 19' ' ' THR . 83.5 mtp180 -64.08 -37.1 86.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -65.05 -42.46 94.21 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 82.4 t -61.63 -45.45 98.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 119.526 -0.87 . . . . 0.0 109.878 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.491 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.5 t80 -68.55 -46.94 68.15 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.037 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 15' ' ' ARG . 54.5 p -68.73 -45.82 70.51 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -51.79 -44.02 63.28 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.816 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' TYR . . . -77.28 -133.14 0.59 Allowed Glycine 0 CA--C 1.52 0.353 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.583 ' CD2' ' N ' ' A' ' 23' ' ' GLY . 8.6 t80 147.41 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 123.221 0.608 . . . . 0.0 110.007 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.583 ' N ' ' CD2' ' A' ' 22' ' ' TYR . . . -166.92 173.34 42.22 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 111.571 -0.612 . . . . 0.0 111.571 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' H ' HD12 ' A' ' 262' ' ' LEU . 3.1 m-85 -118.75 -175.74 2.95 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.014 0.435 . . . . 0.0 112.015 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.59 -10.24 7.62 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.88 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 47' ' ' ALA 0.269 3.6 mp -120.18 135.41 54.98 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -176.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.705 HG23 ' HB2' ' A' ' 277' ' ' LEU . 97.2 mt -84.48 115.67 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -103.34 139.7 38.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.509 -1.678 . . . . 0.0 114.533 -173.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 87.1 mt -114.91 119.31 36.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 113.655 -1.612 . . . . 0.0 107.819 177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -120.97 131.14 54.13 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.967 0.413 . . . . 0.0 111.455 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 53.7 mt -110.95 123.1 49.51 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -126.02 129.88 50.06 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.9 m -130.18 119.36 22.85 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -113.1 121.11 43.56 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.282 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -85.42 158.31 20.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.33 -17.67 62.82 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.674 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.72 -166.62 0.91 Allowed 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 62' ' ' TYR . . . -70.24 -18.85 75.34 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.432 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 39' ' ' LEU . 77.3 mt -62.54 127.91 33.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.141 0.972 . . . . 0.0 112.839 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -139.67 95.9 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.476 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CD2' ' OG1' ' A' ' 60' ' ' THR . 63.0 m-85 -96.06 119.27 34.26 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.278 -0.569 . . . . 0.0 112.01 -178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' THR . 2.7 m -122.97 104.62 9.36 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.263 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 p -95.41 160.17 14.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.4 p -146.82 162.97 37.52 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.478 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.29 114.8 0.61 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.3 t -134.22 137.01 44.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -78.96 157.09 28.24 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.78 178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 50' ' ' GLU . 58.1 t-20 -102.2 109.24 20.88 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 25' ' ' GLY . 67.4 p -63.22 36.32 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.123 -0.631 . . . . 0.0 112.701 -176.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 48' ' ' ASN . 48.6 tp10 -159.59 -51.31 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 121.194 -0.203 . . . . 0.0 111.203 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.426 ' C ' ' OG1' ' A' ' 52' ' ' THR . 43.0 p -85.14 -17.66 36.59 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 74.18 31.02 1.15 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.155 -178.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.26 150.24 29.0 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.813 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' SER . 94.4 t -115.37 107.25 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 122.984 0.514 . . . . 0.0 110.909 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -106.84 131.39 53.99 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.7 -154.11 8.74 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.178 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 p -176.28 165.47 2.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.32 0.581 . . . . 0.0 111.506 178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.47 HD12 ' CE3' ' A' ' 75' ' ' TRP . 98.1 mt -130.2 107.06 9.01 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.189 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -110.92 123.87 50.99 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.462 ' OG1' ' CD2' ' A' ' 41' ' ' PHE . 97.2 m -130.53 113.56 14.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.651 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -118.61 145.95 45.02 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.228 0.467 . . . . 0.0 111.722 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 15.3 t80 -114.25 91.62 3.69 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -109.47 77.62 1.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.561 ' C ' ' H ' ' A' ' 66' ' ' GLU . 45.7 m95 -61.22 -36.12 79.07 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 117.946 -1.502 . . . . 0.0 107.284 175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 64.08 -7.36 0.22 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.934 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.9 mm-40 -72.46 -81.02 0.06 Allowed 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -88.45 26.33 1.48 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.612 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 62.93 42.22 99.72 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 121.189 -0.529 . . . . 0.0 113.116 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 87' ' ' VAL . 96.6 mt -98.63 77.04 2.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.052 0.426 . . . . 0.0 111.096 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.9 m -90.93 105.48 17.86 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.006 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.632 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.4 m-30 -106.31 97.08 6.93 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 m -88.0 134.53 33.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.408 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.47 117.9 46.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -117.99 107.58 14.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.499 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.47 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.7 t90 -120.89 96.08 4.96 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.588 178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.84 164.32 14.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.34 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -63.06 -34.98 78.74 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.082 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.0 m-20 -57.44 -11.24 1.78 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.243 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 8.0 m120 99.91 0.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.528 1.142 . . . . 0.0 112.647 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.6 m -64.0 124.99 23.01 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.789 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.0 mt -120.25 123.94 44.45 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.64 122.66 2.19 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 119.621 -1.275 . . . . 0.0 112.38 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.5 m -117.84 118.37 31.82 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.112 0.482 . . . . 0.0 110.154 177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -119.75 113.15 20.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.809 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.632 HG23 ' CD2' ' A' ' 71' ' ' PHE . 89.2 mt -105.54 119.36 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 120.435 -0.506 . . . . 0.0 109.678 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 68' ' ' GLY . 8.8 m -128.0 125.96 40.42 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 87' ' ' VAL . 33.7 m -109.83 102.03 13.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.43 135.91 36.47 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 55.41 53.71 9.51 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 117.822 0.283 . . . . 0.0 111.605 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.655 ' HB2' HD13 ' A' ' 95' ' ' LEU . 71.3 mt-30 -60.28 -10.12 4.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 27.6 tp -148.96 40.32 0.88 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 122.369 1.08 . . . . 0.0 109.232 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 73.16 -0.24 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.734 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 93.1 mtt180 -139.71 167.11 22.85 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 122.309 1.052 . . . . 0.0 113.626 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' A' ' 119' ' ' LYS . . . -29.71 64.26 0.0 OUTLIER Glycine 0 C--O 1.223 -0.585 0 CA-C-N 112.073 -2.33 . . . . 0.0 116.073 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 90' ' ' GLN . 3.3 tt -132.33 101.74 5.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 87.6 tttt -124.89 119.17 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.582 0.551 . . . . 0.0 111.022 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 12.3 mt -120.55 112.43 18.91 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m -112.68 99.81 8.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -81.5 135.13 35.6 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -121.69 144.08 48.98 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.953 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.2 t -136.06 106.03 6.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.097 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.418 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -107.98 100.03 9.42 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 121.612 0.72 . . . . 0.0 109.939 178.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -106.46 85.42 2.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.237 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -107.12 160.56 25.97 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.788 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' O ' ' O ' ' A' ' 104' ' ' SER . 80.7 Cg_exo -37.9 -129.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 124.53 3.487 . . . . 0.0 114.772 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.67 -41.83 92.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.555 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.7 p -89.22 166.58 13.71 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.993 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 38.61 54.54 2.25 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -51.77 -112.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.658 0.266 . . . . 0.0 111.651 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -97.65 110.15 22.77 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.879 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -119.56 129.22 54.55 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.97 120.84 32.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.576 ' NZ ' HH12 ' A' ' 139' ' ' ARG . 63.7 mttt -120.46 145.81 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.584 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.14 108.33 24.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -103.85 118.02 35.7 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 54.1 m -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.12 130.49 9.92 Favored Glycine 0 N--CA 1.434 -1.498 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.202 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 94' ' ' GLY . 63.1 t80 -120.14 132.99 55.61 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' H ' ' HA3' ' A' ' 94' ' ' GLY . 44.7 mttt -123.17 152.11 41.52 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 123.393 0.433 . . . . 0.0 110.473 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.0 ttp180 177.18 109.49 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.5 mt-10 44.41 102.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.512 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 33.8 m170 44.13 1.9 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 176.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.549 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.4 mt -116.34 114.21 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 118.67 0.668 . . . . 0.0 112.632 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.557 ' ND2' HG11 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -122.06 125.11 45.52 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 175.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.4 mt -124.36 115.8 21.56 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 117.567 -1.206 . . . . 0.0 110.213 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -118.96 146.29 18.34 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 120.166 1.348 . . . . 0.0 111.169 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 13.5 t -125.23 102.56 7.51 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 124.125 0.544 . . . . 0.0 110.812 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -94.7 108.48 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.1 mtp -103.01 99.3 9.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.563 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -92.49 114.35 26.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.02 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -80.8 78.32 7.59 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.909 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 135' ' ' GLY . 37.0 t70 -96.19 175.5 6.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.65 -41.04 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.044 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -87.73 2.19 51.81 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.43 170.85 50.11 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 107.984 -2.046 . . . . 0.0 107.984 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.92 126.56 1.16 Allowed 'Cis proline' 0 N--CA 1.515 2.738 0 CA-C-N 120.938 2.369 . . . . 0.0 116.488 -0.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.5 m -112.47 110.91 21.39 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.08 104.07 15.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.433 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.576 HH12 ' NZ ' ' A' ' 113' ' ' LYS . 90.1 mtm180 -108.48 102.22 11.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.461 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -106.08 162.43 14.0 Favored Glycine 0 C--O 1.209 -1.41 0 CA-C-O 117.795 -1.558 . . . . 0.0 109.624 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.79 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.99 128.98 31.37 Favored 'General case' 0 C--N 1.353 0.722 0 CA-C-N 118.743 1.272 . . . . 0.0 108.121 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 27.9 mt -109.79 114.58 28.27 Favored 'General case' 0 C--O 1.211 -0.962 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.557 HG11 ' ND2' ' A' ' 124' ' ' ASN . 40.2 t -107.87 126.0 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.737 0.779 . . . . 0.0 110.542 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 84.7 mt -118.0 134.0 55.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.715 -1.129 . . . . 0.0 108.955 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -105.42 153.27 17.24 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 120.006 -1.092 . . . . 0.0 112.137 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.621 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.8 t80 -150.3 76.34 1.27 Allowed 'General case' 0 C--O 1.207 -1.173 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 53.4 40.8 31.87 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.18 -14.36 11.07 Favored Glycine 0 C--O 1.228 -0.22 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.7 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.8 m95 -96.31 129.98 43.52 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.862 -179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.862 HD13 HD23 ' A' ' 10' ' ' LEU . 76.5 mt -122.09 114.58 21.1 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -119.45 143.76 47.33 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.85 148.77 17.81 Favored Glycine 0 C--N 1.343 0.92 0 C-N-CA 119.974 -1.108 . . . . 0.0 113.181 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -128.34 113.14 15.23 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 58.0 tt0 -108.19 121.03 44.02 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 118.59 0.632 . . . . 0.0 109.946 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.6 ttp -109.0 117.82 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.48 0.487 . . . . 0.0 111.793 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.409 HD22 ' N ' ' A' ' 157' ' ' PHE . 0.4 OUTLIER -98.92 118.49 35.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.426 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.5 t80 -107.89 99.46 8.91 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.9 mt-10 -78.74 92.12 4.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 69.9 p -67.39 -36.04 80.52 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.4 91.22 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.401 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.45 -12.6 25.64 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 158' ' ' GLU . 25.3 m 55.08 53.89 9.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.087 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -128.33 129.77 46.78 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.014 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 157' ' ' PHE . 48.3 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.2 p -132.61 -58.4 0.93 Allowed 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.932 0.872 . . . . 0.0 111.297 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.39 109.19 1.52 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.028 -1.442 . . . . 0.0 111.056 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 88.6 p -141.91 151.15 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.971 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.583 HD21 ' ND2' ' A' ' 183' ' ' ASN . 16.8 t-20 -127.63 125.84 40.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.411 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -98.02 108.58 21.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.708 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.18 134.66 34.66 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.458 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.74 125.91 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.55 133.75 7.35 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.368 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -128.29 124.75 37.32 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -98.78 144.18 28.3 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 122.415 1.102 . . . . 0.0 113.348 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 18.3 m -142.04 161.69 37.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 113.126 -1.852 . . . . 0.0 107.557 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 178' ' ' PHE . 58.8 t0 -41.53 115.23 0.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.77 -0.582 . . . . 0.0 111.861 -178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' A' ' 197' ' ' LYS . 75.0 mt-10 57.91 -13.07 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.727 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.4 t80 -106.06 128.68 54.03 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -175.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.428 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 88.9 mt-30 -116.75 143.72 45.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.092 176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.492 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 55.0 tp -119.0 101.44 8.03 Favored 'General case' 0 C--O 1.215 -0.741 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.449 ' CE1' HD12 ' A' ' 150' ' ' LEU . 20.6 m-70 -118.16 122.23 42.51 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.612 HG22 ' HA2' ' A' ' 192' ' ' GLY . 75.6 p -129.82 159.85 35.28 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.583 ' ND2' HD21 ' A' ' 168' ' ' ASN . 48.2 p-10 -145.49 137.72 25.66 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.051 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.777 HG13 ' CE2' ' A' ' 190' ' ' PHE . 97.3 t -97.34 107.36 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -90.78 114.12 26.42 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.756 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 54.02 26.37 6.35 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 125.406 1.692 . . . . 0.0 113.114 178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.16 8.99 33.06 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 35.2 m -112.91 -71.38 0.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -103.72 115.03 29.73 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.549 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.777 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.64 148.19 22.52 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.815 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -112.08 166.9 12.26 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.612 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.35 140.14 7.14 Favored Glycine 0 N--CA 1.47 0.906 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 9.4 p -144.79 152.48 40.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.623 0.725 . . . . 0.0 111.551 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.727 HG23 ' CE2' ' A' ' 178' ' ' PHE . 68.2 mt -131.43 115.29 28.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.104 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -110.73 107.06 16.48 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -122.05 123.78 42.42 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.442 ' O ' ' CD ' ' A' ' 177' ' ' GLU . 88.1 tttt -101.05 100.34 10.92 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.47 -43.55 42.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.24 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.483 ' CG ' ' H ' ' A' ' 200' ' ' LYS . 66.9 t30 -165.82 -170.29 1.74 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.483 ' H ' ' CG ' ' A' ' 199' ' ' ASN . 88.8 tttt -61.21 -41.12 96.29 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.708 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -97.05 -8.53 30.14 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 11.9 mt -117.97 106.32 12.82 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -119.83 108.32 14.24 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.8 p -122.83 158.79 29.49 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.894 -0.504 . . . . 0.0 111.509 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.96 144.89 26.14 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.463 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.709 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.2 t -115.91 126.81 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.478 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.491 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 92.0 m-20 -108.73 133.72 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.8 mp -125.89 116.58 21.74 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.456 0.473 . . . . 0.0 110.936 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.75 140.79 52.5 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.578 ' CH2' ' O ' ' A' ' 212' ' ' ALA . 0.0 OUTLIER -134.75 -179.68 5.75 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.419 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 27.7 m -144.16 105.84 4.3 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.648 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.578 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 43.98 -156.65 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.243 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.85 52.95 0.16 Allowed Glycine 0 CA--C 1.533 1.162 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.495 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.508 ' O ' ' CE3' ' A' ' 210' ' ' TRP . 83.9 m-20 -128.4 132.37 48.5 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.4 m -81.7 -3.64 54.17 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -175.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -86.49 110.8 20.01 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.727 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.465 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 30.7 m -103.57 113.36 26.81 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.601 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.06 115.32 15.65 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.297 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -135.5 140.36 44.73 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.728 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.96 152.03 17.52 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.382 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.58 HD12 ' CG1' ' A' ' 237' ' ' VAL . 9.2 mt -118.25 104.4 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -103.89 127.46 51.4 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.71 0.631 . . . . 0.0 112.08 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -124.33 125.85 45.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.001 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -105.86 98.59 8.26 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.624 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -101.16 100.06 10.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.915 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -73.49 117.06 14.8 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.624 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.392 0.2 OUTLIER -92.88 -48.03 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 120.667 1.576 . . . . 0.0 112.282 -176.532 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.7 178.32 1.81 Allowed Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 172.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.71 -12.82 35.77 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 CA-C-N 121.207 1.467 . . . . 0.0 112.09 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -115.67 8.67 15.05 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -151.31 138.86 19.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 119.788 -0.765 . . . . 0.0 112.276 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -143.47 136.87 28.12 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.696 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 43.4 t80 -109.52 116.34 31.61 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -107.72 122.45 46.75 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.062 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.696 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.53 145.84 51.42 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 119.211 -0.423 . . . . 0.0 110.062 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 78.6 mttt -145.58 115.63 7.42 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.256 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.58 ' CG1' HD12 ' A' ' 221' ' ' ILE . 0.6 OUTLIER -106.03 113.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.881 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.576 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 17.3 p-10 -84.65 167.41 16.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 217' ' ' THR . 0.0 OUTLIER -89.76 5.54 45.55 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.563 -0.855 . . . . 0.0 112.498 -179.049 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.576 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 77.6 p -89.41 3.19 53.08 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 175.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.568 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.3 OUTLIER 88.56 32.04 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.603 178.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 241' ' ' SER . 9.5 mp -111.74 108.12 17.45 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.335 0.516 . . . . 0.0 111.886 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -90.89 128.22 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.41 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -110.25 134.84 12.45 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 65.5 mt -123.41 106.78 10.94 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 124.546 0.792 . . . . 0.0 109.61 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -119.04 106.59 1.29 Allowed Glycine 0 N--CA 1.471 1.015 0 C-N-CA 119.671 -1.252 . . . . 0.0 112.624 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -99.16 121.74 41.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.332 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.689 ' CG2' HD21 ' A' ' 251' ' ' LEU . 44.2 m -100.62 133.23 45.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.363 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.505 ' O ' ' CB ' ' A' ' 250' ' ' THR . 84.9 mt-30 -134.18 154.05 51.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 249' ' ' GLN . 2.0 m 91.69 -104.26 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 O-C-N 124.179 0.924 . . . . 0.0 110.381 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.689 HD21 ' CG2' ' A' ' 248' ' ' THR . 20.4 mt 71.01 -151.77 0.09 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.971 0.415 . . . . 0.0 110.24 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.635 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 59.88 145.77 0.06 OUTLIER Pre-proline 0 N--CA 1.445 -0.709 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 252' ' ' LYS . 74.2 Cg_exo -39.04 85.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.306 1.338 . . . . 0.0 111.227 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -178.63 -113.48 0.37 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.852 -178.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 250' ' ' THR . 95.8 mt -123.34 146.75 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.502 0.668 . . . . 0.0 112.53 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.471 ' HG2' HD23 ' A' ' 251' ' ' LEU . 98.9 mttt -110.55 129.36 55.82 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.032 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.08 105.54 10.71 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.916 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 47.2 m -123.04 138.49 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 61.5 mt -105.99 145.73 30.97 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.407 ' HB3' ' CG ' ' A' ' 24' ' ' PHE . 2.8 m -133.87 144.29 48.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.12 115.69 4.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.292 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.472 HD12 ' H ' ' A' ' 24' ' ' PHE . 1.6 mt -114.01 102.86 10.58 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 263' ' ' LEU . 10.3 mp -96.59 119.52 35.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.124 -178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -85.81 109.47 18.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.671 0.748 . . . . 0.0 112.095 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -57.6 -41.5 93.64 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.069 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.7 mttt -84.38 -7.69 59.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.572 1.686 . . . . 0.0 109.566 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 56.89 -24.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 266' ' ' LYS . 69.1 t -74.76 -37.17 42.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 118.471 0.578 . . . . 0.0 109.877 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -63.51 -44.4 94.42 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.56 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -84.93 -35.65 21.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 118.226 -1.39 . . . . 0.0 108.226 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.02 -9.65 2.84 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.57 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.41 -134.5 2.62 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.528 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -141.03 118.36 11.41 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 0.0 111.039 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.69 120.65 29.23 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.504 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 97.5 mt -133.6 124.65 27.22 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.16 153.41 20.94 Favored Glycine 0 N--CA 1.463 0.476 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.065 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.705 ' HB2' HG23 ' A' ' 27' ' ' ILE . 84.4 mt -134.08 126.33 29.89 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.01 114.74 4.96 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 80.7 mt -121.27 103.29 8.87 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -115.7 131.5 56.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.441 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -111.24 133.95 53.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.35 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.1 mm-40 -97.86 128.81 44.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.689 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . 73.13 113.09 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.644 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -82.2 147.06 29.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.826 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.6 m . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.66 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.16 139.9 57.48 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.529 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.81 70.07 11.21 Favored Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.909 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.716 ' CB ' HD11 ' A' ' 10' ' ' LEU . 2.2 Cg_endo -83.8 159.67 14.07 Favored 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.073 2.515 . . . . 0.0 113.873 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 36.6 Cg_endo -69.98 -171.07 0.45 Allowed 'Trans proline' 0 N--CA 1.534 3.868 1 C-N-CA 125.47 4.113 . . . . 0.0 115.464 -177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.815 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.8 p -49.45 136.06 16.9 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.621 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.33 -49.69 1.43 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.621 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -52.68 -39.38 61.85 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 116.434 -2.106 . . . . 0.0 110.148 -175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -68.92 -23.72 64.21 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 116.863 -1.935 . . . . 0.0 110.584 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.716 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.3 mm? -60.68 133.62 56.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 118.81 -1.156 . . . . 0.0 108.598 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.2 8.88 62.57 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 120.537 -0.84 . . . . 0.0 111.921 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -56.65 -41.57 77.45 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.4 m -58.12 -44.18 87.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.516 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -59.54 -45.79 90.74 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.04 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -63.72 -38.96 93.05 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.593 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -66.01 -38.73 89.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.42 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.24 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.551 ' C ' HG23 ' A' ' 19' ' ' THR . 89.3 t80 -61.68 -48.67 79.76 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.551 HG23 ' C ' ' A' ' 18' ' ' PHE . 1.1 p 68.4 166.49 0.25 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 120.992 0.425 . . . . 0.0 112.095 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -65.86 -43.21 89.09 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 22' ' ' TYR . . . -172.43 -56.88 0.04 OUTLIER Glycine 0 CA--C 1.542 1.761 0 CA-C-N 114.729 -1.123 . . . . 0.0 112.953 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 21' ' ' GLY . 58.6 t80 56.22 112.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 118.492 1.146 . . . . 0.0 110.512 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 72.18 -115.34 5.39 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.321 -0.466 . . . . 0.0 112.003 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLY . 48.3 m-85 17.8 92.8 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.49 -39.16 2.98 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.755 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.255 2.6 mp -120.22 132.22 55.27 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.687 HG23 ' HB3' ' A' ' 277' ' ' LEU . 96.9 mt -84.04 118.66 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -102.97 132.68 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.912 -1.494 . . . . 0.0 114.145 -174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.4 mt -106.76 118.49 36.81 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.924 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 53.3 t0 -121.02 132.71 55.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.498 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 59.4 mt -115.28 121.27 42.37 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.73 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 76.8 tttt -116.86 126.37 52.92 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' OXT' ' A' ' 285' ' ' SER . 93.6 m -119.62 122.9 42.59 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.89 135.23 44.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.884 -0.327 . . . . 0.0 111.85 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 m -81.94 169.63 16.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -55.79 -46.59 77.97 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.757 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -176.42 82.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.2 -85.18 0.06 OUTLIER Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 mt -84.03 152.87 24.15 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.018 0.913 . . . . 0.0 113.153 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -131.69 95.8 3.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.656 -1.611 . . . . 0.0 108.345 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.49 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.2 m-85 -99.46 112.17 24.41 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.583 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 42' ' ' THR . 2.6 m -123.83 105.5 9.7 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 53.1 m -98.93 160.83 13.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 p -144.14 166.34 25.3 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.51 -0.876 . . . . 0.0 112.595 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.08 110.57 0.41 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 1.1 t -127.72 132.7 49.57 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.79 154.13 34.27 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.354 -1.293 . . . . 0.0 109.764 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 50' ' ' GLU . 58.6 t-20 -103.32 107.31 18.09 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.1 p -63.33 36.63 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.769 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 48' ' ' ASN . 79.4 tt0 -156.97 -50.67 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.51 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.465 ' O ' ' CB ' ' A' ' 52' ' ' THR . 28.6 p -86.8 -18.49 30.89 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 76.21 31.44 0.64 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.999 -178.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -112.79 154.12 26.74 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.6 t -119.17 106.81 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 122.845 0.458 . . . . 0.0 110.853 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.1 p -101.44 128.29 47.72 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.065 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.22 -153.28 9.14 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.238 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 p -176.12 166.24 2.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.373 0.606 . . . . 0.0 111.732 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.3 mt -130.43 106.83 8.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.508 176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -107.54 120.23 41.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.49 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 65.9 m -130.37 105.67 8.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.955 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -112.5 126.45 55.33 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 54.6 t80 -106.97 137.8 44.35 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.628 ' O ' ' CG ' ' A' ' 64' ' ' TRP . 55.0 mmt-85 72.8 -105.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 O-C-N 124.542 1.151 . . . . 0.0 111.735 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 43.2 m0 131.35 -110.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 O-C-N 124.672 1.233 . . . . 0.0 110.502 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 66' ' ' GLU . 72.0 p -117.18 6.38 12.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.913 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' THR . 80.4 mm-40 -44.55 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -88.35 27.05 1.3 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 78.02 19.95 73.99 Favored Glycine 0 C--N 1.337 0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.172 176.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 77.0 mt -100.07 88.64 3.79 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.361 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.0 m -89.5 98.05 11.54 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 7.8 m-85 -104.86 77.46 1.34 Allowed 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.4 m -87.92 138.64 31.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.25 -176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 56.0 t -130.14 123.19 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.93 177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -124.2 113.95 18.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.009 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.542 ' CE3' HD12 ' A' ' 58' ' ' LEU . 10.4 t90 -120.96 109.2 14.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.484 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -95.51 158.91 15.25 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.127 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.8 p -61.24 -35.12 76.38 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.315 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 30.1 p30 -58.59 -10.28 2.15 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.436 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 51.2 m-20 103.34 -2.62 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.488 1.118 . . . . 0.0 112.749 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 37.3 m -63.45 125.52 24.47 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.997 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 17.8 mt -120.45 115.47 23.56 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -132.67 126.82 4.61 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.752 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 94.0 m -124.91 129.66 50.81 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-O 121.047 0.451 . . . . 0.0 110.434 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -119.9 121.49 39.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.876 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.58 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 95.9 mt -113.16 111.39 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 68' ' ' GLY . 13.8 m -123.41 132.03 53.83 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.2 p -122.0 101.93 10.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.35 153.98 17.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.631 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 73.38 46.22 0.23 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' CB ' HD23 ' A' ' 95' ' ' LEU . 77.9 mm-40 -90.21 -38.85 13.17 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.684 HD23 ' CE1' ' A' ' 118' ' ' TYR . 48.7 tp -83.57 -70.56 0.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 175.95 -40.99 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.927 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -82.49 -63.92 1.28 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.15 97.93 0.14 Allowed Glycine 0 C--O 1.215 -1.082 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.589 HD23 ' CB ' ' A' ' 90' ' ' GLN . 53.0 tp -121.34 119.81 33.25 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -124.66 125.15 43.64 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 123.564 0.54 . . . . 0.0 111.445 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.41 ' CD2' HG23 ' A' ' 116' ' ' THR . 7.0 mt -120.48 111.12 17.31 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -112.85 99.89 8.24 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -81.84 128.95 34.55 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -117.76 152.16 35.84 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.537 0.523 . . . . 0.0 111.021 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.5 t -139.02 113.14 8.68 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.223 0.952 . . . . 0.0 110.789 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -120.31 104.81 10.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.461 0.648 . . . . 0.0 109.721 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.63 90.36 3.33 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.682 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -85.0 160.86 54.37 Favored Pre-proline 0 N--CA 1.467 0.38 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.518 -178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.51 ' O ' ' O ' ' A' ' 104' ' ' SER . 94.3 Cg_exo -37.5 175.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.76 2.973 . . . . 0.0 113.505 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -48.3 -31.03 5.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.234 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.7 m -62.16 -45.01 95.31 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.788 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.33 -172.11 43.01 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.04 -165.42 1.79 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.576 0.227 . . . . 0.0 111.234 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -98.22 122.87 41.91 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.032 0.444 . . . . 0.0 111.224 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.03 123.49 42.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.773 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.36 130.38 56.68 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -119.13 145.72 45.73 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 120.238 -0.585 . . . . 0.0 112.375 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 HD12 ' HE1' ' A' ' 131' ' ' PHE . 97.0 mt -116.1 103.88 15.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -99.7 115.43 29.45 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.41 HG23 ' CD2' ' A' ' 97' ' ' LEU . 70.5 m -131.13 120.84 23.93 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.628 177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.588 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -137.8 163.71 25.53 Favored Glycine 0 N--CA 1.425 -2.05 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.908 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.684 ' CE1' HD23 ' A' ' 91' ' ' LEU . 54.0 t80 -143.3 139.86 30.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.092 -1.054 . . . . 0.0 109.668 178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -110.27 169.97 8.39 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.049 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 121' ' ' GLU . 58.1 ttp180 178.21 91.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.6 mt-10 40.33 115.03 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.579 0.704 . . . . 0.0 112.752 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 55.62 -13.46 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.1 mt -113.18 112.94 42.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 CA-C-N 118.639 0.654 . . . . 0.0 112.688 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 1.4 t30 -122.15 123.52 41.71 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.51 132.54 53.47 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.639 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -131.14 147.23 18.41 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.6 t -125.28 101.96 7.22 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 117.034 0.417 . . . . 0.0 111.318 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.9 112.71 24.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.459 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -108.17 99.85 9.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.027 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -82.61 110.31 17.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.734 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.402 ' HE1' HD12 ' A' ' 114' ' ' ILE . 83.8 m-85 -90.84 86.27 6.26 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.749 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -119.2 169.38 10.01 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.7 mt -62.3 -41.35 91.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.658 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 160' ' ' ALA . . . -72.95 -33.12 65.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.44 -171.49 8.14 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 106.722 -2.551 . . . . 0.0 106.722 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.28 126.6 1.06 Allowed 'Cis proline' 0 N--CA 1.509 2.436 0 CA-C-N 120.99 2.395 . . . . 0.0 115.562 -0.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.26 121.87 45.75 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.79 105.38 17.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.89 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.552 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 96.1 mtt180 -107.8 101.56 10.83 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.787 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -101.38 157.76 18.88 Favored Glycine 0 C--O 1.211 -1.34 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.4 123.81 22.04 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 118.603 1.202 . . . . 0.0 107.818 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.602 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 55.5 mt -100.37 132.56 45.68 Favored 'General case' 0 C--O 1.203 -1.367 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.11 121.6 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 119.345 0.975 . . . . 0.0 109.511 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.0 mt -120.0 137.85 53.84 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.4 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -108.95 153.51 16.79 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 119.557 -1.306 . . . . 0.0 112.07 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.538 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 47.4 t80 -145.38 79.56 1.58 Allowed 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 56.41 29.23 14.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.02 -19.7 5.17 Favored Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.287 -0.958 . . . . 0.0 112.132 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.658 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 2.9 m95 -90.71 140.48 29.74 Favored 'General case' 0 C--O 1.209 -1.044 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.149 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 71.9 mt -122.17 116.09 23.57 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -125.61 146.31 49.76 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -144.86 165.15 27.72 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 118.393 -1.861 . . . . 0.0 114.118 -178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.416 ' HB3' HD12 ' A' ' 142' ' ' LEU . 59.5 t80 -129.31 125.16 36.12 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 118.054 -0.974 . . . . 0.0 108.704 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.645 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 59.5 tt0 -113.1 119.65 38.56 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 119.144 0.883 . . . . 0.0 109.768 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.2 ttm -109.9 117.64 34.34 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.568 0.543 . . . . 0.0 111.916 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.552 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 38.7 t-20 -98.85 119.67 38.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.504 ' CD1' HG22 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -109.26 96.14 6.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.618 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.5 mt-10 -74.05 96.44 2.69 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 75.8 p -67.08 -32.19 73.18 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 134' ' ' ALA . . . -60.5 -40.72 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.284 -0.966 . . . . 0.0 109.861 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.2 -12.78 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.2 m 56.35 56.53 5.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.069 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.3 mtp85 -130.91 133.78 46.17 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.318 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 157' ' ' PHE . 46.0 t -104.72 101.91 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 18.1 p -128.29 -57.87 1.21 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.919 0.866 . . . . 0.0 111.623 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -72.06 109.25 5.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.057 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 18.2 p -141.86 151.71 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.743 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -128.34 143.17 50.98 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.433 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 55.6 m-85 -108.06 113.24 26.26 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.429 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.511 ' HB2' HD22 ' A' ' 183' ' ' ASN . . . -93.19 133.03 36.79 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.402 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.7 t -132.15 115.28 25.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 O-C-N 123.628 0.58 . . . . 0.0 109.764 177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -137.19 157.81 24.04 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.273 0.93 . . . . 0.0 113.98 -177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.51 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 90.9 t80 -130.83 131.93 44.91 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.473 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -100.38 146.9 26.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 122.176 0.988 . . . . 0.0 113.158 -176.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.2 OUTLIER -137.9 131.89 31.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 113.376 -1.738 . . . . 0.0 106.653 177.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 175' ' ' THR . 48.7 t0 -34.6 -25.38 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.3 mt-10 -122.88 -41.31 2.36 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.524 ' CD2' ' N ' ' A' ' 178' ' ' PHE . 0.4 OUTLIER -105.35 137.28 43.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -175.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -116.53 142.49 46.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.135 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.51 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 60.6 tp -109.44 106.88 16.82 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 29.3 m170 -118.51 101.74 8.37 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.486 0.492 . . . . 0.0 111.67 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 192' ' ' GLY . 49.5 p -129.27 157.76 40.97 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.599 ' ND2' ' CZ ' ' A' ' 7' ' ' TYR . 38.5 t-20 -158.44 152.33 23.69 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.772 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.649 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.7 t -95.95 126.78 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -103.34 108.94 20.38 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.729 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 55.67 27.28 10.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 124.879 1.362 . . . . 0.0 113.134 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.12 9.46 48.03 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 99.0 m -117.63 -72.65 0.68 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -96.13 113.15 24.72 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.94 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.649 ' CE2' HG13 ' A' ' 184' ' ' VAL . 9.0 m-85 -86.29 142.89 28.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.25 0.477 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -111.04 160.56 13.18 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.3 139.96 7.02 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.0 t -147.56 151.36 36.15 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.422 0.63 . . . . 0.0 111.896 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 54.1 mt -132.2 118.99 38.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.594 175.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -107.64 103.29 12.56 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.465 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 29.4 tt0 -104.66 111.46 24.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -102.58 93.1 4.94 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.477 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 67.6 t -74.33 -46.74 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.158 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 84.2 m-20 -160.13 -174.45 4.55 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.85 -39.56 89.59 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.962 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.96 -8.92 38.66 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 53.7 tp -126.88 107.25 9.93 Favored 'General case' 0 C--O 1.248 0.984 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.76 108.51 14.5 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.103 177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.465 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 18.0 p -120.01 158.51 26.62 Favored 'General case' 0 C--N 1.333 -0.112 0 O-C-N 121.705 -0.622 . . . . 0.0 111.043 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.507 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.06 143.46 27.21 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.001 -0.679 . . . . 0.0 111.585 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -114.6 121.24 66.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 219' ' ' PHE . 98.5 m-20 -103.23 132.12 49.73 Favored 'General case' 0 C--O 1.218 -0.568 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.921 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.2 mp -125.6 112.61 16.37 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.656 0.598 . . . . 0.0 111.144 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.83 140.53 52.84 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.657 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -133.85 179.61 6.13 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.657 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 47.0 m -137.75 112.54 8.94 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.318 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -43.59 101.03 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.082 0.467 . . . . 0.0 109.91 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 173.74 -153.41 17.3 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 107.32 -2.312 . . . . 0.0 107.32 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -101.15 11.62 39.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.668 0.734 . . . . 0.0 109.939 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.518 ' O ' ' CZ3' ' A' ' 210' ' ' TRP . 18.6 p -81.97 165.32 20.81 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.384 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.7 p30 -89.75 -177.61 5.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 18.9 m -103.4 112.75 25.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.056 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.33 114.59 16.31 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' A' ' 219' ' ' PHE . 4.4 p90 -132.44 138.18 47.53 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.977 178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -119.79 155.19 16.21 Favored Glycine 0 C--N 1.338 0.664 0 O-C-N 124.912 1.383 . . . . 0.0 112.049 -178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 88.0 mt -120.4 103.89 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.56 116.86 33.71 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.942 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.64 122.11 45.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -105.4 98.55 8.23 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -98.09 99.86 11.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.895 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -73.06 114.13 10.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.3 OUTLIER -93.2 -44.44 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 118.907 -1.117 . . . . 0.0 112.087 -174.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.89 176.63 2.69 Favored Pre-proline 0 N--CA 1.472 0.653 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 170.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.79 -13.38 38.97 Favored 'Trans proline' 0 C--N 1.295 -2.262 0 CA-C-N 121.096 1.427 . . . . 0.0 112.055 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -112.32 3.63 17.16 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.41 ' C ' ' SG ' ' A' ' 232' ' ' CYS . . . -149.38 146.72 27.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.253 -0.979 . . . . 0.0 112.328 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.41 ' SG ' ' C ' ' A' ' 231' ' ' ALA . 2.7 m -144.96 133.1 21.51 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.643 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -103.26 122.65 45.21 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.779 0.323 . . . . 0.0 110.644 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 30.1 t -107.87 142.42 37.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.123 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -143.74 133.85 24.28 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.504 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 98.9 mttt -128.64 114.23 16.4 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.502 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 74.0 t -110.62 119.84 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.532 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 1.082 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -100.42 167.78 10.17 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.436 178.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -88.77 5.58 42.79 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 119.632 -0.827 . . . . 0.0 112.606 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.542 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 50.6 p -102.03 21.66 14.4 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 22.5 p 72.11 26.12 2.86 Favored 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 113.886 -1.507 . . . . 0.0 113.838 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 1.082 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.8 mt -104.46 109.14 20.89 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.754 0.706 . . . . 0.0 111.099 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.4 mt -109.57 136.7 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 118.713 -0.66 . . . . 0.0 110.361 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 262' ' ' LEU . . . -129.66 154.32 20.37 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.152 178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 37.5 mt -126.91 125.8 42.19 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.015 -0.593 . . . . 0.0 109.588 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.71 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.104 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.924 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -96.24 116.56 29.2 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.011 -0.675 . . . . 0.0 110.354 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.8 m -104.75 126.69 52.08 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.269 0.356 . . . . 0.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.72 110.02 19.09 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.621 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.483 HG22 ' NZ ' ' A' ' 256' ' ' LYS . 72.6 p -96.52 130.59 43.66 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 255' ' ' ILE . 2.0 mm? -110.47 127.02 54.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 117.72 -1.133 . . . . 0.0 111.692 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -43.93 -54.25 11.42 Favored Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 89.5 Cg_exo -40.33 -19.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.169 1.912 . . . . 0.0 112.982 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 101.35 32.88 5.05 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.52 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 251' ' ' LEU . 95.2 mt -123.07 127.66 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.483 ' NZ ' HG22 ' A' ' 250' ' ' THR . 33.2 tttp -109.39 120.78 43.55 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.817 -0.552 . . . . 0.0 110.569 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 279' ' ' LEU . 25.7 mt -122.66 105.71 10.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.659 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.6 m -119.11 133.42 55.81 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.2 mp -105.62 142.22 35.73 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.753 177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.441 ' HG ' ' HA ' ' A' ' 24' ' ' PHE . 4.4 p -137.67 148.95 46.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.535 0.683 . . . . 0.0 111.642 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -157.38 118.4 3.6 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.651 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.501 HD12 ' HA3' ' A' ' 244' ' ' GLY . 0.7 OUTLIER -113.23 103.24 11.14 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.1 mt -96.7 121.68 38.81 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.533 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.477 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 8.4 t0 -83.09 111.7 19.13 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 122.316 1.055 . . . . 0.0 112.775 -178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -17.9 -83.95 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 CA-C-N 114.178 -1.374 . . . . 0.0 114.571 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -89.17 2.08 54.72 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.787 1.794 . . . . 0.0 111.073 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.449 ' ND2' ' CE1' ' A' ' 273' ' ' HIS . 31.2 m120 63.7 -3.43 0.42 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.796 -1.547 . . . . 0.0 114.308 176.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.75 -40.48 32.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.901 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -64.22 -45.04 89.98 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.748 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.24 -35.75 19.82 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.581 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 81.73 1.42 90.19 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.236 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -161.63 -149.85 5.76 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.612 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.449 ' CE1' ' ND2' ' A' ' 267' ' ' ASN . 98.3 m-70 -141.63 121.52 13.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.89 0.376 . . . . 0.0 110.463 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -74.12 131.19 41.07 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.265 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.629 ' C ' ' H ' ' A' ' 25' ' ' GLY . 91.0 mt -126.8 114.82 18.45 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' N ' ' H ' ' A' ' 25' ' ' GLY . . . -131.49 147.27 18.52 Favored Glycine 0 N--CA 1.467 0.762 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.19 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.687 ' HB3' HG23 ' A' ' 27' ' ' ILE . 7.8 tp -134.92 139.81 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -118.99 114.76 2.89 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 257' ' ' LEU . 83.6 mt -118.33 104.11 10.43 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -117.01 124.77 50.15 Favored 'General case' 0 CA--C 1.515 -0.388 0 O-C-N 123.609 0.568 . . . . 0.0 110.776 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -106.23 119.36 39.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.371 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.79 133.47 40.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.278 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -141.85 146.48 35.87 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.017 0.437 . . . . 0.0 111.96 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.429 ' O ' ' OXT' ' A' ' 285' ' ' SER . 95.8 mtt-85 -101.99 136.71 41.36 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.454 ' OXT' HG23 ' A' ' 33' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.54 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -71.47 142.5 50.2 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.592 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.414 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.65 69.68 2.76 Favored Pre-proline 0 CA--C 1.541 0.602 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.411 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -82.13 155.63 17.18 Favored 'Trans proline' 0 CA--C 1.567 2.125 0 C-N-CA 122.916 2.411 . . . . 0.0 114.337 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' O ' HG21 ' A' ' 143' ' ' VAL . 40.8 Cg_endo -70.46 -168.65 0.32 Allowed 'Trans proline' 0 N--CA 1.534 3.892 0 C-N-CA 125.184 3.923 . . . . 0.0 115.85 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.712 HG22 ' HA3' ' A' ' 126' ' ' GLY . 5.9 p -48.24 132.33 16.16 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.29 -32.78 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -176.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CD2' ' A' ' 7' ' ' TYR . . . -81.06 -38.83 26.71 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 117.132 -1.827 . . . . 0.0 109.951 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -68.74 -25.46 64.75 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 116.936 -1.906 . . . . 0.0 109.926 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 181' ' ' HIS . 31.0 tp -58.28 134.46 56.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 120.817 -1.177 . . . . 0.0 109.218 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.21 12.14 71.17 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.93 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.58 -43.53 93.61 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.6 m -60.08 -45.25 93.55 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.523 -0.471 . . . . 0.0 112.123 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.16 -41.28 99.22 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.097 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -63.79 -38.94 92.99 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 20' ' ' LYS . 93.6 m-20 -63.31 -41.45 98.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.1 -42.39 96.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 C-N-CA 119.601 -0.839 . . . . 0.0 109.524 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 82.9 t80 -62.66 -43.14 99.57 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.632 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.5 p -105.55 4.12 30.06 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 16' ' ' ASP . 61.4 tttp -52.37 -44.33 65.22 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 117.51 -1.676 . . . . 0.0 109.759 -178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.8 107.13 0.29 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.567 ' O ' ' CD1' ' A' ' 24' ' ' PHE . 96.9 m-85 -62.54 -45.85 91.05 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 24' ' ' PHE . . . 67.04 -128.2 28.3 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 22' ' ' TYR . 10.6 m-85 36.77 107.45 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.5 -35.72 3.99 Favored Glycine 0 C--N 1.341 0.829 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.694 176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.06 123.16 46.14 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.8 mt -84.32 121.04 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -114.3 139.53 49.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.012 -174.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 72.0 mt -106.34 120.97 43.27 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.491 ' OD2' HG23 ' A' ' 42' ' ' THR . 14.6 t70 -118.63 128.5 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.011 0.434 . . . . 0.0 111.448 -179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.27 124.12 51.05 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -130.89 133.21 45.68 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.3 m -124.02 125.95 45.44 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.49 127.95 54.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.182 0.515 . . . . 0.0 112.213 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 m -100.85 162.23 13.05 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -99.11 -8.91 24.53 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.547 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -67.72 -36.6 80.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 149.95 -25.87 1.15 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 HD13 ' HE2' ' A' ' 41' ' ' PHE . 48.5 mt -65.42 141.78 58.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 122.18 0.991 . . . . 0.0 112.947 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -134.48 94.68 3.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.362 -1.745 . . . . 0.0 108.168 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.516 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 45.9 m-85 -100.57 114.13 27.53 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.298 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.491 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.1 m -124.53 104.7 8.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.325 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 90.7 p -89.89 159.1 17.13 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -134.51 145.02 48.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.661 0.744 . . . . 0.0 112.477 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.62 110.31 0.52 Allowed Glycine 0 CA--C 1.52 0.376 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.6 m -135.65 172.02 13.61 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -138.84 166.96 23.08 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.169 177.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -103.38 122.79 45.58 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.1 p -68.84 -8.89 47.92 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.54 -0.864 . . . . 0.0 113.071 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -101.16 -42.97 6.15 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.217 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.419 ' C ' ' OG1' ' A' ' 52' ' ' THR . 12.9 p -101.06 -2.65 31.02 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.1 OUTLIER 65.11 10.28 6.22 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.149 -0.62 . . . . 0.0 109.781 -179.022 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 65.6 tttt -58.75 166.89 1.71 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.643 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' SER . 47.9 t -130.26 108.84 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.347 1.059 . . . . 0.0 109.961 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.7 p -122.73 132.31 54.18 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 118.996 0.816 . . . . 0.0 110.38 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.42 -156.96 10.03 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.303 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.8 p -176.19 164.64 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.578 0.704 . . . . 0.0 111.123 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -130.33 107.39 9.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.212 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -111.37 114.99 28.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.516 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 32.9 m -131.03 114.96 15.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.905 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HG2' HG23 ' A' ' 72' ' ' THR . 94.3 mttt -129.89 145.35 51.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.075 -178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 4.9 t80 -115.63 117.22 29.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -114.83 83.55 1.92 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.538 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 85.6 m95 -73.84 85.09 1.7 Allowed 'General case' 0 C--N 1.348 0.502 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 m -57.3 -1.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.24 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.5 mt-10 -82.92 -79.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.263 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -77.33 25.05 0.18 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.782 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.96 51.83 28.3 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.425 -0.653 . . . . 0.0 112.99 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.703 ' CD2' HG22 ' A' ' 87' ' ' VAL . 52.4 mt -110.35 101.62 10.33 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.341 0.571 . . . . 0.0 112.44 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.7 m -100.17 103.46 14.93 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.33 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.606 ' CD2' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -101.08 94.05 5.79 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 61' ' ' LYS . 3.2 m -87.69 130.12 34.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.454 -176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.4 117.42 46.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -122.97 109.3 13.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.527 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.712 ' CE2' HD22 ' A' ' 81' ' ' LEU . 5.0 m95 -114.39 135.22 54.33 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -132.16 159.12 39.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -62.79 -34.63 77.67 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.984 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 95.2 m-20 -58.28 -11.25 2.54 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.225 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 45.9 m-80 96.81 3.82 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.234 0.959 . . . . 0.0 112.41 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 19.2 m -73.17 129.66 38.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.078 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.712 HD22 ' CE2' ' A' ' 75' ' ' TRP . 12.6 mt -120.72 130.8 54.21 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.44 116.99 1.81 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 77.8 m -117.29 115.47 25.33 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -119.84 115.39 23.74 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.119 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.606 HG23 ' CD2' ' A' ' 71' ' ' PHE . 95.2 mt -109.74 117.15 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.2 m -124.94 122.72 38.16 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.703 HG22 ' CD2' ' A' ' 69' ' ' LEU . 51.9 t -109.46 101.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -96.08 147.86 23.28 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 91' ' ' LEU . 86.6 m-20 60.7 60.65 1.86 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.768 ' OE1' HD13 ' A' ' 95' ' ' LEU . 83.0 mt-30 -61.64 26.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.615 -0.834 . . . . 0.0 113.224 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 88.68 -13.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.64 -139.37 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.833 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -84.25 -65.52 1.0 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.36 97.23 0.16 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.768 HD13 ' OE1' ' A' ' 90' ' ' GLN . 4.0 tt -121.1 125.09 46.37 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' N ' HD23 ' A' ' 95' ' ' LEU . 99.1 mttt -124.15 113.3 18.15 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.8 tp -109.04 105.09 14.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 120.174 -0.61 . . . . 0.0 110.071 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 98' ' ' THR . 68.1 m -110.55 99.13 8.17 Favored 'General case' 0 C--N 1.345 0.387 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -82.22 134.3 35.29 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 175.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -127.08 146.58 50.32 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 120.989 0.424 . . . . 0.0 110.741 -175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.26 109.24 5.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.01 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.3 t -121.13 111.11 17.02 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.651 0.738 . . . . 0.0 110.05 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -113.42 104.08 11.93 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.643 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' O ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -125.83 161.02 53.61 Favored Pre-proline 0 N--CA 1.475 0.814 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' O ' ' O ' ' A' ' 104' ' ' SER . 77.0 Cg_exo -39.16 174.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 123.833 3.022 . . . . 0.0 112.995 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -46.35 -20.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.458 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 29.9 p -67.05 -33.82 76.35 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.063 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -145.27 97.5 0.19 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.5 mttt -54.96 -153.82 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.792 0.33 . . . . 0.0 111.288 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.34 129.26 42.55 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 121.034 -0.266 . . . . 0.0 111.105 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -120.95 133.99 55.29 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.926 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.25 112.96 13.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.85 146.01 45.21 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.8 mt -126.19 104.61 13.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 175.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -97.49 129.48 44.66 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 95.3 m -127.65 105.35 8.41 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -113.63 116.11 3.81 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -112.24 124.16 51.86 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.886 0.85 . . . . 0.0 109.172 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -99.64 149.36 23.37 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.029 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.637 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.1 ttt-85 -166.53 87.09 0.32 Allowed 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.637 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.8 tt0 31.68 117.16 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.047 0.842 . . . . 0.0 112.24 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.572 ' ND1' ' C ' ' A' ' 122' ' ' HIS . 1.8 t-80 66.41 -35.97 0.24 Allowed 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 86.8 mt -107.17 119.71 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.475 HD22 ' HB ' ' A' ' 143' ' ' VAL . 0.4 OUTLIER -122.41 130.0 52.65 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 175.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.409 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -119.52 114.72 22.7 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.855 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.712 ' HA3' HG22 ' A' ' 6' ' ' THR . . . -111.54 136.14 13.33 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.419 1.009 . . . . 0.0 111.137 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 2.2 t -121.58 103.47 8.93 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.588 0.233 . . . . 0.0 110.827 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -104.72 109.45 21.39 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.7 mtp -107.43 134.8 49.95 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -106.05 113.87 27.67 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.128 0.267 . . . . 0.0 110.576 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -89.12 87.03 7.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.057 0.456 . . . . 0.0 110.649 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -138.42 167.06 22.71 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.8 mt -62.82 -39.73 86.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.926 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.4 -31.91 70.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.23 -176.39 48.55 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 106.195 -2.762 . . . . 0.0 106.195 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.23 127.27 1.23 Allowed 'Cis proline' 0 N--CA 1.51 2.448 0 CA-C-N 121.438 2.619 . . . . 0.0 115.515 -0.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 18.9 m -113.59 133.42 55.29 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 91.2 mt -105.42 103.16 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.994 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.676 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 95.7 mtt180 -107.39 102.2 11.5 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-O 121.313 0.578 . . . . 0.0 109.591 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.51 158.45 17.26 Favored Glycine 0 C--O 1.214 -1.097 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.517 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.63 122.82 20.45 Favored 'General case' 0 C--N 1.347 0.484 0 CA-C-N 117.695 0.747 . . . . 0.0 109.108 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 86.2 mt -102.85 105.75 16.19 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 118.215 -0.897 . . . . 0.0 108.996 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.475 ' HB ' HD22 ' A' ' 124' ' ' ASN . 3.2 t -96.74 127.91 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 119.301 -0.96 . . . . 0.0 109.359 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.9 mt -119.4 134.51 55.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.956 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.52 ' O ' ' CD2' ' A' ' 122' ' ' HIS . . . -103.83 152.04 17.73 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 119.662 -1.256 . . . . 0.0 112.177 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.2 t80 -142.98 73.1 1.39 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 52.13 39.19 26.15 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.358 0.874 . . . . 0.0 113.358 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 126.84 -19.38 6.16 Favored Glycine 0 N--CA 1.458 0.111 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.135 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.719 ' C ' HD12 ' A' ' 150' ' ' LEU . 1.6 m95 -93.26 140.65 29.3 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.368 -0.933 . . . . 0.0 109.416 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.719 HD12 ' C ' ' A' ' 149' ' ' TRP . 2.4 mp -121.74 114.17 20.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.46 136.47 54.95 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -127.68 149.8 18.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.003 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -128.31 116.03 19.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 9.6 tt0 -116.92 129.14 55.87 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.974 -178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 79.2 mtm -115.86 122.93 46.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.863 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.676 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 44.4 t-20 -98.87 116.88 32.1 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -108.06 94.92 5.33 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.802 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 96.2 mt-10 -74.23 95.45 2.62 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 62.9 p -67.84 -33.91 75.68 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.69 -40.62 97.69 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.034 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.59 -14.17 23.78 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.4 m 55.19 52.12 12.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.222 -178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -125.54 130.8 52.46 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.722 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 165' ' ' THR . 69.5 t -104.79 124.54 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.0 p -161.13 -56.8 0.05 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 122.059 0.933 . . . . 0.0 110.745 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.433 ' OE1' ' NH1' ' A' ' 139' ' ' ARG . 2.3 mt-30 -66.28 108.58 2.36 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.834 -1.53 . . . . 0.0 110.766 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.1 t -142.51 150.87 41.04 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.508 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.461 ' ND2' ' OD1' ' A' ' 185' ' ' ASN . 7.4 m120 -127.87 134.24 49.38 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -103.39 109.39 21.0 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.457 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -88.45 133.16 34.2 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.921 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.0 110.99 17.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -127.62 154.98 19.87 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.682 -0.77 . . . . 0.0 113.548 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.8 t80 -131.87 128.61 39.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.853 -1.174 . . . . 0.0 107.91 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -101.15 146.95 26.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.213 1.006 . . . . 0.0 113.568 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 16.6 p -131.99 143.0 49.78 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.408 -1.724 . . . . 0.0 106.678 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -45.47 -12.39 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 175' ' ' THR . 95.8 mt-10 -132.19 -39.32 1.05 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.2 OUTLIER -108.98 145.23 35.84 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -175.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -116.87 140.63 49.22 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.272 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 48.8 tp -110.34 108.46 18.54 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.765 ' CE1' HD11 ' A' ' 10' ' ' LEU . 49.6 m170 -118.94 99.41 6.73 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.039 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.424 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 75.6 p -120.79 154.65 35.43 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 182' ' ' THR . 5.7 m-20 -149.47 149.19 30.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.427 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.677 HG13 ' CE1' ' A' ' 190' ' ' PHE . 8.7 t -99.3 117.66 44.75 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 58.7 t30 -95.69 112.22 23.99 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.012 -178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 55.85 27.34 10.82 Favored 'General case' 0 C--O 1.232 0.177 0 O-C-N 125.191 1.557 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.19 12.96 52.25 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 28.5 m -118.06 -77.67 0.57 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.03 114.01 25.6 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.343 -0.943 . . . . 0.0 113.276 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.677 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -97.13 160.65 14.22 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 121.098 0.475 . . . . 0.0 111.011 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.4 171.19 17.75 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 177.85 -157.11 21.19 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -117.56 164.69 14.55 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.307 0.575 . . . . 0.0 111.717 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.579 HD12 ' HB ' ' A' ' 206' ' ' VAL . 66.3 mt -131.9 114.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.509 ' CZ ' ' OE1' ' A' ' 203' ' ' GLU . 38.9 t80 -91.71 121.63 33.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.416 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 41.5 tt0 -123.59 103.43 8.42 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.04 98.48 11.79 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 83.7 t -74.36 -42.58 50.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.263 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.781 HD21 HD13 ' A' ' 202' ' ' LEU . 9.8 p30 -168.52 -167.32 0.77 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.38 -41.35 98.57 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.354 -0.538 . . . . 0.0 112.146 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.684 ' C ' HD12 ' A' ' 202' ' ' LEU . 98.7 mttt -96.92 -10.97 25.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.781 HD13 HD21 ' A' ' 199' ' ' ASN . 9.2 mp -115.62 113.8 24.05 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 195' ' ' TYR . 51.7 tp10 -120.13 108.66 14.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.1 p -120.32 154.97 34.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 121.761 -0.587 . . . . 0.0 110.717 -177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.712 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.92 126.19 20.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.885 178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.579 ' HB ' HD12 ' A' ' 194' ' ' ILE . 16.5 t -101.77 132.06 48.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.46 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 97.3 m-20 -112.54 134.84 53.86 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.419 HD11 HD11 ' A' ' 194' ' ' ILE . 13.0 mt -117.67 115.45 25.08 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.631 0.582 . . . . 0.0 110.947 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.29 129.03 50.79 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.551 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -135.9 -178.07 4.97 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.502 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 88.3 m -145.7 106.57 4.13 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.571 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -43.36 115.23 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.999 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 121.65 -25.96 6.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -106.35 141.32 37.86 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.1 p -88.74 -7.27 56.56 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -104.64 138.69 40.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.176 0.898 . . . . 0.0 112.962 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.603 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 53.3 m -103.73 112.96 26.14 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.177 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -74.15 115.79 14.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 118.584 -1.246 . . . . 0.0 107.679 176.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.3 p90 -134.65 143.45 47.28 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 119.388 -0.925 . . . . 0.0 111.137 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -116.58 154.0 17.07 Favored Glycine 0 C--N 1.334 0.439 0 O-C-N 125.097 1.498 . . . . 0.0 112.038 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 90.0 mt -123.82 103.35 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.18 43.15 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.981 -0.688 . . . . 0.0 111.503 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -119.53 125.18 48.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.252 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -105.83 103.79 13.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.733 ' CE2' HD21 ' A' ' 202' ' ' LEU . 5.5 t80 -101.08 97.67 8.19 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -73.52 117.61 15.49 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 228' ' ' ASP 0.289 0.1 OUTLIER -90.23 -56.66 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.551 -174.027 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.616 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.1 OUTLIER -137.37 175.92 3.12 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 174.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.74 -17.1 58.5 Favored 'Trans proline' 0 C--N 1.286 -2.712 0 CA-C-N 121.189 1.46 . . . . 0.0 112.508 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.503 ' N ' ' OD2' ' A' ' 228' ' ' ASP . 96.8 m-20 -111.54 7.22 20.55 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -148.93 137.95 21.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.235 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.8 t -142.12 142.36 32.76 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.526 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.8 t80 -116.28 120.18 38.08 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 122.082 -0.386 . . . . 0.0 111.364 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.6 p -106.84 137.61 44.57 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 120.922 0.391 . . . . 0.0 110.447 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -142.18 143.96 33.2 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -133.03 116.99 17.05 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.675 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 16.9 t -105.24 119.35 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 1.056 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -101.42 166.37 10.77 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.055 -1.058 . . . . 0.0 108.935 177.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.603 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.1 p-10 -90.22 8.4 33.31 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.64 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.503 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 16.8 p -101.09 21.53 13.73 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.9 m 70.6 30.05 3.19 Favored 'General case' 0 C--O 1.208 -1.094 0 CA-C-N 113.899 -1.5 . . . . 0.0 113.848 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 1.056 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 12.2 mt -108.39 108.85 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.642 0.656 . . . . 0.0 111.546 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 262' ' ' LEU . 85.4 mt -97.34 129.5 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.816 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.02 133.23 11.54 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 71.5 mt -120.41 110.93 17.09 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 124.268 0.629 . . . . 0.0 109.852 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.43 106.33 0.8 Allowed Glycine 0 CA--C 1.529 0.94 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.372 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.01 100.67 13.49 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 122.374 -0.486 . . . . 0.0 110.05 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.48 HG23 ' HZ3' ' A' ' 256' ' ' LYS . 20.3 m -89.88 118.36 29.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.254 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -113.76 110.52 20.29 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 53.6 m -85.84 86.74 7.35 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.591 ' O ' ' O ' ' A' ' 252' ' ' LYS . 55.7 tp -79.4 101.72 8.3 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.261 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.606 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER 62.11 126.88 0.02 OUTLIER Pre-proline 0 N--CA 1.452 -0.373 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -178.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.49 -11.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 121.113 1.209 . . . . 0.0 112.606 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -90.66 -43.57 4.8 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 121.137 -0.554 . . . . 0.0 113.763 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' O ' ' O ' ' A' ' 251' ' ' LEU . 86.9 mt -108.32 126.05 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.48 ' HZ3' HG23 ' A' ' 248' ' ' THR . 48.5 tttm -115.98 122.9 46.63 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.251 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 57.9 tp -123.4 105.14 9.56 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 54.0 m -116.22 130.8 56.97 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.851 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.0 mt -97.13 141.48 30.22 Favored 'General case' 0 N--CA 1.461 0.098 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 1.8 p -138.06 146.9 43.51 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.327 0.584 . . . . 0.0 112.153 -179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.47 119.86 2.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.359 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 243' ' ' ILE . 51.1 tp -113.37 103.71 11.57 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 91.5 mt -94.58 115.55 27.71 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.488 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.465 ' OD1' ' CD2' ' A' ' 242' ' ' LEU . 31.8 t0 -79.6 110.62 15.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.887 0.851 . . . . 0.0 112.01 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.27 -41.36 98.31 Favored Glycine 0 CA--C 1.54 1.601 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.213 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.4 mttp -83.45 -8.62 59.34 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 118.803 1.302 . . . . 0.0 109.803 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 55.67 -20.42 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.9 t -77.14 -37.21 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 118.862 0.755 . . . . 0.0 110.634 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -63.57 -45.04 92.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.014 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.25 -35.71 19.82 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.776 -1.17 . . . . 0.0 108.788 176.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.8 -6.97 0.76 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.462 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -144.15 -133.92 2.75 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.086 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -141.63 119.21 11.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.199 0.523 . . . . 0.0 111.316 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -88.68 118.83 28.63 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.954 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.51 ' C ' ' H ' ' A' ' 25' ' ' GLY . 87.4 mt -132.78 131.82 41.54 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.463 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -151.21 136.86 5.73 Favored Glycine 0 C--O 1.224 -0.492 0 C-N-CA 119.819 -1.181 . . . . 0.0 111.248 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 27' ' ' ILE . 47.8 mt -122.05 130.64 53.45 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.94 114.94 4.8 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.24 102.79 10.7 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -116.91 125.52 51.6 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.253 0.549 . . . . 0.0 110.632 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.54 117.42 33.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.094 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -97.76 134.79 40.45 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.424 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -141.62 143.09 33.48 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.869 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.7 138.43 48.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.626 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 99.2 p . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.732 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.487 1.394 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -69.42 140.54 54.13 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.95 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 2' ' ' ALA . 17.3 m -157.49 62.8 2.69 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.567 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.2 Cg_endo -82.29 166.97 15.93 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 123.227 2.618 . . . . 0.0 113.978 -178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.9 Cg_endo -71.61 -176.72 2.11 Favored 'Trans proline' 0 N--CA 1.531 3.723 0 C-N-CA 124.928 3.752 . . . . 0.0 117.299 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 5' ' ' PRO . 76.9 p -41.55 135.61 2.07 Favored 'General case' 0 C--N 1.377 1.798 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -39.09 -47.47 1.54 Allowed 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -175.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.677 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -66.82 -40.03 87.89 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 116.673 -2.011 . . . . 0.0 111.117 -176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -68.6 -25.25 64.77 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 117.815 -1.554 . . . . 0.0 110.538 -175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 4' ' ' PRO . 14.4 tp -66.22 121.01 14.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.01 12.11 37.76 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.429 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -58.0 -39.3 77.92 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.1 t -59.79 -46.6 88.71 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.003 -178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.04 -42.49 98.58 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.064 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -37.82 88.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -65.03 -41.79 94.94 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.6 t -63.6 -42.69 96.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 118.9 0.773 . . . . 0.0 110.564 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' O ' ' C ' ' A' ' 19' ' ' THR . 87.6 t80 -62.83 -46.92 85.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.573 HG22 ' N ' ' A' ' 20' ' ' LYS . 73.8 m 2.02 -92.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' N ' HG22 ' A' ' 19' ' ' THR . 98.7 mttt -146.16 -1.53 0.74 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.018 0.437 . . . . 0.0 110.051 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 71.15 -166.18 52.71 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -135.26 137.72 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.44 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 97.58 -102.73 2.74 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.307 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 23' ' ' GLY . 84.3 m-85 19.9 79.36 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 112.46 -34.78 4.98 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.235 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mp -116.92 122.76 45.22 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 277' ' ' LEU . 95.8 mt -83.39 120.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -113.86 138.73 49.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.837 -1.529 . . . . 0.0 113.468 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 76.9 mt -106.37 120.43 41.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -116.94 131.5 56.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.034 0.445 . . . . 0.0 111.439 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 72.3 mt -111.08 120.77 43.45 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.527 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -118.28 124.22 47.31 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -116.38 126.94 54.18 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -110.92 130.24 55.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.9 m -83.13 179.02 7.85 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -55.77 -49.06 74.18 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.913 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -164.16 164.0 22.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.82 -84.57 1.31 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.471 HD22 ' CZ ' ' A' ' 41' ' ' PHE . 40.2 mt -64.8 134.29 53.8 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 122.611 1.196 . . . . 0.0 113.142 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -145.74 99.96 3.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.026 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.471 ' CZ ' HD22 ' A' ' 39' ' ' LEU . 31.5 m-85 -98.95 119.46 37.76 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.569 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.4 m -120.51 104.95 10.38 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 m -89.76 159.16 17.19 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.9 m -135.52 145.72 47.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.509 0.671 . . . . 0.0 112.396 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.5 107.54 0.39 Allowed Glycine 0 C--O 1.225 -0.419 0 N-CA-C 107.394 -2.283 . . . . 0.0 107.394 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 60.5 p -134.44 171.58 14.09 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -136.36 166.94 22.3 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.969 1.418 . . . . 0.0 110.199 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -103.56 126.11 50.51 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 80.6 p -72.2 -1.98 17.12 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.549 -0.86 . . . . 0.0 113.14 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -108.31 -47.08 3.59 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.122 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' THR . 48.0 p -91.59 -15.52 28.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.581 HG23 ' C ' ' A' ' 51' ' ' THR . 1.5 p 74.17 18.85 3.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.827 0.346 . . . . 0.0 110.555 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.1 mttt -77.13 169.73 17.8 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.605 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' SER . 43.7 t -130.06 109.86 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 124.542 1.137 . . . . 0.0 109.885 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.4 p -121.81 133.38 54.9 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 118.967 0.803 . . . . 0.0 110.42 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.68 -157.11 10.18 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.768 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.6 p -173.85 162.94 4.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.266 0.555 . . . . 0.0 111.228 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.9 mt -130.1 107.07 9.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.498 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -114.19 121.91 45.17 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 94.2 m -130.52 116.12 17.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.828 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -122.71 141.11 52.14 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.642 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 64.0 t80 -121.3 91.21 3.47 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -109.92 87.89 2.62 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.642 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.6 m0 -87.96 71.14 9.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -41.46 -13.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.527 -0.469 . . . . 0.0 112.178 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 64' ' ' TRP . 97.6 mt-10 -45.35 -84.27 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.847 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -87.18 26.24 1.23 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.909 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 56.96 47.25 88.55 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.616 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.8 mt -99.73 74.49 1.85 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 117.163 0.482 . . . . 0.0 111.32 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.8 m -79.85 98.15 6.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.117 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CZ ' HG23 ' A' ' 85' ' ' ILE . 3.7 m-85 -104.49 88.26 2.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 177.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -88.08 140.37 29.56 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.026 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.7 t -129.8 121.29 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.83 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -114.93 108.3 16.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.266 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.58 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 5.4 m95 -117.21 128.75 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -130.82 157.78 41.95 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 110.478 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 p -62.31 -35.03 77.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.521 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 65.4 t0 -61.21 -11.2 8.41 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 78' ' ' ASP . 39.4 m-20 100.28 6.45 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.535 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -64.64 122.38 16.71 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.08 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 56.3 mt -120.64 114.28 21.47 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.97 124.17 3.18 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 119.59 -1.291 . . . . 0.0 112.457 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.8 m -122.36 125.72 46.52 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.147 0.499 . . . . 0.0 110.394 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -119.49 117.51 28.62 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.631 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CZ ' ' A' ' 71' ' ' PHE . 98.2 mt -109.25 114.74 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 68' ' ' GLY . 26.0 m -126.83 126.64 43.7 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.77 102.67 14.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -94.99 144.68 25.49 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.64 46.98 16.62 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.53 ' HB2' HD23 ' A' ' 95' ' ' LEU . 81.8 mt-30 -56.65 -19.92 18.8 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 82.7 mt -140.27 41.43 1.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.736 0.779 . . . . 0.0 110.399 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 75.18 -6.95 1.86 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 114.029 -1.442 . . . . 0.0 111.212 178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.0 mtm-85 -140.49 175.3 9.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.619 1.199 . . . . 0.0 113.837 -179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -29.97 64.78 0.0 OUTLIER Glycine 0 C--O 1.22 -0.728 0 CA-C-N 111.662 -2.517 . . . . 0.0 115.766 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.612 ' N ' ' O ' ' A' ' 93' ' ' ARG . 32.2 tp -137.17 110.78 8.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -124.67 124.17 41.61 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.516 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.434 ' HG ' HE22 ' A' ' 90' ' ' GLN . 0.5 OUTLIER -116.25 105.11 12.2 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 82.6 m -112.4 99.05 7.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.975 1.843 . . . . 0.0 115.975 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 114' ' ' ILE . 4.5 m-85 -83.53 134.75 34.82 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -118.49 138.66 52.35 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.368 -175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 t -133.44 104.9 6.63 Favored 'General case' 0 C--N 1.333 -0.139 0 O-C-N 123.768 0.668 . . . . 0.0 111.138 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.426 ' HB3' HD22 ' A' ' 111' ' ' ASN . 0.1 OUTLIER -115.85 103.61 10.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.605 0.717 . . . . 0.0 109.469 178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 4.4 m-85 -113.37 86.84 2.47 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.447 -1.251 . . . . 0.0 109.99 -179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -93.07 160.99 32.48 Favored Pre-proline 0 N--CA 1.47 0.541 0 C-N-CA 120.307 -0.557 . . . . 0.0 112.341 -178.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' O ' ' A' ' 104' ' ' SER . 92.6 Cg_exo -37.91 172.53 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.866 3.044 . . . . 0.0 113.327 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 107' ' ' THR . 51.7 p30 -46.88 -30.49 2.55 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.69 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 73.3 m -62.69 -44.42 96.29 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -86.47 -179.88 49.32 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -135.39 153.86 51.67 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.739 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.425 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.5 mttm -61.41 128.89 38.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.144 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 102' ' ' SER . 79.2 m-20 -120.58 129.58 53.83 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.236 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.54 110.53 12.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -120.85 145.91 47.12 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' CE1' ' A' ' 99' ' ' PHE . 97.5 mt -122.94 113.61 38.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 175.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -106.31 127.05 52.97 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.7 m -118.08 108.94 15.82 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.99 114.56 3.9 Favored Glycine 0 N--CA 1.435 -1.376 0 O-C-N 123.863 0.727 . . . . 0.0 111.631 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -108.82 113.43 26.36 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 53.0 mttt -116.96 169.18 9.6 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.499 -175.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 119' ' ' LYS . 60.6 ttt180 159.63 123.0 0.0 OUTLIER 'General case' 0 C--N 1.344 0.338 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.22 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.6 m170 45.02 0.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.7 mt -115.33 115.02 48.11 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 CA-C-N 118.912 0.778 . . . . 0.0 112.307 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.503 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.29 121.04 35.84 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 175.276 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.3 mt -123.1 115.62 22.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 118.342 -0.837 . . . . 0.0 109.899 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -117.36 145.41 18.61 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 119.636 1.107 . . . . 0.0 111.275 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.8 t -124.97 103.19 7.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.517 -0.341 . . . . 0.0 110.707 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.71 111.69 23.46 Favored 'General case' 0 C--O 1.232 0.176 0 O-C-N 123.855 0.722 . . . . 0.0 110.466 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.7 mtp -108.14 104.9 14.41 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.03 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -91.49 114.61 27.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.991 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -88.3 86.49 7.07 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.827 0.346 . . . . 0.0 110.505 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 135' ' ' GLY . 50.0 t0 -117.42 167.94 10.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -62.41 -41.02 90.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.814 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.35 2.8 42.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -97.42 -178.19 34.15 Favored Glycine 0 C--N 1.339 0.738 0 N-CA-C 106.242 -2.743 . . . . 0.0 106.242 176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -54.71 133.85 5.26 Favored 'Cis proline' 0 N--CA 1.51 2.492 0 CA-C-N 121.527 2.663 . . . . 0.0 115.575 -0.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.405 ' HB3' HD21 ' A' ' 156' ' ' ASN . 13.2 m -112.86 124.05 51.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 90.2 mt -100.28 102.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.364 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -106.32 101.89 11.33 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.161 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.579 ' O ' ' NE2' ' A' ' 154' ' ' GLN . . . -98.46 154.68 20.11 Favored Glycine 0 C--O 1.213 -1.193 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.433 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.14 109.87 8.09 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 117.914 0.857 . . . . 0.0 109.26 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.555 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.4 mp -89.94 131.13 36.01 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 41.1 t -123.97 127.59 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.794 0.725 . . . . 0.0 109.336 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.1 mt -120.17 134.47 55.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.203 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -110.03 151.94 17.34 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.727 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.726 ' O ' ' N ' ' A' ' 148' ' ' GLY . 98.1 m-85 -149.64 -158.73 0.95 Allowed 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 118.809 -0.615 . . . . 0.0 109.396 177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.559 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 97.0 mt-10 -47.47 50.62 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.789 1.306 . . . . 0.0 113.036 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.726 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.08 35.37 8.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.559 ' NE1' ' O ' ' A' ' 147' ' ' GLU . 4.9 m95 -134.33 135.81 43.02 Favored 'General case' 0 C--O 1.215 -0.759 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.518 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 mt -122.61 114.38 20.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.4 157.19 44.09 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.05 171.46 31.4 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 118.569 -1.777 . . . . 0.0 114.467 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.14 127.6 41.73 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.579 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 67.5 tp60 -109.84 114.99 29.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 ttp -106.1 111.81 24.58 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.263 0.352 . . . . 0.0 111.479 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.421 ' OD1' ' OE1' ' A' ' 166' ' ' GLN . 0.4 OUTLIER -98.24 115.23 27.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.22 94.68 5.17 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 162' ' ' SER . 56.6 mp0 -74.29 100.38 3.72 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 60.3 p -66.7 -35.12 79.39 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -62.17 -40.39 95.84 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.567 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.41 ' HB3' HH21 ' A' ' 163' ' ' ARG . 98.9 mttt -92.6 -14.89 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.558 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.3 m 51.67 52.75 13.98 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.494 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.424 ' O ' ' OE1' ' A' ' 158' ' ' GLU . 82.5 mtt85 -137.32 143.9 42.32 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.825 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.89 101.72 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 175.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 50.2 p -118.91 -56.81 2.08 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 122.071 0.938 . . . . 0.0 110.705 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.449 ' N ' ' OG1' ' A' ' 165' ' ' THR . 5.0 mt-30 -71.98 109.4 5.78 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.428 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 31.0 t -140.13 146.05 38.35 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.022 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -128.19 146.33 50.75 Favored 'General case' 0 C--N 1.346 0.438 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -113.37 108.91 17.86 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.695 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.586 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -93.75 130.53 39.7 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.844 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.3 t -132.13 114.11 23.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 O-C-N 123.704 0.627 . . . . 0.0 109.957 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -122.31 145.88 16.66 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.053 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.481 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 25.1 t80 -125.21 127.92 47.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.102 -1.049 . . . . 0.0 108.269 177.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -100.52 145.27 28.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 178' ' ' PHE . 0.8 OUTLIER -141.95 154.4 45.03 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.041 -1.891 . . . . 0.0 107.383 177.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.595 ' C ' ' H ' ' A' ' 178' ' ' PHE . 65.8 t0 -42.26 124.81 2.93 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.711 -0.618 . . . . 0.0 111.844 -177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 59.41 -20.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 176' ' ' ASP . 0.8 OUTLIER -103.25 131.67 50.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -175.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -116.41 141.33 48.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.659 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.524 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 50.8 tp -112.29 109.16 18.65 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -118.78 106.52 12.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.653 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -124.41 153.89 41.23 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 2.3 t30 -151.91 147.39 26.52 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.527 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.587 HG13 ' CE2' ' A' ' 190' ' ' PHE . 6.6 t -97.31 124.6 50.29 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.45 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 49.8 t30 -101.64 109.77 21.63 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.187 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 188' ' ' THR . 83.2 m-20 55.47 29.54 13.47 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 125.133 1.521 . . . . 0.0 112.942 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.22 10.4 41.08 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 186' ' ' ASP . 74.0 p -117.95 -75.76 0.58 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -177.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.76 115.4 28.02 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 119.889 -0.725 . . . . 0.0 112.929 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.587 ' CE2' HG13 ' A' ' 184' ' ' VAL . 13.9 m-85 -87.71 146.18 25.8 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.817 -0.552 . . . . 0.0 111.169 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -115.67 160.12 13.46 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.653 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -153.89 140.38 7.48 Favored Glycine 0 C--O 1.224 -0.515 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 13.8 p -153.89 157.38 39.18 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.895 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.667 HD12 ' HB ' ' A' ' 206' ' ' VAL . 85.2 mt -131.8 120.34 44.38 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.001 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -114.64 111.98 22.17 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.935 0.772 . . . . 0.0 109.578 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.434 ' NE2' ' CE2' ' A' ' 178' ' ' PHE . 28.2 tt0 -123.34 135.77 54.34 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -108.4 104.69 14.11 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 174.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 201' ' ' LYS . 38.9 t -70.99 -41.8 76.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 29.9 t30 90.23 -71.39 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.292 0.37 . . . . 0.0 110.612 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.56 -40.47 89.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.565 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.57 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.7 mttt -92.98 -66.17 0.94 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -176.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER 173.88 -139.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 118.559 0.618 . . . . 0.0 110.93 -177.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.687 ' H ' HD12 ' A' ' 202' ' ' LEU . 93.0 mt-10 -96.15 156.21 16.43 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 203' ' ' GLU . 22.0 p -159.28 124.86 4.26 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.65 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.453 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.51 155.4 41.84 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.226 -0.99 . . . . 0.0 112.244 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 220' ' ' GLY . 38.6 t -127.93 134.21 65.72 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.488 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.644 178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.455 HD22 ' C ' ' A' ' 206' ' ' VAL . 1.0 OUTLIER -111.4 127.03 55.54 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.048 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.0 OUTLIER -125.43 118.78 26.59 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.125 0.265 . . . . 0.0 110.997 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.85 137.35 54.96 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.404 ' CE2' ' CB ' ' A' ' 190' ' ' PHE . 1.5 p90 -140.14 170.58 15.58 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.414 0.626 . . . . 0.0 110.043 177.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 97.1 m -127.09 117.53 22.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.47 56.19 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.4 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.67 22.88 19.05 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.696 -1.138 . . . . 0.0 113.905 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 -60.09 138.15 57.94 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 58.1 m -57.74 -35.64 70.98 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.73 112.19 19.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.6 m -103.5 122.65 45.36 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.576 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.55 114.58 19.54 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 19.0 p90 -139.64 147.93 41.72 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.767 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.676 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -123.13 146.03 16.34 Favored Glycine 0 C--N 1.342 0.865 0 O-C-N 125.522 1.764 . . . . 0.0 111.332 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 98.4 mt -111.17 103.73 15.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.31 118.93 37.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 120.372 -0.531 . . . . 0.0 110.887 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -132.71 128.22 36.47 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.24 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -106.15 122.29 45.9 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.533 ' HE1' ' HB ' ' A' ' 227' ' ' ILE . 2.0 t80 -114.54 94.01 4.59 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.63 ' HB3' HD23 ' A' ' 202' ' ' LEU . 55.4 tt0 -115.71 113.95 24.18 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 104.875 -2.269 . . . . 0.0 104.875 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.533 ' HB ' ' HE1' ' A' ' 225' ' ' TYR 0.414 0.3 OUTLIER -72.98 -26.35 23.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 118.086 -1.446 . . . . 0.0 112.282 -173.726 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.637 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 6.3 m-20 150.96 -38.88 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 122.635 0.374 . . . . 0.0 110.603 172.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 228' ' ' ASP . 10.8 Cg_exo -66.23 -112.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.297 -2.133 0 C-N-CA 121.959 1.773 . . . . 0.0 113.138 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.436 ' CG ' ' O ' ' A' ' 250' ' ' THR . 96.9 m-20 -123.34 -0.29 8.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -101.91 118.22 36.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.529 0.604 . . . . 0.0 112.473 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.2 t -122.5 120.52 34.12 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.121 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.474 ' CE1' ' CE1' ' A' ' 247' ' ' TYR . 53.3 m-85 -111.68 116.26 30.46 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 46.6 t -107.73 140.33 40.95 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.938 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -142.11 135.35 28.99 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.542 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.0 mttt -127.5 106.26 9.06 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 121.178 -0.209 . . . . 0.0 110.753 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.23 116.65 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.163 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.63 ' OD1' ' N ' ' A' ' 242' ' ' LEU . 12.8 p-10 -101.27 165.3 11.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.342 177.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -88.71 5.78 41.66 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.875 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.428 ' HB2' HD21 ' A' ' 238' ' ' ASN . 48.8 m -100.56 21.66 12.98 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 176.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.34 26.55 2.63 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 113.976 -1.465 . . . . 0.0 113.969 178.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.63 ' N ' ' OD1' ' A' ' 238' ' ' ASN . 11.6 mt -106.61 108.04 19.36 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.503 0.592 . . . . 0.0 111.912 179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 76.9 mt -100.4 132.26 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 119.066 -0.492 . . . . 0.0 110.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -114.87 142.24 17.5 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.3 mt -125.12 115.11 19.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.98 106.49 0.79 Allowed Glycine 0 N--CA 1.468 0.788 0 C-N-CA 119.73 -1.224 . . . . 0.0 112.839 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.474 ' CE1' ' CE1' ' A' ' 233' ' ' PHE . 35.8 t80 -100.05 114.2 27.35 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.3 m -102.49 131.53 49.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.933 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.426 ' CG ' ' CE2' ' A' ' 247' ' ' TYR . 83.4 mt-30 -117.07 110.37 18.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.436 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 83.8 m -102.19 109.1 20.7 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 252' ' ' LYS . 1.0 OUTLIER -75.04 142.18 43.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.421 -177.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -43.84 -54.79 10.16 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.499 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.6 Cg_exo -42.05 -114.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.205 2.603 . . . . 0.0 113.168 177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -154.05 34.18 0.73 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.12 131.55 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -112.42 125.8 54.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.318 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 58.1 tp -123.57 107.01 11.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.1 m -120.52 136.02 54.9 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.68 145.54 34.85 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.902 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 8.6 p -139.84 150.24 44.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.432 . . . . 0.0 111.864 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.98 120.66 2.66 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.473 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 242' ' ' LEU . 25.0 tp -114.96 103.16 10.65 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.51 117.7 30.53 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.812 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.437 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 30.1 t0 -82.95 110.13 17.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.914 0.864 . . . . 0.0 112.339 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.46 -41.46 97.11 Favored Glycine 0 C--N 1.309 -0.946 0 CA-C-N 114.568 -1.196 . . . . 0.0 112.453 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 268' ' ' VAL . 83.9 mttt -84.53 -9.04 58.69 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.682 178.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 73.9 m-20 56.67 -22.67 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.1 t -75.33 -37.23 38.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.517 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -63.13 -44.87 94.35 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.793 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.57 -35.27 19.57 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.832 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.01 -7.06 0.31 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.44 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -141.37 -135.06 3.1 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.772 -0.727 . . . . 0.0 111.766 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -140.73 122.47 15.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 0.0 111.257 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.6 115.36 27.83 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.135 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.647 ' C ' ' H ' ' A' ' 25' ' ' GLY . 89.4 mt -133.84 129.28 36.25 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.94 129.75 3.17 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.236 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.551 ' HB2' HG23 ' A' ' 27' ' ' ILE . 38.6 mt -115.79 129.41 56.43 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.74 115.08 4.87 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 76.8 mt -113.36 104.73 12.6 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -116.44 136.42 53.01 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.343 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -116.86 137.84 51.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.344 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -99.66 133.0 44.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.352 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.24 155.56 44.53 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.071 0.463 . . . . 0.0 112.004 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.1 mtp180 -86.04 137.46 32.67 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.633 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.814 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 121.201 0.524 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.848 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -128.99 144.09 51.08 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.719 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -173.35 73.71 0.39 Allowed Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.598 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -80.7 157.59 21.51 Favored 'Trans proline' 0 CA--C 1.566 2.12 0 C-N-CA 123.414 2.743 . . . . 0.0 113.756 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 29.8 Cg_endo -65.24 -58.4 0.2 Allowed 'Trans proline' 1 N--CA 1.541 4.272 2 C-N-CA 126.18 4.587 . . . . 0.0 122.908 -173.956 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 5' ' ' PRO . 14.6 p -165.85 156.33 13.03 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 120.152 -1.593 . . . . 0.0 114.765 -176.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.682 ' H ' ' CB ' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -37.64 -42.0 0.52 Allowed 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 113.461 -1.699 . . . . 0.0 110.542 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.42 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . . . -88.59 -39.43 14.11 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 117.778 -1.569 . . . . 0.0 110.628 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -82.54 12.2 4.86 Favored 'General case' 0 C--O 1.264 1.816 0 CA-C-O 121.06 0.457 . . . . 0.0 111.607 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 6' ' ' THR . 57.0 tp -66.91 118.05 9.86 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 65.59 42.43 95.55 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.269 -0.967 . . . . 0.0 110.792 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -51.58 -39.75 58.48 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.4 m -59.32 -44.52 92.58 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.709 -0.619 . . . . 0.0 111.867 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.38 98.14 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.028 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 19' ' ' THR . 77.4 ttt-85 -63.63 -39.44 94.35 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -62.73 -40.76 98.2 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.8 t -62.52 -44.63 99.5 Favored 'Isoleucine or valine' 0 C--N 1.343 0.305 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.009 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.64 ' CG ' ' ND2' ' A' ' 207' ' ' ASN . 67.5 t80 -65.25 -44.91 86.64 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.936 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 15' ' ' ARG . 57.9 p -64.95 -45.02 87.5 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -54.81 127.19 27.35 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 118.93 -1.108 . . . . 0.0 109.867 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.57 136.89 3.22 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.254 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.53 160.95 43.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 99.87 -103.44 2.67 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.043 -0.598 . . . . 0.0 112.032 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.405 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.3 m-85 27.46 72.32 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.633 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.94 -30.99 5.87 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.623 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -120.07 135.15 55.05 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 118.472 1.136 . . . . 0.0 113.701 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 277' ' ' LEU . 80.3 mt -84.36 121.0 36.1 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 103.7 -2.704 . . . . 0.0 103.7 177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -108.23 133.33 52.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.849 -1.069 . . . . 0.0 113.086 -173.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.6 mt -106.56 118.15 35.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.329 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.473 ' OD2' HG23 ' A' ' 42' ' ' THR . 27.2 t70 -119.55 132.83 55.83 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.151 0.5 . . . . 0.0 111.854 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.7 mt -108.57 121.92 46.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.688 178.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.644 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 88.3 tttt -115.09 127.42 55.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 p -123.89 116.89 23.65 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -101.66 122.82 44.6 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.487 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.1 p -82.07 161.19 23.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 37' ' ' ASN . 79.4 mm-40 -70.82 91.63 0.85 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.219 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 36' ' ' GLU . 99.0 m-20 56.69 120.24 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.137 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.99 -107.59 1.51 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 64.9 mt -60.24 142.97 53.74 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.523 1.154 . . . . 0.0 113.185 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -141.07 95.0 2.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.123 -1.853 . . . . 0.0 108.333 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.525 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 48.6 m-85 -100.42 113.76 26.78 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.037 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.473 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.3 m -123.56 105.19 9.54 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.432 177.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.7 t -87.58 157.8 19.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.6 m -138.17 148.92 45.36 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.743 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -148.89 129.53 3.11 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.674 ' O ' HG13 ' A' ' 54' ' ' VAL . 10.4 p -131.62 172.16 12.58 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-O 121.542 0.687 . . . . 0.0 112.833 -177.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.24 147.74 31.74 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.8 t30 -76.52 140.33 41.12 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -37.82 -30.71 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.239 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' O ' ' CB ' ' A' ' 51' ' ' THR . 79.5 mm-40 -101.68 -7.56 22.55 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 118.525 0.602 . . . . 0.0 111.6 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.2 OUTLIER 85.25 16.42 0.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.2 p -75.72 -27.55 58.22 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.482 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 48' ' ' ASN . 99.2 mttt -136.58 148.67 47.65 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.014 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 46' ' ' SER . 8.7 t -129.4 108.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.068 0.547 . . . . 0.0 109.84 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' O ' ' OG ' ' A' ' 46' ' ' SER . 65.0 p -104.91 133.36 49.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.734 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.75 -160.5 11.27 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -176.13 161.95 2.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.226 0.536 . . . . 0.0 111.293 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.3 mt -130.16 107.0 8.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.309 -0.86 . . . . 0.0 108.773 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -104.97 114.2 28.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.637 0.732 . . . . 0.0 109.246 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.525 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 22.8 m -130.19 106.28 8.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.54 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -126.38 144.81 50.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.613 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.526 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 t80 -120.19 100.66 7.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -105.37 91.88 3.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.526 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.9 m95 -77.4 91.21 3.85 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 104.602 -2.369 . . . . 0.0 104.602 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.0 p -62.25 -3.1 1.18 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.564 -0.854 . . . . 0.0 112.769 -176.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -80.81 -76.18 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.203 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -76.26 22.05 0.17 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.791 -0.364 . . . . 0.0 111.818 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.49 51.67 41.85 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.215 -0.77 . . . . 0.0 113.15 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 mt -109.15 102.38 11.34 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 36.3 m -95.28 91.29 6.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.91 177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.663 ' CE2' HG23 ' A' ' 85' ' ' ILE . 4.7 m-85 -99.24 80.79 2.47 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.7 m -87.91 136.18 33.08 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.428 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.83 123.14 56.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.534 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -121.99 114.43 20.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.926 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -120.96 133.78 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -131.01 165.26 23.59 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.327 0.584 . . . . 0.0 110.33 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.5 p -64.06 -34.72 78.66 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.297 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -59.27 -11.6 4.3 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.274 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 30.1 m-20 99.8 0.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.602 1.189 . . . . 0.0 112.491 178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.516 HG23 ' OG ' ' A' ' 104' ' ' SER . 29.1 m -64.91 121.82 15.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.189 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 42.6 mt -120.59 116.57 25.62 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.59 131.36 6.31 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.001 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 55.6 m -123.53 124.19 42.28 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.385 0.612 . . . . 0.0 109.833 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' OE2' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -119.69 117.97 29.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.67 -179.006 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.663 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.2 mt -114.71 114.53 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.366 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.41 HG21 ' HE2' ' A' ' 96' ' ' LYS . 9.5 m -122.36 128.6 51.19 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.6 t -115.64 101.89 12.95 Favored 'Isoleucine or valine' 0 C--N 1.349 0.566 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.22 154.03 17.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.554 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 65.28 55.27 1.1 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' OE1' HD22 ' A' ' 95' ' ' LEU . 77.9 mt-30 -94.78 -33.49 12.86 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 95' ' ' LEU . 8.4 mp -105.02 15.01 28.41 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.336 0.589 . . . . 0.0 109.908 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 84.45 -36.88 0.06 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.874 -1.057 . . . . 0.0 112.801 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.55 -90.16 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.879 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.44 93.63 0.14 Allowed Glycine 0 C--N 1.309 -0.938 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.725 HD13 HD13 ' A' ' 91' ' ' LEU . 5.6 tt -127.2 127.17 44.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.338 -0.931 . . . . 0.0 109.824 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.709 ' N ' HD23 ' A' ' 95' ' ' LEU . 64.6 tttm -124.78 118.67 26.92 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.908 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.4 tp -111.13 104.54 13.08 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.51 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 92.8 m -112.11 99.57 8.17 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -83.26 129.85 35.03 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -123.02 150.99 42.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.784 0.326 . . . . 0.0 111.141 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.0 t -137.05 120.93 17.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.634 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.01 105.97 9.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.274 0.559 . . . . 0.0 109.743 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -116.93 79.21 1.3 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.115 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' HG23 ' A' ' 80' ' ' THR . 0.4 OUTLIER -125.61 156.37 70.88 Favored Pre-proline 0 N--CA 1.475 0.824 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' O ' ' O ' ' A' ' 106' ' ' ASN . 94.3 Cg_exo -40.67 -36.13 1.78 Allowed 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.979 3.119 . . . . 0.0 114.684 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 105' ' ' PRO . 99.8 m-20 -43.96 171.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.613 0.244 . . . . 0.0 111.588 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.5 p -62.63 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.782 0.325 . . . . 0.0 110.731 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.64 -32.13 72.97 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 68.4 mttm 50.27 -114.25 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.962 -0.14 . . . . 0.0 110.97 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.3 tttt -89.96 114.4 26.22 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.627 0.58 . . . . 0.0 110.966 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -120.98 128.34 52.63 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.484 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.3 110.9 13.31 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.18 145.88 41.1 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.24 104.13 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -95.92 127.71 42.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 88.9 m -125.19 103.84 8.19 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.49 135.09 12.63 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -130.83 124.88 32.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -106.49 153.25 22.56 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.29 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.9 ttt-85 -175.01 93.32 0.07 Allowed 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' O ' ' A' ' 120' ' ' ARG . 84.0 tt0 39.06 110.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' H ' HG13 ' A' ' 3' ' ' VAL . 64.7 m170 52.56 -6.6 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 121' ' ' GLU . 97.3 mt -117.21 112.67 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 5' ' ' PRO . 8.8 t30 -122.35 128.05 50.53 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 120.696 -0.402 . . . . 0.0 109.945 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 11.6 mt -122.91 112.69 18.15 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 117.997 -1.002 . . . . 0.0 110.43 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.72 139.52 15.23 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 119.949 1.25 . . . . 0.0 111.165 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.9 t -125.32 107.54 10.8 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 124.288 0.64 . . . . 0.0 111.83 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -97.77 109.76 22.46 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.377 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 99.4 mtp -101.75 111.38 23.61 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -97.64 108.05 20.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.281 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -78.67 84.06 4.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 110.234 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.462 ' C ' ' H ' ' A' ' 135' ' ' GLY . 42.2 t0 -118.24 168.12 10.89 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 83.7 mt -62.15 -40.77 88.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.02 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' A' ' 160' ' ' ALA . . . -87.66 3.29 48.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.47 -179.74 29.6 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 106.053 -2.819 . . . . 0.0 106.053 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.52 131.77 3.5 Favored 'Cis proline' 0 N--CA 1.51 2.455 0 CA-C-N 121.72 2.76 . . . . 0.0 115.144 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.7 m -113.57 137.36 51.69 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.22 102.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.596 0.634 . . . . 0.0 110.74 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -110.17 104.83 13.72 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 121.674 0.75 . . . . 0.0 110.473 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -125.07 164.49 18.62 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.454 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.682 ' CB ' ' H ' ' A' ' 7' ' ' TYR . . . -135.54 141.33 45.2 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 118.352 1.076 . . . . 0.0 109.502 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.53 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 19.0 mt -112.38 115.78 29.27 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.449 HG11 ' HD2' ' A' ' 4' ' ' PRO . 2.8 t -103.61 126.94 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.014 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -115.52 132.57 56.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.437 -1.256 . . . . 0.0 108.726 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 122' ' ' HIS . . . -104.17 147.99 16.7 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 119.735 -1.222 . . . . 0.0 112.352 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.713 ' O ' ' N ' ' A' ' 148' ' ' GLY . 96.6 m-85 -143.65 -161.12 1.21 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.494 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 98.8 mt-10 -45.6 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 O-C-N 124.823 1.327 . . . . 0.0 113.705 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 89.32 37.22 7.17 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.497 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 5.9 m95 -135.73 148.7 48.94 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 120.332 -0.547 . . . . 0.0 112.391 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 70.5 mt -122.08 113.68 19.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.364 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.59 133.13 56.28 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 170' ' ' ALA . . . -122.72 147.61 16.83 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.689 -177.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -128.31 112.95 15.02 Favored 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.682 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 10.1 tt0 -109.98 124.2 51.0 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 99.5 mtp -111.7 124.44 52.33 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.846 0.717 . . . . 0.0 111.343 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -102.1 111.17 23.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -105.83 96.49 6.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.507 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.8 mt-10 -77.97 93.47 4.45 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 59.5 p -67.94 -31.59 71.45 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 134' ' ' ALA . . . -61.65 -40.35 94.59 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 119.593 -0.843 . . . . 0.0 109.821 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -97.46 -12.62 22.47 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.0 m 54.8 53.54 10.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.238 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -127.68 126.26 41.61 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.644 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 165' ' ' THR . 72.0 t -104.9 124.22 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 176.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 164' ' ' VAL . 22.2 p -160.79 -56.91 0.05 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.963 0.887 . . . . 0.0 110.791 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -64.53 108.65 1.73 Allowed 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.551 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.2 t -142.44 150.94 41.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.999 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -128.04 137.97 52.39 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -99.5 111.79 24.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.662 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.541 ' HB3' ' HA3' ' A' ' 152' ' ' GLY . . . -89.62 133.79 34.45 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.769 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.0 t -131.56 130.44 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -150.01 156.26 26.66 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 119.8 -1.191 . . . . 0.0 113.316 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.511 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 74.0 t80 -129.46 133.96 47.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.088 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -108.42 147.43 31.61 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.314 1.054 . . . . 0.0 113.391 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.1 p -133.62 154.84 50.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.724 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -52.73 -18.41 1.82 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.28 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 177' ' ' GLU . 57.7 mp0 -130.25 -37.35 1.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.956 0.408 . . . . 0.0 111.866 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.593 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -105.9 139.7 40.06 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -175.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -117.22 142.72 46.7 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.364 176.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.511 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 45.1 tp -109.22 110.75 22.04 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -118.54 117.98 30.46 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 123.415 0.447 . . . . 0.0 111.559 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -134.65 149.82 50.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -136.69 133.44 36.15 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 119.478 1.035 . . . . 0.0 109.635 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.429 HG22 ' CE1' ' A' ' 190' ' ' PHE . 5.2 t -98.45 114.01 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.944 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -92.93 114.6 27.2 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.406 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 53.65 28.01 7.49 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 125.498 1.749 . . . . 0.0 112.888 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.56 17.24 64.28 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.443 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 4.7 m -122.4 -72.69 0.67 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.15 119.17 38.36 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -177.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CD2' ' NE1' ' A' ' 210' ' ' TRP . 11.6 m-85 -87.57 152.0 22.54 Favored 'General case' 0 C--N 1.348 0.515 0 O-C-N 122.19 -0.319 . . . . 0.0 110.839 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -176.66 139.15 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.065 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.36 -162.55 28.26 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -137.74 174.68 10.32 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.593 HD11 HD11 ' A' ' 208' ' ' LEU . 8.8 mt -131.6 108.57 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 176.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -81.93 120.35 25.11 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -123.52 105.96 10.21 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -90.7 95.19 10.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.62 -43.58 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.06 -175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 23.2 p30 -159.84 -174.18 4.47 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -61.06 -40.56 94.12 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.798 -177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.402 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 99.1 mttt -96.85 -8.03 32.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.523 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 55.7 tp -120.06 109.3 15.32 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -119.28 116.73 26.85 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.817 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 223' ' ' ALA . 6.6 p -122.11 162.66 20.85 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.437 -0.789 . . . . 0.0 110.537 -177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -141.39 121.37 13.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.53 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.529 ' HB ' HD12 ' A' ' 194' ' ' ILE . 3.1 t -97.66 129.82 47.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.64 ' ND2' ' CG ' ' A' ' 18' ' ' PHE . 91.7 m-20 -103.28 128.59 50.27 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.12 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.593 HD11 HD11 ' A' ' 194' ' ' ILE . 81.8 mt -113.49 111.01 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.489 0.493 . . . . 0.0 110.678 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.84 123.75 41.71 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.436 178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.617 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 3.2 p90 -142.67 176.91 8.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.293 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.13 109.86 6.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 38.58 90.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.471 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.16 162.52 11.45 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -103.76 14.16 31.55 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 62.0 p -62.28 -98.94 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.932 -1.031 . . . . 0.0 112.688 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -96.97 106.95 19.38 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 52.3 m -103.77 114.93 29.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.724 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -77.38 114.96 16.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.94 146.96 52.25 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.621 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.41 158.61 14.35 Favored Glycine 0 C--O 1.223 -0.588 0 CA-C-N 113.658 -1.61 . . . . 0.0 111.983 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 88.6 mt -127.41 103.78 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.21 113.54 26.29 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.156 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -110.82 120.93 44.02 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.808 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -105.81 99.79 9.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.464 ' CD1' HD13 ' A' ' 202' ' ' LEU . 5.3 t80 -99.57 99.63 10.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.588 -177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -73.23 113.58 10.46 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.359 -2.46 . . . . 0.0 104.359 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . 0.459 0.8 OUTLIER -92.86 -42.99 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 119.03 -1.068 . . . . 0.0 112.12 -175.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 176.8 2.31 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 104.113 -2.551 . . . . 0.0 104.113 170.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.98 -15.87 51.63 Favored 'Trans proline' 0 C--N 1.293 -2.394 0 CA-C-N 121.213 1.469 . . . . 0.0 111.9 -178.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -108.51 4.03 23.74 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.429 ' HB1' ' OH ' ' A' ' 247' ' ' TYR . . . -149.76 141.0 23.12 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 119.516 -0.874 . . . . 0.0 112.152 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 m -141.98 150.53 41.5 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -117.8 110.05 17.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.462 0.173 . . . . 0.0 111.386 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.4 t -107.71 112.63 25.41 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -130.13 157.1 43.35 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -137.43 120.58 16.74 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.684 HG13 HG12 ' A' ' 243' ' ' ILE . 15.6 t -104.12 115.18 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 118.591 -0.718 . . . . 0.0 110.564 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.611 HD21 ' CD1' ' A' ' 242' ' ' LEU . 16.2 p-10 -99.74 161.93 13.31 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -90.16 4.17 51.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 241' ' ' SER . 60.4 m -91.42 9.97 29.56 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.1 p 84.76 22.73 0.1 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 114.031 -1.44 . . . . 0.0 113.267 178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.611 ' CD1' HD21 ' A' ' 238' ' ' ASN . 3.5 mp -113.32 112.31 23.47 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.571 0.623 . . . . 0.0 111.028 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.684 HG12 HG13 ' A' ' 237' ' ' VAL . 87.8 mt -112.65 140.74 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -124.44 152.18 17.38 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 62.3 mt -126.73 121.74 32.87 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 123.981 0.459 . . . . 0.0 109.859 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.51 106.36 0.73 Allowed Glycine 0 CA--C 1.532 1.116 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.976 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.429 ' OH ' ' HB1' ' A' ' 231' ' ' ALA . 15.1 t80 -98.86 125.91 44.38 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.677 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 99.9 m -112.86 127.28 56.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.257 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -122.09 109.93 15.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.438 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 3.2 p -108.47 106.6 16.78 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 252' ' ' LYS . 7.9 mt -71.47 157.07 38.68 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.549 ' O ' ' O ' ' A' ' 253' ' ' PRO . 0.1 OUTLIER -42.79 -56.83 5.55 Favored Pre-proline 0 C--N 1.357 0.909 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -41.06 -126.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.125 0 C-N-CA 123.553 2.835 . . . . 0.0 113.935 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -142.2 32.62 1.97 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.677 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.83 127.44 75.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 112.132 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.08 127.28 55.86 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.13 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 39.9 tp -123.39 107.29 11.45 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.826 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.493 ' C ' HD22 ' A' ' 259' ' ' LEU . 15.2 m -114.06 133.04 55.79 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.098 -0.641 . . . . 0.0 112.643 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.5 mm? -108.06 144.73 35.01 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.534 177.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.5 p -141.9 149.17 39.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.415 0.626 . . . . 0.0 112.157 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.96 121.23 3.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.479 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 24.7 tp -114.41 102.77 10.4 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 77.6 mt -95.05 120.15 34.78 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.09 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -85.28 107.67 17.42 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.852 0.834 . . . . 0.0 111.609 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.63 93.94 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.192 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 268' ' ' VAL . 51.9 mmtt -84.69 -7.35 59.26 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 119.559 1.68 . . . . 0.0 110.971 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 55.83 -20.99 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 266' ' ' LYS . 50.0 t -77.92 -34.75 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.39 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -64.68 -44.86 89.01 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.113 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.63 -35.85 20.71 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 118.367 -1.333 . . . . 0.0 108.832 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.95 -5.25 3.74 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.533 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -146.09 -137.47 3.07 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.04 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -139.55 121.26 15.34 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.023 0.439 . . . . 0.0 111.57 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -91.61 114.91 27.58 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.907 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.633 ' C ' ' H ' ' A' ' 25' ' ' GLY . 84.2 mt -133.75 118.74 18.43 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -137.41 147.75 19.41 Favored Glycine 0 N--CA 1.463 0.445 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.164 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.627 ' HB2' HG23 ' A' ' 27' ' ' ILE . 5.8 mp -134.54 143.87 47.66 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.91 114.85 2.29 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 28.5 mt -111.64 106.62 15.5 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.26 125.44 53.31 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.215 0.531 . . . . 0.0 110.352 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -104.43 124.12 48.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.952 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -77.95 129.41 35.28 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.501 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -138.89 146.63 41.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.972 0.415 . . . . 0.0 111.91 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.4 mtp180 -89.62 138.93 31.04 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.657 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.748 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.182 0.515 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -150.37 146.5 26.75 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.338 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.41 HG22 ' C ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -160.8 67.05 2.45 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.938 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -81.82 164.49 18.09 Favored 'Trans proline' 0 CA--C 1.567 2.135 0 C-N-CA 122.865 2.377 . . . . 0.0 114.806 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 6' ' ' THR . 40.3 Cg_endo -70.31 -173.03 0.71 Allowed 'Trans proline' 0 N--CA 1.526 3.436 1 C-N-CA 125.672 4.248 . . . . 0.0 115.201 -176.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 45.7 p -40.25 132.27 1.98 Allowed 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.8 OUTLIER -38.44 -43.26 0.82 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.663 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -67.22 -39.13 86.24 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 116.429 -2.109 . . . . 0.0 110.399 -177.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -68.67 -25.53 64.85 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.495 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.3 tp -59.8 133.62 56.27 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.682 -1.262 . . . . 0.0 109.353 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.99 10.35 61.36 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.211 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -51.39 -35.34 38.47 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.6 t -60.18 -47.55 85.48 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 120.316 -0.553 . . . . 0.0 112.163 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.44 96.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.785 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 19' ' ' THR . 78.9 ttt-85 -64.92 -40.66 95.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -62.18 -42.98 99.78 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 222' ' ' ALA . 58.1 t -62.58 -44.93 99.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.23 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -60.06 -40.64 90.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 15' ' ' ARG . 57.4 p -74.23 -10.05 59.21 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.16 -32.6 23.75 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 117.988 -1.485 . . . . 0.0 110.478 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.668 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 69.56 -128.6 21.41 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 19.3 m-85 171.62 -179.84 0.06 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.42 -25.26 74.88 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.579 ' CE1' HD22 ' A' ' 262' ' ' LEU . 64.4 m-85 33.19 64.75 0.28 Allowed 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.52 -15.91 59.43 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 119.782 -1.199 . . . . 0.0 113.532 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mp -116.05 123.93 49.16 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 118.998 1.399 . . . . 0.0 114.358 -177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' A' ' 277' ' ' LEU . 1.7 mp -84.19 120.4 34.94 Favored 'Isoleucine or valine' 0 C--O 1.249 1.052 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 mttt -106.51 140.58 39.18 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.922 -175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.8 mt -111.85 119.5 38.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -118.53 133.73 55.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.085 0.469 . . . . 0.0 112.23 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.3 mt -109.83 128.98 55.67 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -130.9 134.89 47.18 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.7 m -127.24 124.15 38.2 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -105.11 122.97 47.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.947 0.403 . . . . 0.0 111.846 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.508 ' O ' ' N ' ' A' ' 37' ' ' ASN . 4.5 m -82.26 149.57 27.77 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.77 83.87 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.97 -0.692 . . . . 0.0 111.394 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 35' ' ' SER . 49.4 t30 63.07 121.42 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.53 -106.53 0.94 Allowed Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.483 HD22 ' CE1' ' A' ' 41' ' ' PHE . 42.0 mt -66.68 141.95 57.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.248 1.023 . . . . 0.0 113.197 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -137.15 97.35 3.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 113.207 -1.815 . . . . 0.0 108.136 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.507 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 45.1 m-85 -102.55 113.73 27.34 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.765 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' THR . 2.0 m -123.64 104.76 9.21 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.5 p -88.48 161.03 17.23 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 57' ' ' SER . 5.8 p -135.59 146.1 47.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.619 0.723 . . . . 0.0 111.822 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.81 116.59 0.84 Allowed Glycine 0 C--O 1.223 -0.536 0 N-CA-C 107.331 -2.308 . . . . 0.0 107.331 178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 89.8 p -135.41 172.34 13.15 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -132.91 164.76 26.2 Favored 'General case' 0 N--CA 1.433 -1.309 0 O-C-N 124.874 1.359 . . . . 0.0 110.673 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 50' ' ' GLU . 1.6 m-80 -97.27 125.57 41.92 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 50' ' ' GLU . 53.7 m 42.87 -89.64 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.495 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 48' ' ' ASN . 97.2 mt-10 -147.34 90.14 1.85 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.812 0.339 . . . . 0.0 111.581 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 73.82 6.28 4.89 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 16.2 p -71.22 -25.76 62.63 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.605 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 13.4 tttt -173.24 166.56 4.86 Favored 'General case' 0 C--O 1.214 -0.812 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 46' ' ' SER . 36.3 t -129.91 120.76 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 C-N-CA 124.575 1.15 . . . . 0.0 110.105 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -124.6 132.09 53.45 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 118.104 0.411 . . . . 0.0 110.073 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.61 -163.07 12.15 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.319 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.532 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.0 p -175.49 164.52 3.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.2 0.524 . . . . 0.0 111.144 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.22 113.42 14.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.556 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -115.74 116.55 28.24 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.507 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 49.4 m -130.66 117.46 19.51 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.233 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.2 mttt -129.3 140.83 51.27 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.606 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -121.88 103.66 9.0 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 177.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -108.59 91.44 3.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.606 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 76.4 m95 -77.75 77.73 4.26 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.6 p -51.57 -6.95 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.008 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.6 mt-10 -74.98 -79.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.596 -0.841 . . . . 0.0 110.351 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -76.14 23.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.701 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 55.44 51.61 53.4 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.914 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 mt -108.09 102.35 11.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 117.813 0.806 . . . . 0.0 112.126 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' O ' ' O ' ' A' ' 84' ' ' GLU . 36.2 m -95.01 87.42 4.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.149 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.7 m-85 -98.96 77.54 2.2 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 m -88.03 141.85 28.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.384 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.1 t -129.96 122.82 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 124.176 0.923 . . . . 0.0 109.847 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -123.29 106.09 10.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.21 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.621 ' CD2' HD22 ' A' ' 81' ' ' LEU . 2.9 m95 -114.81 130.01 56.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -126.42 155.88 41.48 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.221 0.534 . . . . 0.0 110.654 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.4 p -62.98 -35.09 79.02 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.381 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 86.7 m-20 -56.47 -12.09 1.56 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.38 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.7 m120 100.58 0.05 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.738 1.274 . . . . 0.0 112.468 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.6 m -75.91 126.27 30.69 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 119.149 -1.02 . . . . 0.0 109.98 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD22 ' CD2' ' A' ' 75' ' ' TRP . 11.0 mt -120.91 126.67 50.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.45 122.65 2.99 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.185 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 74.2 m -123.5 125.42 44.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.04 0.42 . . . . 0.0 109.92 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 70' ' ' THR . 81.6 tt0 -119.41 122.68 42.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.578 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.593 HG23 ' CE1' ' A' ' 71' ' ' PHE . 69.6 mt -113.97 106.44 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.9 m -117.15 126.39 52.72 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 t -115.75 106.03 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.01 155.08 16.88 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.482 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 63.11 45.41 5.2 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.573 ' HB2' HD23 ' A' ' 95' ' ' LEU . 46.3 mt-30 -79.43 -35.89 39.78 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.47 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 64.9 tp -90.86 -64.67 1.1 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 175.29 -43.17 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.643 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 85.2 mmt-85 -75.69 -79.08 0.1 Allowed 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.81 96.03 0.14 Allowed Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 117' ' ' GLY . 44.5 tp -120.42 121.75 39.22 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 113.766 -1.217 . . . . 0.0 109.781 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -124.62 122.72 38.33 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.066 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' CB ' HE22 ' A' ' 90' ' ' GLN . 55.7 tp -115.1 106.86 14.59 Favored 'General case' 0 C--N 1.347 0.46 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 98' ' ' THR . 71.2 m -110.67 98.96 8.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -84.46 132.8 34.52 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 112' ' ' ALA . 26.4 t0 -123.07 145.5 48.49 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.576 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.55 107.6 5.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 124.494 1.121 . . . . 0.0 110.772 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.37 114.16 17.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.869 0.842 . . . . 0.0 110.518 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -113.2 102.37 10.3 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.452 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.5 161.0 52.99 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 104' ' ' SER . 76.6 Cg_exo -38.84 176.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.833 0 C-N-CA 124.235 3.29 . . . . 0.0 113.288 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.5 p30 -45.69 -14.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.858 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.478 ' N ' ' O ' ' A' ' 105' ' ' PRO . 30.0 p -68.86 -32.83 72.78 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.259 -0.577 . . . . 0.0 109.751 178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -157.38 94.85 0.14 Allowed Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 108' ' ' GLY . 71.1 tttt -57.64 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 120.699 0.285 . . . . 0.0 111.542 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.64 124.35 33.98 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.006 0.431 . . . . 0.0 111.366 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -119.05 104.73 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.901 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 100' ' ' ASP . . . -116.02 111.3 20.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.33 146.05 46.52 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.4 mt -126.16 108.68 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -100.63 127.8 46.9 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.0 p -120.68 106.06 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.611 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.47 129.81 9.22 Favored Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 -178.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.421 ' CE2' HD23 ' A' ' 91' ' ' LEU . 71.2 t80 -123.39 126.3 46.55 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.874 0.845 . . . . 0.0 109.098 178.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -105.66 151.59 24.2 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.22 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.567 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.7 ttt-85 -172.25 91.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.567 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.6 mt-10 39.42 113.51 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 145' ' ' GLY . 37.1 m-70 55.02 -19.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.53 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -107.04 112.72 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.546 HD22 ' CG1' ' A' ' 143' ' ' VAL . 0.7 OUTLIER -122.48 124.18 42.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.2 mt -122.58 119.08 29.77 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.34 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.69 18.16 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 120.161 1.346 . . . . 0.0 111.305 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -122.68 103.03 8.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.548 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.07 112.08 24.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.638 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 65.8 mtt -108.97 137.77 46.36 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -108.88 115.74 30.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 119.283 -0.389 . . . . 0.0 110.522 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -90.36 86.05 6.36 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 123.501 0.5 . . . . 0.0 110.576 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 133' ' ' ILE . 32.9 t0 -142.51 168.38 19.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.412 ' N ' ' OD2' ' A' ' 132' ' ' ASP . 80.3 mt -62.11 -40.93 89.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.171 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.78 -32.72 73.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.91 -177.39 50.55 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 106.463 -2.655 . . . . 0.0 106.463 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.73 126.0 0.86 Allowed 'Cis proline' 0 N--CA 1.507 2.306 0 CA-C-N 121.385 2.592 . . . . 0.0 115.107 0.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 75.1 m -113.27 126.79 55.79 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.0 mt -102.26 105.73 18.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.838 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.625 ' NH1' HD21 ' A' ' 156' ' ' ASN . 84.7 mtt85 -107.93 101.81 11.05 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.959 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.33 153.91 20.32 Favored Glycine 0 C--O 1.209 -1.434 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.3 115.17 12.18 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 118.063 0.932 . . . . 0.0 108.978 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 76.7 mt -94.73 129.7 41.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.546 ' CG1' HD22 ' A' ' 124' ' ' ASN . 59.1 t -122.57 127.26 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.022 0.828 . . . . 0.0 109.602 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.6 mt -118.79 129.53 55.29 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.513 ' O ' ' ND1' ' A' ' 122' ' ' HIS . . . -128.96 99.15 0.47 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 119.725 -1.226 . . . . 0.0 112.339 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -99.48 88.12 3.78 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 32.11 37.81 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.192 -0.913 . . . . 0.0 113.444 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.41 -38.38 0.63 Allowed Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.622 -1.275 . . . . 0.0 112.189 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.483 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.7 m95 -90.48 117.45 29.19 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 90.1 mt -121.6 107.1 12.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.54 38.34 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.701 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -148.35 167.84 29.06 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 118.484 -1.817 . . . . 0.0 114.022 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -129.03 119.95 25.15 Favored 'General case' 0 CA--C 1.498 -1.046 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -113.73 120.02 39.4 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.992 -178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.1 ttp -110.97 116.75 31.73 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.501 0.501 . . . . 0.0 112.05 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.625 HD21 ' NH1' ' A' ' 139' ' ' ARG . 38.8 t-20 -97.08 117.93 32.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 95.02 5.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.853 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.4 mt-10 -74.3 95.78 2.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 81.9 p -66.93 -33.93 76.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.195 1.184 . . . . 0.0 114.195 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.61 95.09 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.968 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -97.46 -12.29 22.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.559 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.9 m 53.47 56.31 7.5 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.256 -178.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -127.63 130.98 49.91 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.846 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 60.7 t -104.61 103.24 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 176.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.6 p -137.82 -59.15 0.66 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.838 0.827 . . . . 0.0 111.478 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -64.12 108.56 1.58 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.73 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 28.8 t -142.34 151.36 41.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.983 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.529 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 56.1 m-20 -127.37 130.34 49.23 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -102.68 107.88 18.94 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.655 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.615 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -92.78 132.95 36.52 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.425 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.46 109.14 15.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 O-C-N 123.725 0.64 . . . . 0.0 110.185 177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -114.55 147.44 18.82 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.281 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -131.25 123.52 28.58 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.88 146.43 24.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.387 1.089 . . . . 0.0 113.637 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.22 154.6 48.04 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 112.845 -1.98 . . . . 0.0 107.516 177.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.569 ' O ' ' CG ' ' A' ' 178' ' ' PHE . 95.0 m-20 -37.18 109.99 0.11 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 60.25 -9.44 0.06 Allowed 'General case' 0 C--O 1.245 0.839 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 176' ' ' ASP . 1.2 m-85 -106.07 137.44 44.0 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -176.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -116.74 140.41 49.45 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.369 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.525 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 51.0 tp -120.66 101.74 7.94 Favored 'General case' 0 C--O 1.215 -0.747 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.493 ' HD1' ' HA3' ' A' ' 172' ' ' GLY . 26.2 m-70 -117.62 126.83 53.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 75.5 p -125.08 154.37 41.48 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -140.38 135.2 31.86 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.169 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.702 HG13 ' CE1' ' A' ' 190' ' ' PHE . 16.5 t -93.88 109.22 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 47.9 t30 -93.24 110.97 22.49 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.533 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 54.25 28.11 8.76 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 125.257 1.598 . . . . 0.0 112.959 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.05 9.84 43.3 Favored Glycine 0 N--CA 1.464 0.526 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 47.0 m -117.17 -74.43 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -94.82 113.23 24.95 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 184' ' ' VAL . 12.4 m-85 -88.14 145.67 25.81 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.489 -0.757 . . . . 0.0 110.858 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -113.0 164.18 12.07 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -152.71 139.52 7.03 Favored Glycine 0 N--CA 1.465 0.579 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 67.2 m -142.12 147.43 36.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.318 0.58 . . . . 0.0 112.015 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.679 HD12 ' HB ' ' A' ' 206' ' ' VAL . 88.3 mt -131.75 104.54 8.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.19 175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.34 115.74 31.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.487 ' CD ' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -114.82 104.03 11.54 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.587 ' C ' HG23 ' A' ' 198' ' ' VAL . 64.3 tttm -88.2 109.46 19.94 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.587 HG23 ' C ' ' A' ' 197' ' ' LYS . 8.9 t 93.19 54.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 123.651 0.594 . . . . 0.0 110.729 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.548 ' ND2' ' OG1' ' A' ' 204' ' ' THR . 2.3 t-20 -84.73 -162.68 0.71 Allowed 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.44 -38.81 92.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 119.809 -0.757 . . . . 0.0 111.795 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.63 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 15.4 mttp -105.18 -5.03 21.08 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.63 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 10.4 tp 143.2 -103.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 119.114 0.87 . . . . 0.0 109.764 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.58 ' N ' ' HG ' ' A' ' 202' ' ' LEU . 92.1 mt-10 -117.49 104.84 11.47 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.548 ' OG1' ' ND2' ' A' ' 199' ' ' ASN . 25.6 p -127.38 162.04 27.25 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.301 -0.56 . . . . 0.0 111.179 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.69 30.65 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.78 -0.768 . . . . 0.0 112.2 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 194' ' ' ILE . 25.4 t -125.43 130.39 72.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.869 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -107.96 137.25 46.28 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -125.68 121.45 33.5 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.216 0.322 . . . . 0.0 110.849 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.71 137.1 55.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 3.6 p90 -141.05 176.85 8.48 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.08 177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.7 m -131.81 115.06 15.47 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.74 41.74 1.88 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.498 0.666 . . . . 0.0 109.729 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.46 24.56 69.4 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 114.863 -1.062 . . . . 0.0 113.738 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -60.62 148.31 38.76 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 77.9 p -60.49 -33.43 72.6 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 216' ' ' ASN . 52.0 p-10 -84.22 113.48 21.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.007 0.821 . . . . 0.0 112.988 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.8 m -103.64 113.62 27.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.999 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.79 114.45 13.25 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -136.92 142.23 42.69 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.116 -1.033 . . . . 0.0 111.844 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -121.35 148.65 17.36 Favored Glycine 0 C--O 1.227 -0.307 0 CA-C-N 113.263 -1.789 . . . . 0.0 112.66 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.6 mt -116.02 103.43 15.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.628 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -103.28 114.66 29.12 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.895 -179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -120.28 130.45 54.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.423 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.52 ' O ' HD23 ' A' ' 202' ' ' LEU . 88.7 tttt -103.03 97.95 7.97 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 2.6 t80 -82.9 115.16 21.65 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.298 -0.561 . . . . 0.0 112.314 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.566 ' HB2' HD22 ' A' ' 202' ' ' LEU . 33.1 tt0 -84.94 110.51 18.94 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 225' ' ' TYR 0.444 0.2 OUTLIER -93.23 -35.26 6.42 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 C-N-CA 118.442 -1.303 . . . . 0.0 111.851 -176.944 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.466 ' OD2' ' O ' ' A' ' 227' ' ' ILE . 0.0 OUTLIER -156.7 -177.5 0.75 Allowed Pre-proline 0 N--CA 1.47 0.541 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 172.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 14.1 Cg_exo -64.08 -19.05 65.77 Favored 'Trans proline' 0 C--N 1.298 -2.109 0 CA-C-N 121.27 1.489 . . . . 0.0 111.758 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.66 -10.3 13.11 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -120.82 127.15 51.66 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.711 0.687 . . . . 0.0 111.872 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.14 132.12 35.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.278 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 29.8 t80 -117.68 122.29 43.13 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . 0.4 ' CB ' ' OH ' ' A' ' 22' ' ' TYR . 15.2 m -107.77 136.68 47.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.736 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.652 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -137.9 148.21 45.13 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.598 ' NZ ' ' H ' ' A' ' 21' ' ' GLY . 99.6 mttt -138.84 110.99 7.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.963 0.347 . . . . 0.0 110.59 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.472 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 97.4 t -102.42 108.86 24.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.732 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.567 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.89 HD21 HD13 ' A' ' 242' ' ' LEU . 41.7 p30 -87.55 164.87 15.88 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.95 178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -90.23 3.54 53.23 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.462 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.473 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.0 p -85.64 3.35 41.3 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.88 27.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.168 177.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.89 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -114.8 113.38 24.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.434 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.0 mt -95.23 132.03 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.437 ' CA ' HD12 ' A' ' 262' ' ' LEU . . . -113.61 137.33 14.07 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.48 116.5 23.3 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -127.8 106.72 0.81 Allowed Glycine 0 CA--C 1.527 0.791 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.008 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -90.55 114.96 27.3 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.663 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -105.84 131.37 53.25 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.403 0.44 . . . . 0.0 110.527 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -124.75 113.52 18.06 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.445 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 96.0 m -107.08 123.57 48.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.495 HD12 ' HB ' ' A' ' 255' ' ' ILE . 7.7 mt -104.42 139.77 38.89 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 117.65 -1.167 . . . . 0.0 111.598 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.6 -53.78 14.16 Favored Pre-proline 0 C--N 1.358 0.94 0 O-C-N 124.63 1.206 . . . . 0.0 108.0 176.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 97.0 Cg_exo -38.84 -19.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.802 2.334 . . . . 0.0 112.955 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 97.76 38.09 4.26 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.895 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' HB ' HD12 ' A' ' 251' ' ' LEU . 93.3 mt -123.05 131.75 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -113.34 119.13 36.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.26 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 tp -123.66 104.73 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.832 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.1 m -121.26 133.19 55.14 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 88.3 mt -108.15 143.81 36.42 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.3 m -131.67 145.95 51.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.382 0.611 . . . . 0.0 111.937 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -151.41 113.83 4.59 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.149 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 24' ' ' PHE . 15.0 tp -111.46 102.85 11.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 80.2 mt -95.28 114.39 26.17 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.317 0.58 . . . . 0.0 111.59 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -80.32 108.8 14.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.954 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.74 -39.4 95.24 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.942 178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.487 ' C ' ' H ' ' A' ' 268' ' ' VAL . 85.5 mttt -83.16 -7.96 59.56 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 119.125 1.463 . . . . 0.0 110.206 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 56.05 -20.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 115.07 1.508 . . . . 0.0 115.07 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.487 ' H ' ' C ' ' A' ' 266' ' ' LYS . 54.9 t -78.28 -36.93 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.354 0.525 . . . . 0.0 110.963 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -64.2 -44.22 92.61 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.478 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -85.51 -35.53 21.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 118.325 -1.35 . . . . 0.0 108.79 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 67.64 -15.47 0.46 Allowed Glycine 0 CA--C 1.526 0.731 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.321 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.92 -131.29 2.69 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.892 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -140.21 123.48 16.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.019 0.438 . . . . 0.0 111.312 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.74 115.24 27.66 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.715 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 74.2 mt -134.1 112.53 11.23 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 124.434 1.084 . . . . 0.0 108.108 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -124.27 151.06 17.12 Favored Glycine 0 N--CA 1.463 0.459 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.4 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.7 tt -134.82 138.56 44.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.577 -0.449 . . . . 0.0 109.894 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.64 114.89 2.34 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.42 104.25 11.58 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -114.64 124.15 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.107 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -107.07 136.85 46.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.622 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -99.42 123.85 44.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.756 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 64.6 114.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.59 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -79.46 145.23 33.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.708 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.843 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.26 149.74 31.43 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.24 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 3' ' ' VAL . 29.6 m -155.02 64.76 4.37 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.746 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.553 ' HG2' HD22 ' A' ' 150' ' ' LEU . 2.1 Cg_endo -81.73 158.88 18.92 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 122.974 2.449 . . . . 0.0 113.634 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 119' ' ' LYS . 53.7 Cg_endo -72.21 -174.22 1.33 Allowed 'Trans proline' 0 N--CA 1.528 3.522 0 C-N-CA 125.251 3.967 . . . . 0.0 116.686 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.8 p -48.64 141.13 7.44 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-O 121.469 0.652 . . . . 0.0 110.095 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.22 -42.55 0.7 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.212 -176.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.638 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -73.68 -38.88 64.76 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 116.589 -2.044 . . . . 0.0 110.864 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.476 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 71.1 m-20 -69.72 -24.6 63.58 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 117.48 -1.688 . . . . 0.0 110.4 -176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.685 HD11 ' CE1' ' A' ' 181' ' ' HIS . 43.0 tp -57.47 134.02 55.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.751 -1.218 . . . . 0.0 108.835 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.7 13.18 65.41 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.572 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -56.98 -41.51 78.54 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.6 m -58.57 -45.4 89.12 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.705 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.46 -41.7 97.63 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.109 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.706 ' O ' HG23 ' A' ' 19' ' ' THR . 60.7 ttp180 -63.63 -41.57 98.25 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -62.33 -43.02 99.79 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.97 -42.63 97.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.275 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.0 t80 -62.99 -43.34 99.05 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.005 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 15' ' ' ARG . 70.4 p -61.46 -50.18 73.81 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' NZ ' ' NZ ' ' A' ' 224' ' ' LYS . 99.2 mttt -46.96 91.56 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.19 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 19' ' ' THR . . . -76.18 -80.31 0.6 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.272 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.475 ' O ' ' O ' ' A' ' 21' ' ' GLY . 96.8 m-85 44.49 103.79 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.973 0.386 . . . . 0.0 111.45 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' O ' ' CG ' ' A' ' 24' ' ' PHE . . . 111.9 98.46 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.225 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.55 ' CG ' ' O ' ' A' ' 23' ' ' GLY . 83.3 m-85 -161.95 30.59 0.12 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 112.88 -0.33 25.76 Favored Glycine 0 C--N 1.339 0.725 0 C-N-CA 120.23 -0.986 . . . . 0.0 113.528 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -119.78 129.12 54.32 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.963 1.382 . . . . 0.0 114.317 -177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 277' ' ' LEU . 97.1 mt -84.04 121.74 36.9 Favored 'Isoleucine or valine' 0 C--O 1.248 1.003 0 N-CA-C 104.143 -2.54 . . . . 0.0 104.143 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -111.18 140.38 45.78 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.302 -1.317 . . . . 0.0 112.749 -174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 73.4 mt -110.09 121.18 44.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -119.42 133.26 55.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.384 0.611 . . . . 0.0 111.735 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 77.5 mt -111.58 124.75 52.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 99.0 mttt -122.29 137.54 54.81 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 87.5 m -128.59 124.53 36.14 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -106.12 135.91 46.74 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.2 m -92.8 -179.79 5.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -91.62 91.12 7.88 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.335 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 56.73 90.66 0.04 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.419 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 150.5 -103.46 0.25 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 41' ' ' PHE . 33.1 mt -63.86 141.67 58.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 122.187 0.994 . . . . 0.0 113.444 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -138.28 94.23 2.84 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.397 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 39' ' ' LEU . 49.7 m-85 -99.24 115.87 30.12 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.488 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.424 ' O ' HG22 ' A' ' 42' ' ' THR . 4.0 m -122.75 104.4 9.28 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.428 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.9 p -93.06 159.5 15.27 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 57' ' ' SER . 6.6 p -139.91 145.76 38.38 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.561 0.696 . . . . 0.0 112.39 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -144.91 116.6 0.94 Allowed Glycine 0 C--O 1.225 -0.448 0 N-CA-C 107.294 -2.322 . . . . 0.0 107.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.9 p -133.14 171.61 13.77 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -144.68 166.74 24.33 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.539 177.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 7.6 t-20 -76.03 143.07 41.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.2 t -39.72 -26.67 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 120.149 -0.62 . . . . 0.0 112.364 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 51' ' ' THR . 95.9 mt-10 -100.52 -7.5 24.08 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 118.271 0.487 . . . . 0.0 111.702 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER 86.02 10.35 0.25 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 178.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.8 p -68.28 -31.15 70.4 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.742 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 68.7 mttm -127.94 150.85 49.71 Favored 'General case' 0 C--O 1.212 -0.892 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' SER . 24.9 t -129.73 110.18 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 124.496 1.118 . . . . 0.0 109.851 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.7 p -120.28 135.54 54.97 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.239 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.414 ' H ' HG21 ' A' ' 77' ' ' THR . . . -120.13 -159.04 10.74 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.688 -0.768 . . . . 0.0 111.499 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.528 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.3 p -174.74 161.25 3.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.195 0.521 . . . . 0.0 111.04 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.37 108.35 9.92 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.7 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -109.86 117.37 33.65 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.474 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.4 m -130.67 114.5 15.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.209 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -129.88 145.92 51.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 122.001 -0.437 . . . . 0.0 111.603 -177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.533 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -120.03 111.75 18.28 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' THR . 96.1 mtt180 -114.54 83.19 1.85 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.533 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 83.5 m95 -69.92 80.45 0.47 Allowed 'General case' 0 C--N 1.343 0.324 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' ARG . 70.2 p -51.69 -7.8 0.05 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.177 -0.609 . . . . 0.0 112.009 -177.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' TRP . 98.2 mt-10 -77.39 -80.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.399 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -75.88 25.18 0.12 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.847 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 66' ' ' GLU . . . 49.43 49.08 33.29 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-O 119.5 -0.611 . . . . 0.0 112.477 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 71' ' ' PHE . 73.2 mt -109.02 96.58 6.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 119.911 -0.716 . . . . 0.0 111.932 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 74.7 m -97.72 106.87 19.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.062 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.6 m-85 -105.69 88.62 2.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.6 m -87.88 137.11 32.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.105 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.86 124.45 61.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.613 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.93 112.3 22.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.218 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.649 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.7 m95 -120.8 86.94 2.66 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -86.47 160.95 18.85 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.081 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.5 ' O ' ' ND2' ' A' ' 79' ' ' ASN . 73.7 p -62.61 -35.12 78.54 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.99 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.7 m-20 -53.96 -9.92 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.293 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.51 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 3.3 m120 96.76 2.32 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.158 0.911 . . . . 0.0 112.349 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -66.91 128.84 37.85 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.326 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD22 ' CE2' ' A' ' 75' ' ' TRP . 33.3 mt -120.37 115.3 23.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -133.75 126.12 4.17 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.846 -1.168 . . . . 0.0 112.406 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.4 m -120.9 122.01 39.3 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.128 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -119.58 124.52 46.58 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.1 mt -109.7 123.78 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 97' ' ' LEU . 41.6 m -127.72 123.73 36.11 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.97 107.53 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -95.29 105.99 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.216 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -106.09 -0.87 24.41 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.653 0.263 . . . . 0.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -49.45 -11.11 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -176.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 91' ' ' LEU . 96.7 mt -67.42 -4.48 11.29 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.275 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 93' ' ' ARG . . . -140.16 46.81 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.955 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 55.9 mtt85 133.55 -89.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 O-C-N 124.541 1.151 . . . . 0.0 111.364 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 166.25 59.96 0.03 OUTLIER Glycine 0 C--O 1.208 -1.481 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.4 tp -113.39 117.31 31.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.858 -0.671 . . . . 0.0 109.955 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.61 124.91 43.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 86' ' ' THR . 4.2 tt -104.57 104.09 13.87 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.292 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 36.4 m -117.3 99.25 6.89 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -92.2 136.84 32.86 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 175.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -118.74 142.83 47.32 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.02 0.438 . . . . 0.0 110.998 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.77 99.31 3.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.476 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.95 104.59 12.56 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 121.83 0.824 . . . . 0.0 109.785 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -110.85 115.99 30.47 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.226 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.3 t -115.23 87.57 16.38 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.124 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -41.39 -41.3 5.07 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.838 2.359 . . . . 0.0 114.459 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' ND2' ' OD1' ' A' ' 79' ' ' ASN . 91.7 m-20 -63.23 -40.84 98.6 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.943 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 58.5 p -98.19 -11.55 22.62 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.146 178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.14 30.5 73.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -105.11 111.14 23.79 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -98.62 131.03 45.14 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.571 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -120.4 125.0 46.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.49 109.67 9.43 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 123.169 0.293 . . . . 0.0 110.305 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -119.38 146.35 45.41 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.6 mt -121.01 103.78 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 30.3 tttt -103.94 126.75 51.29 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.735 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 35.4 p -127.22 106.25 9.11 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.25 94.2 1.09 Allowed Glycine 0 N--CA 1.44 -1.059 0 O-C-N 123.777 0.673 . . . . 0.0 111.572 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -92.95 114.5 27.08 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' ' 5' ' ' PRO . 32.5 mttt -123.92 171.84 9.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.358 -174.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 162.15 126.4 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.551 0.74 . . . . 0.0 109.403 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.2 tt0 50.62 88.93 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.741 -0.6 . . . . 0.0 112.5 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 48.04 -6.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -107.94 117.96 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 118.974 0.806 . . . . 0.0 112.123 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.521 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -122.14 119.82 32.42 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.2 mt -119.54 113.59 20.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.585 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.32 141.42 16.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 119.334 0.97 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 7.5 t -124.09 107.22 11.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.749 -0.725 . . . . 0.0 110.516 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' ' 128' ' ' ASP . 5.6 t0 -106.85 110.27 22.39 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 124.116 0.885 . . . . 0.0 110.018 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -108.0 134.74 50.48 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 136' ' ' PRO . 43.0 t0 -107.18 113.78 27.43 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.996 0.185 . . . . 0.0 110.63 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -89.11 86.69 6.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.865 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -140.07 168.01 20.81 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.5 mt -61.8 -41.4 90.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.681 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.49 -33.78 75.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.2 -177.94 48.69 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 106.632 -2.587 . . . . 0.0 106.632 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 130' ' ' ASP . 77.4 Cg_exo -54.0 126.0 0.9 Allowed 'Cis proline' 0 N--CA 1.508 2.335 0 CA-C-N 121.393 2.596 . . . . 0.0 115.376 0.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.4 m -113.22 126.74 55.75 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 173.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.0 mt -101.03 105.47 17.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 119.829 -0.748 . . . . 0.0 111.35 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -108.12 102.0 11.19 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -102.85 155.67 18.24 Favored Glycine 0 C--O 1.209 -1.41 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 7' ' ' TYR . . . -136.21 119.11 16.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.342 1.071 . . . . 0.0 108.867 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.528 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 78.9 mt -101.93 104.59 15.3 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.086 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.3 t -104.35 129.19 57.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-O 121.583 0.706 . . . . 0.0 110.297 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -117.96 140.42 49.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.624 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -106.49 151.77 16.97 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.828 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.637 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.1 t80 -148.68 74.34 1.27 Allowed 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 118.549 1.175 . . . . 0.0 108.373 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.87 40.13 31.2 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.01 -15.1 9.52 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.345 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.656 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.3 m0 -95.62 132.14 41.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.19 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.553 HD22 ' HG2' ' A' ' 4' ' ' PRO . 59.2 mt -121.47 115.21 22.43 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.58 136.06 54.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.44 152.16 19.11 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 120.223 -0.989 . . . . 0.0 113.5 -177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -127.94 115.76 19.04 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.652 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.4 tm0? -111.81 123.97 51.37 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.527 -178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 56.6 ttm -116.66 119.54 35.83 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.86 0.362 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -99.82 121.01 40.66 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.416 ' CD2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.66 96.1 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.193 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' SER . 94.1 mt-10 -73.66 95.89 2.41 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -68.47 -36.22 78.65 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.71 80.97 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.612 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.19 -14.14 21.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.4 m 55.98 53.82 8.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.294 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -127.78 127.67 43.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.434 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 165' ' ' THR . 37.6 t -104.84 123.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 176.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.7 p -158.69 -57.76 0.07 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.966 0.888 . . . . 0.0 110.639 -177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -65.87 108.73 2.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.6 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.5 p -142.32 151.66 42.18 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.071 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.471 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 1.0 OUTLIER -127.53 141.72 51.57 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -110.61 108.33 18.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.065 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 7' ' ' TYR . . . -88.01 135.6 33.34 Favored 'General case' 0 CA--C 1.509 -0.601 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.436 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.0 t -131.86 111.89 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.602 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.41 147.54 16.56 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.723 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.634 ' HB2' HD12 ' A' ' 180' ' ' LEU . 90.4 m-85 -132.43 127.79 36.12 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -96.61 143.29 27.72 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.442 1.115 . . . . 0.0 113.601 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 176' ' ' ASP . 31.5 m -141.99 141.43 32.88 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 112.96 -1.927 . . . . 0.0 107.55 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.587 ' C ' ' H ' ' A' ' 178' ' ' PHE . 50.8 t0 -32.43 121.97 0.33 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 117.988 0.358 . . . . 0.0 111.683 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 63.43 -27.62 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 O-C-N 123.619 0.575 . . . . 0.0 112.338 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.587 ' H ' ' C ' ' A' ' 176' ' ' ASP . 18.4 m-85 -95.15 128.73 42.21 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -116.39 139.58 50.27 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.518 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.634 HD12 ' HB2' ' A' ' 173' ' ' TYR . 95.9 mt -110.92 107.14 16.5 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.685 ' CE1' HD11 ' A' ' 10' ' ' LEU . 54.9 m170 -119.03 107.8 13.96 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.663 HG22 ' HA2' ' A' ' 192' ' ' GLY . 69.8 p -128.52 159.59 34.98 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.046 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 33.7 p30 -154.83 147.07 23.82 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.994 -1.082 . . . . 0.0 111.27 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.542 HG13 ' CZ ' ' A' ' 190' ' ' PHE . 16.8 t -95.24 119.94 43.98 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.406 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 22.2 t-20 -96.57 110.37 22.79 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.853 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 54.46 28.37 9.52 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 125.175 1.547 . . . . 0.0 112.88 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.97 9.94 49.16 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 p -117.21 -77.14 0.57 Allowed 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.29 112.71 24.74 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 119.595 -0.842 . . . . 0.0 113.182 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.542 ' CZ ' HG13 ' A' ' 184' ' ' VAL . 6.8 m-85 -86.11 139.42 31.13 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.779 -0.575 . . . . 0.0 110.855 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.86 162.11 12.78 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.663 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -156.39 141.5 8.01 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 12.0 p -151.41 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.919 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.668 HD12 ' HB ' ' A' ' 206' ' ' VAL . 84.5 mt -132.31 122.96 49.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.496 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -114.68 120.46 40.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.674 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.522 ' CD ' ' CZ ' ' A' ' 178' ' ' PHE . 7.1 tt0 -123.14 119.79 31.3 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -108.39 92.61 4.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.28 -49.18 85.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.522 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.451 ' CG ' ' O ' ' A' ' 199' ' ' ASN . 9.3 t30 173.59 60.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 109.806 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 57.0 tttt 69.58 -52.81 0.61 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.454 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.517 ' O ' ' O ' ' A' ' 226' ' ' GLN . 99.4 mttt -64.42 -43.61 93.81 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.444 HD11 ' CG2' ' A' ' 204' ' ' THR . 57.0 tp -123.8 118.56 27.43 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.83 103.67 10.87 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.33 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.491 ' OG1' ' NE2' ' A' ' 196' ' ' GLN . 44.0 p -113.2 155.07 25.68 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.717 -177.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.551 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.85 148.21 28.89 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.958 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.668 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.8 t -117.13 124.69 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.502 178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.49 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.9 m-20 -103.41 129.46 50.51 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.394 -0.522 . . . . 0.0 109.817 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 3.6 mp -125.59 108.91 12.04 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.315 0.384 . . . . 0.0 110.739 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.86 143.33 49.94 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.934 -0.306 . . . . 0.0 110.631 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -150.26 -162.4 1.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.881 -0.728 . . . . 0.0 109.861 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 87.6 m -145.3 119.34 9.4 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.098 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.514 ' HB2' ' CE2' ' A' ' 190' ' ' PHE . . . -46.16 123.1 4.38 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.062 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 106.96 -24.62 24.69 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.59 141.34 34.61 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.9 p -92.17 -21.45 20.38 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 -176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -85.38 126.79 34.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.068 0.849 . . . . 0.0 113.161 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 89.7 m -103.44 118.72 37.39 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.066 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -80.64 115.49 20.17 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -136.64 142.23 43.23 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.908 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -122.9 158.09 17.5 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.231 -177.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 97.2 mt -122.47 103.76 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.39 121.67 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.798 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.78 119.16 36.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.645 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.462 ' NZ ' ' NZ ' ' A' ' 20' ' ' LYS . 88.1 tttt -106.44 98.54 8.2 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.503 ' CZ ' ' HB ' ' A' ' 227' ' ' ILE . 86.3 t80 -97.58 97.42 9.04 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.759 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.517 ' O ' ' O ' ' A' ' 201' ' ' LYS . 58.5 tt0 -111.95 116.54 30.78 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.694 HG23 ' HD2' ' A' ' 229' ' ' PRO 0.331 4.8 tt -85.82 -41.46 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 118.312 -1.355 . . . . 0.0 111.143 -172.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 229' ' ' PRO . 1.8 m-20 154.22 -47.47 0.0 OUTLIER Pre-proline 0 N--CA 1.507 2.398 0 CA-C-N 120.63 1.559 . . . . 0.0 111.501 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.694 ' HD2' HG23 ' A' ' 227' ' ' ILE . 7.3 Cg_exo -69.97 -99.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.287 -2.666 0 C-N-CA 122.206 1.937 . . . . 0.0 111.396 178.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 0.2 OUTLIER -136.14 49.43 2.12 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -177.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.44 132.5 18.24 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.863 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.28 118.19 13.31 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.646 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -115.78 114.92 25.43 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.881 0.372 . . . . 0.0 111.586 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.1 p -107.92 144.99 34.4 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.369 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.08 27.83 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 18' ' ' PHE . 87.1 mttt -140.28 119.93 13.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.799 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 72.6 t -106.92 116.08 49.85 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.592 0 CA-C-O 118.862 -0.589 . . . . 0.0 110.945 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.708 HD21 HD13 ' A' ' 242' ' ' LEU . 17.0 p-10 -97.32 164.67 12.37 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.678 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -90.14 4.13 51.33 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.714 -0.794 . . . . 0.0 113.045 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.6 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 4.5 p -91.08 6.82 43.4 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.561 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.9 p 86.42 26.1 0.05 Allowed 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.105 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 242' ' ' LEU . 3.5 mp -111.27 108.48 18.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.5 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 82.3 mt -102.31 135.35 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.883 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -119.49 143.48 17.11 Favored Glycine 0 C--N 1.339 0.697 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 76.0 mt -126.88 115.52 19.43 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.16 106.59 0.87 Allowed Glycine 0 N--CA 1.469 0.835 0 C-N-CA 120.304 -0.951 . . . . 0.0 112.575 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -101.96 129.4 48.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.813 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 96.2 m -116.87 124.72 50.18 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.482 0.488 . . . . 0.0 110.369 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -109.72 110.24 21.2 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 57.8 m -91.35 131.84 36.57 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.617 HD12 ' HB ' ' A' ' 255' ' ' ILE . 87.1 mt -110.41 130.29 55.58 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 117.069 -1.443 . . . . 0.0 111.518 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 254' ' ' GLY . 3.8 mmtt -39.93 -55.03 3.99 Favored Pre-proline 0 N--CA 1.477 0.881 0 O-C-N 124.685 1.241 . . . . 0.0 107.655 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -37.99 -13.98 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.915 2.41 . . . . 0.0 113.427 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 91.19 28.99 13.25 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.32 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.617 ' HB ' HD12 ' A' ' 251' ' ' LEU . 97.0 mt -123.15 129.96 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.5 129.48 54.95 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.954 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 45.6 mt -123.37 103.84 8.74 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.233 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.3 m -109.08 139.76 43.53 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.5 mt -117.09 130.78 56.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.529 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 55.6 m -129.23 150.52 50.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.376 0.607 . . . . 0.0 112.295 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.93 112.63 3.41 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.876 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.491 ' H ' ' HB2' ' A' ' 274' ' ' LYS . 43.3 tp -109.61 102.79 11.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 119.106 -1.038 . . . . 0.0 109.051 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 74.5 mt -104.46 121.72 44.02 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.03 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -88.47 110.77 21.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.527 0.679 . . . . 0.0 112.782 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -52.57 -40.26 54.8 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.723 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 268' ' ' VAL . 51.0 mmtt -84.69 0.17 51.36 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.646 178.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 271' ' ' GLY . 90.7 m-20 55.23 -18.9 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.488 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 266' ' ' LYS . 60.9 t -72.44 -42.69 64.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.289 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.533 ' CB ' HD21 ' A' ' 242' ' ' LEU . 73.7 m-20 -63.2 -42.64 99.34 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.297 -178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -83.63 -35.62 24.48 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 118.714 -1.194 . . . . 0.0 108.35 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 65.48 -12.36 0.32 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.388 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -151.83 -126.93 1.29 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.508 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -139.13 119.41 13.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.938 0.399 . . . . 0.0 111.186 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 72.0 mmtt -94.94 115.84 27.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.533 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 88.7 mt -134.13 110.92 9.91 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.486 1.116 . . . . 0.0 108.253 175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -119.67 153.43 16.8 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.513 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.682 ' HB3' HG23 ' A' ' 27' ' ' ILE . 6.5 tp -134.69 142.36 46.79 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -124.48 114.95 2.37 Favored Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 85.4 mt -113.72 102.51 10.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -114.57 129.03 56.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.785 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -108.73 118.23 36.24 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.833 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.98 130.15 36.16 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.391 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -135.24 151.95 51.08 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.985 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -94.84 137.32 34.06 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.749 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.97 -1.015 . . . . 0.0 110.766 179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 120.899 0.38 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.65 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . . . -135.2 134.4 40.05 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.613 178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.682 ' O ' HG13 ' A' ' 3' ' ' VAL . 14.9 p -178.99 68.18 0.18 Allowed Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.809 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.613 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 2.9 Cg_endo -81.22 167.25 17.85 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.972 2.448 . . . . 0.0 113.839 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.539 ' C ' HD21 ' A' ' 124' ' ' ASN . 33.4 Cg_endo -68.11 -167.82 0.18 Allowed 'Trans proline' 0 N--CA 1.535 3.916 1 C-N-CA 126.001 4.468 . . . . 0.0 115.552 -175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.477 HG23 ' NZ ' ' A' ' 115' ' ' LYS . 42.9 p -43.63 123.22 3.02 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.632 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -38.74 -47.64 1.4 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -54.1 -39.63 66.54 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 116.281 -2.167 . . . . 0.0 110.247 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -67.74 -25.73 65.78 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 116.846 -1.942 . . . . 0.0 110.606 -175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.515 ' N ' HD12 ' A' ' 10' ' ' LEU . 6.3 mp -61.84 137.11 58.22 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.207 -1.558 . . . . 0.0 109.052 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.43 11.11 78.56 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.895 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.02 -44.65 91.76 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.432 ' OG ' ' CE1' ' A' ' 195' ' ' TYR . 38.3 t -61.79 -43.72 98.3 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.692 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . . . -62.8 -43.91 97.55 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.655 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -61.67 -37.09 82.77 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -63.53 -44.58 93.84 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.1 -44.57 87.97 Favored 'Isoleucine or valine' 0 C--N 1.345 0.4 0 CA-C-N 119.361 0.982 . . . . 0.0 110.368 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -67.34 -46.33 73.74 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.5 p -95.43 136.77 35.38 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -157.97 4.12 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.427 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.14 -138.06 49.82 Favored Glycine 0 N--CA 1.47 0.949 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.543 ' O ' ' NZ ' ' A' ' 274' ' ' LYS . 94.8 m-85 -40.73 -35.16 0.45 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.943 0.872 . . . . 0.0 110.716 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.58 -128.0 37.68 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.166 -0.54 . . . . 0.0 112.113 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' HB3' ' HG ' ' A' ' 260' ' ' SER . 28.4 m-85 -68.04 -174.47 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 275' ' ' LEU . . . 119.39 -17.0 10.52 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.837 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -120.64 133.21 55.39 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 HD12 ' A' ' 277' ' ' LEU . 2.7 mp -84.77 118.91 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -105.39 140.98 37.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.446 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.1 mt -112.2 111.16 21.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.627 -1.17 . . . . 0.0 107.969 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -116.29 132.54 56.64 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.584 -0.446 . . . . 0.0 112.036 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.6 mt -111.58 122.71 48.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.869 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -119.72 134.86 55.07 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.4 p -131.43 123.88 29.08 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -113.03 120.31 40.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.715 0.293 . . . . 0.0 111.327 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -88.36 168.93 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -93.06 -11.35 33.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.862 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -63.55 -38.2 90.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.95 -16.49 1.96 Allowed Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 41' ' ' PHE . 33.3 mt -66.21 140.5 58.17 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 122.274 1.035 . . . . 0.0 113.401 -178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.66 96.01 4.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.336 -1.756 . . . . 0.0 108.354 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.555 ' CE1' HD22 ' A' ' 39' ' ' LEU . 42.7 m-85 -104.73 107.68 18.76 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.91 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.7 m -122.26 104.75 9.65 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 m -90.78 158.38 16.88 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.4 t -136.56 144.96 44.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.511 0.672 . . . . 0.0 112.476 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.42 113.66 0.78 Allowed Glycine 0 CA--C 1.522 0.473 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 3.5 m -131.78 172.3 12.46 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.16 153.02 52.12 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.0 -1.454 . . . . 0.0 109.898 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' GLU . 45.2 t-20 -86.94 126.86 34.98 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 50' ' ' GLU . 20.7 m 45.41 -86.48 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 O-C-N 123.816 0.697 . . . . 0.0 110.155 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' ASN . 80.3 tt0 -153.51 86.61 1.21 Allowed 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.401 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 81.61 -6.34 1.5 Allowed 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.533 0.52 . . . . 0.0 112.244 178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 48' ' ' ASN . 29.5 p -61.54 -31.22 71.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.793 -178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 21.2 tttt -163.92 169.54 17.96 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' SER . 38.3 t -129.5 132.75 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.404 1.081 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -142.23 128.5 19.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 118.213 0.46 . . . . 0.0 110.727 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.7 -158.0 10.47 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.084 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 p -172.9 158.69 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.49 0.662 . . . . 0.0 111.849 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -130.42 106.78 8.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.428 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -109.34 117.75 34.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.493 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 20.6 m -130.46 104.47 7.26 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.601 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -124.55 142.69 51.15 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.8 t80 -114.85 118.58 33.92 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -116.53 83.13 1.91 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.61 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 87.1 m95 -71.62 149.86 45.2 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' TYR . 69.3 p -98.45 144.98 27.22 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 119.471 1.032 . . . . 0.0 111.108 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 70.03 -34.84 0.3 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.569 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 65' ' ' THR . 91.7 m-85 -74.33 -5.51 42.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.706 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 51.81 29.8 27.35 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-O 119.528 -0.595 . . . . 0.0 112.751 176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.2 mt -100.46 78.75 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.239 0.519 . . . . 0.0 111.293 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 m -93.1 107.71 19.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.615 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.646 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.9 m-30 -105.8 92.05 4.01 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -88.12 133.25 34.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.328 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.7 t -129.59 121.43 52.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 O-C-N 123.553 0.533 . . . . 0.0 110.192 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -120.61 104.54 10.01 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.248 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.442 ' CE2' HD22 ' A' ' 81' ' ' LEU . 6.5 m0 -112.95 134.9 54.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -137.44 163.13 31.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.007 0.432 . . . . 0.0 110.829 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 79' ' ' ASN . 41.8 p -65.19 -35.09 79.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.526 -179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 45.6 p30 -54.54 -8.85 0.26 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.079 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 27.4 m-20 96.81 9.68 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.325 1.016 . . . . 0.0 112.686 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 30.2 m -75.96 125.23 28.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.291 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 75' ' ' TRP . 19.6 mt -120.54 107.81 13.3 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -128.07 130.35 6.62 Favored Glycine 0 C--O 1.217 -0.924 0 C-N-CA 119.964 -1.112 . . . . 0.0 113.058 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 63.0 m -133.27 123.63 25.86 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -119.8 111.62 18.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.763 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.646 HG23 ' CD1' ' A' ' 71' ' ' PHE . 92.2 mt -103.19 114.72 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.441 178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 68' ' ' GLY . 16.0 m -121.84 130.67 53.56 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 7.3 p -116.76 102.02 12.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 89' ' ' ASP . 68.1 mt-10 -95.28 150.31 20.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.637 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 3.1 m-20 81.39 46.62 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.098 0.249 . . . . 0.0 111.45 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -86.8 -40.72 14.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.552 HD12 HD22 ' A' ' 95' ' ' LEU . 13.1 mt -103.1 23.17 12.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.491 0.587 . . . . 0.0 110.196 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 75.58 -37.84 0.34 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.816 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.439 HH11 ' HA ' ' A' ' 120' ' ' ARG . 79.8 mtp85 -74.82 -89.71 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.41 94.04 0.14 Allowed Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.552 HD22 HD12 ' A' ' 91' ' ' LEU . 59.6 tp -134.14 123.47 24.45 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.315 -0.943 . . . . 0.0 109.652 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -124.45 132.02 53.5 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.861 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 tp -117.62 108.58 15.62 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.7 m -110.61 99.44 8.41 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -82.58 125.12 30.79 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.419 ' OD2' ' N ' ' A' ' 101' ' ' SER . 20.9 t0 -119.07 157.76 27.2 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.103 -175.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.419 ' N ' ' OD2' ' A' ' 100' ' ' ASP . 32.2 t -140.51 117.2 10.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.162 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.487 ' C ' ' CG ' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -118.47 104.41 10.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.723 179.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 103' ' ' PHE . 1.2 m-85 80.69 160.84 0.16 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.669 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -125.4 159.37 60.49 Favored Pre-proline 0 N--CA 1.473 0.717 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -39.6 -51.59 2.8 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.939 3.093 . . . . 0.0 114.612 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.29 -39.95 94.96 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 104' ' ' SER . 96.6 m -128.31 129.61 46.56 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.737 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 -162.03 50.06 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -119.74 121.68 39.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.975 0.417 . . . . 0.0 110.725 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.34 111.76 0.95 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.29 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -119.2 105.39 11.32 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 131.06 54.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.513 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -118.84 145.73 45.43 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.329 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 ' O ' ' O ' ' A' ' 127' ' ' CYS . 96.0 mt -118.92 103.3 14.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' NZ ' HG23 ' A' ' 6' ' ' THR . 43.0 tttm -97.0 121.31 38.74 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.097 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 p -124.54 104.1 8.53 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -109.78 97.7 1.05 Allowed Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.698 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -91.88 142.2 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -127.3 159.55 34.05 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.667 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.1 ttt180 -178.96 92.44 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 96.2 mt-10 37.31 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 57.51 -15.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.501 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.8 mt -110.95 113.98 45.81 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.753 HD22 HG21 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -122.45 122.92 40.11 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.1 mt -120.57 118.33 29.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.479 -0.772 . . . . 0.0 109.863 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -114.66 138.83 15.13 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 119.594 1.088 . . . . 0.0 110.89 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.416 ' O ' ' O ' ' A' ' 114' ' ' ILE . 5.0 t -123.57 102.28 7.78 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.061 -0.57 . . . . 0.0 110.82 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -103.67 105.72 16.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.553 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 96.3 mtp -104.34 106.86 17.51 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -92.27 109.89 21.27 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.768 0.668 . . . . 0.0 111.393 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -82.69 84.23 7.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.665 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.5 t0 -112.98 169.14 9.13 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.0 mt -61.99 -41.02 89.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.321 -0.552 . . . . 0.0 109.919 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.89 2.2 46.89 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -103.92 -175.33 25.65 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 105.856 -2.898 . . . . 0.0 105.856 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.64 133.34 4.78 Favored 'Cis proline' 0 N--CA 1.509 2.42 0 CA-C-N 121.925 2.863 . . . . 0.0 115.376 0.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 14.8 m -113.33 138.22 50.36 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 106.009 -1.848 . . . . 0.0 106.009 173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 95.9 mt -104.27 106.5 20.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.626 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.525 ' NH2' ' ND2' ' A' ' 156' ' ' ASN . 93.9 mtt-85 -104.58 101.78 11.42 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 119.986 -0.686 . . . . 0.0 109.958 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.16 150.03 19.54 Favored Glycine 0 C--O 1.216 -1.007 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -135.7 120.92 18.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 96.1 mt -102.64 129.0 49.09 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 117.236 -1.364 . . . . 0.0 107.658 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.753 HG21 HD22 ' A' ' 124' ' ' ASN . 21.3 t -124.63 116.55 47.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 119.294 0.952 . . . . 0.0 108.969 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.9 134.42 55.25 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -120.59 157.87 15.72 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 118.407 -1.854 . . . . 0.0 111.852 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -147.33 92.73 2.14 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.788 0.804 . . . . 0.0 109.791 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 54.47 15.87 1.14 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.303 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.91 -31.89 1.59 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.288 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.493 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 36.5 m95 -76.58 140.91 41.23 Favored 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.01 108.3 13.23 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 170' ' ' ALA . . . -114.86 136.09 53.48 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.165 0.893 . . . . 0.0 109.418 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 142' ' ' LEU . . . -144.96 167.76 27.15 Favored Glycine 0 C--N 1.346 1.089 0 C-N-CA 118.378 -1.867 . . . . 0.0 113.882 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.441 ' CZ ' ' OG ' ' A' ' 167' ' ' SER . 8.0 t80 -127.94 128.51 45.23 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 1.0 OUTLIER -117.08 105.29 12.11 Favored 'General case' 0 C--O 1.216 -0.66 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 40.6 ttm -109.34 128.57 55.21 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.543 ' N ' ' OD1' ' A' ' 156' ' ' ASN . 0.1 OUTLIER -108.54 126.99 53.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -115.85 95.7 5.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.319 -179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.572 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.6 mt-10 -72.74 105.54 4.36 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 71.9 p -66.65 -31.15 71.64 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.77 86.17 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 119.393 -0.923 . . . . 0.0 109.78 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.73 -16.91 17.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 55.06 58.17 4.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.275 -178.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -136.27 147.06 47.34 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.929 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 157' ' ' PHE . 51.0 t -104.59 101.76 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 175.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 67.1 p -106.69 -53.04 2.68 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.153 0.978 . . . . 0.0 111.061 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 156' ' ' ASN . 86.2 mt-30 -84.31 114.77 22.09 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.281 -1.781 . . . . 0.0 112.014 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.441 ' OG ' ' CZ ' ' A' ' 153' ' ' TYR . 38.2 t -135.82 137.78 41.89 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -128.73 149.44 50.69 Favored 'General case' 0 C--N 1.346 0.442 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' O ' ' OD1' ' A' ' 183' ' ' ASN . 60.2 m-85 -109.6 113.99 27.23 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 7' ' ' TYR . . . -93.34 129.42 39.45 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.435 -0.506 . . . . 0.0 110.209 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.3 p -133.02 116.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -133.74 164.35 24.38 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.579 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.456 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 40.7 t80 -136.88 130.0 31.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.972 -1.114 . . . . 0.0 108.507 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.65 ' NZ ' ' HB2' ' A' ' 2' ' ' ALA . 87.8 tttt -98.83 147.23 25.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.821 HG21 ' CE1' ' A' ' 178' ' ' PHE . 9.6 m -139.45 129.78 25.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 113.243 -1.799 . . . . 0.0 106.91 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -37.54 -21.37 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.577 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.7 mt-10 -108.09 -48.84 3.3 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.821 ' CE1' HG21 ' A' ' 175' ' ' THR . 31.2 p90 -123.9 152.62 42.21 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -116.03 143.88 44.86 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.201 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 31.2 tp -101.45 112.9 25.57 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -118.59 99.83 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.991 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.534 HG22 ' HA3' ' A' ' 192' ' ' GLY . 11.0 p -127.91 149.57 50.26 Favored 'General case' 0 CA--C 1.506 -0.736 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.1 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.635 ' OD1' ' N ' ' A' ' 184' ' ' VAL . 43.4 t-20 -155.03 154.34 32.34 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 118.826 -1.15 . . . . 0.0 110.779 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.635 ' N ' ' OD1' ' A' ' 183' ' ' ASN . 3.2 t -96.55 127.98 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.181 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -99.25 114.06 26.68 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.61 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 55.52 24.02 6.49 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 125.456 1.722 . . . . 0.0 112.51 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 67.34 17.68 68.67 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 119.64 -1.266 . . . . 0.0 110.493 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.425 ' H ' ' HG1' ' A' ' 188' ' ' THR . 7.6 p -122.16 -69.61 0.82 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -102.06 120.67 40.81 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' CD1' ' CZ2' ' A' ' 210' ' ' TRP . 7.6 m-85 -90.66 140.57 29.65 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.609 0.242 . . . . 0.0 110.767 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.12 127.72 1.95 Allowed Glycine 0 C--O 1.239 0.437 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.44 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.534 ' HA3' HG22 ' A' ' 182' ' ' THR . . . -154.61 170.3 32.96 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.42 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 59.5 p -167.96 145.38 4.29 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.004 -1.078 . . . . 0.0 113.212 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 96.7 mt -95.33 130.5 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.702 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.528 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . 79.5 t80 -119.16 122.69 42.59 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.491 ' NE2' ' OD1' ' A' ' 199' ' ' ASN . 37.7 tt0 -112.39 141.65 45.87 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.661 0.743 . . . . 0.0 112.667 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.562 ' C ' HG23 ' A' ' 198' ' ' VAL . 67.9 mttm -108.29 101.14 10.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.569 176.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 197' ' ' LYS . 3.4 t 83.61 69.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.229 0 O-C-N 123.716 0.635 . . . . 0.0 111.382 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 201' ' ' LYS . 39.0 t30 -105.58 94.33 5.14 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 44.98 -76.74 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 O-C-N 124.245 0.966 . . . . 0.0 111.599 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.649 ' N ' ' O ' ' A' ' 199' ' ' ASN . 68.1 mttm -64.15 -44.15 93.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -178.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 201' ' ' LYS . 56.9 tp 166.82 -92.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-O 121.369 0.604 . . . . 0.0 110.717 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 204' ' ' THR . 89.3 mt-10 -114.2 151.27 33.02 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 203' ' ' GLU . 25.1 p -159.32 122.34 3.63 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.684 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -124.89 131.24 53.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.774 0.715 . . . . 0.0 111.527 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 38.1 t -114.2 122.77 68.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.09 129.96 54.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.662 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 2.0 mp -123.54 119.89 31.25 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 123.218 0.324 . . . . 0.0 110.622 178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.11 132.99 54.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.722 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 1.9 p90 -137.7 172.22 13.27 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 94.7 m -129.18 115.96 18.46 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 41.36 47.24 3.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.733 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.43 24.22 61.32 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.848 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.44 143.26 57.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 63.3 m -57.91 -36.17 72.07 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -175.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -80.8 112.61 18.34 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 53.0 m -103.54 119.16 38.35 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.421 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -80.26 113.84 18.73 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -135.53 148.58 49.2 Favored 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.579 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -124.76 148.78 16.84 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.472 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 13.5 mt -122.43 104.69 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.469 ' HB1' ' HZ2' ' A' ' 236' ' ' LYS . . . -99.66 125.93 45.59 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.799 0.687 . . . . 0.0 111.685 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -131.93 127.69 36.94 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.814 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -106.62 138.33 42.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -114.13 104.72 12.39 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.458 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.402 ' HB2' HD22 ' A' ' 202' ' ' LEU . 51.5 tt0 -74.66 102.21 4.52 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.682 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.462 0.8 OUTLIER -93.4 -49.98 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 119.661 -0.815 . . . . 0.0 111.643 -174.631 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -137.61 178.85 1.52 Allowed Pre-proline 0 N--CA 1.47 0.549 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 170.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -63.5 -16.1 52.54 Favored 'Trans proline' 0 C--N 1.299 -2.063 0 CA-C-N 121.805 1.68 . . . . 0.0 112.307 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -111.08 8.98 22.01 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -135.12 145.13 47.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.178 0.899 . . . . 0.0 112.751 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.13 107.55 3.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.741 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -95.02 120.06 34.59 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 122.178 -0.326 . . . . 0.0 111.81 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 3.7 m -107.6 145.03 33.8 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 111.215 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -150.65 141.08 22.44 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.469 ' HZ2' ' HB1' ' A' ' 222' ' ' ALA . 34.4 mttm -140.38 118.41 11.88 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.227 0.467 . . . . 0.0 110.095 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.503 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 0.5 OUTLIER -103.27 110.22 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.64 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.912 HD21 HD13 ' A' ' 242' ' ' LEU . 51.8 p-10 -86.98 163.63 16.97 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.758 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -90.28 4.29 51.12 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.519 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.457 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.5 p -88.17 4.76 44.41 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.0 OUTLIER 88.29 24.59 0.04 OUTLIER 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.688 -1.597 . . . . 0.0 113.444 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.912 HD13 HD21 ' A' ' 238' ' ' ASN . 2.9 mp -115.62 118.61 33.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.756 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 72.9 mt -101.02 134.27 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.84 139.39 15.64 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 53.7 mt -125.83 112.12 15.65 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -126.88 106.81 0.85 Allowed Glycine 0 N--CA 1.469 0.865 0 C-N-CA 119.812 -1.185 . . . . 0.0 113.508 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -92.44 115.9 28.51 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.69 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . 0.41 HG23 ' OG1' ' A' ' 258' ' ' THR . 52.1 m -98.7 115.45 28.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -106.35 110.29 22.47 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.535 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 250' ' ' THR . 5.6 m -88.61 87.57 7.31 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.634 ' O ' ' O ' ' A' ' 252' ' ' LYS . 84.4 mt -82.51 102.75 11.57 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 118.983 -0.532 . . . . 0.0 109.957 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.634 ' O ' ' O ' ' A' ' 251' ' ' LEU . 0.1 OUTLIER 59.86 125.61 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 118.135 -1.426 . . . . 0.0 107.921 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -42.68 -12.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 120.863 1.042 . . . . 0.0 112.094 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.45 -38.85 6.96 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 121.328 -0.463 . . . . 0.0 113.631 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 251' ' ' LEU . 95.2 mt -113.53 125.04 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -115.74 123.59 48.65 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.386 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 50.6 tp -123.61 104.65 9.16 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.382 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.41 ' OG1' HG23 ' A' ' 248' ' ' THR . 98.3 m -117.67 136.6 53.22 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 277' ' ' LEU . 4.9 mp -110.52 140.95 44.32 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.247 178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.506 ' HG ' ' HB3' ' A' ' 24' ' ' PHE . 12.9 p -132.75 148.61 52.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.312 0.577 . . . . 0.0 111.807 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.0 111.48 3.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.82 103.07 12.06 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 85.2 mt -94.67 114.25 26.16 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.027 0.441 . . . . 0.0 111.952 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.5 t0 -76.66 110.11 10.97 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -14.69 -84.66 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 CA-C-O 119.183 -0.787 . . . . 0.0 115.063 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -91.49 3.52 54.78 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.271 1.535 . . . . 0.0 111.644 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 271' ' ' GLY . 82.0 m-20 68.0 -0.38 2.09 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 113.708 -1.587 . . . . 0.0 114.263 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 77.4 t -76.54 -41.65 34.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.278 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.25 -45.66 92.3 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.633 -0.667 . . . . 0.0 110.693 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.67 -35.72 20.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 119.113 -1.035 . . . . 0.0 108.887 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 267' ' ' ASN . . . 80.53 -16.03 16.06 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.266 -1.445 . . . . 0.0 113.077 177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -140.64 -140.93 3.93 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -141.29 118.5 11.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.963 0.411 . . . . 0.0 111.123 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.543 ' NZ ' ' O ' ' A' ' 22' ' ' TYR . 89.6 mttt -80.41 125.15 29.57 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.714 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.415 ' H ' ' HA2' ' A' ' 25' ' ' GLY . 91.8 mt -134.08 122.27 22.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -136.9 125.56 3.45 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.528 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 27' ' ' ILE . 78.1 mt -112.79 124.04 51.68 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.72 115.17 5.11 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.5 mt -115.48 102.31 9.69 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -116.08 120.35 38.77 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.252 0.549 . . . . 0.0 110.332 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -105.0 116.72 32.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.459 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -100.36 114.6 28.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.453 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -68.29 149.32 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.045 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -68.06 135.88 52.93 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.365 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.66 179.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.89 151.12 36.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.819 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.3 68.4 3.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.994 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.496 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.7 Cg_endo -83.44 158.44 14.67 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.845 2.363 . . . . 0.0 113.455 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.07 -170.11 0.39 Allowed 'Trans proline' 1 N--CA 1.536 4.021 0 C-N-CA 125.249 3.966 . . . . 0.0 117.495 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 7' ' ' TYR . 81.4 p -41.76 129.66 3.35 Favored 'General case' 0 C--N 1.396 2.618 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -37.57 -51.95 1.19 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -175.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.661 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.41 -39.17 89.75 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 117.755 -1.578 . . . . 0.0 111.012 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -68.65 -24.0 64.49 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 117.657 -1.617 . . . . 0.0 109.833 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 4' ' ' PRO . 43.0 tp -65.39 131.13 45.66 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.866 176.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.91 11.83 67.16 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.862 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -59.68 -37.47 78.9 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.4 t -60.44 -45.71 92.67 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.964 -0.46 . . . . 0.0 111.697 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.67 -43.98 97.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.07 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -61.05 -39.81 91.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.4 -38.06 89.67 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.7 t -63.15 -44.02 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 119.35 0.977 . . . . 0.0 109.881 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.508 ' CG ' ' OD1' ' A' ' 207' ' ' ASN . 87.0 t80 -64.31 -44.74 90.66 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.8 p -85.6 -26.44 26.09 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 22' ' ' TYR . 66.0 mttm -78.37 10.64 2.93 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 118.761 -1.176 . . . . 0.0 110.427 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.19 157.67 12.39 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 20' ' ' LYS . 94.2 m-85 -154.28 156.83 37.73 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 103.72 -114.62 4.85 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.47 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' GLY . 86.2 m-85 21.14 75.85 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.29 -34.05 4.73 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.027 177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -117.38 124.1 48.06 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 118.128 0.964 . . . . 0.0 113.458 -177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 277' ' ' LEU . 93.2 mt -83.91 118.43 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -107.12 138.04 44.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.873 -174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.41 121.49 42.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.361 -1.29 . . . . 0.0 107.586 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.458 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.9 t0 -119.65 129.11 54.42 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.288 0.566 . . . . 0.0 111.249 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 73.8 mt -112.87 121.03 43.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -115.7 124.89 51.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -111.24 122.58 48.23 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -101.98 105.96 16.81 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.406 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.4 t -76.17 150.42 37.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.14 -33.0 74.98 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.827 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -63.95 -78.21 0.05 OUTLIER 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 161.43 33.11 0.02 OUTLIER Glycine 0 C--O 1.223 -0.571 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 61' ' ' LYS . 10.3 mt -60.11 -30.16 69.08 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 123.76 0.329 . . . . 0.0 110.737 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.517 ' HB3' ' H ' ' A' ' 61' ' ' LYS . 41.9 tp10 55.82 74.8 0.36 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 119.13 -0.462 . . . . 0.0 112.192 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -99.11 108.95 21.71 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.546 0.688 . . . . 0.0 112.327 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 m -125.97 110.73 13.94 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.701 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.7 m -104.32 161.52 13.99 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.9 p -145.24 161.79 38.71 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.411 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.6 109.01 0.37 Allowed Glycine 0 CA--C 1.521 0.452 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.594 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 4.7 p -127.96 140.24 52.1 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -176.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.96 160.19 19.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 113.813 -1.54 . . . . 0.0 109.646 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 50' ' ' GLU . 42.9 t-20 -103.39 111.05 23.29 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 25' ' ' GLY . 68.3 p -62.3 24.65 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.561 ' H ' ' C ' ' A' ' 48' ' ' ASN . 95.7 mt-10 -146.86 -53.63 0.23 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.123 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.596 ' C ' HG23 ' A' ' 52' ' ' THR . 53.7 p -84.59 -15.62 44.98 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.596 HG23 ' C ' ' A' ' 51' ' ' THR . 1.4 p 74.9 22.18 1.92 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 118.191 0.45 . . . . 0.0 110.125 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.426 ' H ' ' HB3' ' A' ' 48' ' ' ASN . 87.9 tttt -94.68 142.38 27.52 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.314 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 46' ' ' SER . 64.9 t -108.03 106.16 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 123.255 0.622 . . . . 0.0 111.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 46' ' ' SER . 33.3 p -104.33 126.11 51.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.86 -160.18 11.15 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.847 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 p -173.39 162.39 4.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.295 0.569 . . . . 0.0 111.66 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.2 mt -130.45 107.05 8.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.214 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -108.14 119.41 39.41 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.6 m -130.3 104.43 7.27 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.6 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' H ' ' HB3' ' A' ' 40' ' ' GLU . 47.8 tttt -118.54 128.98 55.08 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -103.72 104.07 14.05 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 HH21 ' HD3' ' A' ' 61' ' ' LYS . 95.5 mtm-85 -105.94 85.35 2.2 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 -177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.636 ' C ' ' H ' ' A' ' 66' ' ' GLU . 38.3 m95 -52.99 -37.9 61.77 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.2 -11.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.34 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.57 -178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.636 ' H ' ' C ' ' A' ' 64' ' ' TRP . 96.2 mt-10 -88.64 -78.91 0.32 Allowed 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.443 ' O ' ' CD1' ' A' ' 69' ' ' LEU . 95.8 m-85 -77.14 20.85 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.745 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 69' ' ' LEU . . . 65.14 38.65 95.51 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.62 -0.544 . . . . 0.0 113.453 177.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 69' ' ' LEU . 10.5 mp -106.79 93.61 4.66 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 m -101.18 108.73 20.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.609 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.732 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.9 95.24 5.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -87.83 134.5 33.68 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.571 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.2 t -128.93 121.32 54.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 123.797 0.686 . . . . 0.0 110.017 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -123.31 110.82 15.66 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.917 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.424 ' CE3' HD12 ' A' ' 58' ' ' LEU . 14.5 t90 -120.81 127.78 52.26 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -124.5 166.28 16.31 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.418 0.628 . . . . 0.0 109.979 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.8 p -64.32 -34.83 79.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.527 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -54.91 -13.93 1.27 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.111 -0.236 . . . . 0.0 110.366 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.542 HD22 ' ND2' ' A' ' 106' ' ' ASN . 53.5 m-20 98.43 9.38 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.348 1.03 . . . . 0.0 112.683 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 m -78.4 127.45 32.21 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.335 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 40.6 mt -120.6 121.95 39.47 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.44 122.76 2.86 Favored Glycine 0 C--O 1.221 -0.679 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.069 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.0 m -122.56 119.35 30.58 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -119.43 117.82 29.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.865 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.732 HG23 ' CD2' ' A' ' 71' ' ' PHE . 90.5 mt -106.62 123.08 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 86.0 m -126.93 127.88 45.56 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.0 t -116.22 102.16 13.25 Favored 'Isoleucine or valine' 0 C--N 1.342 0.263 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -95.19 155.69 16.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.748 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 67.75 38.48 2.94 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.575 HE22 ' CB ' ' A' ' 97' ' ' LEU . 50.2 mt-30 -75.57 -43.55 47.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 52.2 tp -82.77 -66.62 0.87 Allowed 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 171.85 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.353 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -75.47 -71.89 0.34 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.55 95.94 0.12 Allowed Glycine 0 CA--C 1.533 1.203 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.4 ' HB3' ' H ' ' A' ' 91' ' ' LEU . 41.5 tp -123.27 123.08 39.94 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.112 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HE3' ' HZ2' ' A' ' 119' ' ' LYS . 99.6 mttt -124.97 129.35 50.17 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.795 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.575 ' CB ' HE22 ' A' ' 90' ' ' GLN . 60.5 tp -119.53 106.84 12.6 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.6 m -109.54 99.25 8.48 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -82.43 135.11 35.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -120.64 141.94 49.89 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.856 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.25 100.21 3.95 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.141 0.9 . . . . 0.0 110.906 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t -120.41 108.48 14.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.726 0.774 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 1.8 m-85 -111.78 111.87 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.794 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 107' ' ' THR . 1.3 t -125.46 90.62 50.36 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-N 119.148 0.886 . . . . 0.0 113.013 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -39.68 -49.38 3.38 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 123.058 2.505 . . . . 0.0 114.575 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' ND2' HD22 ' A' ' 79' ' ' ASN . 89.6 m-20 -62.99 -41.15 99.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.654 -0.419 . . . . 0.0 111.909 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.487 ' O ' ' OG ' ' A' ' 104' ' ' SER . 2.4 t -147.0 148.07 31.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.847 0.356 . . . . 0.0 110.253 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 54.06 101.52 0.01 OUTLIER Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 108' ' ' GLY . 68.4 mttm -57.29 -120.2 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 O-C-N 122.822 -0.222 . . . . 0.0 111.187 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -97.95 129.77 44.84 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.813 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -121.05 115.77 23.77 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.934 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 114.67 23.84 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 57.4 mttt -119.98 145.83 46.41 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.17 113.03 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -104.86 126.92 52.43 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 52.3 m -121.3 106.9 11.91 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -112.01 119.4 5.03 Favored Glycine 0 N--CA 1.438 -1.167 0 O-C-N 123.982 0.801 . . . . 0.0 111.669 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -112.98 137.63 51.08 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HZ2' ' HE3' ' A' ' 96' ' ' LYS . 95.0 mttt -121.96 155.62 35.14 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.676 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.495 ' O ' ' O ' ' A' ' 121' ' ' GLU . 74.3 ttt-85 179.55 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' A' ' 123' ' ' ILE . 80.8 mm-40 42.29 108.52 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.283 0.564 . . . . 0.0 112.485 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 56.4 m170 48.97 -9.61 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.3 mt -105.98 112.34 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 5.0 t-20 -122.0 121.53 37.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.415 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 73.6 mt -122.67 114.66 20.88 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 117.765 -1.112 . . . . 0.0 110.971 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.87 142.99 17.79 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.201 1.364 . . . . 0.0 111.44 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.4 t -124.92 102.48 7.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.786 -0.207 . . . . 0.0 110.543 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -96.68 109.44 22.08 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.65 0.594 . . . . 0.0 110.048 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -107.5 107.29 18.08 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.755 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.63 108.16 19.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.719 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -87.19 86.22 7.26 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.32 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -126.39 166.43 17.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.34 -41.14 90.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.716 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.99 -32.2 68.95 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.56 -173.16 29.96 Favored Glycine 0 C--N 1.34 0.789 0 N-CA-C 106.556 -2.618 . . . . 0.0 106.556 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.1 124.13 0.64 Allowed 'Cis proline' 0 N--CA 1.509 2.391 0 CA-C-N 121.594 2.697 . . . . 0.0 115.708 -1.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -113.49 124.68 52.97 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' MET . 79.3 mt -100.12 104.93 16.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.597 -178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -107.6 101.67 10.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.732 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.0 159.22 19.53 Favored Glycine 0 C--O 1.21 -1.355 0 CA-C-O 117.689 -1.617 . . . . 0.0 109.354 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.15 114.66 11.81 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 118.444 1.122 . . . . 0.0 108.546 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.536 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 56.0 mt -98.16 104.95 17.03 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.63 ' C ' HD22 ' A' ' 144' ' ' LEU . 18.0 t -104.44 123.0 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 122.511 1.148 . . . . 0.0 109.149 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.63 HD22 ' C ' ' A' ' 143' ' ' VAL . 4.3 mm? -115.64 141.49 48.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.659 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.44 148.54 16.52 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 120.239 -0.982 . . . . 0.0 111.663 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.609 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 1.9 t80 -143.3 74.56 1.44 Allowed 'General case' 0 C--O 1.207 -1.177 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.19 33.3 21.83 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.34 -19.62 5.66 Favored Glycine 0 C--O 1.227 -0.343 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.7 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -92.27 137.28 32.5 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.873 -178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.29 114.8 21.87 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -117.72 138.29 52.12 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -126.73 148.53 17.29 Favored Glycine 0 C--N 1.348 1.203 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.308 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -128.56 116.83 20.25 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 50.7 tt0 -110.2 123.73 50.3 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.266 -178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 138' ' ' ILE . 62.5 ttp -112.54 115.31 28.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.534 0.521 . . . . 0.0 111.724 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -96.31 115.41 27.38 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -108.1 94.45 5.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.872 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.6 tt0 -73.31 97.17 2.42 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 74.1 p -68.71 -30.02 68.57 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.52 95.12 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 119.734 -0.787 . . . . 0.0 109.883 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -100.92 -10.86 20.24 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 53.98 58.07 5.39 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.165 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.5 131.38 48.32 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.684 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 157' ' ' PHE . 62.1 t -104.83 102.22 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 41.2 p -131.34 -59.25 0.98 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 122.14 0.971 . . . . 0.0 111.381 -177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.56 108.87 3.49 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 113.426 -1.716 . . . . 0.0 110.907 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 29.3 p -142.09 151.26 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.568 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -128.14 138.34 52.47 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -106.25 109.38 21.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.745 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.63 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.88 133.78 34.56 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 120.36 -0.536 . . . . 0.0 109.774 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 41.8 t -131.02 114.02 25.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.577 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -131.09 151.96 19.82 Favored Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.265 -0.88 . . . . 0.0 113.609 -177.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.438 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 88.9 t80 -131.44 128.71 40.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.707 -1.246 . . . . 0.0 107.956 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -102.06 146.88 27.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 26.2 m -132.65 135.79 46.06 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 113.11 -1.859 . . . . 0.0 106.224 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 26.6 t0 -39.42 -16.08 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 93.6 mt-10 -128.2 -37.37 1.87 Allowed 'General case' 0 C--O 1.244 0.789 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.407 ' CZ ' ' OE2' ' A' ' 177' ' ' GLU . 0.6 OUTLIER -112.41 144.58 41.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' ILE . 81.6 mt-30 -116.53 141.54 48.05 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.371 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.577 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 47.2 tp -109.51 109.56 20.4 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -118.54 109.74 16.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.285 0.366 . . . . 0.0 111.09 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 65.1 p -124.98 147.64 48.81 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 191' ' ' GLY . 1.2 p30 -136.85 138.06 40.37 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 119.696 1.135 . . . . 0.0 110.123 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.431 HG22 ' CD2' ' A' ' 190' ' ' PHE . 3.3 t -99.38 120.1 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.827 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -96.81 113.63 25.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.978 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 56.15 21.67 5.39 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 125.481 1.738 . . . . 0.0 113.24 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 71.37 17.44 76.12 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.0 m -123.74 -68.72 0.85 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -103.07 121.47 42.66 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 184' ' ' VAL . 9.1 m-85 -90.43 151.79 21.25 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 122.246 -0.284 . . . . 0.0 110.366 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.526 ' O ' ' ND2' ' A' ' 183' ' ' ASN . . . 179.34 141.2 4.39 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.204 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.05 -168.07 36.99 Favored Glycine 0 C--N 1.331 0.256 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 10.6 p -133.73 174.73 10.13 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.73 0.776 . . . . 0.0 112.845 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.51 HD12 ' HB ' ' A' ' 206' ' ' VAL . 6.3 mt -131.55 117.19 34.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.268 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.403 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 43.8 t80 -88.56 122.62 32.22 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -123.46 102.42 7.88 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.254 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -99.91 97.63 8.49 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 199' ' ' ASN . 40.4 t -75.51 -21.72 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 115.265 -0.88 . . . . 0.0 112.968 -175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 198' ' ' VAL . 32.4 t30 90.67 -40.91 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.559 0.537 . . . . 0.0 110.935 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 202' ' ' LEU . 99.0 mttt -81.79 80.81 8.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.702 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 38.34 21.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 200' ' ' LYS . 45.1 tp -131.72 113.96 14.19 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -119.32 112.62 19.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.1 p -120.02 160.45 22.76 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.831 -177.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -133.85 117.98 17.45 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.816 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.51 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.6 t -94.48 127.45 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.508 ' OD1' ' CG ' ' A' ' 18' ' ' PHE . 5.9 m120 -108.99 123.67 49.49 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 41.1 mt -113.6 114.52 26.57 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.73 0.644 . . . . 0.0 111.271 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.76 122.76 39.5 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CZ2' ' CD2' ' A' ' 190' ' ' PHE . 1.4 p90 -139.77 170.41 15.94 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.513 0.673 . . . . 0.0 110.063 178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 72.9 m -130.5 114.13 15.12 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.71 46.17 11.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.874 0.845 . . . . 0.0 109.469 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 54.7 25.82 37.46 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 113.97 -1.468 . . . . 0.0 114.52 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -60.09 149.43 32.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 19.4 m -59.16 -36.83 75.97 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.75 109.17 17.29 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 96.5 m -103.43 117.26 34.05 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.385 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -76.63 115.73 16.66 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.2 144.22 42.75 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.763 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -117.29 152.81 17.61 Favored Glycine 0 C--N 1.337 0.588 0 O-C-N 125.364 1.665 . . . . 0.0 112.112 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.7 mt -125.15 103.58 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.95 114.79 29.01 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.78 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.46 ' HB1' HD11 ' A' ' 202' ' ' LEU . . . -111.51 124.26 51.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 123.854 0.721 . . . . 0.0 111.057 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -105.94 98.57 8.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.56 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 49.8 t80 -99.09 99.84 10.9 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.174 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -74.0 115.9 13.99 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.56 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.471 0.1 OUTLIER -92.64 -49.05 13.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 C-N-CA 118.204 -1.398 . . . . 0.0 111.943 -176.19 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.43 179.55 1.35 Allowed Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -64.46 -15.88 52.19 Favored 'Trans proline' 0 C--N 1.299 -2.076 0 CA-C-N 121.748 1.66 . . . . 0.0 112.586 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.1 p30 -117.57 11.77 13.87 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.24 126.84 11.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.027 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.96 138.27 43.86 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.459 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 45.4 t80 -108.9 113.63 26.71 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 122.146 -0.346 . . . . 0.0 111.702 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 26.5 t -102.84 128.17 49.71 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.421 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.592 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -133.1 141.13 48.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -131.92 112.26 12.27 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.073 0.233 . . . . 0.0 110.523 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 61.9 t -101.57 113.36 37.58 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.69 0 CA-C-O 118.673 -0.68 . . . . 0.0 110.554 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.964 HD21 HD13 ' A' ' 242' ' ' LEU . 51.7 p-10 -96.85 161.28 13.92 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.065 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -90.19 4.92 49.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.57 -178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 241' ' ' SER . 2.2 p -86.29 3.1 44.73 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 176.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 240' ' ' SER . 0.8 OUTLIER 88.9 28.73 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 113.572 -1.649 . . . . 0.0 113.592 178.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.964 HD13 HD21 ' A' ' 238' ' ' ASN . 3.1 mp -119.31 118.08 30.28 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 118.224 0.466 . . . . 0.0 111.718 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.5 mt -100.78 134.36 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.46 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.57 141.94 17.04 Favored Glycine 0 C--N 1.367 2.281 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 66.6 mt -123.84 116.89 23.69 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.195 0.585 . . . . 0.0 110.005 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.81 106.63 0.77 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 119.759 -1.21 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -96.21 119.88 35.5 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.818 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 3.0 m -97.06 134.67 40.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.983 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.606 ' O ' ' OG1' ' A' ' 250' ' ' THR . 78.5 mt-30 -129.25 155.29 45.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.307 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 249' ' ' GLN . 45.0 p 67.09 -101.15 0.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 O-C-N 123.977 0.798 . . . . 0.0 109.837 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.46 ' O ' ' C ' ' A' ' 252' ' ' LYS . 55.5 tp 64.74 -34.7 0.17 Allowed 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.502 0.501 . . . . 0.0 111.469 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 254' ' ' GLY . 1.5 mttp -42.28 158.21 0.21 Allowed Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -40.6 88.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.867 1.711 . . . . 0.0 111.76 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 170.43 -101.73 0.17 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.774 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.479 ' O ' ' OG1' ' A' ' 250' ' ' THR . 97.1 mt -123.22 140.93 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -106.01 125.57 51.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.939 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 49.5 tp -120.84 101.63 7.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.925 0.765 . . . . 0.0 109.191 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 99.3 m -121.5 131.73 54.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.598 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.95 143.52 26.41 Favored 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -136.43 146.5 46.44 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.91 0.386 . . . . 0.0 111.709 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.81 118.76 2.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.546 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 242' ' ' LEU . 27.1 tp -113.5 103.11 10.94 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.5 mt -92.55 116.0 28.61 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.793 -178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -79.9 108.93 13.86 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.35 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -61.08 -38.08 94.97 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 268' ' ' VAL . 54.4 mmtt -86.1 -7.75 58.37 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.968 1.384 . . . . 0.0 109.535 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.98 -21.89 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 266' ' ' LYS . 53.4 t -77.01 -35.24 22.98 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.438 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -64.34 -44.48 91.37 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.788 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.479 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.94 -34.89 19.18 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 118.564 -1.254 . . . . 0.0 107.814 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.93 -12.97 0.36 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.356 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -139.62 -131.59 2.82 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.126 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -140.77 118.01 11.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.0 0.429 . . . . 0.0 111.695 -178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -86.51 117.79 25.52 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.599 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 25' ' ' GLY . 98.8 mt -133.3 133.22 42.29 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.07 136.72 6.1 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.288 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.583 ' HB2' HG23 ' A' ' 27' ' ' ILE . 54.6 mt -123.41 130.76 53.17 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -104.69 115.13 4.89 Favored Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.91 115.52 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 -116.21 132.94 56.52 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.27 110.09 16.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.663 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 254' ' ' GLY . 87.5 mt-30 -75.59 142.58 42.67 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.593 -178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -151.32 156.86 41.66 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.238 0.542 . . . . 0.0 112.089 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 80.1 mtp85 -100.41 138.19 37.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.5 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.839 -179.887 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -132.6 139.51 47.83 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.741 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' C ' HD21 ' A' ' 124' ' ' ASN . 17.9 m -158.38 65.84 3.16 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.705 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' O ' ' ND2' ' A' ' 124' ' ' ASN . 3.4 Cg_endo -82.15 159.35 17.85 Favored 'Trans proline' 0 CA--C 1.57 2.318 0 C-N-CA 123.154 2.569 . . . . 0.0 113.765 -178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -69.5 -170.99 0.41 Allowed 'Trans proline' 0 N--CA 1.527 3.459 1 C-N-CA 125.839 4.359 . . . . 0.0 115.54 -176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.435 ' O ' ' C ' ' A' ' 7' ' ' TYR . 71.0 p -40.11 129.62 2.2 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.68 ' CD2' ' HB2' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -37.1 -51.59 0.98 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.674 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.21 -38.36 90.85 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 117.185 -1.806 . . . . 0.0 111.45 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.14 -25.39 65.25 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 117.685 -1.606 . . . . 0.0 110.241 -176.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 4' ' ' PRO . 35.7 tp -63.99 131.29 47.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 120.573 -1.33 . . . . 0.0 109.045 176.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.97 7.94 62.17 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.958 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.8 -36.04 35.13 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 17' ' ' VAL . 68.4 m -60.3 -43.11 96.59 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.895 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.73 -45.1 94.28 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.936 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -63.54 -41.44 98.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -40.25 95.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 13' ' ' SER . 48.9 t -61.92 -44.43 98.87 Favored 'Isoleucine or valine' 0 C--N 1.344 0.342 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.535 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -64.75 -47.32 78.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 38.3 p -71.17 -45.04 64.3 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.17 132.47 49.22 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 118.929 -1.108 . . . . 0.0 109.147 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.56 ' O ' ' CG ' ' A' ' 22' ' ' TYR . . . 163.08 170.25 27.7 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.915 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.56 ' CG ' ' O ' ' A' ' 21' ' ' GLY . 98.4 m-85 -163.6 -120.27 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 40.73 -115.14 0.63 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.706 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CG ' HD12 ' A' ' 262' ' ' LEU . 66.4 m-85 14.64 73.63 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 118.53 -35.33 4.03 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.944 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 47' ' ' ALA . 4.1 mp -117.64 119.92 36.46 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 118.12 0.96 . . . . 0.0 113.407 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.508 HG13 ' H ' ' A' ' 277' ' ' LEU . 4.5 mp -83.95 120.96 35.82 Favored 'Isoleucine or valine' 0 C--O 1.255 1.353 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -119.22 140.64 49.88 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -174.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -96.97 125.75 41.62 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 113.865 -1.516 . . . . 0.0 108.159 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -119.83 132.97 55.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 111.668 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 68.7 mt -110.55 127.08 55.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.439 178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.92 131.53 49.35 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.8 m -127.55 121.47 30.71 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -111.37 131.49 55.14 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.785 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -79.13 170.62 16.39 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -58.31 -42.09 85.96 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.596 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 49.5 p30 -167.9 134.54 2.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 114.17 -99.2 0.94 Allowed Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.688 HD22 ' CE1' ' A' ' 41' ' ' PHE . 44.0 mt -58.4 141.44 51.43 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.573 1.178 . . . . 0.0 113.518 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CD ' HH12 ' A' ' 63' ' ' ARG . 78.6 tt0 -143.32 95.65 2.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.23 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.688 ' CE1' HD22 ' A' ' 39' ' ' LEU . 63.0 m-85 -102.9 111.51 23.88 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.673 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 m -124.17 113.04 17.79 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.434 ' OG ' HD23 ' A' ' 58' ' ' LEU . 58.8 m -105.27 160.76 14.85 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.2 p -145.97 159.31 43.43 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.2 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.79 121.28 1.39 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.0 p -129.19 117.57 20.98 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . -74.3 155.75 37.88 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 50' ' ' GLU . 61.1 t-20 -101.96 107.65 18.85 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 25' ' ' GLY . 82.1 p -61.93 27.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.983 -176.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.584 ' H ' ' C ' ' A' ' 48' ' ' ASN . 98.3 mt-10 -149.93 -52.52 0.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.304 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.505 ' OG1' ' ND2' ' A' ' 48' ' ' ASN . 43.6 p -83.63 -14.75 51.2 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.41 ' OG1' ' C ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 72.19 26.76 2.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.067 -178.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -104.47 148.53 26.35 Favored 'General case' 0 C--O 1.206 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.238 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.9 t -116.02 106.12 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.699 -0.626 . . . . 0.0 111.333 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.3 p -101.55 127.48 48.23 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.6 -156.97 10.15 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.363 -0.922 . . . . 0.0 112.55 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 p -173.93 165.48 4.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.735 0.779 . . . . 0.0 112.25 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.52 HD12 ' CE3' ' A' ' 75' ' ' TRP . 96.6 mt -130.25 106.79 8.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.945 176.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -104.19 117.37 34.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.494 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 25.5 m -130.18 110.52 11.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.51 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -127.23 144.56 51.02 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.943 0.338 . . . . 0.0 111.364 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -119.71 95.84 4.94 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.494 HH12 ' CD ' ' A' ' 40' ' ' GLU . 95.4 mtm-85 -106.94 89.31 2.97 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.6 ' C ' ' H ' ' A' ' 66' ' ' GLU . 39.8 m95 -59.97 -36.31 76.85 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 118.277 -1.369 . . . . 0.0 107.436 174.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.99 -12.91 0.1 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 113.455 -1.702 . . . . 0.0 110.268 -178.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 64' ' ' TRP . 80.3 mm-40 -70.33 -80.13 0.06 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -84.87 23.5 1.19 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.539 -178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.24 41.66 99.72 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.201 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 71' ' ' PHE . 3.6 mt -102.96 81.64 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.515 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.0 m -86.15 106.31 17.18 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.226 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.427 ' CE2' ' HB3' ' A' ' 69' ' ' LEU . 1.0 OUTLIER -102.21 92.35 4.7 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 m -87.74 131.19 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.752 -176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.4 t -128.63 117.82 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 O-C-N 123.769 0.668 . . . . 0.0 109.709 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -123.84 113.05 18.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.943 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.52 ' CE3' HD12 ' A' ' 58' ' ' LEU . 11.7 t90 -120.98 114.57 21.72 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.21 0.319 . . . . 0.0 110.275 178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -106.13 162.57 13.52 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.226 0.536 . . . . 0.0 109.81 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.5 p -60.89 -35.05 75.65 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.583 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 96.5 m-20 -58.69 -10.59 2.4 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.396 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 18.3 m-20 100.52 -4.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 124.271 0.982 . . . . 0.0 112.362 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.5 m -61.82 126.33 26.98 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.077 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.598 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 22.1 mt -120.4 118.92 31.58 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -125.3 123.47 4.98 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.72 -1.228 . . . . 0.0 112.367 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.444 ' H ' ' HB2' ' A' ' 101' ' ' SER . 12.8 p -119.18 119.25 33.57 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 120.716 -0.393 . . . . 0.0 109.971 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -119.32 113.51 20.94 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.438 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 9.8 mm -111.48 114.22 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.3 m -126.31 127.43 45.55 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 69' ' ' LEU . 2.4 t -116.15 105.6 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.06 146.26 24.4 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 56.6 49.66 14.22 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.554 ' HB2' HD23 ' A' ' 95' ' ' LEU . 74.6 mt-30 -59.26 -7.85 1.42 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 22.4 tp -153.7 40.9 0.51 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.461 1.124 . . . . 0.0 109.202 178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 77.48 -15.8 0.71 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 113.726 -1.579 . . . . 0.0 111.871 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' LEU . 81.6 mtt85 -131.58 173.43 11.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.927 1.346 . . . . 0.0 113.632 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 119' ' ' LYS . . . -28.51 68.73 0.0 OUTLIER Glycine 0 C--N 1.311 -0.822 0 CA-C-N 111.401 -2.636 . . . . 0.0 116.779 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.554 HD23 ' HB2' ' A' ' 90' ' ' GLN . 23.9 tp -139.2 109.5 6.5 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -124.87 125.11 43.45 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.688 -178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.0 tp -120.29 105.05 10.56 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 118.148 0.431 . . . . 0.0 109.847 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 98' ' ' THR . 98.5 m -110.49 99.17 8.21 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -85.55 129.68 34.76 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 174.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 101' ' ' SER . 21.6 t0 -124.15 156.1 37.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.208 0.528 . . . . 0.0 111.382 -175.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 83' ' ' THR . 13.8 m -140.5 122.21 15.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 110.948 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.441 ' OG ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -126.71 107.64 10.35 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.794 0.807 . . . . 0.0 111.392 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 3.0 m-85 -93.88 153.63 18.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.823 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' O ' ' A' ' 105' ' ' PRO . 12.5 m -115.19 147.59 38.83 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 120.367 -0.533 . . . . 0.0 112.413 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' O ' ' O ' ' A' ' 104' ' ' SER . 65.5 Cg_exo -37.49 -125.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.104 0 C-N-CA 124.571 3.514 . . . . 0.0 114.707 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -58.94 -31.83 69.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.442 -178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.4 m -59.61 -42.47 92.72 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.092 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 18.86 79.57 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 104' ' ' SER . 88.4 tttt -66.94 123.42 20.15 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.752 0.31 . . . . 0.0 110.181 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -98.14 136.44 38.36 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.441 ' ND2' ' OG ' ' A' ' 102' ' ' SER . 98.6 m-20 -120.57 143.44 48.62 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.68 110.53 5.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.42 145.98 45.78 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.26 114.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.1 mttt -104.79 126.61 52.04 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 55.5 m -115.72 106.83 14.32 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.79 138.42 14.03 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.252 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -131.53 112.01 12.26 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' O ' ' HA3' ' A' ' 94' ' ' GLY . 57.4 mttt -109.63 152.91 24.94 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.215 -175.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.2 ttm-85 172.67 109.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.0 mt-10 44.73 102.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 46.07 -4.74 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.5 mt -112.25 111.12 34.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.249 0.932 . . . . 0.0 113.216 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.536 HD21 ' C ' ' A' ' 3' ' ' VAL . 2.3 m-20 -122.43 122.88 40.03 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.34 118.01 27.44 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.492 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -119.56 146.25 18.06 Favored Glycine 0 C--N 1.344 0.997 0 CA-C-N 120.443 1.474 . . . . 0.0 111.471 178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.3 t -125.06 102.8 7.68 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.702 -0.249 . . . . 0.0 110.569 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -92.07 110.8 22.18 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.933 0.77 . . . . 0.0 110.183 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 72.2 mtm -107.67 107.46 18.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.476 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -92.77 116.33 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.173 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.03 87.49 7.23 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.885 0.374 . . . . 0.0 110.702 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.9 t0 -122.27 170.23 10.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.75 -40.97 91.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.044 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.19 4.42 38.68 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -101.48 177.97 27.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 105.744 -2.943 . . . . 0.0 105.744 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.46 132.38 3.91 Favored 'Cis proline' 0 N--CA 1.51 2.457 0 CA-C-N 122.137 2.969 . . . . 0.0 115.499 0.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.6 m -113.13 127.49 56.21 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 155' ' ' MET . 18.1 mm -100.26 103.0 14.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.514 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.594 HH21 ' ND2' ' A' ' 156' ' ' ASN . 78.4 mtp85 -106.82 101.44 10.88 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.696 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.735 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.18 154.52 20.81 Favored Glycine 0 C--O 1.21 -1.389 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.67 108.87 7.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 117.818 0.809 . . . . 0.0 109.109 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 3.0 mp -98.38 106.56 18.86 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.638 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.27 127.56 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 121.81 0.814 . . . . 0.0 110.212 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 89.3 mt -118.66 137.85 53.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.188 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -105.5 150.59 17.0 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 119.639 -1.267 . . . . 0.0 111.34 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.692 ' O ' ' N ' ' A' ' 148' ' ' GLY . 93.6 m-85 -145.17 -162.07 1.43 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.454 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 77.3 mm-40 -46.7 47.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 125.11 1.506 . . . . 0.0 113.597 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.692 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.92 39.63 5.44 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 4.5 m95 -139.26 149.0 43.8 Favored 'General case' 0 CA--C 1.506 -0.729 0 C-N-CA 120.236 -0.586 . . . . 0.0 112.415 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -120.88 111.33 17.4 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.66 128.51 56.45 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -125.08 149.34 17.0 Favored Glycine 0 C--N 1.345 1.045 0 C-N-CA 120.033 -1.08 . . . . 0.0 113.23 -177.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.37 118.22 23.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.735 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 21.0 tp60 -112.83 121.92 46.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 118.59 0.632 . . . . 0.0 110.506 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.2 ttp -116.14 115.74 26.58 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.356 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.594 ' ND2' HH21 ' A' ' 139' ' ' ARG . 27.9 t-20 -96.04 116.35 28.83 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.549 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.5 OUTLIER -108.34 94.62 5.16 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.473 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.8 mm-40 -73.55 96.85 2.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 63.7 p -66.57 -31.02 71.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.17 88.1 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.826 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -103.74 -10.92 17.93 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.6 m 53.72 58.61 4.96 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.393 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -127.41 128.19 45.39 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.095 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.549 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 65.7 t -104.46 102.06 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 105.431 -2.062 . . . . 0.0 105.431 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 p -133.56 -59.86 0.85 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.81 0.814 . . . . 0.0 111.264 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -69.13 108.97 3.81 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.574 -178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.425 ' C ' ' ND2' ' A' ' 168' ' ' ASN . 11.9 p -142.4 151.64 42.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.771 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.425 ' ND2' ' C ' ' A' ' 167' ' ' SER . 4.9 m120 -127.72 141.69 51.53 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -108.88 108.96 19.94 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.417 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.39 133.05 35.25 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.781 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 49.6 t -132.38 112.22 19.0 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 O-C-N 123.706 0.628 . . . . 0.0 109.685 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.24 157.06 21.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.679 -177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 77.9 t80 -128.7 131.09 47.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.92 146.65 27.55 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.398 1.094 . . . . 0.0 113.735 -176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.43 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 0.3 OUTLIER -137.09 142.79 42.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 112.91 -1.95 . . . . 0.0 106.372 177.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 66.8 t0 -36.27 -40.09 0.21 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -115.83 -34.33 4.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.1 OUTLIER -103.02 134.41 46.52 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -175.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.497 ' OE1' ' NE2' ' A' ' 181' ' ' HIS . 76.8 mt-30 -116.39 143.22 45.84 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.517 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.46 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 50.9 tp -110.97 111.01 21.82 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 176.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.497 ' NE2' ' OE1' ' A' ' 179' ' ' GLN . 51.7 m-70 -118.68 99.72 6.96 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.006 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.489 HG22 ' HA2' ' A' ' 192' ' ' GLY . 67.9 p -122.63 155.89 35.42 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.421 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 5.9 p30 -157.61 154.43 28.45 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.982 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 190' ' ' PHE . 5.4 t -98.31 123.32 50.78 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -100.98 109.22 21.11 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.952 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 55.09 29.92 13.39 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 124.887 1.367 . . . . 0.0 113.456 178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.98 7.1 21.69 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 17.8 m -113.15 -74.12 0.64 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -99.3 115.36 28.99 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.633 ' CE2' HG13 ' A' ' 184' ' ' VAL . 3.4 m-85 -85.93 135.55 33.63 Favored 'General case' 0 C--O 1.243 0.747 0 O-C-N 121.281 -0.887 . . . . 0.0 110.621 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -103.82 165.48 15.42 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.489 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -158.37 140.32 6.88 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.334 -0.707 . . . . 0.0 111.334 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 153.43 36.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 0.0 111.786 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.647 HD12 ' HB ' ' A' ' 206' ' ' VAL . 75.3 mt -131.91 118.58 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.52 175.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.5 116.81 30.85 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -123.14 119.04 29.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -107.96 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.4 t -60.41 -50.53 79.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.719 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . . . . . . . . . 52.4 p30 178.91 63.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.128 0.489 . . . . 0.0 110.231 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 45.8 tttm 68.42 -55.59 0.52 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.86 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 227' ' ' ILE . 98.7 mttt -62.99 -43.59 98.38 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.658 HD11 ' CD1' ' A' ' 225' ' ' TYR . 9.7 mp -115.49 117.27 29.91 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -117.33 102.1 8.96 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.5 p -119.97 156.49 30.73 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 120.871 -1.143 . . . . 0.0 111.049 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -149.55 156.59 42.2 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.642 -0.823 . . . . 0.0 112.119 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.647 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -125.26 123.96 66.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.048 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -104.97 130.38 53.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 4.8 mp -125.85 106.62 9.8 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.343 0.402 . . . . 0.0 111.184 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.99 145.01 48.87 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.499 ' CG ' ' N ' ' A' ' 211' ' ' THR . 0.0 OUTLIER -140.2 -160.78 1.11 Allowed 'General case' 0 N--CA 1.459 -0.023 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.558 177.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.499 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 3.8 m -148.62 116.0 6.19 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.461 -177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -48.92 110.16 0.33 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.502 0.668 . . . . 0.0 111.049 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 120.42 -46.02 1.17 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -96.65 116.0 28.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.9 m -67.03 -37.8 84.76 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -51.21 123.15 8.9 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.581 ' O ' ' ND2' ' A' ' 239' ' ' ASN . 50.3 m -103.54 111.53 24.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.4 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -72.19 117.14 13.45 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 118.166 -1.413 . . . . 0.0 107.791 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 239' ' ' ASN . 30.1 p90 -134.21 132.88 40.25 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 119.095 -1.042 . . . . 0.0 112.045 178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -118.51 152.95 17.24 Favored Glycine 0 C--O 1.226 -0.384 0 CA-C-N 113.583 -1.644 . . . . 0.0 112.363 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.04 103.77 14.25 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.442 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.36 116.36 32.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.377 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -113.53 121.82 45.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.476 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -103.48 106.9 17.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.658 ' CD1' HD11 ' A' ' 202' ' ' LEU . 76.7 t80 -102.2 96.9 7.29 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.976 -177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -112.43 110.46 20.67 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.42 HG22 ' HD3' ' A' ' 201' ' ' LYS . 0.2 OUTLIER -88.89 -53.94 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 117.189 -1.804 . . . . 0.0 110.454 -178.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.27 -178.4 0.7 Allowed Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.471 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 16.5 Cg_exo -62.56 121.3 9.2 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 CA-C-N 121.628 1.617 . . . . 0.0 110.556 -176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER 164.88 -66.46 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -164.26 121.57 1.7 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.793 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 2.1 t -96.45 136.01 37.54 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.812 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 36.9 t80 -114.12 119.11 35.99 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.5 t -107.72 134.88 50.05 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.716 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -136.36 139.42 42.52 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.197 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -133.93 110.22 9.56 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.278 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 89.3 t -101.9 112.08 33.82 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 CA-C-O 118.572 -0.727 . . . . 0.0 111.369 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.782 HD21 HD13 ' A' ' 242' ' ' LEU . 17.7 p-10 -93.94 162.84 13.74 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.617 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 217' ' ' THR . 5.4 p-10 -89.78 7.27 37.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.279 -0.968 . . . . 0.0 113.077 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 241' ' ' SER . 73.3 m -90.69 6.76 42.67 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.594 ' C ' HD12 ' A' ' 242' ' ' LEU . 0.9 OUTLIER 86.05 30.28 0.04 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 113.947 -1.479 . . . . 0.0 113.205 178.505 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.782 HD13 HD21 ' A' ' 238' ' ' ASN . 4.8 mp -114.24 108.24 16.68 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 118.129 0.422 . . . . 0.0 111.841 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.499 ' O ' HD23 ' A' ' 262' ' ' LEU . 94.3 mt -91.94 130.38 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.02 135.44 12.86 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 69.8 mt -124.43 112.26 16.7 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 124.407 0.71 . . . . 0.0 109.557 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -123.68 106.6 0.99 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 119.883 -1.151 . . . . 0.0 112.724 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -97.76 117.53 32.27 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.041 -0.682 . . . . 0.0 110.335 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 72.8 m -104.7 128.73 52.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.257 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -121.7 124.48 44.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.926 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 69.9 m -99.6 117.02 33.07 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.88 86.72 2.51 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.273 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 254' ' ' GLY . 11.0 mttt 72.54 116.96 0.03 OUTLIER Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 252' ' ' LYS . 73.1 Cg_exo -38.62 93.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.391 1.394 . . . . 0.0 111.797 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 162.63 -35.85 0.34 Allowed Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.761 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.22 127.11 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 117.497 0.649 . . . . 0.0 112.386 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -114.97 131.42 56.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.752 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.4 tp -123.51 104.19 8.91 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.042 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.431 ' C ' HD22 ' A' ' 259' ' ' LEU . 54.3 m -114.8 137.65 51.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 259' ' ' LEU . 1.0 OUTLIER -107.85 143.75 36.03 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 5.6 p -136.36 144.76 44.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.073 0.464 . . . . 0.0 111.504 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -156.07 115.31 3.52 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.48 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 24' ' ' PHE . 1.1 mt -111.37 102.81 11.16 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.9 mt -96.66 117.03 30.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.423 0.63 . . . . 0.0 111.905 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -83.29 108.22 16.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.27 96.0 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 268' ' ' VAL . 83.4 mttt -85.23 -5.99 59.29 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 120.19 1.995 . . . . 0.0 110.33 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 54.13 -18.77 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 266' ' ' LYS . 54.0 t -79.04 -35.98 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.316 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -64.15 -44.34 92.46 Favored 'General case' 0 N--CA 1.434 -1.241 0 O-C-N 121.445 -0.785 . . . . 0.0 110.702 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -85.53 -35.75 20.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 117.905 -1.518 . . . . 0.0 108.706 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.61 -3.98 3.28 Favored Glycine 0 N--CA 1.47 0.907 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.986 177.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -150.21 -134.58 2.28 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.066 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -140.51 118.24 11.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 111.72 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -87.21 117.43 25.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.646 ' C ' ' H ' ' A' ' 25' ' ' GLY . 83.4 mt -133.98 128.86 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -151.69 136.06 5.32 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 119.501 -1.333 . . . . 0.0 111.325 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.686 HD12 ' C ' ' A' ' 276' ' ' GLY . 11.0 mp -119.35 132.57 55.88 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -106.45 114.84 4.54 Favored Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 69.8 mt -113.8 107.67 16.04 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -116.38 124.08 49.17 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.275 0.559 . . . . 0.0 110.48 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -113.29 111.98 22.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.009 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.61 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 56.8 tt0 -99.55 129.62 45.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.471 -179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 282' ' ' GLN . . . 76.87 108.01 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -77.75 147.97 35.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.748 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.603 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.29 144.26 50.04 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.692 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.74 71.67 3.69 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.061 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.1 Cg_endo -82.63 157.43 16.33 Favored 'Trans proline' 0 CA--C 1.563 1.927 0 C-N-CA 122.925 2.417 . . . . 0.0 113.197 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' HG21 ' A' ' 143' ' ' VAL . 37.9 Cg_endo -70.76 -174.21 1.05 Allowed 'Trans proline' 0 N--CA 1.533 3.801 1 C-N-CA 126.105 4.537 . . . . 0.0 116.401 -177.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.46 ' C ' ' O ' ' A' ' 5' ' ' PRO . 42.6 p -37.99 129.11 1.24 Allowed 'General case' 0 C--N 1.372 1.545 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.685 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.37 -51.46 1.53 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.685 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -61.78 -37.93 86.18 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 117.192 -1.803 . . . . 0.0 111.446 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 97.9 m-20 -68.63 -25.55 64.9 Favored 'General case' 0 C--O 1.254 1.336 0 C-N-CA 118.169 -1.413 . . . . 0.0 110.649 -177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.68 127.4 31.09 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.019 -1.05 . . . . 0.0 109.073 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.62 12.44 53.53 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.758 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -54.36 -33.63 59.5 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.492 ' OG ' ' CD1' ' A' ' 195' ' ' TYR . 78.5 p -61.33 -44.93 96.36 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.849 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -63.82 -41.78 97.8 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.954 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 19' ' ' THR . 78.4 mtp85 -63.89 -36.3 83.48 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.59 -40.63 95.86 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.9 t -60.62 -45.27 97.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.142 0.883 . . . . 0.0 109.816 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.461 ' CB ' HD22 ' A' ' 207' ' ' ASN . 86.5 t80 -65.78 -44.73 84.92 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 15' ' ' ARG . 48.6 p -81.47 -34.47 31.35 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -76.78 11.02 1.87 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.314 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.57 148.57 9.27 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -152.19 164.73 36.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 90.25 -113.35 4.21 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.002 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' C ' ' O ' ' A' ' 23' ' ' GLY . 69.2 m-85 19.84 84.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.632 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.61 -36.05 4.39 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.592 -0.814 . . . . 0.0 113.297 177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.49 121.96 44.29 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 118.223 1.011 . . . . 0.0 112.107 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 277' ' ' LEU . 72.5 mt -84.36 122.5 38.02 Favored 'Isoleucine or valine' 0 C--O 1.254 1.294 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -116.5 140.71 49.07 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.499 -1.228 . . . . 0.0 113.269 -175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.9 mt -107.9 116.75 32.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.553 -1.203 . . . . 0.0 107.97 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.529 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 62.8 t0 -115.86 132.36 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.504 0.668 . . . . 0.0 111.975 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 80.3 mt -113.72 123.68 50.47 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.593 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -130.98 141.0 50.21 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.3 m -105.27 126.31 51.96 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' C ' ' HG ' ' A' ' 285' ' ' SER . 88.2 tttt -102.26 103.72 14.22 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.4 m -100.86 -176.73 3.26 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.77 63.94 0.3 Allowed 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 119.982 -0.687 . . . . 0.0 110.477 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.442 HD22 ' HA ' ' A' ' 37' ' ' ASN . 8.3 m120 53.31 32.4 13.56 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.325 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -81.39 -130.07 1.09 Allowed Glycine 0 C--O 1.234 0.103 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 61' ' ' LYS . 0.8 OUTLIER -56.62 -28.38 60.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 124.354 0.679 . . . . 0.0 110.538 -179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 47.5 88.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.583 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 39.3 m-85 -99.36 118.09 35.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.392 0.615 . . . . 0.0 111.973 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.57 104.9 9.32 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.148 -0.933 . . . . 0.0 108.77 177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.1 m -96.83 155.34 16.82 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -136.76 147.25 46.57 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.935 -0.706 . . . . 0.0 112.529 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.33 114.22 0.75 Allowed Glycine 0 CA--C 1.517 0.202 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 59.4 p -137.1 171.75 14.04 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.56 167.06 21.8 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 124.944 1.403 . . . . 0.0 110.049 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -103.4 126.49 50.59 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.1 p -73.72 -3.74 30.18 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -105.16 -46.65 4.19 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.763 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 52' ' ' THR . 59.6 p -92.07 -18.06 24.14 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.44 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.97 16.71 1.75 Allowed 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.759 -0.588 . . . . 0.0 110.066 -178.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.0 mttt -73.86 170.33 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.488 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 46' ' ' SER . 49.3 t -130.29 107.02 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 124.723 1.209 . . . . 0.0 110.194 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 46' ' ' SER . 80.4 p -119.43 134.14 55.36 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 119.18 0.9 . . . . 0.0 109.898 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.55 -156.09 9.92 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.427 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.2 p -173.94 163.51 4.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.467 0.651 . . . . 0.0 111.537 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 58' ' ' LEU . 91.1 mt -129.92 108.65 10.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.609 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -115.98 117.77 31.05 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.522 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 72.3 m -130.85 116.06 17.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.28 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 39' ' ' LEU . 98.9 mttt -125.48 127.43 46.47 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.816 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.529 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 3.1 t80 -103.2 107.36 18.14 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' THR . 99.3 mtt180 -108.06 82.06 1.58 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 66' ' ' GLU . 89.5 m95 -70.38 71.66 0.45 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 174.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 63' ' ' ARG . 69.5 p -47.16 -4.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 64' ' ' TRP . 84.3 tt0 -80.62 -79.91 0.15 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.471 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -75.29 23.37 0.11 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.02 51.46 19.29 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.066 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 HD23 HG22 ' A' ' 87' ' ' VAL . 23.5 mt -106.52 82.02 1.67 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 117.33 0.565 . . . . 0.0 111.952 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -75.07 95.73 3.1 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.277 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 85' ' ' ILE . 4.9 m-85 -103.2 81.94 2.01 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -88.05 142.0 28.13 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.158 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.51 122.75 56.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.252 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -119.04 104.97 10.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.358 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.556 ' CE2' HD22 ' A' ' 81' ' ' LEU . 3.8 m0 -116.65 131.94 56.82 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -132.08 156.78 45.71 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.218 0.532 . . . . 0.0 110.185 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.6 p -61.75 -34.92 76.69 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.628 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 66.5 t0 -57.47 -12.42 2.62 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m120 99.7 6.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.702 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.3 m -69.91 125.07 25.67 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.735 HD12 ' OG ' ' A' ' 104' ' ' SER . 44.5 mt -120.49 113.66 20.63 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.34 123.37 3.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 119.537 -1.316 . . . . 0.0 112.625 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 87.8 m -124.72 130.6 52.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.917 0.389 . . . . 0.0 110.208 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -119.6 122.27 41.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.611 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 71' ' ' PHE . 68.3 mt -111.45 108.59 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -122.22 126.16 47.63 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG22 HD23 ' A' ' 69' ' ' LEU . 11.3 t -114.81 105.81 19.38 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -95.33 153.72 17.54 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.36 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 63.92 39.65 7.97 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.543 ' HB2' HD23 ' A' ' 95' ' ' LEU . 88.0 mt-30 -69.04 -40.29 78.68 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 57.7 tp -91.41 -56.74 3.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 162.3 -39.49 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.51 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -74.26 -77.94 0.11 Allowed 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.83 93.42 0.12 Allowed Glycine 0 C--O 1.212 -1.269 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.543 HD23 ' HB2' ' A' ' 90' ' ' GLN . 52.1 tp -125.36 123.58 39.68 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.956 -0.622 . . . . 0.0 109.627 179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -124.6 121.94 36.17 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.106 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.14 104.97 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.497 HG22 ' O ' ' A' ' 98' ' ' THR . 54.9 m -111.22 99.3 8.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.44 ' HE2' ' HB1' ' A' ' 112' ' ' ALA . 35.8 t80 -84.12 135.66 34.3 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -118.95 146.16 45.2 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.518 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.1 t -136.41 115.42 12.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.099 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.497 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -128.8 112.48 14.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.73 0.776 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' CE1' ' OG ' ' A' ' 102' ' ' SER . 1.9 m-85 78.84 165.11 0.21 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.842 178.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.735 ' OG ' HD12 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -117.38 160.94 35.78 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 121.09 0.471 . . . . 0.0 112.203 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' A' ' 107' ' ' THR . 91.7 Cg_exo -39.53 135.89 1.19 Allowed 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 123.598 2.866 . . . . 0.0 113.372 178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 49.8 5.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.708 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 105' ' ' PRO . 76.4 m -127.21 86.3 2.48 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.08 14.51 74.63 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.59 112.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.871 0.367 . . . . 0.0 110.952 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -60.92 128.97 39.11 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.522 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -117.9 104.72 11.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' A' ' 99' ' ' PHE . . . -114.33 109.87 19.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.622 -178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -111.6 146.02 38.13 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 93.3 mt -119.24 109.22 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' NZ ' ' OD1' ' A' ' 9' ' ' ASP . 21.4 tttt -111.25 125.41 53.79 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.216 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 64.3 m -130.97 119.07 21.56 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.171 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -119.2 117.1 3.53 Favored Glycine 0 N--CA 1.433 -1.538 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.282 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -105.43 125.76 51.35 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.236 -0.982 . . . . 0.0 108.512 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -112.02 162.57 15.23 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.132 -1.394 . . . . 0.0 111.104 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 121' ' ' GLU . 72.7 ttt-85 -179.94 100.28 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 123' ' ' ILE . 97.7 mt-10 41.74 108.69 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 31.7 m170 54.43 -21.61 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 96.6 mt -99.35 112.57 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.885 0.766 . . . . 0.0 112.987 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.481 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -122.37 120.55 34.32 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.471 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 76.8 mt -122.9 120.07 32.37 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.989 -178.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -115.45 145.96 18.76 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 120.004 1.274 . . . . 0.0 110.92 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 2.8 t -125.28 102.31 7.39 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -99.29 112.07 24.31 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 124.111 0.882 . . . . 0.0 110.662 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.0 mtm -109.45 99.79 8.96 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.996 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -81.77 116.64 21.56 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.587 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -89.72 87.25 6.92 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.588 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.9 t0 -116.2 171.03 8.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -63.7 -40.61 89.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.138 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.84 4.0 43.04 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.39 -179.21 31.2 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 105.793 -2.923 . . . . 0.0 105.793 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.35 134.45 5.49 Favored 'Cis proline' 0 N--CA 1.509 2.407 0 CA-C-N 121.96 2.88 . . . . 0.0 115.464 0.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.7 m -113.86 130.87 56.44 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 87.7 mt -101.0 104.85 16.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 119.969 -0.693 . . . . 0.0 110.331 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.479 ' NH1' HD21 ' A' ' 156' ' ' ASN . 85.0 mtt85 -105.56 101.69 11.2 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.808 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -95.59 153.64 20.74 Favored Glycine 0 C--O 1.214 -1.114 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.71 114.04 10.82 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-N 117.883 0.841 . . . . 0.0 109.111 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.509 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 85.9 mt -90.2 128.37 36.36 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 5' ' ' PRO . 39.8 t -124.55 125.45 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 119.446 1.021 . . . . 0.0 109.497 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.1 mt -118.22 129.95 55.79 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -133.91 104.8 0.54 Allowed Glycine 0 C--N 1.337 0.635 0 C-N-CA 119.464 -1.35 . . . . 0.0 112.15 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' GLY . 64.6 t80 -121.33 111.61 17.55 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 118.168 0.984 . . . . 0.0 112.071 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 61.14 -67.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.079 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . -150.06 30.88 1.09 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.966 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.535 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 20.2 m95 -125.93 116.19 21.1 Favored 'General case' 0 C--O 1.208 -1.093 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.45 107.24 12.65 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -134.76 158.59 43.75 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.506 1.048 . . . . 0.0 109.458 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.75 168.82 31.76 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.958 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -128.98 123.77 33.32 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.698 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 51.5 tt0 -114.84 120.05 38.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.386 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 66.8 ttp -113.15 120.42 41.2 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 123.313 0.383 . . . . 0.0 111.252 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.479 HD21 ' NH1' ' A' ' 139' ' ' ARG . 54.4 t-20 -100.74 119.42 38.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CD1' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -109.41 95.32 5.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.244 -179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.2 mt-10 -73.19 96.09 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 77.3 p -68.15 -33.88 75.3 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.53 84.32 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.742 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -98.98 -13.03 20.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.7 m 55.09 55.5 7.56 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.304 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -128.54 128.03 43.51 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.703 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.467 ' CG2' ' CD1' ' A' ' 157' ' ' PHE . 42.8 t -104.75 123.64 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 164' ' ' VAL . 37.0 p -158.45 -57.36 0.07 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.781 0.8 . . . . 0.0 110.661 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.19 108.43 3.15 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.555 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 35.2 p -142.48 152.04 42.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.591 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.428 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 19.2 m-20 -127.53 139.44 52.78 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 120.154 -0.618 . . . . 0.0 112.57 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -103.13 111.59 24.03 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.3 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.68 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -94.08 129.3 40.67 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.645 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.6 t -132.24 110.77 16.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 O-C-N 123.642 0.589 . . . . 0.0 109.604 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -119.41 147.09 18.26 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.055 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.7 ' HB2' HD12 ' A' ' 180' ' ' LEU . 11.4 m-85 -121.79 130.43 53.4 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 tttt -98.41 146.74 25.42 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.515 ' OG1' ' CD2' ' A' ' 178' ' ' PHE . 2.3 p -123.83 163.94 20.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.261 -1.79 . . . . 0.0 106.618 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -44.96 -46.18 10.93 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -124.75 -10.28 7.28 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.624 ' CD1' ' NE2' ' A' ' 196' ' ' GLN . 0.1 OUTLIER -112.77 148.27 35.15 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -116.53 143.23 45.85 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 173' ' ' TYR . 82.0 mt -111.22 114.85 28.37 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -118.8 104.14 10.29 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 72.7 p -121.76 145.7 47.78 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 22.6 p-10 -150.4 153.74 36.52 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.888 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.674 HG13 ' CE2' ' A' ' 190' ' ' PHE . 39.1 t -105.87 116.1 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -97.26 113.85 25.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.877 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 57.34 26.17 12.11 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 125.302 1.626 . . . . 0.0 112.891 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 63.78 13.11 50.66 Favored Glycine 0 N--CA 1.461 0.353 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 10.5 m -120.28 -75.86 0.58 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -98.41 113.99 26.17 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.238 -0.914 . . . . 0.0 112.938 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.674 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -91.82 143.4 26.55 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.646 -0.659 . . . . 0.0 111.416 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -106.58 168.27 14.52 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 208' ' ' LEU . . . -159.32 140.43 6.84 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.9 157.24 41.56 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.993 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 62.1 mt -132.04 114.2 23.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.779 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.492 ' CD1' ' OG ' ' A' ' 13' ' ' SER . 16.2 t80 -105.58 123.08 47.33 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.624 ' NE2' ' CD1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -119.4 117.68 29.15 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.85 -178.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 198' ' ' VAL . 65.2 tttm -88.01 114.73 24.91 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 197' ' ' LYS . 3.9 t 24.84 106.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.523 ' ND2' ' OE1' ' A' ' 196' ' ' GLN . 63.0 t30 -132.57 79.42 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.136 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.1 tttt 67.12 7.03 5.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.29 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.548 ' O ' ' CB ' ' A' ' 202' ' ' LEU . 99.5 mttt -139.16 -60.09 0.58 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.548 ' CB ' ' O ' ' A' ' 201' ' ' LYS . 1.0 OUTLIER 150.51 -90.74 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.068 0.855 . . . . 0.0 110.448 -177.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.617 ' O ' HG23 ' A' ' 204' ' ' THR . 79.6 tt0 -109.6 135.98 49.71 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.617 HG23 ' O ' ' A' ' 203' ' ' GLU . 3.0 p -159.66 127.61 4.85 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.609 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.472 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.94 152.15 32.15 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.223 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 39.1 t -127.26 134.38 66.03 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.461 HD22 ' CB ' ' A' ' 18' ' ' PHE . 92.9 m-20 -113.87 130.67 56.46 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.856 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 192' ' ' GLY . 1.5 mp -125.33 109.63 13.02 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.305 0.378 . . . . 0.0 110.877 178.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -120.98 142.25 49.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.602 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -133.38 -175.06 3.68 Favored 'General case' 0 N--CA 1.457 -0.113 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.52 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 85.0 m -147.78 104.51 3.6 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.699 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -44.36 114.29 0.66 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.72 0.771 . . . . 0.0 111.433 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 124.11 -26.83 5.75 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -108.36 140.16 42.04 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 87.4 p -89.61 -2.82 58.42 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -104.23 140.08 38.34 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 119.229 0.922 . . . . 0.0 113.103 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.35 117.64 34.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.571 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -80.45 114.67 19.51 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.758 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.522 ' CZ ' ' OD1' ' A' ' 239' ' ' ASN . 7.2 p90 -138.37 144.55 40.34 Favored 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.471 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.632 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -121.74 148.78 17.23 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 113.009 -1.905 . . . . 0.0 111.928 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.4 103.9 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.73 120.02 38.46 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 119.974 -0.691 . . . . 0.0 111.451 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.08 121.77 32.44 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.7 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -106.34 112.96 26.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -99.49 104.32 16.14 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 228' ' ' ASP . 57.3 tp60 -73.12 107.53 5.51 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 231' ' ' ALA 0.452 1.0 OUTLIER -93.22 -46.81 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 119.496 -0.881 . . . . 0.0 112.415 -175.616 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.527 ' O ' ' NE2' ' A' ' 226' ' ' GLN . 0.2 OUTLIER -135.58 179.61 1.33 Allowed Pre-proline 0 C--N 1.314 -0.941 0 N-CA-C 103.684 -2.709 . . . . 0.0 103.684 171.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -64.11 -19.41 66.13 Favored 'Trans proline' 0 C--N 1.298 -2.13 0 CA-C-N 121.894 1.712 . . . . 0.0 112.686 -178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -109.35 9.73 25.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 227' ' ' ILE . . . -134.29 137.91 44.61 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 119.106 0.866 . . . . 0.0 112.59 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.498 ' SG ' ' OE1' ' A' ' 226' ' ' GLN . 1.2 m -143.7 116.08 8.54 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.276 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -95.7 109.66 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 122.168 -0.332 . . . . 0.0 110.924 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 6.0 t -107.52 113.91 27.55 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 110.425 -0.213 . . . . 0.0 110.425 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -125.45 151.41 46.27 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -135.86 112.61 10.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.023 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.432 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 20.4 t -96.1 113.13 29.74 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 CA-C-O 118.84 -0.6 . . . . 0.0 110.641 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 45.2 p-10 -98.15 160.48 14.27 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.298 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.522 ' OD1' ' CZ ' ' A' ' 219' ' ' PHE . 1.9 m120 -90.69 3.57 53.87 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.582 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.454 ' O ' ' CB ' ' A' ' 241' ' ' SER . 9.0 t -84.88 4.52 32.95 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.454 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.7 p 88.68 25.66 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 113.666 -1.606 . . . . 0.0 113.511 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 3.0 mp -117.6 121.54 41.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.729 0.695 . . . . 0.0 111.598 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 78.1 mt -105.32 136.09 40.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.487 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.563 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -115.24 142.22 17.48 Favored Glycine 0 N--CA 1.465 0.62 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.868 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 54.0 mt -124.74 116.03 21.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -128.23 106.84 0.81 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.714 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -93.64 113.52 25.63 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.027 -0.69 . . . . 0.0 110.523 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 7.7 m -97.62 126.67 43.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.242 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -123.63 109.97 14.41 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.32 0.387 . . . . 0.0 111.464 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 91.4 m -107.99 110.86 22.68 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 252' ' ' LYS . 44.1 tp -112.07 121.64 45.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 251' ' ' LEU . 50.2 tttm 56.61 104.56 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.46 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.427 ' C ' ' O ' ' A' ' 252' ' ' LYS . 68.8 Cg_exo -36.22 101.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.916 1.744 . . . . 0.0 111.875 -177.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 154.67 -31.58 0.68 Allowed Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.887 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.9 mt -121.05 120.77 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 117.714 0.757 . . . . 0.0 112.112 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -114.95 124.1 50.83 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.544 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 59.7 tp -123.31 101.81 7.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.717 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 86.7 m -116.05 132.11 56.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 79.5 mt -100.17 140.28 34.64 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 3.0 p -131.6 142.26 49.84 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.028 0.442 . . . . 0.0 111.572 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.01 109.89 3.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.233 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 103.04 11.76 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 82.6 mt -96.22 120.33 36.31 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.263 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.429 ' O ' ' C ' ' A' ' 265' ' ' GLY . 8.1 t0 -77.91 110.29 12.69 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 264' ' ' ASP . . . -11.22 -89.37 0.01 OUTLIER Glycine 0 N--CA 1.483 1.832 0 CA-C-N 115.224 -0.898 . . . . 0.0 115.026 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -89.12 5.26 45.38 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-N 117.137 0.469 . . . . 0.0 111.395 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 264' ' ' ASP . 61.1 t30 62.98 -5.94 0.19 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.62 -39.64 27.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.02 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.51 -45.72 89.33 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.998 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -87.23 -36.3 18.04 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.86 -5.92 84.13 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 119.44 -1.362 . . . . 0.0 112.479 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.532 ' O ' ' CD2' ' A' ' 273' ' ' HIS . . . -159.46 -151.32 6.1 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.939 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . 0.532 ' CD2' ' O ' ' A' ' 272' ' ' GLY . 33.6 m170 -142.44 119.3 11.22 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.136 0.468 . . . . 0.0 110.948 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -66.94 133.52 50.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.767 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.632 ' C ' ' H ' ' A' ' 25' ' ' GLY . 95.2 mt -130.05 123.82 31.4 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.696 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -149.83 132.95 4.2 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 119.764 -1.208 . . . . 0.0 111.823 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.696 HD12 ' C ' ' A' ' 276' ' ' GLY . 10.9 mp -119.2 129.62 55.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -103.32 114.96 5.0 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.651 -0.979 . . . . 0.0 110.651 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 66.5 mt -115.25 104.94 12.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -116.74 123.04 46.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.459 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -110.27 105.29 14.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.615 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -100.54 138.09 38.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.075 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -135.64 147.67 48.69 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.976 0.417 . . . . 0.0 111.806 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -68.17 139.33 56.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . 0.443 ' HG ' ' C ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.834 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.29 149.21 31.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.433 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 3' ' ' VAL . 8.3 p 178.18 74.7 0.13 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.969 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.3 Cg_endo -81.47 169.17 15.77 Favored 'Trans proline' 0 N--CA 1.504 2.094 0 C-N-CA 123.287 2.658 . . . . 0.0 113.812 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.42 -170.08 0.35 Allowed 'Trans proline' 1 N--CA 1.545 4.53 0 C-N-CA 125.255 3.97 . . . . 0.0 117.888 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' TYR . 63.0 p -44.14 130.43 6.14 Favored 'General case' 0 C--N 1.376 1.717 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.654 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -36.68 -48.64 0.72 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -175.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.654 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.84 -39.42 93.54 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 117.778 -1.569 . . . . 0.0 111.072 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' OD2' ' NZ ' ' A' ' 115' ' ' LYS . 86.9 m-20 -68.94 -24.83 64.32 Favored 'General case' 0 C--O 1.249 1.044 0 C-N-CA 117.387 -1.725 . . . . 0.0 109.735 -176.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 ' NE2' ' A' ' 181' ' ' HIS . 44.6 tp -63.52 131.77 49.16 Favored 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 120.921 -1.112 . . . . 0.0 108.848 176.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.18 10.77 65.71 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -57.17 -40.68 77.79 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.0 p -62.85 -43.07 99.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.971 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -62.83 -43.68 98.16 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.073 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -63.6 -40.04 95.91 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.88 -39.47 94.26 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.62 -42.04 94.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 CA-C-N 119.179 0.9 . . . . 0.0 109.515 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 60.5 t80 -62.72 -45.32 93.3 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 20' ' ' LYS . 6.9 p -96.04 167.25 11.34 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.518 ' NZ ' ' NZ ' ' A' ' 74' ' ' LYS . 98.6 mttt 45.83 -174.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.7 24.94 68.52 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 118.861 -1.638 . . . . 0.0 110.565 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -139.84 160.39 40.01 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . -119.52 -43.93 0.48 Allowed Glycine 0 CA--C 1.532 1.128 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 57.1 m-85 18.74 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.72 -32.55 5.79 Favored Glycine 0 CA--C 1.518 0.277 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.274 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -120.58 128.33 52.95 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.531 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.6 mt -84.02 123.01 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 103.391 -2.818 . . . . 0.0 103.391 177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -113.02 137.93 50.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.181 -1.372 . . . . 0.0 112.826 -174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.65 121.32 44.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.908 -1.042 . . . . 0.0 108.356 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 61.4 t0 -121.08 132.55 54.94 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.609 0.718 . . . . 0.0 111.535 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 55.4 mt -109.86 119.7 40.16 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -117.04 132.32 56.72 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -134.79 120.24 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -116.23 124.79 51.12 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -100.76 125.92 47.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.63 -6.25 30.1 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.315 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -68.17 -34.71 76.81 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.48 -44.98 0.56 Allowed Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.656 HD22 ' CE2' ' A' ' 41' ' ' PHE . 38.9 mt -61.69 139.05 58.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 122.575 1.179 . . . . 0.0 113.266 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.87 94.16 3.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 112.821 -1.991 . . . . 0.0 108.581 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.656 ' CE2' HD22 ' A' ' 39' ' ' LEU . 43.0 m-85 -104.59 111.81 24.64 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 119.574 -0.851 . . . . 0.0 111.835 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 m -121.15 105.01 10.19 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.913 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 m -88.11 152.82 21.73 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -137.03 147.35 46.14 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.75 -0.78 . . . . 0.0 112.671 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.34 130.47 3.57 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.018 -2.033 . . . . 0.0 108.018 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.679 ' O ' HG13 ' A' ' 54' ' ' VAL . 3.5 t -131.99 172.1 12.76 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.77 151.49 38.04 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 36.2 t30 -82.0 140.11 34.14 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 m -40.28 -27.78 0.05 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.474 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.598 ' C ' HG23 ' A' ' 51' ' ' THR . 98.6 mt-10 -101.68 -3.61 27.96 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.443 0.565 . . . . 0.0 111.289 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.598 HG23 ' C ' ' A' ' 50' ' ' GLU . 2.5 p 76.8 22.28 1.13 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 p -87.38 -21.25 25.76 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.283 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -138.01 144.98 41.34 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-O 120.696 0.284 . . . . 0.0 111.076 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' SER . 9.8 t -129.05 106.84 14.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.045 0.538 . . . . 0.0 110.252 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.44 ' O ' ' CB ' ' A' ' 46' ' ' SER . 52.8 p -100.05 133.95 43.68 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.938 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.01 -164.91 12.74 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 p -174.61 156.57 2.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.445 0.64 . . . . 0.0 111.604 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.5 mt -130.16 110.56 11.68 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.056 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.41 117.64 34.69 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.566 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 55.1 m -130.12 105.4 7.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.698 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -126.13 147.34 49.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.482 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 6.7 t80 -121.55 111.63 17.48 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -112.29 88.1 2.73 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.482 ' NE1' ' CE2' ' A' ' 62' ' ' TYR . 67.7 m95 -73.78 84.6 1.66 Allowed 'General case' 0 C--N 1.344 0.341 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 174.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.5 p -56.4 -1.43 0.05 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.446 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' TRP . 95.8 mt-10 -84.14 -78.76 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.678 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -76.61 25.04 0.14 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 49.36 49.94 30.64 Favored Glycine 0 N--CA 1.467 0.736 0 CA-C-O 119.517 -0.601 . . . . 0.0 112.731 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 87' ' ' VAL . 15.6 mt -109.37 98.18 7.63 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 m -96.2 105.04 17.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.242 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' CD1' HG23 ' A' ' 85' ' ' ILE . 7.2 m-85 -103.88 86.55 2.61 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -87.93 134.57 33.69 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.164 -176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.7 123.92 58.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 O-C-N 123.836 0.71 . . . . 0.0 109.932 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' NZ ' ' NZ ' ' A' ' 20' ' ' LYS . 86.4 tttt -121.38 114.74 21.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.799 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -120.78 124.1 44.27 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -121.25 170.14 9.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.049 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.451 ' C ' ' H ' ' A' ' 79' ' ' ASN . 56.7 p -65.26 -35.02 79.74 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.493 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -57.51 -7.64 0.67 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.343 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 77' ' ' THR . 46.8 m-20 92.71 1.64 0.09 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.955 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 24.5 m -63.92 125.54 24.73 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.97 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.1 mt -120.61 109.63 15.47 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.01 132.09 6.87 Favored Glycine 0 C--O 1.222 -0.627 0 C-N-CA 119.543 -1.313 . . . . 0.0 112.563 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.4 m -128.58 123.97 34.73 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.43 127.07 52.75 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.032 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.629 HG23 ' CD1' ' A' ' 71' ' ' PHE . 93.2 mt -113.4 119.49 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.4 m -126.98 127.64 45.14 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 2.2 t -114.77 104.49 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.24 145.66 24.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.382 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 61.58 40.73 13.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.609 ' HB2' HD23 ' A' ' 95' ' ' LEU . 72.9 mt-30 -51.35 -37.52 48.34 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 6.7 tp 166.12 56.27 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.985 0.897 . . . . 0.0 110.067 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -161.47 -150.58 0.2 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.526 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -81.02 -42.64 20.8 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.6 95.14 0.12 Allowed Glycine 0 CA--C 1.534 1.244 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 90' ' ' GLN . 39.6 tp -115.55 115.18 26.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.618 -0.791 . . . . 0.0 108.996 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.92 125.18 46.77 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.64 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.457 ' HB2' HE22 ' A' ' 90' ' ' GLN . 43.2 tp -119.14 106.51 12.45 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' THR . 38.7 m -111.15 99.61 8.42 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -82.99 136.76 34.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -120.0 142.17 49.03 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.642 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.446 ' HG ' ' HE2' ' A' ' 103' ' ' PHE . 13.0 t -137.34 108.91 6.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.836 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.49 105.33 10.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.664 0.745 . . . . 0.0 110.176 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HE2' ' HG ' ' A' ' 101' ' ' SER . 3.7 m-85 -104.93 99.17 8.81 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.722 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -125.68 161.09 52.84 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.5 Cg_exo -38.79 -179.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 124.036 3.158 . . . . 0.0 113.129 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -51.9 -32.26 31.82 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.686 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 63.4 p -64.05 -35.95 82.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.166 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 104' ' ' SER . . . -131.75 80.68 0.33 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 108' ' ' GLY . 99.1 mttt -54.19 -159.0 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.929 0.395 . . . . 0.0 111.326 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -84.08 131.85 34.76 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.195 0.522 . . . . 0.0 111.324 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -120.96 128.8 53.08 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.551 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.52 110.59 11.09 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -117.71 145.8 44.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 98.1 mt -118.56 106.55 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.545 ' NZ ' ' OD2' ' A' ' 9' ' ' ASP . 19.9 tttt -105.93 125.83 51.46 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.6 m -130.41 112.14 12.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 125' ' ' LEU . . . -116.8 129.83 8.61 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.386 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.505 ' CE1' ' O ' ' A' ' 119' ' ' LYS . 28.5 t80 -121.24 133.88 55.17 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 122.076 0.941 . . . . 0.0 108.975 178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.505 ' O ' ' CE1' ' A' ' 118' ' ' TYR . 97.8 mttt -109.35 154.13 22.97 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.945 -177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 121' ' ' GLU . 76.7 ttt-85 -175.61 98.21 0.07 Allowed 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' O ' ' A' ' 120' ' ' ARG . 98.9 mt-10 40.34 110.18 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 49.01 -7.71 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.528 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.3 mt -109.79 112.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.935 0.789 . . . . 0.0 113.096 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 7.8 t-20 -121.9 120.8 35.55 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.43 ' O ' ' HA2' ' A' ' 117' ' ' GLY . 79.0 mt -122.65 115.47 22.16 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.16 -0.924 . . . . 0.0 111.112 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -112.59 144.16 17.83 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-N 119.88 1.218 . . . . 0.0 111.4 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 10.2 t -124.85 102.96 7.8 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.509 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -102.27 109.13 20.72 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.905 0.753 . . . . 0.0 110.42 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.5 mtp -106.46 105.91 16.17 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.472 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -86.49 107.69 18.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.582 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -87.61 85.89 7.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.685 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -124.17 168.72 12.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.45 -41.49 92.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.805 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.56 -32.02 67.63 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -71.75 -175.09 22.98 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 106.566 -2.614 . . . . 0.0 106.566 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -54.05 124.74 0.7 Allowed 'Cis proline' 0 N--CA 1.51 2.46 0 CA-C-N 121.652 2.726 . . . . 0.0 115.566 -1.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 66.1 m -113.39 125.76 54.61 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 155' ' ' MET . 82.0 mt -100.72 104.15 15.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.482 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -106.24 102.14 11.57 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -103.3 158.35 17.45 Favored Glycine 0 C--O 1.215 -1.066 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.8 118.34 15.88 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.588 0.694 . . . . 0.0 109.356 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.614 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 48.1 mt -102.45 106.71 17.5 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.231 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 19.5 t -106.13 128.04 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.832 0.825 . . . . 0.0 109.305 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 92.8 mt -121.89 141.08 51.63 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.147 -1.388 . . . . 0.0 109.479 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -105.9 151.52 17.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.186 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 0.8 OUTLIER -146.5 75.09 1.38 Allowed 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 57.55 32.61 22.09 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 125.67 -17.33 6.88 Favored Glycine 0 C--N 1.323 -0.188 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.719 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.2 m0 -91.53 134.58 34.53 Favored 'General case' 0 CA--C 1.5 -0.956 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.333 -178.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -121.45 115.47 22.94 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -122.02 140.66 52.21 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -128.34 151.92 18.99 Favored Glycine 0 C--N 1.34 0.766 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.36 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -127.41 114.79 17.98 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.741 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -111.32 119.5 39.08 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.557 -178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.4 ' O ' ' O ' ' A' ' 138' ' ' ILE . 79.3 mtm -110.46 121.7 45.94 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -101.99 115.71 31.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 164' ' ' VAL . 1.2 t80 -107.23 95.72 5.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.005 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 162' ' ' SER . 84.8 tt0 -74.69 96.2 2.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 72.6 p -66.8 -31.03 71.4 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.57 91.85 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 119.803 -0.759 . . . . 0.0 109.944 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -101.62 -11.47 19.19 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.4 m 54.24 58.13 5.26 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 114.768 -1.106 . . . . 0.0 109.219 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -127.27 132.05 50.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.924 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 157' ' ' PHE . 94.9 t -104.47 102.21 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.3 p -132.72 -59.28 0.91 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.826 0.822 . . . . 0.0 110.879 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -66.32 108.44 2.33 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.817 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.9 p -142.42 151.24 41.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.623 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.452 ' ND2' ' OE1' ' A' ' 154' ' ' GLN . 68.4 m-20 -127.84 135.78 50.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.533 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -102.63 111.55 23.92 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -91.93 131.83 36.95 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.281 -0.567 . . . . 0.0 109.901 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 50.2 t -131.94 112.83 20.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -129.86 153.0 19.83 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-O 121.945 0.747 . . . . 0.0 113.165 -177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.733 ' HB2' HD12 ' A' ' 180' ' ' LEU . 86.0 m-85 -131.06 130.05 42.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -100.99 146.94 26.76 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.269 1.033 . . . . 0.0 113.655 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.623 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 22.2 p -127.93 146.11 50.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.377 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -47.99 -7.78 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 175' ' ' THR . 88.8 mt-10 -139.08 -35.32 0.56 Allowed 'General case' 0 C--O 1.241 0.629 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.623 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.3 OUTLIER -110.62 146.08 36.77 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.948 -175.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -116.12 138.1 51.54 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.371 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 173' ' ' TYR . 73.3 mt -109.44 108.09 18.47 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.517 ' NE2' HD21 ' A' ' 10' ' ' LEU . 34.1 m170 -118.85 107.88 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.548 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 44.2 p -123.26 148.72 45.59 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 183' ' ' ASN . 0.3 OUTLIER -139.4 138.8 36.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 119.313 0.961 . . . . 0.0 109.906 178.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.493 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.5 t -96.07 122.0 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -96.64 112.15 24.01 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.88 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 56.02 22.21 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 125.261 1.6 . . . . 0.0 113.253 179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 70.32 17.29 74.12 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.856 -1.297 . . . . 0.0 109.856 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 23.3 m -123.7 -71.17 0.73 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -101.63 120.01 39.66 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.648 -0.821 . . . . 0.0 113.133 -177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.548 ' HE2' ' HB2' ' A' ' 212' ' ' ALA . 11.6 m-85 -87.49 150.48 23.72 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.129 -0.357 . . . . 0.0 110.294 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.406 ' O ' ' OD1' ' A' ' 183' ' ' ASN . . . -179.06 141.85 5.05 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.197 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -177.11 -173.83 43.0 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 p -122.51 169.6 10.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.489 0.662 . . . . 0.0 112.711 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 208' ' ' LEU . 80.0 mt -131.15 106.12 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.192 176.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -83.76 121.18 26.96 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.444 ' OE1' ' CG2' ' A' ' 198' ' ' VAL . 35.9 tt0 -123.55 108.24 12.41 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -94.58 96.24 9.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.444 ' CG2' ' OE1' ' A' ' 196' ' ' GLN . 86.9 t -75.78 -43.93 39.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.617 -175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.443 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 81.9 m-20 -161.87 -171.17 2.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.2 -41.8 98.7 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.038 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -95.71 -11.4 27.12 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.428 HD23 HG11 ' A' ' 198' ' ' VAL . 48.6 tp -117.74 111.41 19.07 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -119.35 110.71 17.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.822 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.7 p -119.57 155.31 32.47 Favored 'General case' 0 C--N 1.316 -0.859 0 O-C-N 121.439 -0.788 . . . . 0.0 110.262 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.702 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -139.96 125.2 18.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.107 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 220' ' ' GLY . 21.4 t -102.33 132.77 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.444 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.2 m-20 -108.09 131.59 54.46 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 194' ' ' ILE . 64.4 mt -114.11 110.79 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 123.731 0.645 . . . . 0.0 111.247 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.09 125.32 44.96 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.286 0.366 . . . . 0.0 110.771 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.513 ' CZ2' ' CD1' ' A' ' 190' ' ' PHE . 3.2 p90 -142.23 172.48 12.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 76.6 p -131.82 114.66 14.97 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.492 -177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.548 ' HB2' ' HE2' ' A' ' 190' ' ' PHE . . . -46.74 131.87 11.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 122.003 0.906 . . . . 0.0 111.732 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 103.94 -28.29 15.92 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.632 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -102.98 141.88 35.03 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 85.1 p -90.24 -4.44 57.19 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -98.37 129.47 45.03 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 119.346 0.975 . . . . 0.0 113.386 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 87.7 m -103.57 116.37 32.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.683 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -79.59 114.17 18.3 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 118.661 -1.216 . . . . 0.0 107.835 175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -133.95 146.37 50.41 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.223 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 206' ' ' VAL . . . -114.98 156.48 15.63 Favored Glycine 0 C--O 1.226 -0.392 0 CA-C-N 113.426 -1.715 . . . . 0.0 111.607 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 95.8 mt -127.59 103.49 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -102.18 123.53 46.18 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.018 -0.673 . . . . 0.0 111.184 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.24 122.91 43.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.73 98.74 8.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.523 ' CD2' HG22 ' A' ' 227' ' ' ILE . 43.1 t80 -100.09 98.34 9.07 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.244 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -73.08 118.28 15.85 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.523 HG22 ' CD2' ' A' ' 225' ' ' TYR 0.407 0.2 OUTLIER -92.75 -47.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 117.637 -1.625 . . . . 0.0 112.532 -176.499 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -135.65 177.7 2.1 Favored Pre-proline 0 C--N 1.315 -0.905 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 173.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -64.13 -16.95 57.85 Favored 'Trans proline' 0 C--N 1.295 -2.269 0 CA-C-N 121.643 1.622 . . . . 0.0 112.58 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 230' ' ' ASP . 20.6 p-10 -108.94 1.9 21.03 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -178.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -144.67 144.56 31.3 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.609 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 41.5 t -149.17 149.51 31.14 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.81 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -116.97 116.0 26.54 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.352 -0.217 . . . . 0.0 111.228 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 38.1 t -107.55 114.48 28.5 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -126.14 149.06 49.23 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.298 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.2 mttt -135.5 119.31 17.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.959 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.45 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 2.8 t -103.03 117.56 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 119.088 -0.482 . . . . 0.0 109.99 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.908 HD21 HD13 ' A' ' 242' ' ' LEU . 52.2 p-10 -101.72 160.38 14.51 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -90.32 4.19 51.49 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 119.565 -0.854 . . . . 0.0 112.669 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.481 ' OG ' ' CD1' ' A' ' 242' ' ' LEU . 2.2 p -84.4 2.72 39.32 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 240' ' ' SER . 1.2 m 88.78 31.15 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 113.369 -1.741 . . . . 0.0 113.661 178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.908 HD13 HD21 ' A' ' 238' ' ' ASN . 2.8 mp -120.21 118.68 31.13 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.663 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 88.7 mt -97.74 133.28 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.664 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -112.99 141.56 16.96 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.143 -1.027 . . . . 0.0 110.689 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 67.5 mt -124.56 119.81 30.16 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -131.87 106.89 0.69 Allowed Glycine 0 CA--C 1.525 0.707 0 C-N-CA 119.706 -1.235 . . . . 0.0 113.05 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -91.52 122.95 34.56 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.058 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 52.6 m -112.04 127.75 55.98 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 123.427 0.455 . . . . 0.0 110.396 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -122.97 116.67 23.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.21 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 80.8 m -111.84 124.54 52.57 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.403 HD12 ' HB ' ' A' ' 255' ' ' ILE . 2.2 mt -102.65 144.07 31.51 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.195 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -44.83 -53.45 15.63 Favored Pre-proline 0 N--CA 1.477 0.888 0 O-C-N 124.733 1.27 . . . . 0.0 107.941 176.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 86.3 Cg_exo -39.9 -15.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.78 2.32 . . . . 0.0 112.782 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 93.77 38.25 5.27 Favored Glycine 0 N--CA 1.464 0.547 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.067 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 251' ' ' LEU . 96.2 mt -123.06 132.2 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -112.74 120.61 42.09 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.362 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 64.5 mt -123.49 103.45 8.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.344 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 19.2 m -116.42 138.85 51.03 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.23 144.57 42.99 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 276' ' ' GLY . 9.6 p -136.41 151.58 49.67 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.865 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.18 118.22 2.61 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' CD ' ' A' ' 274' ' ' LYS . 25.9 tp -112.71 103.3 11.33 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.03 116.33 28.95 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.365 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 267' ' ' ASN . 28.8 t0 -78.83 109.31 12.96 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.74 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.51 95.54 Favored Glycine 0 CA--C 1.54 1.626 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.172 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 268' ' ' VAL . 84.0 mttt -84.33 -10.85 57.25 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.664 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 66.0 t30 58.43 -24.91 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 266' ' ' LYS . 50.3 t -75.71 -34.81 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.235 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -63.82 -45.68 88.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.421 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.82 -35.59 19.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.03 -1.068 . . . . 0.0 108.18 176.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 69.2 -15.08 0.79 Allowed Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.382 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -140.36 -132.03 2.81 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.087 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -141.22 117.5 10.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.899 0.381 . . . . 0.0 111.929 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.57 ' CD ' HD23 ' A' ' 262' ' ' LEU . 92.7 mttt -86.14 118.44 25.6 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.868 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.642 ' C ' ' H ' ' A' ' 25' ' ' GLY . 96.7 mt -133.88 130.51 37.93 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.435 ' O ' ' OG ' ' A' ' 260' ' ' SER . . . -149.83 123.34 1.57 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.996 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 27' ' ' ILE . 16.5 mt -110.77 131.25 55.21 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.69 115.13 4.44 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 62.5 mt -111.06 104.98 13.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -117.37 134.37 54.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.727 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.28 136.67 54.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.116 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -103.21 126.91 50.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.065 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -140.47 154.0 46.46 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.099 0.476 . . . . 0.0 112.056 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -94.65 137.49 33.69 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.713 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.855 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 138.94 53.07 Favored 'General case' 0 C--O 1.251 1.181 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.621 ' CA ' HD21 ' A' ' 124' ' ' ASN . 5.2 m -153.27 66.55 5.95 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.08 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 1.6 Cg_endo -83.54 152.83 13.55 Favored 'Trans proline' 0 CA--C 1.569 2.246 0 C-N-CA 123.109 2.54 . . . . 0.0 113.905 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 10' ' ' LEU . 35.6 Cg_endo -69.47 -166.07 0.17 Allowed 'Trans proline' 1 N--CA 1.536 4.022 1 C-N-CA 125.596 4.197 . . . . 0.0 117.218 -177.126 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.3 p -45.82 132.89 8.72 Favored 'General case' 0 C--N 1.382 1.979 0 O-C-N 120.578 -1.326 . . . . 0.0 108.03 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.619 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.58 -43.8 0.91 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.496 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.619 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -63.16 -37.22 86.38 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.704 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -69.29 -23.79 63.87 Favored 'General case' 0 C--O 1.254 1.312 0 C-N-CA 117.141 -1.824 . . . . 0.0 109.333 -174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 181' ' ' HIS . 10.6 mp -57.2 138.91 54.05 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 120.04 -1.663 . . . . 0.0 109.36 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.73 8.44 73.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.225 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -54.22 -42.81 70.25 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.1 t -61.26 -45.52 94.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.99 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.05 -42.61 98.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.168 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.447 ' O ' HG23 ' A' ' 19' ' ' THR . 99.7 mtt180 -66.48 -37.14 84.46 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.81 -43.84 95.04 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HB1' ' A' ' 222' ' ' ALA . 64.7 t -64.45 -45.24 96.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.716 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.21 -44.74 82.99 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 15' ' ' ARG . 8.0 p -62.82 109.25 1.38 Allowed 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 21' ' ' GLY . 83.0 tttt -146.36 136.64 23.76 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -56.31 -171.52 0.13 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.537 ' C ' ' O ' ' A' ' 21' ' ' GLY . 98.9 m-85 -26.83 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.38 0.59 . . . . 0.0 110.743 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . 60.66 -64.78 0.01 OUTLIER Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.573 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 22' ' ' TYR . 4.0 m-85 -98.77 120.01 38.49 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.586 -0.361 . . . . 0.0 111.965 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 275' ' ' LEU . . . 131.76 -26.35 3.84 Favored Glycine 0 C--O 1.241 0.559 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.329 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.41 124.56 50.33 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.0 mt -84.09 120.96 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -114.21 139.89 49.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.062 -1.427 . . . . 0.0 113.286 -174.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.9 mt -105.88 118.05 35.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.544 -1.207 . . . . 0.0 107.804 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.526 ' OD2' HG23 ' A' ' 42' ' ' THR . 7.8 t0 -115.09 130.5 56.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.228 0.537 . . . . 0.0 111.061 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 74.7 mt -113.73 122.32 46.77 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.081 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 283' ' ' ALA . 98.9 mttt -116.05 132.63 56.6 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.9 m -122.61 128.31 50.52 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -111.36 110.76 21.37 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.524 -0.735 . . . . 0.0 111.884 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 t -86.48 168.75 13.46 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -55.55 -34.98 65.22 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.426 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.23 157.65 35.5 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -80.1 23.62 3.79 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.409 -179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.465 ' C ' ' O ' ' A' ' 61' ' ' LYS . 55.3 mt -57.47 -21.62 38.42 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 116.891 0.345 . . . . 0.0 110.701 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 39' ' ' LEU . 96.9 mt-10 39.56 91.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.355 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.48 ' CE1' ' OG1' ' A' ' 60' ' ' THR . 38.8 m-85 -97.71 121.62 39.84 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.496 0.665 . . . . 0.0 111.315 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.526 HG23 ' OD2' ' A' ' 30' ' ' ASP . 2.2 m -123.18 105.33 9.8 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.034 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -87.32 152.57 22.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.3 m -129.95 146.52 51.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.455 0.645 . . . . 0.0 112.434 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.06 109.87 0.42 Allowed Glycine 0 C--O 1.224 -0.516 0 N-CA-C 107.628 -2.189 . . . . 0.0 107.628 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 55' ' ' THR . 83.1 p -138.25 171.51 14.28 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.03 166.86 22.07 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 124.89 1.369 . . . . 0.0 109.922 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -104.25 126.73 51.6 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 58.6 p -73.91 -2.83 25.55 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 119.249 -0.98 . . . . 0.0 113.12 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -105.34 -46.91 4.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.865 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' THR . 33.4 p -90.46 -17.94 26.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.3 OUTLIER 76.76 15.65 1.99 Allowed 'General case' 0 N--CA 1.47 0.549 0 O-C-N 121.826 -0.546 . . . . 0.0 109.988 -178.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 55.6 mtpt -74.98 168.56 19.71 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.383 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' SER . 40.4 t -130.08 106.57 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 46' ' ' SER . 42.9 p -116.54 133.59 55.83 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.211 0.914 . . . . 0.0 110.093 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.89 -156.42 9.96 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.425 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.486 ' OG ' ' N ' ' A' ' 58' ' ' LEU . 1.0 OUTLIER 172.83 170.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.387 0.613 . . . . 0.0 111.461 178.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' N ' ' OG ' ' A' ' 57' ' ' SER . 52.0 mt -130.1 116.26 18.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.418 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -117.89 119.1 33.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.48 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 89.3 m -130.8 121.64 25.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.603 ' O ' ' O ' ' A' ' 38' ' ' GLY . 70.7 tttt -128.12 129.91 47.31 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 122.034 -0.416 . . . . 0.0 111.715 -176.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 64' ' ' TRP . 93.2 t80 -103.07 87.95 3.03 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -103.78 82.13 1.96 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 9.9 m0 -95.21 89.79 5.64 Favored 'General case' 0 N--CA 1.463 0.175 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 173.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 66' ' ' GLU . 80.7 p -57.97 -10.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.145 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 65' ' ' THR . 95.9 mt-10 -45.08 -80.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.796 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -95.37 27.21 3.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.459 -177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 63.2 48.17 81.86 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.353 -0.693 . . . . 0.0 112.716 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 62' ' ' TYR . 13.6 mt -103.24 88.64 3.18 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -105.11 108.38 19.86 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.876 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.508 ' CD2' HG23 ' A' ' 85' ' ' ILE . 1.4 m-30 -108.4 98.02 7.61 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 m -87.81 134.16 33.74 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.722 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.39 119.1 53.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 O-C-N 124.104 0.877 . . . . 0.0 109.766 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -116.88 96.1 5.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.644 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.476 ' CD2' HD22 ' A' ' 81' ' ' LEU . 3.9 m0 -110.05 129.58 55.66 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -131.83 161.76 32.2 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.241 0.543 . . . . 0.0 110.443 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.2 p -61.19 -34.59 75.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.487 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.473 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.1 m-20 -57.55 -14.08 4.69 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.451 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.5 m120 99.85 7.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 O-C-N 124.636 1.21 . . . . 0.0 112.981 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 m -75.01 122.23 23.2 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.796 178.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD22 ' CD2' ' A' ' 75' ' ' TRP . 10.0 mt -120.75 116.91 26.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -131.96 129.5 5.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.405 -1.379 . . . . 0.0 112.754 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 81.0 m -123.25 120.55 33.46 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.835 0.35 . . . . 0.0 110.265 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -119.72 111.61 18.24 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG23 ' CD2' ' A' ' 71' ' ' PHE . 97.1 mt -104.24 122.46 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 96.1 m -126.27 128.71 47.59 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.75 102.1 12.87 Favored 'Isoleucine or valine' 0 C--N 1.349 0.583 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -95.69 139.64 31.65 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.179 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 65.52 43.79 3.26 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' HB2' HD23 ' A' ' 95' ' ' LEU . 90.4 mt-30 -51.49 -37.4 48.9 Favored 'General case' 0 C--N 1.317 -0.804 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' HB2' ' O ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER 165.16 56.87 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.714 0.769 . . . . 0.0 110.123 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -162.26 -148.49 0.14 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.24 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.0 mtt85 -79.11 -45.79 19.34 Favored 'General case' 0 C--O 1.248 0.985 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -165.37 97.24 0.14 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.474 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 117' ' ' GLY . 43.3 tp -115.08 117.78 31.53 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.946 -0.627 . . . . 0.0 109.484 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -118.07 126.61 52.62 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 38.2 tp -121.68 105.7 10.66 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' HG22 ' A' ' 98' ' ' THR . 74.6 m -113.29 99.59 7.91 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.64 135.16 34.7 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -124.2 143.24 50.63 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.111 -175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.5 113.07 10.77 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.214 0.946 . . . . 0.0 110.953 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -119.8 106.14 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.452 0.644 . . . . 0.0 110.078 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -117.95 80.83 1.57 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.508 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -107.26 160.71 25.51 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 118.874 0.761 . . . . 0.0 112.205 -179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' O ' ' O ' ' A' ' 104' ' ' SER . 75.1 Cg_exo -37.69 -127.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 124.59 3.527 . . . . 0.0 114.306 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -67.16 -41.55 85.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.328 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 108' ' ' GLY . 7.8 p -86.21 163.32 17.86 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.823 178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 37.0 64.1 0.69 Allowed Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.5 mttt -55.28 -119.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.823 0.345 . . . . 0.0 111.64 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' C ' HD22 ' A' ' 111' ' ' ASN . 86.7 tttt -97.91 112.02 24.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 110.746 -179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 110' ' ' LYS . 1.5 m120 -120.68 125.07 46.75 Favored 'General case' 0 CA--C 1.524 -0.049 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.59 110.06 11.92 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -120.28 146.01 46.51 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.95 112.12 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -104.79 124.19 48.99 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.415 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 28.8 m -131.57 118.69 20.45 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.599 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -136.29 164.64 25.07 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.07 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.541 ' CZ ' ' O ' ' A' ' 119' ' ' LYS . 31.0 t80 -141.06 138.09 33.36 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.924 0.868 . . . . 0.0 109.542 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.648 ' CG ' HD22 ' A' ' 124' ' ' ASN . 84.4 mttt -107.18 157.9 17.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.998 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.552 ' O ' ' O ' ' A' ' 121' ' ' GLU . 75.2 ttt180 -175.2 93.27 0.06 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.552 ' O ' ' O ' ' A' ' 120' ' ' ARG . 97.0 mt-10 39.86 113.43 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.429 0.633 . . . . 0.0 112.632 -178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.409 ' CG ' ' O ' ' A' ' 145' ' ' GLY . 37.0 m170 55.24 -19.45 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 177.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' H ' ' C ' ' A' ' 121' ' ' GLU . 95.9 mt -104.96 110.67 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.812 0.733 . . . . 0.0 112.648 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.648 HD22 ' CG ' ' A' ' 119' ' ' LYS . 4.1 m120 -122.16 121.36 36.69 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.4 mt -124.11 126.19 45.78 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.387 -178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -124.96 148.41 16.74 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.701 1.137 . . . . 0.0 110.987 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.6 t -125.02 101.95 7.29 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.943 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.26 113.03 24.67 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 124.015 0.822 . . . . 0.0 110.705 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.7 mtt -111.19 108.94 18.77 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -88.36 111.44 21.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.879 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -84.19 85.35 7.37 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.837 0.351 . . . . 0.0 110.255 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.7 t0 -119.48 170.7 8.92 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.1 mm -63.92 -40.89 90.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.768 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -85.74 4.22 37.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -99.42 178.01 29.99 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 105.844 -2.903 . . . . 0.0 105.844 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.6 132.86 4.35 Favored 'Cis proline' 0 N--CA 1.51 2.477 0 CA-C-N 121.979 2.889 . . . . 0.0 115.505 0.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 69.0 m -113.49 124.25 51.96 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 173.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 155' ' ' MET . 95.6 mt -95.16 104.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.528 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.7 mtt180 -106.5 101.61 11.06 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.23 154.07 19.43 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.65 111.91 9.76 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.891 0.845 . . . . 0.0 109.618 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.574 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 66.0 mt -93.24 129.08 39.41 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.36 126.54 72.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 118.799 0.727 . . . . 0.0 109.501 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 97.3 mt -119.22 129.64 55.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.207 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -129.0 98.42 0.45 Allowed Glycine 0 C--N 1.335 0.497 0 C-N-CA 119.854 -1.165 . . . . 0.0 112.632 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -99.49 89.85 4.31 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 117.971 0.885 . . . . 0.0 111.061 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 38.64 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.33 -42.74 0.49 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.485 -1.341 . . . . 0.0 111.46 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.538 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 19.8 m95 -80.57 115.91 20.33 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 92.6 mt -121.45 107.07 12.03 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 170' ' ' ALA . . . -139.09 165.69 26.48 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.889 0.768 . . . . 0.0 109.478 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -152.33 170.59 31.59 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 118.132 -1.985 . . . . 0.0 113.852 -178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -128.7 121.79 29.27 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 67.8 tp60 -109.59 114.19 27.59 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.282 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.448 ' O ' ' O ' ' A' ' 138' ' ' ILE . 64.7 ttp -106.93 115.63 30.53 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.684 0.615 . . . . 0.0 111.406 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.731 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 31.3 t-20 -101.29 114.93 29.37 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.476 ' CE2' ' CG2' ' A' ' 164' ' ' VAL . 0.4 OUTLIER -108.12 95.93 6.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.554 -179.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 162' ' ' SER . 81.2 tt0 -73.57 97.27 2.58 Favored 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 66.7 p -66.22 -31.44 72.26 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.03 -40.57 94.09 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.06 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.28 -11.72 20.1 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.6 m 53.55 56.45 7.27 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.001 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -125.08 132.17 53.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.896 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.4 t -104.44 102.14 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 175.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.8 p -133.91 -60.13 0.83 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.915 0.864 . . . . 0.0 110.969 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -64.9 108.75 1.87 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.637 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 19.3 p -142.28 151.03 41.64 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.08 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.445 ' H ' ' HB3' ' A' ' 154' ' ' GLN . 7.8 t-20 -128.12 135.55 49.95 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -101.02 108.57 20.32 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.494 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -91.68 131.95 36.71 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.553 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 63.3 t -131.69 134.3 60.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -153.73 162.75 30.54 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.054 -1.07 . . . . 0.0 113.749 -178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.474 ' H ' ' HB3' ' A' ' 180' ' ' LEU . 86.8 t80 -135.15 132.91 38.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.601 -1.3 . . . . 0.0 108.595 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -107.19 146.88 30.83 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.553 ' O ' ' N ' ' A' ' 177' ' ' GLU . 20.9 m -139.86 135.2 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.21 -1.814 . . . . 0.0 106.491 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 175' ' ' THR . 97.8 m-20 -35.01 -26.6 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 175' ' ' THR . 78.8 mm-40 -119.25 -43.02 2.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.666 ' CE2' HG23 ' A' ' 194' ' ' ILE . 1.0 OUTLIER -104.06 134.04 48.0 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -174.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' N ' ' CD2' ' A' ' 178' ' ' PHE . 85.0 mt-30 -116.46 142.17 47.22 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.515 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.474 ' HB3' ' H ' ' A' ' 173' ' ' TYR . 52.3 tp -109.85 107.62 17.64 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 10' ' ' LEU . 92.1 m-70 -118.63 102.66 9.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.966 0.791 . . . . 0.0 111.149 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.601 HG22 ' HA2' ' A' ' 192' ' ' GLY . 33.6 p -130.21 158.46 39.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.422 ' OD1' ' C ' ' A' ' 183' ' ' ASN . 3.0 p30 -156.07 155.96 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.045 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.667 HG13 ' CE1' ' A' ' 190' ' ' PHE . 19.3 t -107.11 111.43 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -93.37 114.83 27.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.834 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 57.46 24.85 10.7 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 125.084 1.49 . . . . 0.0 113.813 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.18 11.76 47.22 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 5.8 m -119.7 -73.64 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -98.56 113.44 25.47 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.978 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.667 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.3 m-30 -94.98 147.7 23.12 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.047 -1.033 . . . . 0.0 111.454 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.71 166.64 12.37 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.97 139.95 6.93 Favored Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.5 m -146.24 151.42 37.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.364 0.602 . . . . 0.0 112.098 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.702 HD12 ' HB ' ' A' ' 206' ' ' VAL . 59.3 mt -131.91 115.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.551 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -110.71 105.31 14.14 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -113.34 123.32 49.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.468 ' O ' ' OE1' ' A' ' 177' ' ' GLU . 87.3 tttt -105.68 99.29 8.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 174.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.462 ' O ' ' OD1' ' A' ' 199' ' ' ASN . 78.7 t -76.61 -45.49 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.51 -175.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 198' ' ' VAL . 83.8 m-20 -159.66 -170.94 3.09 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.2 -39.79 91.52 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.34 -0.544 . . . . 0.0 111.767 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.67 ' C ' HD12 ' A' ' 202' ' ' LEU . 98.6 mttt -96.08 -11.38 26.42 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -177.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.67 HD12 ' C ' ' A' ' 201' ' ' LYS . 10.3 mp -114.93 107.61 15.62 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -176.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.59 106.5 12.24 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 223' ' ' ALA . 29.5 p -122.91 159.66 27.78 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 120.8 -1.187 . . . . 0.0 110.909 -177.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.529 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -151.49 145.23 25.05 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.882 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.702 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.4 t -114.38 126.11 71.83 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.434 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.65 133.36 49.63 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.239 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.8 mp -125.78 113.31 17.12 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 123.359 0.412 . . . . 0.0 111.301 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.91 142.54 50.69 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.616 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -132.96 -175.21 3.7 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.519 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 98.4 m -148.82 105.94 3.61 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.569 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.539 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -42.49 109.7 0.14 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.433 -178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 119.67 -6.13 12.63 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -126.79 130.45 50.31 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 94.4 p -83.55 -7.81 59.45 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -175.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -98.97 140.05 33.71 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.25 0.932 . . . . 0.0 112.917 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 51.6 m -103.51 113.02 26.2 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.437 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.58 116.35 15.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 118.273 -1.371 . . . . 0.0 107.634 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -135.67 138.35 42.72 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.835 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.04 155.46 16.24 Favored Glycine 0 C--O 1.218 -0.886 0 CA-C-N 113.186 -1.825 . . . . 0.0 112.096 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 93.1 mt -121.45 103.35 13.52 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.402 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.2 114.1 27.76 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.162 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -112.53 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.987 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -105.71 99.53 9.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.66 ' CE2' HD21 ' A' ' 202' ' ' LEU . 7.6 t80 -99.41 98.24 9.19 Favored 'General case' 0 C--O 1.224 -0.246 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.498 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -73.57 118.66 16.79 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 225' ' ' TYR 0.339 0.1 OUTLIER -90.34 -55.5 6.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-O 122.073 0.939 . . . . 0.0 109.577 -173.861 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.584 ' N ' HG22 ' A' ' 227' ' ' ILE . 0.0 OUTLIER -139.13 175.98 2.92 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -63.99 -15.97 52.22 Favored 'Trans proline' 0 C--N 1.291 -2.471 0 CA-C-N 121.194 1.462 . . . . 0.0 112.205 -176.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 228' ' ' ASP . 95.8 m-20 -108.1 2.19 22.84 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -149.19 141.55 24.18 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.126 0.875 . . . . 0.0 112.562 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 34.0 t -144.03 133.95 23.97 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.798 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.643 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 38.2 t80 -105.42 118.21 35.98 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.777 0.322 . . . . 0.0 111.45 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 31.3 t -107.78 132.29 53.56 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.457 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.643 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -135.92 145.4 46.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 99.7 mttt -134.3 113.83 12.36 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.046 -0.409 . . . . 0.0 110.9 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 11.9 t -103.05 116.1 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.54 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.622 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.5 p-10 -97.84 163.74 12.67 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.895 177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -90.23 6.66 41.86 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.667 -0.813 . . . . 0.0 112.394 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.484 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 83.9 p -96.22 10.78 36.72 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 83.01 26.23 0.12 Allowed 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.994 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.622 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -109.13 108.62 19.35 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.019 0.372 . . . . 0.0 111.117 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 85.4 mt -101.81 133.3 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 122.185 0.194 . . . . 0.0 110.624 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -117.17 143.57 18.04 Favored Glycine 0 N--CA 1.47 0.917 0 O-C-N 120.901 -1.124 . . . . 0.0 110.907 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 45.5 mt -124.29 118.7 27.36 Favored 'General case' 0 C--N 1.342 0.241 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 259' ' ' LEU . . . -129.1 106.66 0.77 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -92.18 99.45 12.24 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 122.276 -0.543 . . . . 0.0 110.55 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 23.5 m -86.72 124.78 33.36 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.546 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -119.31 110.95 17.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.963 0.411 . . . . 0.0 110.853 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 86.3 m -98.19 118.81 35.65 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' A' ' 255' ' ' ILE . 45.2 mt -97.72 133.25 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.575 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.5 tttt -45.57 -51.94 25.66 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 91.2 Cg_exo -39.48 -14.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.648 2.232 . . . . 0.0 112.634 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 95.05 30.45 8.31 Favored Glycine 0 N--CA 1.466 0.699 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.132 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.652 ' HB ' HD12 ' A' ' 251' ' ' LEU . 95.8 mt -123.48 131.71 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 tttt -110.65 122.44 47.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.499 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 47.8 tp -123.53 105.57 9.87 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.766 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 89.8 m -117.25 115.36 25.15 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.598 -0.841 . . . . 0.0 112.656 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.424 ' O ' ' HA2' ' A' ' 246' ' ' GLY . 71.3 mt -82.58 141.53 32.5 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.8 m -135.32 143.54 46.22 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.913 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.33 112.34 3.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.293 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.428 HD23 ' CD ' ' A' ' 274' ' ' LYS . 51.9 tp -112.33 102.88 10.99 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 33.5 mt -106.98 129.69 54.74 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.671 ' O ' ' N ' ' A' ' 268' ' ' VAL . 67.9 t0 -82.82 109.46 16.98 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.626 1.203 . . . . 0.0 111.224 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.22 83.22 Favored Glycine 0 C--N 1.306 -1.112 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.955 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.551 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 45.5 mmtt -82.99 -2.73 56.0 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.545 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.581 ' C ' ' N ' ' A' ' 269' ' ' ASN . 7.6 m-20 164.58 76.8 0.0 OUTLIER 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' A' ' 264' ' ' ASP . 20.0 t -60.2 -9.61 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.581 ' N ' ' C ' ' A' ' 267' ' ' ASN . 41.7 m-20 -83.36 -30.17 27.65 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 111.582 -2.553 . . . . 0.0 112.273 177.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.531 ' H ' ' HB3' ' A' ' 267' ' ' ASN . . . -84.21 -32.46 24.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 272' ' ' GLY . . . -94.15 35.71 4.07 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.662 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 271' ' ' GLY . . . 31.28 -122.08 0.15 Allowed Glycine 0 N--CA 1.472 1.068 0 CA-C-N 116.807 0.304 . . . . 0.0 112.598 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -142.17 114.44 8.28 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 122.016 -0.697 . . . . 0.0 110.608 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.428 ' CD ' HD23 ' A' ' 262' ' ' LEU . 98.4 mttt -100.54 114.59 28.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.809 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.405 ' O ' ' CA ' ' A' ' 25' ' ' GLY . 96.8 mt -131.33 135.8 47.57 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 124.614 1.196 . . . . 0.0 108.407 176.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.71 131.23 4.53 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.621 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 27' ' ' ILE . 35.9 mt -120.56 118.47 30.29 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.535 ' C ' HD12 ' A' ' 279' ' ' LEU . . . -98.12 115.04 5.17 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.813 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 278' ' ' GLY . 10.5 mp -112.58 99.82 8.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -115.07 132.56 56.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.972 0.415 . . . . 0.0 110.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -115.38 137.52 51.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.228 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -94.46 132.7 38.84 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.433 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LYS . . . -135.69 141.84 45.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.16 0.505 . . . . 0.0 111.992 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -95.37 137.41 34.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.653 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.43 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.8 m . . . . . 0 N--CA 1.487 1.403 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 3' ' ' VAL . . . -72.5 144.67 47.93 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 2' ' ' ALA . 16.4 m -158.42 65.75 3.12 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.715 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 3.0 Cg_endo -82.1 164.96 17.32 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.235 2.623 . . . . 0.0 113.785 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.5 ' C ' HD21 ' A' ' 124' ' ' ASN . 44.1 Cg_endo -70.19 -176.95 1.78 Allowed 'Trans proline' 0 N--CA 1.531 3.692 0 C-N-CA 125.069 3.846 . . . . 0.0 116.802 -176.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 77.3 p -38.58 133.93 0.98 Allowed 'General case' 0 C--N 1.368 1.411 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.691 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -38.61 -51.2 1.64 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -174.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.691 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.0 -39.33 85.41 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 117.674 -1.61 . . . . 0.0 111.208 -176.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -68.84 -24.1 64.32 Favored 'General case' 0 C--O 1.25 1.114 0 C-N-CA 118.352 -1.339 . . . . 0.0 110.81 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 38.5 tp -64.43 122.5 16.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.8 13.93 35.92 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -54.49 -37.29 65.12 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 17' ' ' VAL . 11.7 t -60.73 -46.81 89.0 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.999 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.22 -43.34 99.03 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.889 -179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 19' ' ' THR . 79.2 mtp85 -62.93 -39.31 94.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.97 -39.72 87.28 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 13' ' ' SER . 51.1 t -61.24 -44.63 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.607 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.458 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 87.3 t80 -63.46 -44.63 93.89 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.963 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 15' ' ' ARG . 25.2 p -81.65 -42.29 20.19 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.41 139.34 54.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.73 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 22' ' ' TYR . . . 164.65 173.94 33.85 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.308 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.557 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 64.6 m-85 -160.06 149.76 18.03 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 116.54 -114.37 3.03 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.344 178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' GLY . 54.0 m-85 24.31 70.69 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 110.8 -29.58 8.82 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.03 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.95 123.93 47.0 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG23 ' HB2' ' A' ' 277' ' ' LEU . 4.0 mp -84.08 117.24 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 17.0 tttt -108.04 139.04 43.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 113.69 -1.595 . . . . 0.0 114.285 -174.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -105.32 120.77 42.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.231 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 31' ' ' LEU . 66.0 t0 -120.34 131.81 55.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.405 0.621 . . . . 0.0 111.763 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 75.2 mt -113.54 115.93 28.75 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -117.12 129.79 56.21 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.6 m -125.06 122.29 36.79 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -115.44 132.62 56.56 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.2 m -78.23 176.72 9.01 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -58.37 -43.44 88.44 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.411 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -171.35 113.83 0.38 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 143.92 -97.19 0.19 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD22 ' CE1' ' A' ' 41' ' ' PHE . 54.9 mt -63.8 143.66 57.67 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.381 1.086 . . . . 0.0 113.443 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' OE1' ' NH2' ' A' ' 63' ' ' ARG . 83.0 tt0 -139.94 91.5 2.47 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.886 -1.961 . . . . 0.0 108.709 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.509 ' CE2' ' OG1' ' A' ' 60' ' ' THR . 52.6 m-85 -98.56 114.43 26.86 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.033 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.427 ' CG2' ' OD1' ' A' ' 30' ' ' ASP . 30.5 m -124.95 105.25 9.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.048 177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -94.21 159.86 14.95 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 41.2 p -145.65 159.14 43.59 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.472 -0.891 . . . . 0.0 112.156 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.14 111.44 0.48 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.866 -2.094 . . . . 0.0 107.866 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 5.0 p -133.33 144.24 49.53 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.04 152.64 24.27 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 113.689 -1.596 . . . . 0.0 109.2 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -104.61 105.59 15.75 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 59.1 p 54.92 13.59 0.77 Allowed 'General case' 0 C--N 1.343 0.288 0 O-C-N 123.22 0.325 . . . . 0.0 110.996 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 59.19 45.8 13.85 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.8 m -163.71 -48.54 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.3 m -67.42 -53.56 28.0 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -179.12 -170.01 0.17 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 46' ' ' SER . 10.7 t -129.03 107.02 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 122.466 0.306 . . . . 0.0 110.537 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' SER . 77.4 p -102.79 136.21 43.03 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.98 -153.84 9.01 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.665 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 p -175.68 164.28 2.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 111.302 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -130.07 106.95 8.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.377 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -108.05 120.2 41.64 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.509 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 36.1 m -130.26 112.33 13.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.231 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.589 ' HG2' HG23 ' A' ' 72' ' ' THR . 66.2 mttm -127.12 140.47 52.24 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.395 -0.816 . . . . 0.0 111.598 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.504 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.5 t80 -116.96 110.11 17.87 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' THR . 94.9 mtm-85 -113.64 81.34 1.5 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.588 ' O ' ' N ' ' A' ' 66' ' ' GLU . 87.1 m95 -70.72 71.89 0.51 Allowed 'General case' 0 C--N 1.343 0.307 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ARG . 74.6 p -44.82 -8.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 64' ' ' TRP . 79.1 mm-40 -72.31 -82.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.159 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -76.55 25.14 0.14 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 48.26 51.45 20.67 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.49 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.37 83.55 2.19 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.279 0.54 . . . . 0.0 111.979 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 96.6 m -77.07 91.47 3.67 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.109 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.568 ' CE1' HG23 ' A' ' 85' ' ' ILE . 6.9 m-85 -102.23 83.04 2.27 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.589 HG23 ' HG2' ' A' ' 61' ' ' LYS . 7.4 m -87.92 140.07 29.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.173 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.8 t -129.78 121.65 52.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.626 177.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -114.11 112.18 22.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.481 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 4.9 m95 -120.49 123.97 44.24 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -125.24 159.59 31.27 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.147 0.499 . . . . 0.0 110.29 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.4 p -63.69 -35.02 79.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.088 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 97.7 m-20 -62.21 -11.7 16.12 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.026 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 7.0 m120 101.45 6.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.693 1.245 . . . . 0.0 112.594 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.1 m -62.61 121.3 12.99 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.908 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 75' ' ' TRP . 65.4 mt -120.33 110.86 17.05 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -134.31 125.18 3.76 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.436 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.7 m -121.83 126.12 48.05 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.21 0.529 . . . . 0.0 110.651 178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -119.57 122.51 41.76 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.777 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.568 HG23 ' CE1' ' A' ' 71' ' ' PHE . 94.7 mt -113.48 113.23 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 178.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.42 128.32 47.91 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.27 106.53 20.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -95.14 145.71 24.82 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.563 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 56.97 45.01 21.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 117.632 0.197 . . . . 0.0 111.465 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.572 ' HB2' HD23 ' A' ' 95' ' ' LEU . 82.9 mt-30 -52.63 -20.85 3.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 88.7 mt -138.59 39.55 2.22 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.938 0.875 . . . . 0.0 110.172 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 81.64 -24.63 0.18 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 113.844 -1.526 . . . . 0.0 111.087 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 95' ' ' LEU . 96.7 mtm-85 -126.21 179.48 5.24 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.994 1.378 . . . . 0.0 113.797 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 118' ' ' TYR . . . -29.98 71.25 0.0 OUTLIER Glycine 0 C--O 1.214 -1.11 0 CA-C-N 111.692 -2.504 . . . . 0.0 115.944 -178.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 ' HB2' ' A' ' 90' ' ' GLN . 22.1 tp -142.86 114.32 7.93 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 65.7 tttm -124.65 128.38 48.75 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.892 -177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' C ' HD13 ' A' ' 97' ' ' LEU . 0.7 OUTLIER -120.98 106.81 11.95 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.553 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 94.9 m -113.81 99.13 7.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -87.01 136.28 32.97 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -116.86 143.02 46.18 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.274 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.94 103.73 5.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.972 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.67 107.03 14.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.878 0.847 . . . . 0.0 109.882 179.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -116.59 93.19 4.11 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.998 -1.455 . . . . 0.0 110.481 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.46 159.54 59.87 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.507 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 64.4 Cg_exo -38.11 -63.24 0.26 Allowed 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 123.905 3.07 . . . . 0.0 114.046 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' PRO . 28.7 m120 -147.39 -175.53 4.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.293 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 47.18 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.443 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 106' ' ' ASN . . . 174.92 55.15 0.05 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -55.84 -117.79 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.776 0.322 . . . . 0.0 111.401 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -91.75 112.84 24.92 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.131 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -120.17 122.12 40.29 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.25 111.17 14.25 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -119.22 146.05 45.54 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.16 112.14 32.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -113.57 127.13 55.96 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 62.5 m -131.35 125.43 32.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.442 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -134.91 163.23 24.79 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 94' ' ' GLY . 38.7 t80 -136.5 132.37 35.21 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 58.7 mttt -120.28 170.0 9.75 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.671 -176.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.498 ' CZ ' ' OH ' ' A' ' 118' ' ' TYR . 39.9 ttp180 157.27 122.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 48.82 95.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 45.33 -1.43 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 121' ' ' GLU . 37.3 mm -114.01 113.08 42.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-N 118.766 0.712 . . . . 0.0 112.527 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -122.18 120.4 34.08 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 175.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.7 mt -124.06 128.26 49.07 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.62 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -130.11 146.09 17.16 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 1.7 t -125.25 102.34 7.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.556 0.178 . . . . 0.0 110.523 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -90.78 121.51 32.72 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.042 0.839 . . . . 0.0 110.716 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 64.9 mtt -116.17 99.34 7.16 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.131 0.491 . . . . 0.0 111.047 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -89.22 126.98 35.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.111 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -87.79 85.1 6.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.108 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 135' ' ' GLY . 35.6 t70 -104.71 172.02 7.01 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 80.9 mt -62.64 -41.23 91.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.232 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.43 3.22 44.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.15 169.25 51.44 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.29 129.5 2.55 Favored 'Cis proline' 0 N--CA 1.513 2.658 0 CA-C-N 121.031 2.415 . . . . 0.0 116.613 -0.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 72.0 m -112.43 113.87 26.29 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.0 mt -99.06 103.5 14.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.076 0.465 . . . . 0.0 111.765 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -106.06 101.7 11.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.599 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -96.78 157.83 21.28 Favored Glycine 0 C--O 1.21 -1.386 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 6' ' ' THR . . . -136.5 112.49 9.64 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.586 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 9.8 mp -94.19 129.31 40.85 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.529 ' CG2' HD22 ' A' ' 124' ' ' ASN . 39.5 t -122.57 125.47 72.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 118.79 0.723 . . . . 0.0 109.536 177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 69.8 mt -120.73 138.43 53.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.263 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -112.68 152.93 17.76 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 120.023 -1.084 . . . . 0.0 111.792 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.595 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 97.5 m-85 -153.56 82.81 1.17 Allowed 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 118.321 1.061 . . . . 0.0 108.926 177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 59.29 30.08 19.75 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.9 -13.45 9.8 Favored Glycine 0 N--CA 1.46 0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.589 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.675 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -91.73 124.47 35.9 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -121.07 116.72 25.56 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.0 156.11 46.82 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.586 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -149.68 168.3 29.86 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 118.222 -1.942 . . . . 0.0 113.946 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -129.27 127.83 41.98 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.697 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 56.5 tt0 -111.02 116.91 31.99 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 118.721 0.691 . . . . 0.0 109.427 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.465 ' C ' HD22 ' A' ' 156' ' ' ASN . 63.5 ttp -104.27 114.14 28.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.758 -178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 156' ' ' ASN . 0.7 OUTLIER -95.86 114.39 26.11 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.435 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.3 OUTLIER -107.72 95.12 5.47 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.235 0.54 . . . . 0.0 111.136 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.5 mm-40 -75.23 100.73 4.42 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.1 p -66.64 -35.99 81.49 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.958 1.095 . . . . 0.0 113.958 -176.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.37 90.64 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.253 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -97.41 -2.8 41.46 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 18.4 m 36.45 74.01 0.08 Allowed 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.456 -178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -161.97 152.72 17.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.396 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.435 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 88.0 t -104.67 101.59 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 176.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 71.3 p -105.5 -54.97 2.4 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.118 0.961 . . . . 0.0 109.831 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.54 117.79 28.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.062 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 58.7 m -135.77 150.52 49.51 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.326 177.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.556 HD21 ' ND2' ' A' ' 183' ' ' ASN . 3.4 t-20 -128.17 131.01 48.93 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -103.76 109.4 21.1 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.599 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -95.26 132.28 40.42 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 120.294 -0.563 . . . . 0.0 110.255 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 77.4 t -132.1 114.85 24.98 Favored 'Isoleucine or valine' 0 C--O 1.243 0.738 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -128.34 155.98 20.66 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.57 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.16 131.7 48.91 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -107.65 146.82 31.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.199 0.999 . . . . 0.0 113.46 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.57 ' O ' ' N ' ' A' ' 177' ' ' GLU . 13.6 m -138.08 138.14 38.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 113.481 -1.69 . . . . 0.0 106.465 177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -36.54 -23.01 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.57 ' N ' ' O ' ' A' ' 175' ' ' THR . 97.6 mt-10 -126.47 -39.54 2.01 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 178' ' ' PHE . 0.0 OUTLIER -103.58 132.5 49.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -175.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -116.48 143.08 46.03 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.224 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.515 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 7.7 tt -114.74 111.03 20.63 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -118.73 100.4 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.739 -0.385 . . . . 0.0 111.198 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.542 HG22 ' HA2' ' A' ' 192' ' ' GLY . 26.5 p -122.03 153.41 38.63 Favored 'General case' 0 CA--C 1.506 -0.712 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.556 ' ND2' HD21 ' A' ' 168' ' ' ASN . 12.2 p-10 -155.39 154.05 31.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 119.061 -1.055 . . . . 0.0 110.609 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.699 HG13 ' CE1' ' A' ' 190' ' ' PHE . 51.8 t -104.57 114.92 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' OD1' ' ND2' ' A' ' 168' ' ' ASN . 44.7 t30 -96.05 113.83 25.48 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.882 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 56.48 26.83 11.35 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 125.617 1.823 . . . . 0.0 112.96 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 64.28 12.5 50.87 Favored Glycine 0 CA--C 1.518 0.262 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 212' ' ' ALA . 11.4 m -120.59 -74.57 0.61 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -97.31 112.96 24.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 119.608 -0.837 . . . . 0.0 112.786 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.699 ' CE1' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -93.47 144.14 25.63 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 121.82 -0.55 . . . . 0.0 111.193 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.19 166.72 12.7 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.542 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.23 139.91 6.76 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.75 148.46 35.68 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.19 0.519 . . . . 0.0 111.478 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.568 ' HB ' ' H ' ' A' ' 206' ' ' VAL . 47.6 mm -131.52 114.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.429 176.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -109.08 102.69 11.64 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -109.71 118.65 37.09 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -98.42 91.36 5.15 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 174.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 69.9 t -67.94 -45.84 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.0 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 35.1 p30 -170.46 163.68 8.5 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -40.54 -33.9 0.31 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.74 -26.6 19.43 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.486 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 4.1 mp -116.38 116.28 27.42 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -119.37 104.2 10.15 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.91 175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.6 p -120.07 156.96 29.93 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.72 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.473 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -147.76 140.69 24.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.391 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.568 ' H ' ' HB ' ' A' ' 194' ' ' ILE . 2.4 t -111.75 121.61 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.458 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 98.0 m-20 -103.31 133.35 48.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.129 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 192' ' ' GLY . 4.3 mp -125.41 110.13 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.778 0.674 . . . . 0.0 111.023 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.88 142.48 50.73 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.596 ' NE1' ' CD2' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -137.54 -177.4 4.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.495 ' N ' ' CG ' ' A' ' 210' ' ' TRP . 52.9 m -145.65 108.58 4.55 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.771 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 188' ' ' THR . . . -39.24 123.38 1.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.074 0.464 . . . . 0.0 111.191 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 109.58 -24.85 18.97 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -102.67 139.34 38.38 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.9 m -87.84 -16.21 34.65 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 -176.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -102.67 144.21 31.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.222 0.919 . . . . 0.0 113.344 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.456 ' O ' ' OD1' ' A' ' 239' ' ' ASN . 19.3 m -103.27 118.18 36.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.674 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -77.23 116.01 17.5 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 118.758 -1.177 . . . . 0.0 108.096 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -135.78 140.44 44.29 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.224 -0.99 . . . . 0.0 111.89 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -120.44 153.23 16.74 Favored Glycine 0 C--O 1.224 -0.498 0 CA-C-N 113.693 -1.594 . . . . 0.0 112.016 -178.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 66.8 mt -121.29 103.71 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.19 122.44 43.64 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.024 -0.671 . . . . 0.0 111.493 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -119.54 116.33 25.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.706 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -105.79 98.33 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.48 ' CZ ' HG12 ' A' ' 227' ' ' ILE . 2.5 t80 -100.68 96.76 7.56 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.32 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -101.72 116.82 33.59 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 229' ' ' PRO 0.251 3.0 mt -64.88 -58.3 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.455 0 C-N-CA 119.162 -1.015 . . . . 0.0 112.523 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 156.01 -52.77 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.45 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.373 -176.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.5 Cg_exo -68.91 -95.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.053 1.835 . . . . 0.0 112.466 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.513 ' N ' ' OD2' ' A' ' 230' ' ' ASP . 17.8 p-10 -135.17 15.35 3.51 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 227' ' ' ILE . . . -109.99 114.73 28.49 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.041 0.837 . . . . 0.0 112.068 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.8 t -128.81 129.72 46.01 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.967 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 67.5 t80 -117.83 111.71 19.42 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -107.52 115.33 29.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.065 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -126.1 147.07 49.68 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.49 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -138.6 113.55 9.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.447 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.458 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 99.0 t -102.65 113.63 39.84 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 CA-C-O 118.883 -0.58 . . . . 0.0 111.094 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.53 HD21 ' CG ' ' A' ' 242' ' ' LEU . 15.7 p30 -93.52 163.08 13.71 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.477 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.46 ' C ' ' ND2' ' A' ' 239' ' ' ASN . 0.0 OUTLIER -89.71 6.54 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.43 -178.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.479 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 75.6 p -91.05 4.07 53.09 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 240' ' ' SER . 2.2 p 88.85 30.95 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.448 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.577 ' HB3' HD11 ' A' ' 262' ' ' LEU . 34.8 mt -112.41 107.92 16.88 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.718 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 262' ' ' LEU . 91.7 mt -93.16 129.74 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 119.068 -0.491 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.17 12.59 Favored Glycine 0 C--N 1.343 0.94 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 63.6 mt -122.45 113.24 19.06 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.253 0.619 . . . . 0.0 109.491 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -124.69 106.81 0.95 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.355 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -93.73 100.84 12.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.117 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 18.1 m -91.83 118.23 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.313 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -111.88 110.3 20.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.9 m -85.58 84.9 7.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.654 ' O ' ' O ' ' A' ' 252' ' ' LYS . 89.1 mt -78.46 104.8 9.3 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.654 ' O ' ' O ' ' A' ' 251' ' ' LEU . 47.5 mttt 58.32 128.54 0.01 OUTLIER Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.43 ' O ' ' OE1' ' A' ' 282' ' ' GLN . 97.0 Cg_exo -43.89 -11.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.997 0 C-N-CA 121.204 1.27 . . . . 0.0 112.361 178.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . -88.26 -36.71 8.03 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 121.267 -0.492 . . . . 0.0 113.474 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 251' ' ' LEU . 91.3 mt -117.6 124.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -115.2 123.33 48.59 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.86 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.431 HD12 ' CD2' ' A' ' 279' ' ' LEU . 40.8 tp -123.22 107.65 11.93 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.043 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -120.49 135.95 54.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 86.7 mt -109.5 144.39 37.84 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.606 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 49.8 m -135.68 149.95 49.43 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.269 0.556 . . . . 0.0 111.607 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.81 115.57 3.64 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.255 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.3 tp -116.61 102.56 9.56 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.1 mt -110.09 130.14 55.58 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.866 -177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.709 ' O ' ' N ' ' A' ' 268' ' ' VAL . 66.6 t0 -77.42 113.62 15.41 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-O 122.955 1.36 . . . . 0.0 110.133 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -65.83 -39.03 94.9 Favored Glycine 0 C--N 1.301 -1.375 0 CA-C-N 113.621 -1.627 . . . . 0.0 113.159 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.505 ' O ' ' ND2' ' A' ' 267' ' ' ASN . 49.8 mttp -82.75 -1.99 53.07 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.486 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.575 ' C ' ' N ' ' A' ' 269' ' ' ASN . 8.6 m-20 170.27 74.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.159 0.799 . . . . 0.0 113.159 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.709 ' N ' ' O ' ' A' ' 264' ' ' ASP . 22.0 t -56.47 -12.6 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 176.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.575 ' N ' ' C ' ' A' ' 267' ' ' ASN . 38.5 m-80 -81.51 -29.87 33.44 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 112.282 -2.236 . . . . 0.0 112.14 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.484 ' H ' ' HB3' ' A' ' 267' ' ' ASN . . . -83.15 -31.8 26.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -90.75 32.62 4.99 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.263 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . 36.6 -124.22 0.9 Allowed Glycine 0 N--CA 1.469 0.848 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -142.25 114.57 8.33 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.12 0.486 . . . . 0.0 110.127 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.503 ' HB2' ' H ' ' A' ' 262' ' ' LEU . 71.7 mmtt -101.1 113.73 27.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.362 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.574 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.7 mt -130.37 134.72 47.37 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.521 ' C ' HD12 ' A' ' 277' ' ' LEU . . . -143.74 121.21 1.61 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 119.991 -1.1 . . . . 0.0 111.618 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.539 ' HB2' HG23 ' A' ' 27' ' ' ILE . 10.2 mp -110.08 124.11 50.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -107.96 115.04 4.37 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.431 ' CD2' HD12 ' A' ' 257' ' ' LEU . 57.1 mt -113.19 103.81 11.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -116.38 132.11 56.76 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.174 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -123.56 136.43 54.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.241 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 253' ' ' PRO . 87.7 mt-30 -101.49 129.64 47.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.433 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -66.0 142.83 57.7 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.781 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -75.38 143.45 42.78 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.678 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.764 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CA ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.823 ' O ' HG22 ' A' ' 19' ' ' THR . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 16' ' ' ASP . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.583 HE22 ' CB ' ' A' ' 97' ' ' LEU . 44.6 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 124' ' ' ASN . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.483 HD21 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.48 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.493 ' C ' HE21 ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.905 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.628 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.905 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.479 ' CD2' HD21 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.566 ' H ' ' HB3' ' A' ' 264' ' ' ASP . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.479 HD21 ' CD2' ' A' ' 263' ' ' LEU . 0.9 OUTLIER -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' C ' HG22 ' A' ' 3' ' ' VAL . . . -138.51 145.79 41.19 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.483 ' CA ' HD21 ' A' ' 124' ' ' ASN . 0.0 OUTLIER -161.67 66.6 2.1 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.601 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' O ' ' CG ' ' A' ' 124' ' ' ASN . 2.8 Cg_endo -82.65 165.57 15.82 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.967 2.445 . . . . 0.0 114.118 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 6' ' ' THR . 36.8 Cg_endo -69.35 -171.97 0.49 Allowed 'Trans proline' 0 N--CA 1.534 3.863 0 C-N-CA 125.116 3.877 . . . . 0.0 116.388 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 81.2 p -41.35 130.25 2.96 Favored 'General case' 0 C--N 1.377 1.787 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.667 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.31 -46.58 1.12 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -175.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.667 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -64.99 -40.25 94.69 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 117.122 -1.831 . . . . 0.0 110.434 -177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -68.04 -25.89 65.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 117.472 -1.691 . . . . 0.0 110.065 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.742 HD21 ' CE1' ' A' ' 181' ' ' HIS . 38.8 tp -63.12 132.36 51.59 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 120.751 -1.218 . . . . 0.0 109.009 177.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.67 10.94 64.56 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.523 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.65 -37.86 74.09 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 17' ' ' VAL . 14.2 t -60.2 -47.01 87.77 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.872 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.28 -43.13 99.38 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.0 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -64.15 -37.72 88.47 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.823 ' O ' HG22 ' A' ' 19' ' ' THR . 96.2 m-20 -65.91 -39.69 90.82 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HB1' ' A' ' 222' ' ' ALA . 4.3 t -64.85 -42.58 95.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 119.246 -0.981 . . . . 0.0 109.693 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' THR . 49.5 t80 -64.05 -45.87 86.89 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.823 HG22 ' O ' ' A' ' 16' ' ' ASP . 9.3 t -38.61 177.12 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -62.17 120.13 10.31 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.32 -128.4 0.29 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -141.41 153.56 45.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 88.35 -102.4 2.84 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.789 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.555 ' CD2' ' OG ' ' A' ' 260' ' ' SER . 70.1 m-85 21.79 75.79 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 114.81 -31.63 6.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.111 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.58 122.96 46.17 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.558 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.4 mt -83.97 120.85 35.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -114.61 138.19 50.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.566 -1.652 . . . . 0.0 113.363 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.1 mt -107.32 120.23 41.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.873 177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 34.1 t0 -119.67 132.21 55.62 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.087 0.47 . . . . 0.0 111.853 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 76.1 mt -109.48 127.41 54.4 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -125.13 132.41 53.1 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 p -124.39 121.2 34.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -105.78 122.42 46.05 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.92 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.8 m -93.49 154.44 17.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.678 -0.809 . . . . 0.0 109.993 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -69.83 -176.95 1.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' HE1' ' A' ' 64' ' ' TRP . . . -57.14 -23.47 47.23 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.299 -0.723 . . . . 0.0 112.794 -179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.489 HD22 ' CE1' ' A' ' 41' ' ' PHE . 63.3 mt -59.78 128.48 37.15 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.36 1.076 . . . . 0.0 113.132 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -137.48 96.27 3.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 113.136 -1.847 . . . . 0.0 107.819 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.489 ' CE1' HD22 ' A' ' 39' ' ' LEU . 62.6 m-85 -96.78 120.6 37.42 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.044 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.432 ' CG2' ' OD2' ' A' ' 30' ' ' ASP . 58.0 m -123.98 104.77 9.1 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -88.32 160.25 17.72 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.493 ' OG ' ' CB ' ' A' ' 57' ' ' SER . 9.1 p -137.59 147.35 44.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.524 0.678 . . . . 0.0 112.498 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.17 110.65 0.49 Allowed Glycine 0 CA--C 1.519 0.302 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 77.8 p -136.24 171.7 14.09 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 125.072 1.483 . . . . 0.0 110.171 177.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 51' ' ' THR . 56.9 t30 -103.5 120.44 40.85 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 64.1 p -67.7 -3.11 8.21 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -104.11 -50.4 3.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.038 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.47 ' O ' ' CB ' ' A' ' 52' ' ' THR . 58.1 p -89.96 -18.44 26.05 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.47 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 79.54 17.37 0.81 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.178 0.445 . . . . 0.0 110.051 -178.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 66.2 mttm -74.91 170.67 15.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.662 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 46' ' ' SER . 69.5 t -129.95 107.15 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.6 1.16 . . . . 0.0 109.963 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 46' ' ' SER . 61.9 p -117.47 132.4 56.56 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.96 0.8 . . . . 0.0 109.948 179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.73 -157.35 10.25 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.617 -0.801 . . . . 0.0 111.25 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' CB ' ' OG ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 178.62 165.57 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.749 0.785 . . . . 0.0 111.17 178.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 58' ' ' LEU . 95.9 mt -130.33 110.3 11.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.569 177.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -113.04 123.1 49.51 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.457 ' CG2' ' CE2' ' A' ' 41' ' ' PHE . 98.0 m -130.44 117.56 19.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.354 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -123.22 144.28 49.49 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.547 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 20.8 t80 -114.1 99.68 7.82 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' CZ ' HG21 ' A' ' 65' ' ' THR . 75.7 ttt-85 -110.5 83.75 1.81 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.572 ' HE1' ' H ' ' A' ' 38' ' ' GLY . 26.6 m0 -99.47 85.54 3.18 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 174.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 63' ' ' ARG . 70.9 p -58.89 -10.76 2.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.348 -176.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -49.51 -78.12 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.696 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -91.63 26.52 2.31 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.948 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 86' ' ' THR . . . 60.67 48.62 85.32 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.464 -0.398 . . . . 0.0 112.683 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -104.61 88.85 3.03 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.2 m -102.11 105.94 16.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.165 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.717 ' CD1' HG23 ' A' ' 85' ' ' ILE . 2.0 m-30 -106.88 90.46 3.32 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.5 m -87.98 135.3 33.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.65 -177.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.41 123.68 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 123.78 0.675 . . . . 0.0 110.004 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.63 102.41 8.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.364 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' CD2' HD22 ' A' ' 81' ' ' LEU . 4.3 m0 -111.53 130.42 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -124.71 159.03 31.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.282 0.563 . . . . 0.0 110.037 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.3 p -62.18 -33.76 75.15 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.394 -178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 31.0 p30 -58.65 -10.07 2.07 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 22.9 m-20 100.31 -4.77 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.352 1.032 . . . . 0.0 113.016 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 14.6 m -67.72 126.76 30.41 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.21 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD22 ' CD2' ' A' ' 75' ' ' TRP . 9.9 mt -120.6 133.85 55.34 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.23 119.11 1.24 Allowed Glycine 0 C--O 1.216 -1.019 0 C-N-CA 119.491 -1.338 . . . . 0.0 112.225 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.7 m -120.51 121.09 37.68 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 117.143 0.472 . . . . 0.0 110.072 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -119.39 114.44 22.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.773 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.717 HG23 ' CD1' ' A' ' 71' ' ' PHE . 81.9 mt -105.76 119.12 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.414 ' O ' ' O ' ' A' ' 68' ' ' GLY . 23.2 m -123.21 128.26 49.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.7 t -115.69 103.53 15.36 Favored 'Isoleucine or valine' 0 C--N 1.346 0.43 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -94.98 153.43 17.65 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 121.059 -0.256 . . . . 0.0 111.432 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 63.49 42.16 6.85 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.583 HE22 ' CB ' ' A' ' 97' ' ' LEU . 44.6 mt-30 -73.09 -37.11 66.86 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 43.7 tp -91.1 -64.15 1.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 170.57 -41.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.447 178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -74.41 -74.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -164.28 94.93 0.12 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 117' ' ' GLY . 53.7 tp -122.9 122.26 38.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -124.66 129.37 50.41 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.257 0.348 . . . . 0.0 110.227 -178.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' CB ' HE22 ' A' ' 90' ' ' GLN . 56.5 tp -121.72 107.43 12.34 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.2 m -111.86 99.36 8.06 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.38 132.61 35.21 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 104.878 -2.267 . . . . 0.0 104.878 175.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.83 144.38 48.38 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.79 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.04 107.96 5.42 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.268 0.98 . . . . 0.0 110.636 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -130.49 117.41 19.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.064 0.935 . . . . 0.0 110.989 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 3.9 m-85 -111.27 105.88 14.69 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 113.733 -1.576 . . . . 0.0 109.899 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -95.05 161.03 29.61 Favored Pre-proline 0 N--CA 1.473 0.676 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.911 -179.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.506 ' O ' ' O ' ' A' ' 104' ' ' SER . 83.2 Cg_exo -37.59 174.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.997 3.131 . . . . 0.0 113.355 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -51.48 -31.33 23.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.512 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 40.5 p -64.66 -31.01 72.04 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 120.159 -0.617 . . . . 0.0 109.682 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -104.01 -175.03 25.54 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.129 -0.789 . . . . 0.0 111.129 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -137.69 -163.36 1.43 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.722 0.296 . . . . 0.0 111.17 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -85.7 131.62 34.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.103 0.478 . . . . 0.0 111.294 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -119.19 107.25 13.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.098 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.72 110.9 19.78 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -116.7 145.74 43.25 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -124.69 106.42 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 175.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 68.3 mttt -102.11 123.84 46.67 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 53.5 m -122.54 107.71 12.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' O ' HD12 ' A' ' 95' ' ' LEU . . . -112.63 132.68 10.88 Favored Glycine 0 N--CA 1.438 -1.203 0 O-C-N 123.831 0.707 . . . . 0.0 111.504 -178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -124.61 129.3 50.31 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HG2' HD22 ' A' ' 124' ' ' ASN . 54.9 mttp -114.0 153.87 28.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.404 -1.271 . . . . 0.0 111.005 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 121' ' ' GLU . 57.8 ttp180 -178.29 98.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 123' ' ' ILE . 96.6 mt-10 40.92 109.55 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 145' ' ' GLY . 98.8 m-70 48.73 -6.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' A' ' 121' ' ' GLU . 98.2 mt -112.22 112.47 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 118.963 0.801 . . . . 0.0 113.096 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.483 HD21 ' CA ' ' A' ' 3' ' ' VAL . 2.6 m120 -122.01 125.4 46.21 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 175.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 85.3 mt -121.88 111.35 16.99 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.505 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -113.48 144.14 18.06 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.87 1.213 . . . . 0.0 111.545 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.5 t -125.01 102.43 7.51 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 123.813 0.361 . . . . 0.0 110.57 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -97.44 108.7 21.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 98.1 mtp -105.91 107.52 18.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -93.92 110.94 22.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.872 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -83.58 85.56 7.24 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.627 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.423 ' C ' ' H ' ' A' ' 135' ' ' GLY . 44.1 t0 -116.81 169.74 9.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.6 mt -63.0 -41.16 91.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.985 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.73 3.38 45.15 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -98.51 -179.04 32.47 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.085 -2.806 . . . . 0.0 106.085 176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.405 ' O ' ' OG1' ' A' ' 159' ' ' THR . 76.3 Cg_exo -54.54 133.11 4.51 Favored 'Cis proline' 0 N--CA 1.509 2.432 0 CA-C-N 121.702 2.751 . . . . 0.0 115.466 -0.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 50.9 m -113.41 128.8 56.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 74.0 mt -103.66 104.47 16.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.462 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.48 ' C ' HE22 ' A' ' 154' ' ' GLN . 83.0 mtp180 -105.81 101.96 11.44 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.571 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.708 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.18 154.01 20.38 Favored Glycine 0 C--O 1.206 -1.637 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.85 114.88 12.25 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.484 1.142 . . . . 0.0 108.404 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 142' ' ' LEU . 6.2 mp -102.25 105.59 16.27 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 118.311 -0.852 . . . . 0.0 108.872 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.44 127.46 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.2 mt -120.8 133.31 55.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.497 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -107.76 156.11 15.99 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.572 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.663 ' O ' ' HD1' ' A' ' 149' ' ' TRP . 82.3 t80 -141.35 77.2 1.58 Allowed 'General case' 0 C--O 1.212 -0.874 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 48.93 25.17 0.99 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 150.41 -33.11 1.01 Allowed Glycine 0 C--N 1.321 -0.278 0 C-N-CA 120.107 -1.044 . . . . 0.0 111.261 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.663 ' HD1' ' O ' ' A' ' 146' ' ' TYR . 4.3 m95 -87.41 144.25 26.84 Favored 'General case' 0 C--O 1.217 -0.628 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.662 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -121.95 116.29 24.09 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -120.78 140.77 51.23 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -130.56 152.66 19.91 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.588 -1.291 . . . . 0.0 113.596 -177.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -126.29 116.42 21.22 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 22.7 tp60 -111.5 118.06 34.73 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.801 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.493 ' C ' HE21 ' A' ' 154' ' ' GLN . 66.3 ttp -111.02 118.88 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 123.505 0.503 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -98.41 119.31 36.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -108.4 95.11 5.44 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.701 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 162' ' ' SER . 80.6 mm-40 -73.83 95.48 2.43 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 68.8 p -66.79 -40.72 88.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.44 92.93 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.57 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.4 ' HB3' HH21 ' A' ' 163' ' ' ARG . 99.4 mttt -91.56 -11.13 38.19 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.564 ' N ' ' O ' ' A' ' 158' ' ' GLU . 13.0 m 47.89 48.22 17.95 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.426 -178.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.4 HH21 ' HB3' ' A' ' 161' ' ' LYS . 73.1 mtt85 -127.11 128.21 45.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.627 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 165' ' ' THR . 92.2 t -104.71 125.22 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 164' ' ' VAL . 18.7 p -160.73 -56.62 0.05 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.923 0.868 . . . . 0.0 110.773 -177.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -65.54 108.24 1.96 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.486 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 22.5 p -142.26 151.76 42.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.895 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 185' ' ' ASN . 1.4 m-20 -127.3 138.55 53.08 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -104.56 109.81 21.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.437 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -90.99 133.47 35.27 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.216 -0.594 . . . . 0.0 110.312 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 47.9 t -132.03 116.77 30.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 O-C-N 123.704 0.628 . . . . 0.0 109.491 177.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -136.23 159.67 24.44 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.495 -177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.702 ' HB3' HD12 ' A' ' 180' ' ' LEU . 78.2 t80 -132.07 132.28 43.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.755 -1.223 . . . . 0.0 107.884 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -105.88 147.03 29.19 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.598 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 5.8 p -134.27 151.61 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.336 -1.756 . . . . 0.0 106.793 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -50.11 -17.58 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.266 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -130.53 -39.38 1.29 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.598 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.7 OUTLIER -104.65 136.23 44.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.934 -175.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -116.55 142.92 46.25 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.21 176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 173' ' ' TYR . 95.1 mt -111.95 107.44 16.44 Favored 'General case' 0 C--O 1.216 -0.672 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 176.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.742 ' CE1' HD21 ' A' ' 10' ' ' LEU . 40.1 m-70 -118.73 102.96 9.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.639 HG22 ' HA2' ' A' ' 192' ' ' GLY . 43.1 p -128.86 160.86 31.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.406 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 11.6 p-10 -158.53 157.6 32.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.982 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.762 HG13 ' CE2' ' A' ' 190' ' ' PHE . 32.5 t -104.56 114.06 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.439 ' OD1' ' OD1' ' A' ' 168' ' ' ASN . 40.0 t30 -94.01 116.72 29.18 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.017 -177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 58.58 -0.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 O-C-N 125.224 1.578 . . . . 0.0 113.454 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.75 0.05 75.97 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 86.8 m -111.4 -54.79 2.57 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -113.47 110.64 20.62 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.762 ' CE2' HG13 ' A' ' 184' ' ' VAL . 1.2 m-30 -92.72 147.77 22.6 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.681 -0.637 . . . . 0.0 111.013 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -109.67 168.07 13.06 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.639 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -155.32 139.67 6.82 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 177.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.3 m -146.09 149.04 33.31 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.474 0.654 . . . . 0.0 111.912 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.691 HD12 ' HB ' ' A' ' 206' ' ' VAL . 67.3 mt -131.74 113.83 23.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.549 175.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -101.91 104.31 15.03 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.473 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 30.8 tt0 -105.42 105.57 15.67 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -95.65 95.44 8.35 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.68 -44.44 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.11 -175.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 37.1 p-10 -166.18 -170.38 1.69 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.49 -39.63 88.41 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.656 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.93 -12.74 24.62 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.598 1.332 . . . . 0.0 114.598 -177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.51 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 11.9 mt -115.82 109.09 17.16 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -119.79 103.03 9.01 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 196' ' ' GLN . 23.5 p -122.25 160.27 25.6 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.883 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.501 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -152.11 146.48 25.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.704 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.691 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.3 t -114.59 122.98 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.448 HD21 ' C ' ' A' ' 14' ' ' ALA . 31.4 m-80 -105.18 133.12 50.48 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 192' ' ' GLY . 2.4 mp -125.71 116.1 21.12 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.888 0.743 . . . . 0.0 111.025 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.82 143.29 49.94 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.609 ' CZ2' ' CE1' ' A' ' 190' ' ' PHE . 0.0 OUTLIER -125.15 176.36 6.76 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.5 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.594 ' O ' ' N ' ' A' ' 213' ' ' GLY . 93.3 m -142.45 102.5 4.09 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.279 -0.568 . . . . 0.0 112.064 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.519 ' O ' ' CH2' ' A' ' 210' ' ' TRP . . . 41.38 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.344 0.362 0 CA-C-O 121.611 0.719 . . . . 0.0 110.746 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 211' ' ' THR . . . -49.18 168.19 0.19 Allowed Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 114.677 -1.147 . . . . 0.0 112.515 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -102.08 18.03 21.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.385 -0.907 . . . . 0.0 108.897 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 67.0 m -60.38 -50.41 73.71 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -171.79 149.25 2.49 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 54.9 m -103.6 112.95 26.1 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.847 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -77.7 113.93 16.04 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.695 -1.202 . . . . 0.0 108.334 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 238' ' ' ASN . 21.0 p90 -134.07 138.71 45.48 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.214 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -117.21 155.48 16.14 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 125.787 1.929 . . . . 0.0 112.193 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.3 mt -118.9 103.54 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.675 ' HB1' HG12 ' A' ' 17' ' ' VAL . . . -101.63 113.98 27.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.698 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -114.35 121.1 42.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.42 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -105.32 98.55 8.23 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.707 ' CE2' ' HB ' ' A' ' 227' ' ' ILE . 5.6 t80 -98.23 101.99 13.6 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.508 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -73.23 117.16 14.63 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.707 ' HB ' ' CE2' ' A' ' 225' ' ' TYR 0.451 0.2 OUTLIER -93.01 -44.52 13.89 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 117.947 -1.501 . . . . 0.0 111.853 -176.561 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.76 179.1 1.32 Allowed Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 172.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.08 -15.82 51.47 Favored 'Trans proline' 0 C--N 1.299 -2.072 0 CA-C-N 121.652 1.626 . . . . 0.0 112.34 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -114.99 10.36 16.25 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -150.25 130.42 13.59 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.027 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 3.7 t -139.87 136.8 34.32 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.484 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.714 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 31.9 t80 -109.01 111.4 23.03 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 122.242 -0.286 . . . . 0.0 111.655 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 25.5 t -107.7 121.9 45.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.415 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.714 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -134.64 156.96 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.176 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 44.1 mtmt -142.26 116.01 9.21 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.767 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 88.6 t -113.41 118.08 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.876 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.905 ' ND2' ' H ' ' A' ' 242' ' ' LEU . 0.0 OUTLIER -102.69 179.16 4.37 Favored 'General case' 0 CA--C 1.506 -0.74 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.645 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.416 ' HB2' ' CE1' ' A' ' 219' ' ' PHE . 60.8 t30 -90.68 3.65 53.64 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 119.473 -0.891 . . . . 0.0 113.067 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.628 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 66.7 p -102.01 24.78 9.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.888 0.851 . . . . 0.0 108.762 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.443 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.7 m 72.24 25.63 2.85 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.034 -1.439 . . . . 0.0 113.89 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.905 ' H ' ' ND2' ' A' ' 238' ' ' ASN . 7.4 mp -97.9 111.59 23.83 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.6 mt -115.18 119.68 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 117.494 -1.241 . . . . 0.0 110.703 177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.32 139.05 15.37 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 120.888 1.676 . . . . 0.0 109.342 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 48.3 mt -121.13 106.62 11.71 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -120.84 106.03 1.11 Allowed Glycine 0 CA--C 1.534 1.229 0 C-N-CA 119.171 -1.49 . . . . 0.0 112.882 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -98.74 118.69 36.04 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.438 -0.448 . . . . 0.0 110.865 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 5.0 m -95.1 135.11 37.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.185 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -131.14 152.18 50.69 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.159 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.511 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 1.5 m 72.89 -134.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.164 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.511 ' CB ' ' O ' ' A' ' 250' ' ' THR . 14.6 mt 107.38 -44.15 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.055 0.847 . . . . 0.0 110.268 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.633 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -38.86 155.47 0.13 Allowed Pre-proline 0 CA--C 1.51 -0.562 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -177.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -39.91 83.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.1 1.866 . . . . 0.0 111.118 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.633 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 179.43 -107.48 0.22 Allowed Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.59 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.446 ' O ' ' CG2' ' A' ' 250' ' ' THR . 96.0 mt -123.22 148.05 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -111.11 128.77 55.99 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.517 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 55.7 tp -123.5 106.5 10.67 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 124.268 0.98 . . . . 0.0 110.379 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 96.1 m -122.6 124.14 42.81 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.698 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.34 142.85 29.03 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.555 ' OG ' ' CD2' ' A' ' 24' ' ' PHE . 1.9 t -134.25 142.13 47.24 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.876 0.37 . . . . 0.0 111.645 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.32 109.18 4.06 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.604 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.435 HD23 ' CD ' ' A' ' 274' ' ' LYS . 49.6 tp -110.59 103.44 12.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.624 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.479 ' CD2' HD21 ' A' ' 269' ' ' ASN . 24.7 mt -105.93 116.62 32.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -178.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HB3' ' H ' ' A' ' 268' ' ' VAL . 44.7 t0 -105.63 100.67 10.23 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 16.95 -111.92 0.01 OUTLIER Glycine 0 C--O 1.217 -0.942 0 O-C-N 126.306 2.254 . . . . 0.0 115.704 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' A' ' 270' ' ' ALA . 61.3 mmtt -100.74 7.41 43.85 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 112.125 -2.037 . . . . 0.0 110.004 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -96.82 -75.94 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.525 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.566 ' H ' ' HB3' ' A' ' 264' ' ' ASP . 74.0 t -71.11 -47.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.822 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . 0.479 HD21 ' CD2' ' A' ' 263' ' ' LEU . 0.9 OUTLIER -62.74 -35.17 78.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.23 179.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 266' ' ' LYS . . . -83.77 -8.49 59.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . -121.55 29.17 5.75 Favored Glycine 0 CA--C 1.549 2.177 0 CA-C-N 115.318 -0.856 . . . . 0.0 113.133 179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 268' ' ' VAL . . . 119.68 -173.69 15.22 Favored Glycine 0 N--CA 1.483 1.792 0 CA-C-N 118.117 0.958 . . . . 0.0 111.924 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -142.36 116.93 9.72 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.78 0.79 . . . . 0.0 111.964 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.435 ' CD ' HD23 ' A' ' 262' ' ' LEU . 97.0 mttt -75.25 124.56 27.28 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.099 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 25' ' ' GLY . 90.1 mt -131.52 136.26 47.73 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -142.27 130.1 4.15 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.253 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.558 ' HB2' HG23 ' A' ' 27' ' ' ILE . 60.1 mt -119.3 116.54 26.44 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -96.18 115.14 5.11 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 50.9 mt -117.34 103.82 10.53 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -115.65 135.24 54.25 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.288 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -108.83 114.79 28.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.389 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -81.49 132.01 35.3 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.451 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -143.93 151.75 40.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 111.865 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -83.03 142.04 31.61 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.52 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.834 -179.776 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.09 140.79 58.27 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.744 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.52 70.85 8.22 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.5 ' C ' ' NZ ' ' A' ' 119' ' ' LYS . 2.4 Cg_endo -83.41 160.67 14.92 Favored 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 123.168 2.579 . . . . 0.0 113.297 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.719 ' N ' ' HZ1' ' A' ' 119' ' ' LYS . 45.8 Cg_endo -71.62 -173.79 1.1 Allowed 'Trans proline' 0 N--CA 1.535 3.912 1 C-N-CA 125.307 4.005 . . . . 0.0 116.716 -177.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 5' ' ' PRO . 69.0 p -39.63 134.29 1.35 Allowed 'General case' 0 C--N 1.373 1.603 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -40.42 -48.33 2.72 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -174.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.689 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -59.3 -40.04 84.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 117.859 -1.536 . . . . 0.0 110.626 -176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -68.49 -24.72 64.71 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 118.237 -1.385 . . . . 0.0 111.123 -176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.643 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.7 tt -64.02 123.66 19.59 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.643 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 97.13 15.02 40.14 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.68 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -58.1 -34.92 70.71 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 44.2 t -60.94 -49.25 78.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.985 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -64.73 -36.79 85.42 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.042 -0.663 . . . . 0.0 109.845 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.473 ' NH2' ' O ' ' A' ' 8' ' ' ALA . 99.6 mtt180 -63.99 -37.71 88.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -61.76 -43.35 99.02 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.4 -42.51 95.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.321 0 C-N-CA 119.38 -0.928 . . . . 0.0 109.697 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CD1' ' ND2' ' A' ' 207' ' ' ASN . 73.7 t80 -62.44 -43.36 99.0 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.258 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 44.3 p -88.12 -12.58 43.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.12 -43.51 66.96 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 118.465 -1.294 . . . . 0.0 109.648 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.39 103.04 0.21 Allowed Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -58.99 -44.52 91.63 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.72 -178.82 18.25 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.266 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.651 ' CB ' ' HG ' ' A' ' 260' ' ' SER . 10.8 m-85 -124.16 -149.89 0.43 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.236 0.541 . . . . 0.0 112.432 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' THR . . . 125.41 -13.75 7.37 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.519 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mp -120.81 137.32 54.6 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.646 HG23 ' HB2' ' A' ' 277' ' ' LEU . 2.8 mp -84.59 122.35 37.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -108.13 137.3 46.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 84.6 mt -108.6 116.85 32.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.652 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 65.9 t0 -119.58 131.22 55.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.335 0.588 . . . . 0.0 111.567 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 72.1 mt -111.67 123.48 50.32 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.639 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -117.56 123.65 46.75 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.8 p -120.49 124.16 44.71 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -113.63 117.71 32.35 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.776 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 m -85.6 151.58 23.79 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -62.53 -33.35 74.73 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.721 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -67.69 -167.59 0.07 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.19 -14.59 71.45 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.236 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.658 HD22 ' CE1' ' A' ' 41' ' ' PHE . 38.7 mt -65.65 130.81 44.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.426 1.108 . . . . 0.0 113.577 -177.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -133.0 95.86 3.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 112.987 -1.915 . . . . 0.0 108.263 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.658 ' CE1' HD22 ' A' ' 39' ' ' LEU . 55.0 m-85 -102.34 108.89 20.39 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.1 m -121.34 105.04 10.16 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 p -91.56 161.89 14.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 57' ' ' SER . 9.8 p -145.73 153.69 41.24 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.526 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -149.69 128.84 2.82 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.781 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.5 t -125.2 172.33 9.62 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 121.594 0.712 . . . . 0.0 112.769 -176.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.07 31.08 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.568 ' O ' ' N ' ' A' ' 51' ' ' THR . 28.4 t30 -76.4 140.65 41.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.562 HG23 ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -38.7 -30.05 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.052 -177.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 51' ' ' THR . 97.6 mt-10 -100.01 -9.44 22.7 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.314 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 85.39 14.6 0.17 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 178.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.6 p -74.59 -30.15 61.59 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.653 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -133.49 146.21 50.89 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 120.629 0.252 . . . . 0.0 111.287 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 46' ' ' SER . 14.8 t -129.01 108.33 16.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 46' ' ' SER . 64.6 p -105.55 131.88 52.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.991 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.72 -159.73 11.03 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 44' ' ' SER . 4.7 p -173.63 156.87 3.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.49 0.662 . . . . 0.0 111.836 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -130.22 107.75 9.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.575 177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -110.31 118.97 37.73 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' A' ' 41' ' ' PHE . 21.5 m -130.4 106.07 8.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.689 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -118.17 135.63 54.12 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.478 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 2.4 t80 -114.76 88.86 2.96 Favored 'General case' 0 C--N 1.346 0.446 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -101.85 90.3 3.95 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.556 ' C ' ' H ' ' A' ' 66' ' ' GLU . 46.0 m95 -66.28 95.99 0.33 Allowed 'General case' 0 C--N 1.343 0.317 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 175.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 p -64.0 31.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.675 -177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' A' ' 64' ' ' TRP . 97.3 mt-10 -124.7 -79.82 0.61 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.943 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -76.9 26.42 0.14 Allowed 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 51.59 47.81 51.05 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.774 -0.459 . . . . 0.0 112.663 177.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.602 HD23 HG22 ' A' ' 87' ' ' VAL . 70.8 mt -107.98 88.68 2.79 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.231 0.515 . . . . 0.0 111.984 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.1 m -97.15 108.97 21.8 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.891 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.627 ' CD2' HG23 ' A' ' 85' ' ' ILE . 2.8 m-30 -107.73 92.81 4.22 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -87.93 139.36 30.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.868 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.61 120.3 50.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 O-C-N 123.869 0.731 . . . . 0.0 109.981 177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -114.63 109.62 18.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.462 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -118.49 127.3 53.51 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -132.52 162.06 32.2 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.573 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ASN . 57.7 p -65.3 -35.2 80.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.365 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.443 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 99.2 m-20 -55.01 -10.71 0.53 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.164 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 9.6 m120 94.2 23.99 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 O-C-N 124.377 1.048 . . . . 0.0 112.697 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 15.8 m -88.77 123.54 33.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.232 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mp -120.42 111.1 17.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -130.67 129.15 5.73 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 119.918 -1.134 . . . . 0.0 112.944 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 95.6 m -124.46 121.45 34.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -119.54 116.5 26.2 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.865 -178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' CD2' ' A' ' 71' ' ' PHE . 91.9 mt -107.38 120.72 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 120.479 -0.489 . . . . 0.0 109.826 178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 45.3 m -126.3 129.78 49.54 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG22 HD23 ' A' ' 69' ' ' LEU . 20.0 t -118.41 109.88 28.48 Favored 'Isoleucine or valine' 0 C--N 1.346 0.44 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -94.89 152.76 18.11 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.971 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 58.83 55.98 4.34 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.497 ' HB2' HD23 ' A' ' 95' ' ' LEU . 81.5 mt-30 -82.41 1.9 35.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.639 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 35.0 tp -171.31 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.882 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . 151.37 155.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.95 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD2' HH21 ' A' ' 120' ' ' ARG . 91.5 mtm-85 65.98 62.58 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 123.694 1.712 . . . . 0.0 107.86 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 35.7 94.15 0.01 OUTLIER Glycine 0 C--O 1.221 -0.657 0 CA-C-N 110.768 -2.924 . . . . 0.0 113.719 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 90' ' ' GLN . 15.7 tp -119.84 113.84 21.2 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 176.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.68 132.46 53.4 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 119.557 -0.259 . . . . 0.0 110.457 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.1 tp -119.94 105.93 11.55 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.171 0.441 . . . . 0.0 109.958 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 98' ' ' THR . 89.7 m -110.68 99.36 8.33 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -82.39 133.6 35.22 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 175.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -117.67 141.68 48.11 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.54 -176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.44 106.82 7.69 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.231 0.957 . . . . 0.0 110.462 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 109' ' ' LYS . 0.1 OUTLIER -114.82 102.88 10.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.58 0.705 . . . . 0.0 110.012 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -110.34 90.36 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.486 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 107' ' ' THR . 0.5 OUTLIER -125.39 87.84 55.07 Favored Pre-proline 0 N--CA 1.478 0.959 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -40.69 139.1 1.34 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.537 2.158 . . . . 0.0 113.115 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 57.98 27.03 14.17 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.441 -0.799 . . . . 0.0 112.043 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 107' ' ' THR . 3.2 m 175.13 96.48 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' LYS . . . 63.79 71.69 0.81 Allowed Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 108' ' ' GLY . 98.1 mttt -49.23 -112.47 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -98.24 111.8 24.0 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.983 0.42 . . . . 0.0 111.276 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -120.22 104.67 10.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.493 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -105.79 116.77 32.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 130' ' ' ASP . 46.6 mttm -120.94 145.75 47.37 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.3 mt -121.61 114.87 44.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 128' ' ' ASP . 22.9 mttm -107.9 127.41 53.72 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 72.4 m -120.52 108.56 14.22 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.97 100.14 1.81 Allowed Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.6 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -97.79 130.81 44.7 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.719 ' HZ1' ' N ' ' A' ' 5' ' ' PRO . 62.1 mttt -124.88 172.57 9.26 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.598 -177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' O ' ' O ' ' A' ' 121' ' ' GLU . 54.5 ttt85 175.0 96.36 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 120' ' ' ARG . 79.4 tt0 39.66 113.66 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 57.79 -18.07 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' GLU . 91.5 mt -108.83 117.24 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.482 ' CG ' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -122.11 123.9 42.65 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.47 117.18 24.54 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.562 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -116.59 142.35 17.42 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 119.599 1.09 . . . . 0.0 110.904 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 115' ' ' LYS . 4.8 t -125.01 102.46 7.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.551 -0.325 . . . . 0.0 110.669 178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -95.8 109.17 21.52 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 124.052 0.845 . . . . 0.0 109.946 -179.271 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 89.3 mtp -105.54 103.52 13.05 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.874 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 113' ' ' LYS . 63.7 t0 -88.19 111.53 21.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.903 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -86.88 86.12 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.96 0.409 . . . . 0.0 110.421 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' C ' ' H ' ' A' ' 135' ' ' GLY . 48.9 t0 -120.15 168.86 10.78 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.18 -41.15 90.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.979 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.79 3.43 37.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -102.48 -179.8 26.98 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 106.059 -2.817 . . . . 0.0 106.059 176.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -54.45 132.23 3.79 Favored 'Cis proline' 0 N--CA 1.508 2.382 0 CA-C-N 121.766 2.783 . . . . 0.0 115.402 -0.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 67.0 m -113.16 127.03 56.07 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 155' ' ' MET . 15.8 mm -97.29 103.37 14.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.845 -178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 101.66 11.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.63 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.723 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -100.43 153.51 19.32 Favored Glycine 0 C--O 1.208 -1.511 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.26 111.56 9.1 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 118.12 0.96 . . . . 0.0 108.869 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.623 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.2 mp -93.18 129.77 39.08 Favored 'General case' 0 C--O 1.2 -1.548 0 CA-C-O 117.796 -1.097 . . . . 0.0 108.298 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.56 124.19 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.7 mt -120.87 135.0 55.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.951 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' O ' ' CD2' ' A' ' 146' ' ' TYR . . . -111.42 157.03 15.21 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 120.124 -1.036 . . . . 0.0 111.967 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.644 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.6 m-85 -157.87 78.37 0.84 Allowed 'General case' 0 C--O 1.206 -1.211 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 56.46 37.08 28.52 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.96 -13.2 12.9 Favored Glycine 0 N--CA 1.46 0.266 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.5 m95 -96.32 116.79 29.58 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.517 HD13 HD11 ' A' ' 10' ' ' LEU . 51.9 mt -120.17 113.86 21.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.93 149.49 49.79 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.623 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -142.05 165.52 26.58 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 118.891 -1.623 . . . . 0.0 114.092 -178.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -129.09 125.63 37.6 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.723 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 6.2 tt0 -114.09 118.96 35.53 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.93 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.472 ' O ' ' O ' ' A' ' 138' ' ' ILE . 65.0 ttp -109.06 121.95 46.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.622 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -102.81 114.74 29.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.469 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 1.1 t80 -110.45 95.5 5.61 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.356 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 162' ' ' SER . 97.7 mt-10 -74.89 93.58 2.68 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 80.3 p -67.82 -34.06 75.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.54 91.36 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 119.661 -0.815 . . . . 0.0 109.791 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -97.84 -11.38 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.5 m 53.51 53.68 11.22 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.313 -178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -124.66 126.52 45.86 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.595 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.469 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 55.0 t -104.57 121.42 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 176.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 164' ' ' VAL . 25.1 p -158.79 -56.76 0.07 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.722 0.772 . . . . 0.0 110.856 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -65.6 108.31 2.01 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.171 -1.377 . . . . 0.0 110.404 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.3 p -142.33 151.44 41.96 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.005 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 183' ' ' ASN . 50.7 m-20 -128.37 148.65 50.7 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.71 111.59 22.06 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.628 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -90.49 137.76 32.1 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.003 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 64.1 t -126.99 128.68 70.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -132.44 130.87 6.0 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.734 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -125.93 120.33 30.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -98.6 146.85 25.4 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.165 0.984 . . . . 0.0 113.542 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 178' ' ' PHE . 19.8 p -130.12 150.87 51.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 113.257 -1.792 . . . . 0.0 106.521 176.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -49.69 -3.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.372 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 175' ' ' THR . 67.7 mm-40 -147.89 -33.96 0.24 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.617 ' N ' ' OG1' ' A' ' 175' ' ' THR . 0.4 OUTLIER -111.75 144.24 41.35 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -175.113 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -116.43 139.24 50.65 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.008 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 HG12 ' A' ' 194' ' ' ILE . 42.5 tp -111.07 101.81 10.32 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.476 ' CE1' HD22 ' A' ' 10' ' ' LEU . 33.8 m170 -113.51 109.88 19.37 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 77.0 p -120.88 150.9 40.35 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 168' ' ' ASN . 43.3 t30 -139.91 137.68 35.01 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.561 0.619 . . . . 0.0 110.21 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 58.8 t -94.64 120.65 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -99.48 109.52 22.06 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.465 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 57.95 4.75 0.31 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.723 1.264 . . . . 0.0 113.21 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 88.44 -1.42 84.14 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.354 -0.926 . . . . 0.0 110.975 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 18.0 p -109.21 -57.87 2.1 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.28 111.42 23.82 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 119.797 -0.761 . . . . 0.0 112.147 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 0.8 OUTLIER -101.12 158.83 15.73 Favored 'General case' 0 CA--C 1.527 0.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.987 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.78 164.42 12.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.324 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -178.98 -157.42 19.46 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.3 p -122.9 166.73 14.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.299 0.571 . . . . 0.0 111.951 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.671 HD12 ' HB ' ' A' ' 206' ' ' VAL . 47.1 mt -131.61 108.9 15.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.436 ' HD1' ' HB2' ' A' ' 14' ' ' ALA . 41.6 t80 -83.01 121.06 26.52 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -123.45 102.65 8.01 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.18 96.75 10.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 94.9 t -62.66 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.636 ' OD1' HD12 ' A' ' 202' ' ' LEU . 56.0 p30 -167.49 -135.24 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.85 -0.04 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.089 -0.645 . . . . 0.0 112.479 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -121.21 -32.16 3.96 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.642 ' H ' HD12 ' A' ' 202' ' ' LEU . 0.0 OUTLIER -119.67 127.19 52.66 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -176.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -116.19 110.24 18.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.483 HG22 ' HA ' ' A' ' 223' ' ' ALA . 5.9 p -116.87 155.1 29.61 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.193 -0.942 . . . . 0.0 110.386 -177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.626 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -137.52 123.98 20.8 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.244 -0.583 . . . . 0.0 110.926 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.671 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.9 t -100.52 127.78 53.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.539 ' ND2' ' CD1' ' A' ' 18' ' ' PHE . 2.8 m-20 -108.75 129.96 55.37 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 194' ' ' ILE . 24.2 mt -113.71 128.7 56.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.936 0.772 . . . . 0.0 111.939 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.32 110.73 15.55 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.235 0.335 . . . . 0.0 110.73 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.629 ' NE1' ' OG1' ' A' ' 217' ' ' THR . 0.0 OUTLIER -100.92 137.48 39.24 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-O 121.683 0.754 . . . . 0.0 109.186 176.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.493 ' C ' ' N ' ' A' ' 213' ' ' GLY . 54.7 m -110.33 103.36 12.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.23 -176.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 51.7 16.11 0.44 Allowed 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.493 ' N ' ' C ' ' A' ' 211' ' ' THR . . . 79.51 17.46 75.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.228 178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -65.34 156.22 32.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 40.4 m -59.25 -38.82 81.0 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -74.24 114.67 12.86 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.629 ' OG1' ' NE1' ' A' ' 210' ' ' TRP . 71.2 m -103.5 118.54 36.97 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.039 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -77.8 114.53 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 118.34 -1.344 . . . . 0.0 107.667 176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.635 ' CE2' ' ND2' ' A' ' 239' ' ' ASN . 37.1 p90 -140.9 146.45 37.47 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.826 178.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -119.6 154.4 16.47 Favored Glycine 0 C--O 1.225 -0.457 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.827 -177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.0 mt -124.87 103.74 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.55 120.93 40.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.118 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.483 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -116.13 117.27 29.61 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.858 0.724 . . . . 0.0 111.157 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -105.08 98.33 8.05 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.486 ' OH ' HG12 ' A' ' 227' ' ' ILE . 2.0 t80 -99.32 98.48 9.43 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.097 -177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -112.6 111.44 22.26 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.789 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 2.2 mt -56.2 -56.71 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.604 -1.238 . . . . 0.0 110.872 -179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 158.16 -44.54 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 113.123 -1.853 . . . . 0.0 110.073 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.789 ' HD2' ' HB ' ' A' ' 227' ' ' ILE . 7.9 Cg_exo -68.44 -104.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.507 0 C-N-CA 122.482 2.121 . . . . 0.0 113.098 178.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' A' ' 229' ' ' PRO . 97.3 m-20 -124.58 -1.2 8.03 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -176.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -98.52 121.63 40.71 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.657 0.662 . . . . 0.0 112.472 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 10.4 t -134.24 127.48 31.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.009 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . 0.593 ' CZ ' ' HB2' ' A' ' 235' ' ' ALA . 48.3 t80 -117.89 116.21 26.5 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 49.4 m -107.68 117.9 35.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.495 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . 0.593 ' HB2' ' CZ ' ' A' ' 233' ' ' PHE . . . -129.73 148.72 51.64 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.0 117.12 15.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 121.239 -0.185 . . . . 0.0 110.814 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.488 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 3.0 t -100.24 114.5 39.07 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-O 119.143 -0.456 . . . . 0.0 110.177 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.532 HD21 ' HB2' ' A' ' 242' ' ' LEU . 4.1 p30 -100.12 159.27 15.23 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.231 177.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . 0.635 ' ND2' ' CE2' ' A' ' 219' ' ' PHE . 1.4 m120 -90.37 2.27 55.75 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 119.524 -0.87 . . . . 0.0 112.784 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 241' ' ' SER . 3.9 m -82.09 2.98 28.71 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 240' ' ' SER . 5.1 p 88.88 29.98 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 113.667 -1.606 . . . . 0.0 114.015 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.532 ' HB2' HD21 ' A' ' 238' ' ' ASN . 0.8 OUTLIER -121.19 118.51 29.82 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.517 0.599 . . . . 0.0 111.401 178.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 87.0 mt -95.55 133.32 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.529 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -111.65 135.7 12.99 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 4.1 mp -122.46 117.27 25.57 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -129.29 107.22 0.79 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.266 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 110.65 21.54 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.552 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 31.9 m -101.91 136.84 41.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.548 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -129.55 110.88 12.2 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.086 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.416 ' O ' ' CG ' ' A' ' 230' ' ' ASP . 65.7 m -93.31 122.17 35.44 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -96.16 128.68 43.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 117.329 -1.32 . . . . 0.0 111.685 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' GLY . 5.9 mttt -42.95 -55.82 7.04 Favored Pre-proline 0 C--N 1.359 0.987 0 O-C-N 124.981 1.425 . . . . 0.0 107.32 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 252' ' ' LYS . 96.6 Cg_exo -38.84 -19.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.628 2.219 . . . . 0.0 113.008 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 99.72 32.96 5.48 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.197 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -122.82 130.28 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-O 121.685 0.755 . . . . 0.0 112.821 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -103.44 121.14 42.2 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.447 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.37 106.27 10.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.041 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . 0.593 ' O ' HD23 ' A' ' 277' ' ' LEU . 87.6 m -125.06 139.29 53.93 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.7 142.74 42.21 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.651 ' HG ' ' CB ' ' A' ' 24' ' ' PHE . 3.1 p -130.45 148.07 52.22 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.112 0.482 . . . . 0.0 111.646 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.25 113.11 3.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.249 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 36.7 tp -112.01 102.97 11.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 87.8 mt -93.41 115.33 27.87 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.442 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -80.23 107.59 13.15 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.684 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -59.87 -35.99 88.6 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.665 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 268' ' ' VAL . 51.8 mmtt -84.93 -7.72 59.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 118.407 1.104 . . . . 0.0 110.331 177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 56.1 -23.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 266' ' ' LYS . 54.0 t -74.56 -37.73 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.296 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -62.98 -43.89 97.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.311 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 272' ' ' GLY . . . -86.84 -35.21 19.19 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 118.451 -1.3 . . . . 0.0 108.246 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 62.92 -7.04 0.3 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.048 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 270' ' ' ALA . . . -146.78 -130.54 2.1 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.769 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -139.66 122.08 16.11 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.953 0.406 . . . . 0.0 111.46 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.44 115.4 28.06 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.945 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 91.9 mt -133.99 127.4 32.26 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -137.7 154.84 22.81 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.291 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.646 ' HB2' HG23 ' A' ' 27' ' ' ILE . 1.6 mt -134.97 144.26 47.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -126.77 114.87 2.08 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 83.3 mt -114.93 105.74 13.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -115.21 122.21 45.3 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.106 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -103.08 118.0 35.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.566 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -78.51 129.13 34.5 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.323 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -138.44 142.51 39.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -87.71 138.44 31.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.306 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.637 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.21 140.25 57.42 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.435 ' N ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -152.28 64.01 5.38 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.585 179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.754 ' CB ' HD11 ' A' ' 10' ' ' LEU . 1.8 Cg_endo -83.28 161.12 15.2 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.171 2.581 . . . . 0.0 113.439 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' CA ' ' HZ1' ' A' ' 119' ' ' LYS . 37.3 Cg_endo -70.52 -172.73 0.69 Allowed 'Trans proline' 1 N--CA 1.539 4.177 1 C-N-CA 125.37 4.047 . . . . 0.0 117.377 -177.375 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.3 p -44.96 132.2 6.92 Favored 'General case' 0 C--N 1.364 1.21 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.659 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -38.56 -47.9 1.36 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -175.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.659 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -55.63 -38.94 70.18 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 117.616 -1.634 . . . . 0.0 110.016 -176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -68.17 -24.84 65.01 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 117.03 -1.868 . . . . 0.0 110.02 -174.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.754 HD11 ' CB ' ' A' ' 4' ' ' PRO . 4.5 mm? -55.98 137.59 50.55 Favored 'General case' 0 C--N 1.34 0.154 0 O-C-N 120.651 -1.281 . . . . 0.0 108.95 177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.99 9.34 71.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.268 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -57.22 -42.65 81.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.3 m -59.36 -44.31 92.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.606 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -61.35 -43.55 98.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -64.23 -40.57 96.3 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.92 -41.55 97.62 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.5 t -65.9 -40.92 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.119 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.473 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 38.0 t80 -59.56 -45.6 91.33 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 43.2 m -23.19 115.97 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.54 139.0 35.36 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . 160.69 -172.34 37.01 Favored Glycine 0 CA--C 1.518 0.274 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' C ' ' O ' ' A' ' 21' ' ' GLY . 91.1 m-85 32.46 89.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.614 0.244 . . . . 0.0 110.574 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 120.13 -135.03 10.77 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' GLY . 71.9 m-85 16.42 81.75 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.836 1.05 . . . . 0.0 113.836 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 111.3 -35.02 4.98 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.724 -0.751 . . . . 0.0 113.363 177.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -116.31 122.65 45.55 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.3 mt -83.98 121.2 36.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 23.4 tttm -114.55 138.88 50.09 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.655 -1.611 . . . . 0.0 113.178 -174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.0 mt -106.92 117.34 33.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.743 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 66.7 t0 -119.94 133.18 55.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.437 0.637 . . . . 0.0 111.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 82.6 mt -108.23 126.72 53.13 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.581 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -117.61 134.4 54.93 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.1 m -133.68 119.33 19.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.09 121.83 45.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.035 0.445 . . . . 0.0 111.975 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 61.8 m -100.45 125.35 46.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.49 -8.41 40.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.334 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 37' ' ' ASN . 4.4 m120 -65.58 -36.09 82.75 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 151.6 -33.83 0.9 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.404 HD13 ' HE1' ' A' ' 41' ' ' PHE . 37.5 mt -68.53 132.34 46.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 122.429 1.109 . . . . 0.0 113.309 -178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -121.8 94.18 4.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 112.924 -1.943 . . . . 0.0 109.096 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 60' ' ' THR . 40.6 m-85 -103.28 107.61 18.5 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.102 -178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 91.3 m -122.08 105.1 9.97 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.7 m -90.53 159.44 16.49 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 57' ' ' SER . 4.5 p -137.22 148.47 46.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.622 0.725 . . . . 0.0 112.728 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.3 113.21 0.63 Allowed Glycine 0 CA--C 1.521 0.44 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 56.7 p -135.99 171.87 13.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -137.73 167.12 22.36 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 124.759 1.287 . . . . 0.0 109.964 177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.454 HD22 ' HG1' ' A' ' 51' ' ' THR . 60.7 t30 -103.56 121.28 42.56 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -2.73 10.14 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -105.92 -48.2 3.68 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.148 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.505 ' O ' ' CB ' ' A' ' 52' ' ' THR . 70.4 p -91.95 -20.88 20.92 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.505 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 82.4 17.39 0.36 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 97.4 mttt -72.5 169.81 15.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.68 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 53.4 t -130.05 107.23 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.583 1.153 . . . . 0.0 110.011 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 46' ' ' SER . 69.2 p -119.51 133.44 55.68 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 119.04 0.836 . . . . 0.0 109.831 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' C ' ' OG ' ' A' ' 57' ' ' SER . . . -119.74 -154.36 9.46 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 120.529 -0.844 . . . . 0.0 111.506 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.588 ' CB ' ' HG ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 179.83 165.92 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.517 0.675 . . . . 0.0 111.38 178.598 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.33 116.55 18.48 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.658 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -112.82 114.8 27.51 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.524 HG23 ' CZ ' ' A' ' 41' ' ' PHE . 94.3 m -130.27 108.19 9.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.198 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -125.09 137.87 54.18 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -177.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CE2' ' NE1' ' A' ' 64' ' ' TRP . 3.3 t80 -114.58 112.35 22.79 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' O ' ' N ' ' A' ' 65' ' ' THR . 79.0 mtp85 -114.39 82.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.595 ' C ' ' H ' ' A' ' 66' ' ' GLU . 89.8 m95 -70.28 84.22 0.56 Allowed 'General case' 0 C--N 1.338 0.107 0 N-CA-C 104.111 -2.552 . . . . 0.0 104.111 174.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.438 ' N ' ' O ' ' A' ' 63' ' ' ARG . 23.2 p -60.37 25.19 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' H ' ' C ' ' A' ' 64' ' ' TRP . 79.5 mm-40 -109.42 -76.63 0.61 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -81.7 23.59 0.65 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.4 50.4 47.63 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-O 119.675 -0.514 . . . . 0.0 113.026 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.2 mt -102.1 80.45 1.99 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.022 0.411 . . . . 0.0 111.574 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 99.5 m -81.64 93.47 6.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.686 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.569 ' CE2' HG23 ' A' ' 85' ' ' ILE . 5.9 m-30 -101.35 82.7 2.36 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 177.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.8 m -87.89 136.15 33.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.828 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -129.58 122.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.548 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -122.08 111.18 16.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.505 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' CE2' HD22 ' A' ' 81' ' ' LEU . 4.0 m0 -116.21 134.5 54.85 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -129.1 161.06 30.92 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.159 0.504 . . . . 0.0 110.235 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -62.23 -35.02 77.65 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.23 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 98.5 m-20 -58.2 -10.22 1.86 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 29.7 m-20 97.28 -1.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.148 0.905 . . . . 0.0 112.662 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.4 m -65.59 127.81 33.41 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.197 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' H ' ' HB2' ' A' ' 103' ' ' PHE . 10.4 mt -120.5 121.51 38.61 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.43 119.47 2.92 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 119.834 -1.174 . . . . 0.0 112.403 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.2 p -121.75 121.11 36.52 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.777 0.323 . . . . 0.0 110.233 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -119.59 113.28 20.46 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.707 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.569 HG23 ' CE2' ' A' ' 71' ' ' PHE . 96.7 mt -107.27 110.92 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -125.32 127.97 47.49 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.77 105.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.86 143.08 26.75 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.796 -0.362 . . . . 0.0 111.809 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 59.02 47.79 11.62 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.561 ' HB2' HD23 ' A' ' 95' ' ' LEU . 71.0 mt-30 -55.83 -18.25 8.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 28.1 tp -142.25 41.18 1.63 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.462 1.125 . . . . 0.0 108.978 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 76.63 -13.55 0.91 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 113.994 -1.457 . . . . 0.0 111.585 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.575 ' O ' ' N ' ' A' ' 95' ' ' LEU . 99.1 mtt180 -134.36 174.22 10.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.917 1.341 . . . . 0.0 113.815 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -27.46 66.86 0.0 OUTLIER Glycine 0 CA--C 1.524 0.649 0 CA-C-N 111.327 -2.669 . . . . 0.0 116.165 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 93' ' ' ARG . 29.2 tp -138.89 108.26 6.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' NZ ' ' OG1' ' A' ' 98' ' ' THR . 64.9 tttm -124.81 124.76 42.79 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.296 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 43.5 tp -121.43 104.61 9.81 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.472 ' OG1' ' NZ ' ' A' ' 96' ' ' LYS . 81.4 m -109.28 99.18 8.48 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 -177.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -84.33 123.07 29.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 174.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -118.34 155.51 30.53 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.114 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -140.7 121.93 14.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.403 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.5 108.01 10.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 111.397 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.56 ' HB2' ' H ' ' A' ' 81' ' ' LEU . 25.4 m-85 -96.3 150.97 19.97 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.508 -1.223 . . . . 0.0 109.481 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.534 ' O ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -113.04 153.28 45.35 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' O ' ' O ' ' A' ' 104' ' ' SER . 64.3 Cg_exo -37.37 -124.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 124.399 3.4 . . . . 0.0 114.64 178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -60.26 -35.47 75.6 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.37 -178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.6 p -54.62 -38.53 66.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.868 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.06 20.42 72.83 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -70.56 120.36 16.07 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 110.358 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -98.47 130.63 45.08 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.285 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -116.21 145.17 43.32 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.672 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.03 110.3 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.301 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -115.45 145.95 42.1 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-N 116.186 -0.461 . . . . 0.0 112.177 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.774 HD12 ' CE2' ' A' ' 131' ' ' PHE . 94.2 mt -125.87 107.47 17.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -98.7 124.91 43.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 126' ' ' GLY . 91.0 m -114.63 104.71 12.27 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.75 112.72 3.72 Favored Glycine 0 N--CA 1.441 -0.967 0 O-C-N 123.765 0.666 . . . . 0.0 111.748 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -107.83 110.09 21.79 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HZ1' ' CA ' ' A' ' 5' ' ' PRO . 50.0 mttt -113.48 163.45 14.89 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.421 -175.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 119' ' ' LYS . 55.9 ttp180 168.92 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 123' ' ' ILE . 98.4 mt-10 46.27 98.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 63.0 m80 47.1 -4.7 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 97.1 mt -109.87 113.35 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.688 0.676 . . . . 0.0 112.558 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.593 ' ND2' HG21 ' A' ' 143' ' ' VAL . 0.1 OUTLIER -121.9 121.7 37.72 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.9 mt -121.95 113.99 20.37 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.315 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -114.67 144.73 18.46 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 119.597 1.089 . . . . 0.0 111.705 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.3 t -124.77 103.51 8.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.399 -0.4 . . . . 0.0 110.448 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -97.33 113.02 24.6 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.945 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 79.3 mtm -110.51 141.05 44.18 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -101.34 108.74 20.44 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.518 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.774 ' CE2' HD12 ' A' ' 114' ' ' ILE . 7.2 m-85 -76.28 75.22 3.08 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.339 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -146.48 139.41 25.47 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mm -66.69 -19.46 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.33 -30.73 71.81 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.16 -137.96 9.86 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 105.317 -3.113 . . . . 0.0 105.317 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.6 Cg_exo -57.07 141.18 18.09 Favored 'Cis proline' 0 N--CA 1.51 2.443 0 CA-C-N 121.472 2.636 . . . . 0.0 114.868 -4.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 44.9 m -113.33 137.94 50.76 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 173.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.8 mt -108.87 104.59 17.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.865 0.364 . . . . 0.0 110.685 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.739 ' HE ' ' ND2' ' A' ' 156' ' ' ASN . 99.8 mtt180 -106.35 102.01 11.44 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.822 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -97.58 154.73 20.4 Favored Glycine 0 C--O 1.207 -1.569 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.1 114.98 12.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 117.894 0.847 . . . . 0.0 109.117 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.699 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 10.7 mp -92.47 130.48 38.12 Favored 'General case' 0 C--O 1.205 -1.286 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.593 HG21 ' ND2' ' A' ' 124' ' ' ASN . 39.4 t -124.66 124.51 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 118.866 0.757 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.02 133.55 55.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.484 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -110.87 150.96 17.76 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.088 -1.053 . . . . 0.0 111.51 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.679 ' O ' ' N ' ' A' ' 148' ' ' GLY . 97.1 m-85 -149.0 -160.75 1.22 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.483 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 96.3 mt-10 -48.75 49.67 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 124.765 1.291 . . . . 0.0 113.312 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 146' ' ' TYR . . . 91.37 36.79 6.43 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 3.1 m95 -135.32 136.8 41.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.499 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.436 HD11 ' HE3' ' A' ' 174' ' ' LYS . 98.4 mt -121.51 112.37 18.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.944 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.43 139.28 53.67 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.699 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -136.91 159.02 24.46 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 119.002 -1.571 . . . . 0.0 113.88 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -129.06 121.06 27.08 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.671 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 3.8 tt0 -113.53 119.09 36.34 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.477 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 96.7 mtp -111.68 117.63 33.43 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.43 0.456 . . . . 0.0 111.345 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.739 ' ND2' ' HE ' ' A' ' 139' ' ' ARG . 39.9 t-20 -97.65 114.59 26.58 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -107.86 94.73 5.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.002 -179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' SER . 82.2 tt0 -74.68 98.27 3.39 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 65.8 p -67.61 -31.45 71.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.64 92.33 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.002 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -100.01 -13.04 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 158' ' ' GLU . 3.0 m 54.88 55.16 8.11 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.242 -178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -125.08 133.12 53.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.679 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 47.7 t -104.75 102.03 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 40.3 p -131.53 -59.09 0.97 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.88 0.848 . . . . 0.0 111.112 -177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -67.13 108.29 2.61 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.54 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 33.0 t -142.57 150.32 40.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.101 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.511 ' ND2' ' OH ' ' A' ' 7' ' ' TYR . 68.5 m-20 -128.27 147.81 50.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -112.57 109.02 18.33 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.213 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.64 ' HB2' ' CD2' ' A' ' 7' ' ' TYR . . . -89.56 128.82 36.07 Favored 'General case' 0 C--O 1.219 -0.516 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.243 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.32 110.57 16.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -124.56 147.96 16.65 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-O 121.738 0.632 . . . . 0.0 112.592 -178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 173' ' ' TYR . 4.3 m-85 -124.62 130.35 52.28 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.436 ' HE3' HD11 ' A' ' 150' ' ' LEU . 78.7 mttt -101.62 143.78 31.16 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 178' ' ' PHE . 7.8 m -142.31 137.36 30.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.379 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 178' ' ' PHE . 46.8 t0 -37.14 129.38 0.91 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.329 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 198' ' ' VAL . 66.6 mt-10 69.7 -36.48 0.35 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.573 0.546 . . . . 0.0 112.322 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.875 ' CE1' HG23 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -102.94 129.68 49.75 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -175.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.436 ' N ' ' CD1' ' A' ' 178' ' ' PHE . 7.9 mm-40 -116.24 143.88 44.94 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.373 177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.558 HD23 ' CD1' ' A' ' 173' ' ' TYR . 44.6 tp -111.18 109.16 19.08 Favored 'General case' 0 C--O 1.213 -0.852 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -118.67 105.64 11.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.088 0.243 . . . . 0.0 111.039 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.526 HG22 ' HA2' ' A' ' 192' ' ' GLY . 42.3 p -127.34 156.91 41.24 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -156.04 153.29 29.21 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.41 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.513 HG22 ' HD2' ' A' ' 190' ' ' PHE . 21.8 t -96.19 124.05 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -100.25 107.98 19.94 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.013 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 54.93 28.23 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 124.952 1.407 . . . . 0.0 112.775 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 66.73 8.92 50.19 Favored Glycine 0 N--CA 1.464 0.511 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 68.8 m -115.2 -74.12 0.62 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.42 113.05 24.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.513 ' HD2' HG22 ' A' ' 184' ' ' VAL . 3.4 m-85 -86.37 139.11 31.27 Favored 'General case' 0 C--O 1.243 0.727 0 O-C-N 121.67 -0.644 . . . . 0.0 110.744 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.99 165.09 14.32 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' A' ' 182' ' ' THR . . . -157.77 140.32 6.97 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 4.8 p -149.92 154.76 38.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.572 0.701 . . . . 0.0 112.037 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.875 HG23 ' CE1' ' A' ' 178' ' ' PHE . 73.0 mt -132.1 115.78 27.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.627 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -111.92 114.32 27.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.471 ' NE2' ' OD1' ' A' ' 199' ' ' ASN . 48.6 tt0 -123.31 102.37 7.88 Favored 'General case' 0 CA--C 1.509 -0.633 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.005 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.62 ' O ' HG23 ' A' ' 198' ' ' VAL . 88.2 tttt -101.36 105.33 16.37 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 177.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 197' ' ' LYS . 45.9 t 108.31 64.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 125.144 1.528 . . . . 0.0 112.408 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.471 ' OD1' ' NE2' ' A' ' 196' ' ' GLN . 67.0 t30 -114.87 66.2 0.68 Allowed 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 59.79 71.96 0.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt 65.19 27.85 12.2 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.53 HD11 ' CE1' ' A' ' 225' ' ' TYR . 0.7 OUTLIER -141.57 147.78 38.24 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -119.77 95.01 4.59 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.4 p -121.2 159.99 24.74 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.162 -175.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.558 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -148.82 145.45 27.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.623 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.653 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.5 t -115.57 124.24 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.463 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.5 m-20 -104.92 129.71 53.25 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.58 107.1 10.26 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.79 0.681 . . . . 0.0 111.235 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -122.89 143.93 49.55 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.964 -0.294 . . . . 0.0 110.364 177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.411 ' NE1' ' CD1' ' A' ' 190' ' ' PHE . 19.4 p90 -145.64 -163.27 1.69 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.794 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 214' ' ' ASN . 16.9 m -150.24 116.56 5.72 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.696 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 211' ' ' THR . . . -31.2 113.91 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.463 0.649 . . . . 0.0 112.201 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.52 -0.99 68.59 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.959 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 211' ' ' THR . 55.2 t30 -98.97 107.41 19.84 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 59.1 m -57.75 -34.62 69.73 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -96.15 139.22 32.63 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 92.2 m -103.26 118.11 36.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.625 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -76.04 116.55 16.85 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 176.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 207' ' ' ASN . 24.3 p90 -137.99 141.29 40.46 Favored 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 119.169 -1.012 . . . . 0.0 112.138 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 237' ' ' VAL . . . -116.37 156.19 15.78 Favored Glycine 0 CA--C 1.52 0.402 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.851 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 236' ' ' LYS . 79.7 mt -127.72 103.65 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.699 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.87 52.83 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.155 -178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.46 120.53 28.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.632 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -105.87 99.39 8.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.53 ' CE1' HD11 ' A' ' 202' ' ' LEU . 1.7 t80 -79.78 120.37 23.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 -176.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -113.71 102.38 10.2 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.517 HD13 HG21 ' A' ' 227' ' ' ILE 0.257 1.2 mt -85.49 -57.43 4.34 Favored 'Isoleucine or valine' 0 C--N 1.368 1.398 0 C-N-CA 117.735 -1.586 . . . . 0.0 110.083 -178.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.51 -179.35 0.28 Allowed Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 230' ' ' ASP . 14.8 Cg_exo -64.53 115.31 3.13 Favored 'Trans proline' 0 C--N 1.298 -2.101 0 CA-C-N 121.232 1.476 . . . . 0.0 111.372 -177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 229' ' ' PRO . 0.1 OUTLIER 165.9 -56.76 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 177.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -167.6 129.93 1.6 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.923 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 1.6 m -102.76 153.24 20.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -117.7 108.88 15.95 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 37.0 t -107.65 112.14 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -134.29 155.52 50.05 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.565 ' NZ ' ' O ' ' A' ' 19' ' ' THR . 83.1 mttt -143.77 125.78 15.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.048 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.44 ' O ' ' HA2' ' A' ' 220' ' ' GLY . 58.3 t -107.26 118.16 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.525 179.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.597 ' ND2' ' OG ' ' A' ' 240' ' ' SER . 16.7 p-10 -98.89 165.48 11.74 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.35 4.55 48.55 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.481 -0.888 . . . . 0.0 112.754 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.598 ' OG ' HD13 ' A' ' 242' ' ' LEU . 80.5 p -92.8 7.78 42.26 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.626 ' C ' HD12 ' A' ' 242' ' ' LEU . 1.5 m 85.29 30.78 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 114.01 -1.45 . . . . 0.0 113.432 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 241' ' ' SER . 6.4 mp -114.3 107.96 16.29 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.358 0.526 . . . . 0.0 111.8 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.462 ' O ' HD12 ' A' ' 262' ' ' LEU . 86.8 mt -95.0 131.14 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.322 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -108.65 132.87 11.34 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 83.7 mt -117.69 110.61 18.07 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 124.145 0.556 . . . . 0.0 109.699 178.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -125.25 106.07 0.87 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 119.439 -1.362 . . . . 0.0 113.001 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -97.88 118.89 35.47 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 122.192 -0.593 . . . . 0.0 110.732 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 2.9 m -99.89 131.89 45.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.937 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.47 ' O ' ' OG1' ' A' ' 250' ' ' THR . 83.4 mt-30 -123.55 154.54 39.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.211 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.571 ' O ' ' CB ' ' A' ' 251' ' ' LEU . 78.2 p 54.42 -157.82 0.19 Allowed 'General case' 0 C--O 1.225 -0.191 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.348 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 250' ' ' THR . 20.8 tp 139.23 -79.36 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 O-C-N 124.244 0.965 . . . . 0.0 110.863 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.532 ' N ' ' CD ' ' A' ' 253' ' ' PRO . 0.0 OUTLIER -58.29 -46.18 99.66 Favored Pre-proline 0 CA--C 1.518 -0.276 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 252' ' ' LYS . 99.8 Cg_exo -42.88 -18.55 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.837 1.691 . . . . 0.0 112.182 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 122.94 -26.93 6.04 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.12 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -123.37 142.49 39.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 121.109 0.481 . . . . 0.0 112.243 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 60.5 tttt -116.32 126.87 54.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.023 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 53.6 tp -123.34 101.71 7.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.636 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 97.6 m -119.16 132.04 55.93 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 259' ' ' LEU . 10.5 mp -100.14 144.55 29.04 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.647 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.461 ' HG ' ' H ' ' A' ' 276' ' ' GLY . 10.0 p -138.28 148.45 44.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.178 0.513 . . . . 0.0 111.869 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.34 119.72 2.76 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.81 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 242' ' ' LEU . 48.7 tp -114.67 103.12 10.67 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.2 mt -101.49 124.18 46.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.215 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.511 ' CB ' ' HB2' ' A' ' 270' ' ' ALA . 36.1 t0 -90.83 105.05 17.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 50.93 -102.28 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 125.238 1.399 . . . . 0.0 114.04 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -98.73 6.33 47.02 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.845 -1.677 . . . . 0.0 110.455 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 264' ' ' ASP . 5.7 m120 75.86 -42.28 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.312 -1.313 . . . . 0.0 113.741 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.43 -15.89 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -64.91 -42.93 94.32 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.242 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . 0.511 ' HB2' ' CB ' ' A' ' 264' ' ' ASP . . . -83.11 -34.8 26.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 95.65 -26.0 22.18 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.795 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -112.09 -167.49 17.85 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -140.51 119.18 12.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.059 0.457 . . . . 0.0 111.528 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -90.75 115.15 27.6 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.88 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.639 ' C ' ' H ' ' A' ' 25' ' ' GLY . 81.6 mt -133.83 129.42 36.48 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 176.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.461 ' H ' ' HG ' ' A' ' 260' ' ' SER . . . -147.1 132.14 4.23 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 119.959 -1.115 . . . . 0.0 111.306 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.548 ' HB2' HG23 ' A' ' 27' ' ' ILE . 51.7 mt -117.42 126.01 51.93 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -102.0 115.25 5.18 Favored Glycine 0 CA--C 1.519 0.343 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.33 108.66 16.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -115.99 136.48 52.99 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -120.55 138.09 54.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.148 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -99.36 128.25 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.451 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . 54.54 104.19 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.883 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -65.98 135.93 55.37 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.643 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.065 -0.969 . . . . 0.0 110.812 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.67 142.91 33.37 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.232 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.659 ' O ' HG13 ' A' ' 3' ' ' VAL . 13.0 p -149.42 60.86 4.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.414 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.532 ' O ' ' CB ' ' A' ' 124' ' ' ASN . 2.0 Cg_endo -83.7 153.24 13.36 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.7 2.266 . . . . 0.0 113.737 -178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.442 ' C ' ' ND2' ' A' ' 124' ' ' ASN . 48.2 Cg_endo -71.4 -176.37 1.92 Allowed 'Trans proline' 0 N--CA 1.531 3.718 0 C-N-CA 124.952 3.768 . . . . 0.0 116.725 -178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 5' ' ' PRO . 71.4 p -40.47 132.02 2.14 Favored 'General case' 0 C--N 1.372 1.554 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.72 ' CG ' ' N ' ' A' ' 8' ' ' ALA . 2.0 p90 -38.5 -48.39 1.39 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.72 ' N ' ' CG ' ' A' ' 7' ' ' TYR . . . -60.85 -40.62 93.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 118.14 -1.424 . . . . 0.0 110.507 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.03 -24.76 65.13 Favored 'General case' 0 C--O 1.251 1.162 0 C-N-CA 118.495 -1.282 . . . . 0.0 110.898 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 11' ' ' GLY . 3.0 tt -64.31 121.34 14.06 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.607 ' N ' HD23 ' A' ' 10' ' ' LEU . . . 99.91 15.25 31.68 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.501 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -55.18 -39.66 69.8 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 17' ' ' VAL . 45.9 t -60.2 -45.59 92.64 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.77 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 205' ' ' ALA . . . -60.03 -45.3 93.27 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.099 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -62.03 -42.06 98.76 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -65.56 -37.9 88.01 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 13' ' ' SER . 94.9 t -62.31 -44.0 98.69 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 119.549 -0.86 . . . . 0.0 109.912 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' CB ' ' ND2' ' A' ' 207' ' ' ASN . 78.2 t80 -63.02 -43.63 98.21 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.111 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 97.7 m -95.87 120.46 36.19 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -155.59 111.53 3.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.697 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 22' ' ' TYR . . . -74.07 -127.72 0.15 Allowed Glycine 0 C--N 1.331 0.27 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.512 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 55.5 m-85 28.53 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.804 0.302 . . . . 0.0 111.471 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 24' ' ' PHE . . . 139.63 -142.91 13.18 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.03 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 23' ' ' GLY . 45.9 m-85 20.33 76.76 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' H ' ' C ' ' A' ' 275' ' ' LEU . . . 117.23 -32.11 5.56 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.514 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.68 123.08 45.23 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.295 1.047 . . . . 0.0 113.811 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.586 HG23 ' HB2' ' A' ' 277' ' ' LEU . 96.5 mt -84.42 121.65 36.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.512 ' NZ ' ' CD2' ' A' ' 22' ' ' TYR . 42.7 tttt -113.52 138.43 50.15 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 113.713 -1.585 . . . . 0.0 113.363 -174.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -107.18 118.21 36.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.699 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 31' ' ' LEU . 16.2 t0 -117.66 133.01 56.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.702 0.763 . . . . 0.0 111.803 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.533 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 58.5 mt -110.98 122.42 47.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.189 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 256' ' ' LYS . 99.2 mttt -117.68 139.36 51.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.3 m -132.15 118.54 19.73 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -104.46 130.83 52.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 p -80.75 170.65 16.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -53.25 -45.87 68.97 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.877 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -167.85 145.58 4.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.43 -88.64 0.78 Allowed Glycine 0 CA--C 1.524 0.596 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.642 HD22 ' CE2' ' A' ' 41' ' ' PHE . 37.4 mt -63.55 137.17 58.02 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.349 1.071 . . . . 0.0 113.607 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -138.16 94.05 2.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 112.831 -1.986 . . . . 0.0 108.468 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.642 ' CE2' HD22 ' A' ' 39' ' ' LEU . 56.8 m-85 -99.34 114.11 26.8 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.005 -178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 42' ' ' THR . 2.4 m -123.52 104.96 9.38 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.505 177.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.2 t -91.49 154.89 18.81 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.9 m -133.49 146.47 51.13 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.18 -0.608 . . . . 0.0 112.312 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -146.76 109.44 0.48 Allowed Glycine 0 CA--C 1.522 0.484 0 N-CA-C 107.484 -2.246 . . . . 0.0 107.484 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 55.4 p -134.12 171.88 13.62 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' LYS . . . -135.96 167.13 21.79 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 124.872 1.357 . . . . 0.0 110.082 177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -101.34 127.63 47.88 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.6 p -73.72 -0.8 16.7 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -109.35 -47.64 3.37 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.076 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' CB ' ' A' ' 52' ' ' THR . 64.4 p -90.9 -20.74 21.89 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.502 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.2 OUTLIER 81.09 15.1 0.61 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.01 0.434 . . . . 0.0 110.053 -178.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 95.6 mttt -70.63 170.07 13.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.662 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 46' ' ' SER . 46.4 t -130.06 110.87 20.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.632 1.173 . . . . 0.0 109.768 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 46' ' ' SER . 69.0 p -124.29 133.37 53.49 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 119.004 0.82 . . . . 0.0 110.0 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.71 -154.57 9.51 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.534 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 p -175.52 164.61 3.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.361 0.6 . . . . 0.0 111.314 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.48 HD22 ' CE3' ' A' ' 75' ' ' TRP . 5.5 mp -130.08 107.1 9.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.215 177.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -111.06 117.79 34.28 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.495 ' OG1' ' CE1' ' A' ' 41' ' ' PHE . 45.9 m -130.48 114.72 15.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.306 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -125.16 137.19 54.15 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.708 -0.62 . . . . 0.0 111.943 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.507 ' CE1' ' NE1' ' A' ' 64' ' ' TRP . 1.9 t80 -120.83 97.59 5.61 Favored 'General case' 0 C--N 1.345 0.403 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -107.91 91.38 3.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.507 ' NE1' ' CE1' ' A' ' 62' ' ' TYR . 65.9 m95 -71.86 85.75 0.96 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 174.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 65' ' ' THR . 86.0 m -57.5 -1.99 0.11 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.485 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' TRP . 81.5 tt0 -83.16 -77.24 0.25 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.121 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -76.84 23.09 0.17 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.7 51.72 42.7 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.447 -0.641 . . . . 0.0 113.019 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.621 ' CD2' HG12 ' A' ' 87' ' ' VAL . 36.0 mt -105.02 95.83 6.12 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 117.229 0.515 . . . . 0.0 112.292 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' GLU . 22.7 m -89.86 88.97 7.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.305 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.642 ' CE2' HG23 ' A' ' 85' ' ' ILE . 3.8 m-85 -102.13 77.75 1.71 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.6 m -87.76 141.37 28.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.639 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.6 t -130.0 123.61 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.753 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.635 ' NZ ' ' ND2' ' A' ' 76' ' ' ASN . 65.0 tttm -123.87 108.64 12.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.644 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.48 ' CE3' HD22 ' A' ' 58' ' ' LEU . 10.2 t90 -120.81 100.72 7.26 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.316 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.635 ' ND2' ' NZ ' ' A' ' 74' ' ' LYS . 88.5 m-20 -92.94 162.64 13.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.015 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 79' ' ' ASN . 43.9 p -63.9 -35.32 80.26 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.438 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 79' ' ' ASN . 49.1 p-10 -56.96 -10.04 0.99 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 78' ' ' ASP . 43.7 m-20 101.93 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.488 1.118 . . . . 0.0 112.69 178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.3 m -64.47 123.28 18.81 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 119.394 -0.922 . . . . 0.0 109.959 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 60.7 mt -120.43 109.28 15.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -129.81 128.54 5.71 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.896 -179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.2 m -125.42 126.18 44.56 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.073 0.463 . . . . 0.0 110.143 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' THR . 96.6 mt-10 -119.56 124.07 45.5 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.096 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.642 HG23 ' CE2' ' A' ' 71' ' ' PHE . 89.4 mt -116.31 111.5 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.0 m -124.66 128.89 49.53 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.621 HG12 ' CD2' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -114.03 102.9 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 176.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -95.19 141.94 28.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.76 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 59.66 48.43 9.4 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.651 ' HB2' HD23 ' A' ' 95' ' ' LEU . 78.5 mt-30 -59.17 -11.41 3.78 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -178.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 92' ' ' ALA . 30.0 tp -150.91 40.07 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 122.428 1.109 . . . . 0.0 109.223 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 91' ' ' LEU . . . 74.33 1.76 3.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.455 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 95' ' ' LEU . 32.5 ptt-85 -144.54 171.11 14.82 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 118.719 -1.192 . . . . 0.0 113.787 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -31.77 64.42 0.0 OUTLIER Glycine 0 CA--C 1.522 0.484 0 CA-C-N 111.74 -2.482 . . . . 0.0 115.744 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.651 HD23 ' HB2' ' A' ' 90' ' ' GLN . 27.2 tp -134.13 104.82 6.38 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -124.76 122.3 37.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.99 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' CD1' ' OG1' ' A' ' 116' ' ' THR . 17.2 tp -121.39 110.4 16.05 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.2 m -111.31 99.53 8.32 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 115.124 1.528 . . . . 0.0 115.124 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -82.28 133.83 35.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.8 149.12 48.86 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.356 -176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 26.4 t -137.95 114.49 10.41 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.256 0.973 . . . . 0.0 111.392 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.69 102.51 9.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.465 0.65 . . . . 0.0 109.257 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' NZ ' ' A' ' 110' ' ' LYS . 5.2 m-85 -114.26 108.72 17.31 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.034 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.55 87.62 55.48 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.81 -28.76 0.38 Allowed 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 123.05 2.5 . . . . 0.0 114.586 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 108' ' ' GLY . 56.3 t30 -86.97 105.46 17.14 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.427 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 p 43.09 14.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 106' ' ' ASN . . . -98.82 177.0 30.15 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -139.6 150.16 44.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.725 0.298 . . . . 0.0 110.475 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' NZ ' ' CD1' ' A' ' 103' ' ' PHE . 67.6 mttm -69.02 122.96 19.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.795 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -120.95 130.57 53.9 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.184 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.5 114.74 17.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -121.01 145.63 47.55 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.56 110.74 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -103.1 124.74 49.13 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.432 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 67.8 m -117.8 106.76 13.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.7 96.79 1.61 Allowed Glycine 0 N--CA 1.444 -0.767 0 O-C-N 123.918 0.761 . . . . 0.0 111.456 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 94.5 t80 -93.04 122.84 35.81 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -138.65 160.58 39.27 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.757 -175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -156.47 -96.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.647 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 123' ' ' ILE . 82.8 tt0 -107.73 117.43 34.1 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 55.24 -11.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.512 ' H ' ' C ' ' A' ' 121' ' ' GLU . 96.9 mt -116.47 124.71 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -122.18 127.73 50.38 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.011 175.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.7 mt -123.15 116.45 23.46 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.515 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 116' ' ' THR . . . -115.24 141.49 17.03 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 119.774 1.17 . . . . 0.0 110.918 178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 9.0 t -125.18 102.5 7.5 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 120.454 0.169 . . . . 0.0 110.743 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -95.38 110.6 22.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.804 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 97.9 mtp -106.57 106.22 16.63 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.442 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -93.55 111.93 23.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.772 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -86.19 85.96 7.35 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 110.522 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 135' ' ' GLY . 46.3 t0 -117.38 168.34 10.44 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.8 mt -62.11 -41.06 89.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 119.996 -0.681 . . . . 0.0 110.008 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.86 3.09 39.56 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -100.36 -177.44 30.1 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 105.886 -2.886 . . . . 0.0 105.886 176.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 159' ' ' THR . 60.7 Cg_exo -54.86 131.39 3.38 Favored 'Cis proline' 0 N--CA 1.51 2.444 0 CA-C-N 121.905 2.853 . . . . 0.0 115.254 -0.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 65.4 m -113.48 133.77 55.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 173.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' MET . 84.7 mt -108.47 102.72 14.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.203 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.603 ' NH1' ' ND2' ' A' ' 156' ' ' ASN . 93.3 mtt-85 -103.77 101.64 11.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.626 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.632 ' O ' ' HA ' ' A' ' 154' ' ' GLN . . . -98.03 158.4 20.67 Favored Glycine 0 C--O 1.213 -1.201 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -135.93 112.59 10.1 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.746 ' O ' ' HA2' ' A' ' 152' ' ' GLY . 90.8 mt -92.59 127.16 37.98 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.51 124.08 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.7 137.73 54.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.027 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 149' ' ' TRP . . . -109.16 151.51 17.15 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 120.274 -0.965 . . . . 0.0 111.518 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.63 ' O ' ' CD1' ' A' ' 149' ' ' TRP . 2.0 m-85 -150.46 77.7 1.3 Allowed 'General case' 0 C--O 1.209 -1.073 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 58.48 34.9 24.31 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 118.54 -13.35 12.04 Favored Glycine 0 N--CA 1.458 0.142 0 N-CA-C 111.234 -0.747 . . . . 0.0 111.234 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 149' ' ' TRP . 1.6 m95 -93.97 127.35 39.7 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.37 116.08 24.13 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -121.1 146.98 46.17 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.746 ' HA2' ' O ' ' A' ' 142' ' ' LEU . . . -134.78 156.91 22.73 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 118.911 -1.614 . . . . 0.0 113.68 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -128.92 121.67 28.59 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.632 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 46.2 tt0 -110.95 118.85 37.21 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.163 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.414 ' O ' ' O ' ' A' ' 138' ' ' ILE . 77.1 mtm -111.1 114.41 27.66 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.603 0.564 . . . . 0.0 112.26 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.603 ' ND2' ' NH1' ' A' ' 139' ' ' ARG . 41.0 t30 -94.43 104.69 16.66 Favored 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.461 ' CE1' ' CG2' ' A' ' 164' ' ' VAL . 0.1 OUTLIER -98.35 95.5 7.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.078 -179.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 162' ' ' SER . 98.0 mt-10 -76.66 108.61 9.79 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 136' ' ' PRO . 28.8 p -66.02 -33.57 76.1 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.64 94.4 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.528 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.33 -10.26 28.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.57 ' N ' ' O ' ' A' ' 158' ' ' GLU . 4.3 m 44.51 49.13 8.4 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.546 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -136.03 148.02 48.19 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.21 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.461 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 62.0 t -104.79 101.67 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 166' ' ' GLN . 67.7 p -109.99 -56.33 2.34 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.285 1.04 . . . . 0.0 110.187 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.406 ' N ' ' OG1' ' A' ' 165' ' ' THR . 83.4 mt-30 -82.98 111.05 18.48 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.141 -1.845 . . . . 0.0 111.77 -178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 154' ' ' GLN . 73.5 m -140.49 151.64 44.98 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.779 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 183' ' ' ASN . 46.5 m-20 -128.54 148.97 50.79 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -109.02 112.74 25.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.607 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.572 ' HB2' ' CD1' ' A' ' 7' ' ' TYR . . . -91.41 135.72 33.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.074 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.05 127.26 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 180' ' ' LEU . . . -134.97 129.52 5.15 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.507 -176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -125.47 123.85 40.12 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -102.12 146.84 27.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.407 1.099 . . . . 0.0 113.466 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 177' ' ' GLU . 16.9 m -134.86 140.88 46.15 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.107 -1.861 . . . . 0.0 106.167 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.6 t0 -41.18 -13.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -177.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 175' ' ' THR . 96.0 mt-10 -135.82 -40.92 0.68 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.415 ' H ' ' HB ' ' A' ' 175' ' ' THR . 0.7 OUTLIER -105.06 139.35 39.87 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 194' ' ' ILE . 43.3 mt-30 -116.62 138.73 51.21 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.982 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.506 ' O ' ' HA2' ' A' ' 172' ' ' GLY . 0.2 OUTLIER -110.17 102.07 10.79 Favored 'General case' 0 C--O 1.213 -0.85 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 177.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.549 ' CE1' HD22 ' A' ' 10' ' ' LEU . 87.7 m-70 -116.1 107.33 14.79 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.906 0.384 . . . . 0.0 111.949 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . 0.468 HG23 ' CD1' ' A' ' 180' ' ' LEU . 74.2 p -121.91 152.63 39.43 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.566 ' ND2' ' CE1' ' A' ' 7' ' ' TYR . 27.9 t-20 -137.28 135.18 36.91 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.228 0.922 . . . . 0.0 109.37 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.617 HG13 ' CE1' ' A' ' 190' ' ' PHE . 3.6 t -95.35 120.83 45.29 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.76 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -96.47 110.96 23.24 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.744 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 51.97 30.46 7.35 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 125.538 1.774 . . . . 0.0 113.398 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 65.59 16.23 62.93 Favored Glycine 0 N--CA 1.463 0.451 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 7.7 m -120.13 -75.59 0.59 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -103.92 121.04 42.28 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.617 ' CE1' HG13 ' A' ' 184' ' ' VAL . 7.9 m-85 -89.03 153.91 20.63 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-O 120.717 0.294 . . . . 0.0 110.876 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.92 144.84 5.27 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.247 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.69 -169.2 40.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 78.4 p -127.17 172.16 10.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.957 0.884 . . . . 0.0 112.623 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' A' ' 206' ' ' VAL . 58.8 mt -131.76 120.7 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -92.63 120.13 32.75 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.475 ' OE1' ' OG1' ' A' ' 204' ' ' THR . 39.8 tt0 -123.43 110.17 14.77 Favored 'General case' 0 N--CA 1.461 0.102 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -96.33 97.76 9.74 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.445 HG11 HD23 ' A' ' 202' ' ' LEU . 80.1 t -74.46 -43.95 48.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.336 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 202' ' ' LEU . 27.7 p30 -157.76 -171.45 3.55 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.0 -41.75 98.4 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.475 -0.49 . . . . 0.0 112.225 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -96.84 -7.63 33.05 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 199' ' ' ASN . 53.0 tp -120.98 113.72 20.49 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.033 1.124 . . . . 0.0 114.033 -176.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -118.92 113.91 21.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.035 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.527 HG22 ' HA ' ' A' ' 223' ' ' ALA . 15.4 p -121.21 160.35 24.02 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.784 -0.572 . . . . 0.0 110.499 -177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -141.92 136.47 30.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.873 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' A' ' 194' ' ' ILE . 2.7 t -108.51 128.31 64.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.515 ' ND2' ' CB ' ' A' ' 18' ' ' PHE . 99.8 m-20 -106.39 130.41 54.21 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 52.0 mt -117.33 111.43 19.35 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.975 0.797 . . . . 0.0 111.02 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -123.07 128.51 50.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.521 0.201 . . . . 0.0 110.92 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 12.6 p90 -146.86 -170.61 3.57 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.132 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 40.2 p -142.35 115.84 9.07 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.226 -177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . 45.02 46.49 9.29 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.37 25.8 42.29 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 114.452 -1.249 . . . . 0.0 114.338 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 215' ' ' SER . 59.6 t-20 -59.18 149.29 28.68 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.41 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 78.0 p -59.71 -32.94 70.99 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -85.19 107.99 17.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 112.833 -178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 67.2 m -103.44 116.2 31.96 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.522 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.48 113.69 14.36 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -134.97 144.37 47.36 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 119.327 -0.949 . . . . 0.0 111.51 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 238' ' ' ASN . . . -116.29 155.62 16.13 Favored Glycine 0 C--N 1.334 0.469 0 O-C-N 125.333 1.645 . . . . 0.0 112.128 -178.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 94.8 mt -126.09 103.35 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -100.44 120.44 39.98 Favored 'General case' 0 CA--C 1.51 -0.589 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.864 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 204' ' ' THR . . . -114.96 121.42 43.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.365 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.17 98.46 8.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 227' ' ' ILE . 57.2 t80 -100.9 96.38 7.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.275 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -72.66 115.11 11.54 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 225' ' ' TYR 0.303 2.3 mt -82.83 -57.34 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.471 0 CA-C-O 123.15 1.452 . . . . 0.0 110.632 -178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . 0.41 ' CB ' ' CD ' ' A' ' 229' ' ' PRO . 0.0 OUTLIER -139.32 -178.29 0.82 Allowed Pre-proline 0 C--N 1.35 0.597 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 178.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 228' ' ' ASP . 10.3 Cg_exo -66.12 -16.69 53.05 Favored 'Trans proline' 0 C--N 1.292 -2.424 0 C-N-CA 120.912 1.074 . . . . 0.0 112.607 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 231' ' ' ALA . 41.8 p-10 -68.71 -39.06 80.62 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 230' ' ' ASP . . . -165.2 173.65 11.1 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 119.285 -0.966 . . . . 0.0 113.294 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . 0.478 ' SG ' ' C ' ' A' ' 225' ' ' TYR . 49.6 t -142.11 134.14 27.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.596 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -86.92 111.82 21.18 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.773 0.32 . . . . 0.0 111.486 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 9.2 t -107.72 102.22 11.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.138 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ALA . . . . . . . . . . . . . . . -116.26 154.67 29.72 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.893 -0.323 . . . . 0.0 110.222 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -138.28 119.77 14.93 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 60.7 t -105.78 116.42 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 119.179 -0.438 . . . . 0.0 110.417 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.599 HD21 ' CG ' ' A' ' 242' ' ' LEU . 16.6 p-10 -98.04 168.14 10.46 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.772 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -89.92 5.87 44.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.667 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.577 ' OG ' ' ND2' ' A' ' 238' ' ' ASN . 68.9 p -102.17 21.83 14.24 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.81 24.13 2.74 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.711 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.599 ' CG ' HD21 ' A' ' 238' ' ' ASN . 12.8 mt -106.51 109.45 21.37 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.751 0.705 . . . . 0.0 111.195 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 94.8 mt -113.35 137.24 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.125 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . -127.44 155.17 19.88 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.557 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 70.0 mt -126.94 118.09 23.84 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . -121.19 106.08 1.09 Allowed Glycine 0 CA--C 1.537 1.459 0 C-N-CA 119.451 -1.357 . . . . 0.0 112.682 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -90.05 99.98 12.89 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.208 -0.583 . . . . 0.0 109.857 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' THR . . . . . . . . . . . . . 46.2 m -95.63 117.49 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.05 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -102.87 125.02 49.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.181 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.473 HG23 ' HE2' ' A' ' 256' ' ' LYS . 85.5 m -128.84 86.68 2.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.541 ' CG ' ' H ' ' A' ' 252' ' ' LYS . 0.8 OUTLIER -175.62 -145.71 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.962 -178.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . 0.721 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER 56.25 161.02 0.07 OUTLIER Pre-proline 0 C--O 1.222 -0.367 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -41.69 72.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -2.005 0 C-N-CA 122.032 1.822 . . . . 0.0 113.103 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.721 ' N ' ' O ' ' A' ' 252' ' ' LYS . . . 60.23 43.14 98.77 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.97 -0.35 . . . . 0.0 112.815 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 94.3 mt -123.12 132.01 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 CA-C-N 117.469 0.634 . . . . 0.0 112.594 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.582 ' NZ ' ' NZ ' ' A' ' 32' ' ' LYS . 99.1 mttt -114.64 119.61 37.32 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.727 178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.8 mt -123.49 111.77 16.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.882 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 31.8 m -116.48 134.83 54.4 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.281 -0.887 . . . . 0.0 112.373 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.53 141.66 41.68 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 276' ' ' GLY . 8.2 p -133.17 138.02 46.43 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 111.805 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -147.25 107.9 4.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.194 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.77 103.31 12.1 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 86.2 mt -100.5 123.11 44.29 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.039 0.447 . . . . 0.0 111.251 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.476 ' OD2' ' CD2' ' A' ' 242' ' ' LEU . 26.5 t0 -86.87 111.07 20.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -58.41 -43.16 95.93 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 114.414 -1.266 . . . . 0.0 112.222 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 268' ' ' VAL . 83.4 mttt -84.1 -9.72 58.38 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 118.917 1.359 . . . . 0.0 109.227 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . 0.461 ' H ' ' CG ' ' A' ' 264' ' ' ASP . 66.5 t30 58.3 -26.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.492 ' N ' ' O ' ' A' ' 266' ' ' LYS . 60.0 t -73.45 -36.84 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 118.842 0.747 . . . . 0.0 110.069 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ASN . . . . . . . . . . . . . 48.9 m-20 -62.96 -44.34 96.31 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.999 -0.68 . . . . 0.0 112.344 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -86.14 -35.68 20.02 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.209 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 73.02 -7.13 10.35 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.378 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLY . . . . . . . . . . . . . . . -149.75 -137.39 2.75 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.78 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -140.85 120.07 12.95 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.994 0.426 . . . . 0.0 111.401 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.64 120.88 26.88 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.509 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.638 ' C ' ' H ' ' A' ' 25' ' ' GLY . 94.0 mt -134.01 125.48 28.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.499 ' N ' ' OG ' ' A' ' 260' ' ' SER . . . -145.99 125.84 2.38 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 119.981 -1.105 . . . . 0.0 111.186 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 27' ' ' ILE . 32.4 mt -118.81 124.1 46.38 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -108.04 115.04 4.35 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 5.6 mp -110.14 106.29 15.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.4 127.45 54.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.129 0.49 . . . . 0.0 110.282 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -110.71 138.18 47.43 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.314 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -104.21 124.67 49.54 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.179 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.54 143.46 57.62 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -66.71 133.26 49.84 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.51 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.442 179.988 . . . . . . . . 1 1 . 1 stop_ save_